data_1yws_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1yws _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.645 ' HB ' ' HB2' ' A' ' 55' ' ' ASP . 5.1 p . . . . . 0 N--CA 1.45 -0.47 0 CA-C-O 121.251 0.548 . . . . 0.0 111.615 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -103.06 -16.83 15.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.478 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -102.1 138.35 39.16 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -137.72 114.94 10.95 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -175.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.631 HD11 HD11 ' A' ' 54' ' ' ILE . 4.3 mp -111.36 138.75 38.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.889 0.376 . . . . 0.0 110.235 -176.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.534 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 31.6 mt-10 -66.69 141.6 57.71 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.156 175.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.1 tt -57.07 -28.33 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.995 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -68.14 -28.76 67.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.355 -0.384 . . . . 0.0 112.014 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -82.2 -38.77 24.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.91 0.386 . . . . 0.0 109.995 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 81.1 mmm -53.33 127.07 23.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.496 170.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.3 m -79.1 123.24 27.16 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.659 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 35.7 p90 -94.65 134.47 37.2 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.636 -176.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -107.24 94.26 10.93 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.559 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.9 -27.99 86.16 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.113 2.542 . . . . 0.0 112.763 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -73.74 -27.52 61.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.969 0.414 . . . . 0.0 110.329 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -96.91 -10.08 27.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.895 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 62.66 36.66 13.36 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.833 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -151.78 169.23 22.74 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.456 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.659 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 30.0 m-85 -110.05 140.68 43.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.267 175.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 79.7 p -127.96 163.54 24.28 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.037 0.446 . . . . 0.0 110.759 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -134.8 126.7 18.06 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.31 115.3 1.98 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 123.18 2.587 . . . . 0.0 113.254 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.481 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 41.9 t -128.67 137.37 30.79 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.866 177.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 9.0 Cg_endo -90.3 120.14 0.8 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.487 2.125 . . . . 0.0 111.369 172.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 28.7 p 175.54 -43.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.41 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 160.15 -23.38 0.27 Allowed Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.51 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.423 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 2.8 t0 -142.49 175.71 9.58 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.523 ' HG3' HH11 ' A' ' 30' ' ' ARG . 9.3 ptt85 -113.26 152.96 29.16 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 122.799 0.439 . . . . 0.0 110.706 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' A' ' 22' ' ' THR . 86.7 m-85 -55.4 136.26 49.6 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.334 0.397 . . . . 0.0 110.227 176.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -128.83 124.1 34.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.093 0.473 . . . . 0.0 111.524 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.477 ' HB ' ' HB3' ' A' ' 45' ' ' ALA . 12.0 tt -127.46 127.1 68.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.661 174.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.525 ' O ' ' HG3' ' A' ' 38' ' ' MET . 36.7 m-85 -93.96 131.07 39.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.001 -172.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.27 -31.63 69.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.187 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -54.28 -47.2 72.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.12 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -83.37 -24.53 31.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.271 -176.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.585 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 93.9 mtp -65.1 -38.76 91.76 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.66 174.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -65.61 -29.43 70.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.225 175.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -71.15 -12.32 61.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.214 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.44 -6.86 36.45 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.623 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.585 ' O ' ' HA ' ' A' ' 38' ' ' MET . 9.2 tp10 -94.86 138.39 32.69 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.639 ' HD2' ' HE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -138.71 101.51 4.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 122.103 0.954 . . . . 0.0 111.553 -179.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.3 p -165.23 130.87 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.735 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.487 ' HB2' HD13 ' A' ' 54' ' ' ILE . . . -100.51 131.07 46.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.717 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.76 139.44 34.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.752 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 51' ' ' SER . 18.5 t -108.27 134.45 20.19 Favored Pre-proline 0 N--CA 1.436 -1.129 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.006 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.536 ' O ' ' HB2' ' A' ' 49' ' ' SER . 47.1 Cg_endo -83.0 157.18 15.34 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.16 2.573 . . . . 0.0 111.848 175.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.536 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 75.4 m 84.73 -55.8 0.1 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.889 0.876 . . . . 0.0 110.772 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.2 p -87.67 -33.06 18.92 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 174.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 47' ' ' CYS . 59.3 m 67.42 64.07 0.42 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.613 177.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.454 ' HB3' ' HE1' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -114.54 154.62 27.95 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.277 176.068 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.42 ' HE2' ' HB2' ' A' ' 53' ' ' MET . 41.1 mtm -132.52 137.09 47.03 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.446 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.631 HD11 HD11 ' A' ' 7' ' ' ILE . 2.8 pp -143.68 148.16 19.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.471 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.645 ' HB2' ' HB ' ' A' ' 3' ' ' THR . 4.7 t70 -85.15 152.95 22.99 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -175.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.2 t -134.12 117.79 26.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.54 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.534 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 26.9 t -71.35 108.14 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.605 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.639 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 25.8 p90 -109.77 164.86 12.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.618 0.247 . . . . 0.0 110.407 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.618 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 5.7 t70 -134.09 160.31 38.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.111 0.482 . . . . 0.0 110.647 175.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -62.54 -44.58 96.01 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.755 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -69.39 -35.58 75.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.801 -176.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -67.91 -44.04 77.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.174 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 81.6 mt -59.34 -49.23 78.63 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.183 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.57 -41.63 95.01 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.236 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -66.67 -45.92 77.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.295 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.511 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 84.1 t80 -67.57 -35.7 79.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.082 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.8 -41.31 67.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 110.442 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -70.14 -38.77 75.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.088 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -70.15 -45.89 65.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.3 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.9 -15.48 63.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.197 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.783 0 C-N-CA 120.823 -0.704 . . . . 0.0 111.593 178.527 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.448 -0.57 0 CA-C-O 121.023 0.44 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -83.53 1.42 42.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.157 -177.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -146.0 163.98 33.51 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.555 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 34.6 tt0 -156.96 108.81 2.42 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -176.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 mp -116.16 145.45 21.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.281 -173.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.564 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 44.4 mt-10 -63.33 138.26 58.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 173.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.1 tt -51.51 -29.38 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.715 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -60.19 -34.06 73.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.218 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -81.33 -28.77 34.4 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.52 -172.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.561 ' HA ' ' HD1' ' A' ' 23' ' ' TYR . 84.2 mtp -66.3 156.41 34.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.139 0.495 . . . . 0.0 110.967 176.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.7 m -93.39 110.36 21.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.35 0.595 . . . . 0.0 110.207 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.547 ' HD2' ' HD3' ' A' ' 16' ' ' PRO . 38.8 p90 -74.86 140.08 43.62 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.894 -177.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -124.14 89.06 52.22 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 121.229 0.537 . . . . 0.0 109.943 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.547 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 26.4 Cg_endo -62.23 -26.26 77.4 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.369 2.713 . . . . 0.0 112.747 -173.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -69.34 -21.34 63.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.504 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -116.24 7.94 14.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.839 0.352 . . . . 0.0 110.698 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 57.39 43.1 23.76 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.751 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -154.0 171.72 18.6 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.451 -0.499 . . . . 0.0 111.403 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.518 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 57.6 m-85 -112.86 141.93 46.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.412 176.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 17.2 p -133.63 135.4 44.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.993 0.425 . . . . 0.0 111.107 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.561 ' HD1' ' HA ' ' A' ' 12' ' ' MET . 7.6 t80 -106.36 117.47 57.11 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -56.38 113.37 1.42 Allowed 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.028 2.486 . . . . 0.0 113.717 -173.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 12.2 t -126.86 132.14 24.19 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.65 175.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 2.1 Cg_endo -86.08 118.16 1.68 Allowed 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 121.802 1.668 . . . . 0.0 111.582 174.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 29.3 p -177.09 -46.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.414 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 169.29 -27.46 0.13 Allowed Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.367 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.462 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 3.5 t70 -142.02 175.09 10.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -123.26 147.82 46.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.639 0.2 . . . . 0.0 110.619 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 22' ' ' THR . 96.7 m-85 -46.51 111.35 0.37 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.597 0.561 . . . . 0.0 111.221 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -111.37 135.39 51.99 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.089 0.471 . . . . 0.0 111.073 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.44 ' HB ' ' HB2' ' A' ' 45' ' ' ALA . 16.9 tt -132.62 136.7 55.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.754 177.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.532 ' O ' ' HG3' ' A' ' 38' ' ' MET . 30.0 m-85 -95.02 126.37 40.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.369 -174.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.405 ' O ' HD11 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -55.3 -34.73 64.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.123 0.487 . . . . 0.0 110.625 -178.12 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -57.3 -48.74 78.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.414 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -70.78 -32.16 69.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.909 -178.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.532 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 81.2 mtp -61.18 -43.67 98.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.307 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -66.64 -31.15 71.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.192 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -72.37 -14.23 61.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.427 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.74 0.78 36.74 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.632 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -99.54 93.89 6.11 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.515 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -106.19 101.06 10.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 122.001 0.905 . . . . 0.0 111.265 -176.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 p -166.55 131.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.839 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.44 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -100.39 138.93 36.79 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.323 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.07 139.22 43.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.17 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.564 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 7.0 t -110.6 116.02 53.02 Favored Pre-proline 0 C--N 1.313 -0.989 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.133 176.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.496 ' O ' ' HB3' ' A' ' 49' ' ' SER . 35.1 Cg_endo -71.59 157.14 56.65 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.373 2.049 . . . . 0.0 111.192 172.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 46.2 t 89.93 -59.36 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.045 0.938 . . . . 0.0 110.322 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.9 p -89.46 -29.19 19.18 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.677 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 t 69.01 74.53 0.25 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.621 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.439 HD21 ' HZ ' ' A' ' 31' ' ' PHE . 53.9 tp -138.68 152.02 47.68 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.6 mtm -133.44 137.94 45.98 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.587 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.56 153.5 28.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.155 178.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.555 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 3.8 t70 -80.05 151.81 29.72 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.23 115.59 26.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.976 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.564 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 42.5 t -70.12 118.07 14.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.509 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.405 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 19.8 p90 -122.78 159.96 26.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.571 -177.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.485 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.8 t70 -131.35 167.44 19.25 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.413 ' HB2' ' HE2' ' A' ' 60' ' ' LYS . 23.2 mtmm -63.05 -45.32 92.81 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.342 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -68.69 -40.31 80.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.038 -1.437 . . . . 0.0 111.14 -175.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.47 -42.11 99.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.761 0.315 . . . . 0.0 110.994 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 75.9 mt -63.83 -46.28 85.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.241 177.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.544 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . . . -57.38 -47.21 82.27 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.38 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.18 -46.38 79.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.06 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -67.83 -36.05 79.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.641 -176.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.544 ' HD2' ' HA ' ' A' ' 64' ' ' ALA . 26.3 m-85 -53.49 -48.6 68.78 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.007 0.432 . . . . 0.0 110.378 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -67.52 -43.02 81.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.402 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -74.65 -29.71 61.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -174.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.88 -21.41 26.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.617 0.246 . . . . 0.0 111.103 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.893 -179.325 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.448 -0.547 0 CA-C-O 121.348 0.594 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -80.13 -35.09 37.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.241 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -114.85 159.2 20.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.362 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.543 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 34.9 tt0 -143.11 110.73 5.85 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.39 139.45 43.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.251 -170.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.562 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 39.0 mt-10 -58.2 135.52 57.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.062 0.458 . . . . 0.0 110.34 173.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.411 ' CG2' ' HA ' ' A' ' 58' ' ' PHE . 15.5 tt -54.54 -29.45 20.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.771 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.9 -27.94 68.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.967 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -83.93 -39.91 19.19 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.464 -175.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 83.0 mtp -60.84 142.78 55.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.708 0.29 . . . . 0.0 111.021 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.0 m -79.69 124.68 28.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.973 -176.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.48 ' HB2' ' HE1' ' A' ' 66' ' ' TYR . 39.2 p90 -84.27 141.65 30.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.099 0.476 . . . . 0.0 111.783 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -125.7 92.05 47.26 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 173.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.62 -26.38 53.88 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 123.094 2.529 . . . . 0.0 113.253 -172.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -69.57 -28.93 66.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.007 0.432 . . . . 0.0 110.918 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -107.41 4.54 26.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.838 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 58.56 37.93 25.4 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.993 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -143.12 171.46 14.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.292 0.568 . . . . 0.0 111.841 -174.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.461 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 41.8 m-85 -116.0 148.18 40.41 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.392 173.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 41.5 p -136.27 167.24 21.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.894 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.446 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 84.3 t80 -144.08 118.07 5.9 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -56.97 109.83 0.51 Allowed 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.201 2.601 . . . . 0.0 113.19 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.1 t -127.22 131.3 23.78 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.712 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 5.2 Cg_exo -80.2 119.42 3.85 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.951 1.768 . . . . 0.0 111.472 176.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.448 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 30.6 p -179.4 -52.72 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.448 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 174.44 -28.57 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.215 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.588 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 1.2 t70 -142.8 175.93 9.44 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -115.71 154.87 28.78 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.582 ' O ' ' HA ' ' A' ' 22' ' ' THR . 80.4 m-85 -50.29 134.75 22.61 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.519 0.512 . . . . 0.0 110.61 178.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -131.77 133.29 44.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.168 0.509 . . . . 0.0 111.066 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tt -151.28 126.11 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.009 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -87.29 138.16 31.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.79 0.329 . . . . 0.0 110.895 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.591 ' HG ' ' HD2' ' A' ' 66' ' ' TYR . 1.2 tm? -64.19 -31.73 73.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.018 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -61.92 -29.92 70.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.792 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 1.1 m-20 -82.17 -32.63 29.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.419 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.549 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 84.6 mtp -67.6 -34.12 76.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.145 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -64.64 -24.44 67.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.398 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 52.2 mt-10 -76.93 -12.21 59.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.025 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.91 -11.49 41.26 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.402 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 38' ' ' MET . 9.3 tp10 -89.41 133.77 34.38 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -142.08 100.13 3.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.115 0.96 . . . . 0.0 111.503 -177.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.4 p -167.27 127.7 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.424 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.511 ' HB3' HD12 ' A' ' 54' ' ' ILE . . . -100.73 141.55 33.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.106 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.6 137.42 51.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.687 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.0 t -99.68 111.88 62.53 Favored Pre-proline 0 N--CA 1.431 -1.408 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.588 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 14.7 Cg_endo -62.6 156.6 51.57 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.935 1.757 . . . . 0.0 110.794 174.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 37.4 m 85.5 -55.75 0.08 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.197 0.999 . . . . 0.0 111.192 -176.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.406 ' SG ' ' HB2' ' A' ' 52' ' ' LEU . 16.6 p -98.13 -17.09 19.24 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.836 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.8 t 70.23 29.77 3.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.423 0.689 . . . . 0.0 111.975 172.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.425 HD11 ' HZ ' ' A' ' 31' ' ' PHE . 1.6 tt -86.56 130.57 34.44 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -174.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.4 mtm -115.35 137.39 52.09 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.85 -176.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 45' ' ' ALA . 2.8 pp -141.88 144.21 25.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.543 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 4.9 t0 -84.27 156.06 22.15 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.73 125.32 55.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.045 0.45 . . . . 0.0 112.068 -174.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.562 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 21.8 t -88.86 100.03 10.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.411 ' HA ' ' CG2' ' A' ' 9' ' ' ILE . 50.6 p90 -94.52 160.3 14.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.843 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.568 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 27.3 t70 -116.14 151.65 35.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.857 0.36 . . . . 0.0 110.515 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.44 ' HE2' ' HB2' ' A' ' 60' ' ' LYS . 22.2 mtmm -58.56 -46.36 87.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.14 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -81.09 -32.19 34.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.346 -174.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.4 ' CB ' ' HB3' ' A' ' 59' ' ' ASP . 15.9 t70 -64.44 -43.66 93.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.324 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 54.4 mt -61.03 -47.38 86.67 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.82 0.343 . . . . 0.0 110.391 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.16 -43.01 77.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.185 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -62.99 -44.87 94.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.688 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.591 ' HD2' ' HG ' ' A' ' 35' ' ' LEU . 84.1 t80 -70.54 -35.3 73.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.07 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.5 -42.95 79.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.446 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -74.98 -30.08 61.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.09 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -63.54 -57.83 8.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.264 0.555 . . . . 0.0 110.793 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.62 -25.48 60.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.656 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.516 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.612 -178.88 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.448 -0.558 0 CA-C-O 121.237 0.541 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -94.89 -12.35 27.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.822 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -125.94 155.16 41.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.776 174.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.569 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 33.9 tt0 -151.44 114.43 4.73 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -176.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -127.55 161.8 34.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.591 -173.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -78.57 148.68 33.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.86 0.362 . . . . 0.0 110.388 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.6 tt -57.02 -28.95 30.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.5 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -63.55 -28.19 69.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.993 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -77.49 -31.21 53.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.947 0.403 . . . . 0.0 111.052 -175.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.581 ' HA ' ' HD1' ' A' ' 23' ' ' TYR . 84.4 mtp -69.5 170.52 10.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.951 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.3 m -106.76 121.25 44.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.707 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.529 ' HB2' ' HE1' ' A' ' 66' ' ' TYR . 44.0 p90 -74.56 142.58 44.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.624 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -139.95 93.7 9.27 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 121.356 0.598 . . . . 0.0 110.649 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -66.22 -19.05 56.68 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.69 2.26 . . . . 0.0 112.279 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.83 -35.1 77.27 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.206 0.526 . . . . 0.0 110.603 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -111.61 5.95 19.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.874 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.536 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 2.1 mp0 57.91 31.58 20.77 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.809 178.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 27.4 ptt? -152.33 162.95 40.43 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.462 -174.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -91.39 138.3 31.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.635 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 21.9 p -129.29 143.58 50.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.709 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.581 ' HD1' ' HA ' ' A' ' 12' ' ' MET . 9.8 t80 -112.94 117.15 46.62 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.48 115.97 2.55 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.235 2.623 . . . . 0.0 113.622 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.6 t -135.94 125.65 16.21 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.07 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.96 119.21 2.82 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 121.897 1.732 . . . . 0.0 111.48 174.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.3 p -176.71 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 164.18 -29.15 0.23 Allowed Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 113.968 -1.469 . . . . 0.0 110.237 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.533 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 3.3 t70 -143.2 174.69 10.49 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -119.93 146.23 45.99 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 23' ' ' TYR . 88.5 m-85 -44.33 118.39 1.51 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.679 0.612 . . . . 0.0 111.361 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -114.24 136.94 52.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.019 0.437 . . . . 0.0 110.337 -177.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 20' ' ' MET . 18.4 tt -134.83 129.67 51.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.578 ' O ' ' HG3' ' A' ' 38' ' ' MET . 48.2 m-85 -84.23 126.78 33.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.836 -174.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -33.39 74.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.894 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -58.25 -34.57 70.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.257 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -87.08 -31.16 20.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.578 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 82.9 mtp -64.86 -41.52 95.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.73 0.3 . . . . 0.0 110.983 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -63.04 -25.4 68.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.577 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -77.3 -10.64 59.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.801 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.26 -5.61 38.76 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.689 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 38' ' ' MET . 7.4 tp10 -89.4 130.97 35.68 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.59 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -137.68 100.27 4.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.25 1.024 . . . . 0.0 111.784 -175.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.0 p -166.82 128.98 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.807 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 53' ' ' MET . . . -100.27 139.76 35.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.032 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.54 135.81 57.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.176 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.544 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 8.1 t -104.23 116.78 60.8 Favored Pre-proline 0 N--CA 1.435 -1.208 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.846 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.533 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 49.9 Cg_endo -70.41 156.74 60.99 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.582 2.188 . . . . 0.0 110.98 173.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 33.3 m 86.97 -56.72 0.05 OUTLIER 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.161 0.984 . . . . 0.0 111.398 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.7 p -91.12 -27.29 18.66 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.87 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.6 t 69.05 72.78 0.26 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.183 174.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.529 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 51.7 tp -134.57 148.49 50.47 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 174.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.428 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 35.2 mtm -131.06 137.75 49.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.426 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -138.98 152.46 24.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.254 178.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.569 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 8.2 t70 -80.87 145.63 31.25 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.5 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 83.9 t -134.12 115.34 20.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.223 0.535 . . . . 0.0 111.715 -177.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.8 t -74.17 107.35 4.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.93 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -96.18 165.24 12.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.455 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.537 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 14.7 t70 -115.14 146.16 41.64 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.968 173.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.02 -40.06 96.6 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -76.76 -40.87 46.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.302 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 59' ' ' ASP . 8.7 m-20 -66.59 -32.03 73.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.192 -177.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 48.0 mt -66.96 -53.34 32.61 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.751 176.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 67' ' ' TYR . . . -58.94 -46.05 88.93 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.03 0.443 . . . . 0.0 111.163 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.22 -41.4 88.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.27 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.529 ' HE1' ' HB2' ' A' ' 14' ' ' PHE . 57.5 t80 -65.75 -35.37 80.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.203 -178.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.411 ' HB2' ' O ' ' A' ' 64' ' ' ALA . 12.7 m-85 -52.29 -47.91 65.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.958 0.409 . . . . 0.0 110.342 174.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -74.28 -26.7 60.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.362 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -75.41 -44.0 46.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 0.0 111.303 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.536 ' HB3' ' HA ' ' A' ' 19' ' ' GLN . . . -80.2 -12.85 59.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.411 -176.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.792 178.128 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 120.862 0.363 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -100.09 5.95 44.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.758 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -162.2 172.5 15.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.544 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 36.0 tt0 -154.13 111.7 3.47 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 3.5 mp -116.91 151.04 18.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.029 -177.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.557 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 57.7 mt-10 -78.34 149.97 33.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.886 0.374 . . . . 0.0 110.567 176.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.7 tt -59.01 -28.82 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.886 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -68.82 -29.98 68.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.381 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.438 ' HB3' HG22 ' A' ' 7' ' ' ILE . 31.9 t70 -84.74 -36.16 21.98 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.322 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.551 ' SD ' ' HB2' ' A' ' 23' ' ' TYR . 4.1 tpt -49.25 141.69 8.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.058 170.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 m -87.48 108.99 19.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.982 0.42 . . . . 0.0 110.069 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.5 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 40.0 p90 -74.17 137.7 43.3 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.976 0.417 . . . . 0.0 110.78 -177.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -115.34 93.9 37.6 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.649 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 70' ' ' ALA . 49.2 Cg_endo -68.86 -22.39 36.54 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.739 2.293 . . . . 0.0 112.449 -174.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -77.09 -18.83 57.71 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.075 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.519 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 4.3 t-20 -116.26 -6.7 11.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.516 0.198 . . . . 0.0 111.247 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.479 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 1.8 mp0 64.35 42.35 5.3 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.08 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.531 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 26.2 ptt? -151.46 174.07 13.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.46 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.5 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 36.0 m-85 -109.86 149.12 30.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.955 0.407 . . . . 0.0 110.674 176.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 36.8 p -137.62 159.93 40.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.283 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.551 ' HB2' ' SD ' ' A' ' 12' ' ' MET . 6.1 t80 -141.28 131.39 13.02 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.34 127.06 21.72 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.692 2.261 . . . . 0.0 113.327 -176.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.504 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 20.0 t -140.74 141.37 24.54 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.214 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 12.0 Cg_endo -91.3 117.99 0.52 Allowed 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 122.171 1.914 . . . . 0.0 112.079 174.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.9 p 177.83 -44.38 0.01 OUTLIER 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.208 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.22 -19.86 0.48 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.168 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -140.12 173.63 11.32 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.41 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -122.27 151.63 40.89 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.622 -0.14 . . . . 0.0 110.622 177.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.603 ' O ' ' HA ' ' A' ' 22' ' ' THR . 93.9 m-85 -47.88 126.94 11.27 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 123.802 0.688 . . . . 0.0 110.642 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -127.86 138.64 52.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.857 0.361 . . . . 0.0 110.939 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.531 ' O ' ' HB2' ' A' ' 20' ' ' MET . 12.1 tt -148.88 132.87 8.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.712 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -87.54 142.57 27.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.55 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.422 HD12 HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -67.86 -30.76 70.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.083 0.468 . . . . 0.0 110.741 -177.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -61.26 -31.24 71.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.839 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 6.7 m-20 -80.74 -34.02 34.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.569 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 79.0 mtp -63.99 -35.42 80.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.976 0.417 . . . . 0.0 110.07 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -68.27 -20.77 64.81 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.638 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 44.5 mm-40 -76.59 -13.42 60.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.361 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.49 -3.87 61.6 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.433 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -90.47 105.09 17.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.731 ' HD2' ' HE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -115.4 100.0 7.78 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.995 0.902 . . . . 0.0 110.552 -177.082 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 1.8 p -167.03 129.5 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.727 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.434 ' HB1' HD12 ' A' ' 54' ' ' ILE . . . -100.01 139.0 36.31 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.824 HG21 ' HG2' ' A' ' 53' ' ' MET . 38.4 t -115.67 119.0 60.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.194 -176.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.559 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 6.8 t -90.19 120.88 69.14 Favored Pre-proline 0 C--N 1.317 -0.824 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.43 ' O ' ' HB2' ' A' ' 49' ' ' SER . 58.2 Cg_endo -73.45 154.95 50.76 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.355 2.037 . . . . 0.0 112.578 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 51.4 m 78.09 -54.4 0.5 Allowed 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.963 0.905 . . . . 0.0 111.637 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 12.1 p -82.2 -25.83 33.88 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.4 t 70.49 42.91 0.84 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.04 169.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.507 HD21 ' HZ ' ' A' ' 31' ' ' PHE . 26.7 tp -103.96 128.61 51.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.359 0.599 . . . . 0.0 110.076 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.824 ' HG2' HG21 ' A' ' 46' ' ' VAL . 35.6 mtm -117.07 136.98 52.58 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.918 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -138.68 152.98 25.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.747 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.544 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 4.7 t70 -82.42 151.4 26.6 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.489 HG11 ' HB2' ' A' ' 43' ' ' LYS . 6.3 p -129.7 112.99 25.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.559 0.695 . . . . 0.0 111.378 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.557 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 53.0 t -68.38 118.62 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.709 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.731 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 20.7 p90 -133.37 164.58 26.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.466 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.558 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 11.6 t70 -137.23 159.95 40.44 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.445 ' HD3' ' H ' ' A' ' 60' ' ' LYS . 3.0 mppt? -62.15 -37.64 85.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.028 0.442 . . . . 0.0 109.851 176.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -64.16 -45.16 89.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.523 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.97 -45.54 88.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.667 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 40.8 mt -55.02 -53.68 52.76 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.108 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.13 -43.18 73.88 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.217 0.323 . . . . 0.0 111.368 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -66.2 -49.89 65.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.022 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -67.73 -32.31 72.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.651 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.437 ' HD1' ' O ' ' A' ' 63' ' ' LEU . 2.2 m-85 -50.87 -44.28 59.62 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 172.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -63.21 -49.57 73.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.667 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -68.86 -32.51 72.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.287 -175.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -81.69 -10.63 59.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.776 0.322 . . . . 0.0 111.105 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.62 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.814 177.106 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.448 -0.57 0 CA-C-O 121.083 0.468 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -86.08 -23.24 26.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.972 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.525 ' HB2' HG22 ' A' ' 54' ' ' ILE . 1.6 m-20 -119.46 145.38 46.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.646 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.41 ' HG3' ' CB ' ' A' ' 55' ' ' ASP . 36.5 tt0 -140.36 108.28 5.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.726 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.5 mp -110.95 160.84 9.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -176.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.426 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 5.2 mp0 -79.38 148.99 31.79 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.3 tt -58.15 -29.95 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.129 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -68.07 -27.76 66.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.045 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.28 -39.44 54.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.782 0.325 . . . . 0.0 110.893 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 81.1 mtp -64.2 157.19 26.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.13 0.49 . . . . 0.0 111.154 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.6 m -90.44 109.22 20.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.482 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.586 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 42.1 p90 -78.96 134.63 36.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.192 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.427 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 9.5 tp10 -117.76 97.65 50.95 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.197 177.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 21.9 Cg_endo -61.25 -29.72 86.89 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.981 2.454 . . . . 0.0 111.953 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.62 -23.54 63.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.375 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.81 -11.63 15.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.119 0.485 . . . . 0.0 109.977 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.523 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 1.9 mp0 69.84 35.11 2.41 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.696 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.532 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 25.0 ptt? -157.99 174.71 14.83 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.593 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.586 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 42.8 m-85 -105.33 140.49 38.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.382 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 42.6 p -132.08 163.01 29.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.904 177.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.596 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 45.6 t80 -136.66 118.57 11.48 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.13 118.51 5.25 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 123.23 2.62 . . . . 0.0 112.794 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.0 t -137.55 140.58 30.64 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.57 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -90.94 118.9 0.61 Allowed 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 121.828 1.685 . . . . 0.0 111.973 174.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.2 p 179.52 -41.27 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 160.17 -26.3 0.31 Allowed Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.398 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.556 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 3.5 t0 -142.94 175.23 10.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.21 153.34 25.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.338 0.113 . . . . 0.0 111.137 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.596 ' HB2' ' HB3' ' A' ' 23' ' ' TYR . 81.2 m-85 -52.45 136.12 32.31 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.063 175.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 2.2 pt20 -133.3 136.68 45.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.876 0.37 . . . . 0.0 110.884 -176.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.532 ' O ' ' HB2' ' A' ' 20' ' ' MET . 15.2 tt -151.55 142.5 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.477 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.536 ' O ' ' HG3' ' A' ' 38' ' ' MET . 95.0 m-85 -99.31 147.74 24.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.914 0.388 . . . . 0.0 111.129 -177.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.47 -41.55 93.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.312 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -65.04 -31.99 73.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.186 0.517 . . . . 0.0 110.849 -175.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.01 -44.07 73.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.093 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.536 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 78.5 mtp -62.18 -42.61 99.44 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.684 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -65.93 -16.55 63.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.254 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -81.99 -12.48 58.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.41 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.2 -4.43 35.5 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.749 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -105.77 111.0 23.49 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.424 ' HD3' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -118.75 102.87 9.15 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.842 0.829 . . . . 0.0 110.732 -172.622 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 1.6 p -162.42 126.22 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.665 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.503 ' HB2' HD13 ' A' ' 54' ' ' ILE . . . -99.85 137.2 38.64 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.389 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.756 HG23 ' HG2' ' A' ' 53' ' ' MET . 47.7 t -114.62 123.01 69.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.764 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.516 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 12.0 t -90.73 122.3 67.11 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.556 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 43.2 Cg_endo -74.59 156.31 44.87 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.225 1.95 . . . . 0.0 111.29 175.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 35.5 t 89.28 -58.39 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.857 0.863 . . . . 0.0 110.107 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.4 p -89.3 -26.15 21.28 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 175.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.9 m 67.36 47.99 1.21 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.227 174.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.437 HD21 ' N ' ' A' ' 53' ' ' MET . 1.7 tt -102.71 135.23 44.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.756 ' HG2' HG23 ' A' ' 46' ' ' VAL . 32.3 mtm -117.11 137.14 52.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.466 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.525 HG22 ' HB2' ' A' ' 5' ' ' ASP . 2.8 pp -142.54 146.1 22.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.222 -176.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.41 ' CB ' ' HG3' ' A' ' 6' ' ' GLU . 6.4 m-20 -79.17 151.28 31.37 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.89 109.69 15.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.302 0.572 . . . . 0.0 110.941 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 46.9 t -65.95 112.37 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.423 -177.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -108.09 160.09 16.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.017 0.437 . . . . 0.0 111.651 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.728 ' HB3' ' HB2' ' A' ' 62' ' ' ASP . 20.3 t70 -117.01 146.15 43.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.093 173.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -62.4 -37.66 86.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.881 0.372 . . . . 0.0 110.563 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.39 -26.58 28.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.176 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.728 ' HB2' ' HB3' ' A' ' 59' ' ' ASP . 4.2 m-20 -65.58 -48.39 72.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.071 173.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 83.5 mt -55.08 -49.35 71.91 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.741 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.09 -37.01 83.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.0 0.429 . . . . 0.0 111.534 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -69.16 -52.83 24.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.677 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -64.13 -34.91 79.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.743 0.306 . . . . 0.0 110.934 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -53.83 -46.73 71.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.056 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.28 -41.89 76.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.584 -178.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -59.39 -44.92 92.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.232 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.523 ' HB2' ' HA ' ' A' ' 19' ' ' GLN . . . -81.73 -27.31 33.95 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.521 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.827 -179.824 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' A' ' 55' ' ' ASP . 17.4 p . . . . . 0 N--CA 1.45 -0.471 0 CA-C-O 121.642 0.734 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -110.23 -13.24 14.37 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.509 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.508 ' HB2' HG22 ' A' ' 54' ' ' ILE . 9.5 m-20 -97.42 127.02 43.04 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 176.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -124.46 108.58 12.29 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.717 -173.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.456 HG22 ' HB3' ' A' ' 11' ' ' ASP . 2.7 mp -111.84 150.27 14.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.126 -175.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -71.4 145.32 49.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.985 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.49 HD11 ' HE2' ' A' ' 38' ' ' MET . 20.7 tt -62.36 -27.57 42.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 172.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -56.79 -29.42 62.68 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.573 173.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.456 ' HB3' HG22 ' A' ' 7' ' ' ILE . 27.8 t70 -94.96 -41.13 9.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.794 -0.184 . . . . 0.0 111.224 -175.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.466 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 68.7 mtp -60.78 145.63 49.01 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.17 0.509 . . . . 0.0 110.867 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 m -89.92 124.03 34.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.053 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.423 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . 38.5 p90 -74.27 135.74 42.65 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.291 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -118.3 88.4 32.86 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.131 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.79 -15.91 45.04 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.117 2.544 . . . . 0.0 112.632 -174.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -68.98 -29.7 67.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.866 0.365 . . . . 0.0 111.217 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.569 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 2.0 t-20 -118.47 6.27 11.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.872 0.367 . . . . 0.0 110.571 -177.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 59.43 43.53 16.25 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.007 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.569 ' HG2' ' HB3' ' A' ' 18' ' ' ASN . 22.9 ptt? -145.58 174.45 11.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.975 0.416 . . . . 0.0 110.925 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.442 ' CZ ' HD12 ' A' ' 9' ' ' ILE . 92.0 m-85 -108.14 142.6 38.12 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 73.0 p -137.37 167.07 22.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.716 0.293 . . . . 0.0 111.192 -175.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.466 ' CD1' ' HA ' ' A' ' 12' ' ' MET . 5.6 t80 -146.68 124.04 5.94 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.9 111.71 0.77 Allowed 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.129 2.552 . . . . 0.0 112.993 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.408 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 27.6 t -118.64 137.96 25.39 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.756 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -88.83 116.95 0.85 Allowed 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 121.349 1.366 . . . . 0.0 111.558 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.5 p 175.15 -41.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.497 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 153.66 -15.6 0.63 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.882 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -142.45 176.15 9.23 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.402 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 18.8 ptp180 -113.62 153.62 28.56 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 22' ' ' THR . 91.5 m-85 -55.74 134.28 51.39 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 174.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 30' ' ' ARG . 24.3 mt-30 -129.8 132.18 46.43 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.946 0.403 . . . . 0.0 111.431 -176.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.425 ' O ' ' HB2' ' A' ' 20' ' ' MET . 14.6 tt -141.58 128.14 19.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.731 171.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.421 ' O ' ' HG3' ' A' ' 38' ' ' MET . 69.6 m-85 -91.13 154.56 19.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.904 0.383 . . . . 0.0 110.698 -176.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.76 -34.82 75.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.658 -177.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.522 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 27.4 t70 -59.67 -45.54 91.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.025 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -64.76 -33.74 76.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 110.61 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.49 ' HE2' HD11 ' A' ' 9' ' ' ILE . 59.5 mtp -74.66 -36.12 62.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.987 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -65.08 -29.61 70.51 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.55 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 36' ' ' ASP . 24.6 mm-40 -58.98 -22.94 61.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.617 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.3 8.2 38.84 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.57 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -115.36 157.65 23.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.662 ' HD3' ' N ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -145.47 100.73 3.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.7 0.762 . . . . 0.0 111.566 -174.091 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 1.4 p -166.71 131.41 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.503 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.471 ' HB1' HD12 ' A' ' 54' ' ' ILE . . . -100.57 132.36 45.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.698 HG21 ' HG2' ' A' ' 53' ' ' MET . 47.2 t -115.13 133.89 59.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.437 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 14.2 t -104.38 130.96 22.37 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.411 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.543 ' O ' ' HB2' ' A' ' 49' ' ' SER . 58.4 Cg_endo -79.44 156.45 25.22 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.866 2.377 . . . . 0.0 112.021 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.543 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 41.6 m 83.22 -53.89 0.16 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.196 0.998 . . . . 0.0 111.609 -177.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 18.0 p -90.65 -24.88 20.36 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.631 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.1 t 64.77 49.8 2.16 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.33 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.2 mt -117.32 154.78 30.67 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.366 0.603 . . . . 0.0 111.308 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.698 ' HG2' HG21 ' A' ' 46' ' ' VAL . 25.2 mtm -135.01 138.47 43.99 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.609 -168.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.508 HG22 ' HB2' ' A' ' 5' ' ' ASP . 2.7 pp -140.37 152.49 21.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.319 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.419 ' HB2' ' HB ' ' A' ' 3' ' ' THR . 4.9 t70 -91.81 147.84 22.68 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -173.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 5.1 p -133.9 123.5 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.4 t -79.8 114.76 21.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 122.137 -0.352 . . . . 0.0 110.661 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.557 ' CE1' ' HB3' ' A' ' 43' ' ' LYS . 44.1 p90 -121.63 165.09 16.24 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.707 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.408 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 14.0 t70 -121.26 161.16 22.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.206 0.527 . . . . 0.0 110.086 174.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -61.66 -40.12 93.82 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.46 175.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -78.23 -35.25 48.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.771 -174.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -70.91 -32.1 68.93 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.341 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 61.7 mt -63.51 -48.71 76.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.76 0.314 . . . . 0.0 110.303 172.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.99 -38.92 93.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.326 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -66.49 -48.86 68.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.34 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.423 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 85.4 t80 -62.6 -36.49 82.9 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.945 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -51.99 -42.14 62.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.684 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.41 -37.75 60.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.611 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -60.4 -54.36 46.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.057 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.88 -22.92 45.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.939 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -177.937 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.8 p . . . . . 0 N--CA 1.447 -0.601 0 CA-C-O 121.001 0.429 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -90.11 -11.38 41.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.608 -175.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.437 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 7.3 m-20 -141.99 169.7 17.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.276 176.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 35.5 tt0 -155.86 118.99 4.28 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -134.96 153.89 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.788 -175.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.51 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 45.4 mt-10 -72.81 152.08 41.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.036 0.446 . . . . 0.0 110.813 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.433 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 18.6 tt -55.49 -29.03 23.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.479 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.02 -35.1 80.1 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.402 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -78.08 -27.73 48.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.947 0.403 . . . . 0.0 111.12 -172.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.471 ' HE1' ' HB2' ' A' ' 23' ' ' TYR . 90.4 mtp -75.84 161.18 29.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.283 0.563 . . . . 0.0 111.317 -178.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.8 m -95.12 115.76 27.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.956 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.433 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 44.5 p90 -81.33 138.88 35.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.091 0.472 . . . . 0.0 111.254 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -118.98 91.46 43.31 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.61 -28.36 52.78 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.188 2.592 . . . . 0.0 113.182 -172.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -70.98 -21.56 62.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.8 -175.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -112.97 3.58 16.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.62 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 55.09 44.53 27.84 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.904 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -146.66 165.7 28.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.94 0.4 . . . . 0.0 110.913 -176.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.534 ' HE1' HD21 ' A' ' 35' ' ' LEU . 68.4 m-85 -112.36 145.33 40.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.716 175.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.595 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 36.7 p -133.12 157.87 44.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.75 0.309 . . . . 0.0 110.987 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.478 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 9.6 t80 -140.34 125.17 11.07 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -51.21 127.89 23.47 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.376 2.718 . . . . 0.0 113.743 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.418 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 20.4 t -145.46 135.02 11.48 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.915 177.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 2.5 Cg_endo -87.24 118.09 1.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.026 1.817 . . . . 0.0 111.679 174.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 31.0 p -178.55 -54.05 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.404 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.468 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 169.44 -25.15 0.1 Allowed Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.99 -177.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -136.68 174.43 10.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.5 147.79 43.28 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 122.437 -0.164 . . . . 0.0 110.563 176.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.595 ' O ' ' HA ' ' A' ' 22' ' ' THR . 92.1 m-85 -45.94 128.86 9.38 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.448 0.467 . . . . 0.0 110.445 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -131.51 138.18 48.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.231 0.539 . . . . 0.0 110.884 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.0 tt -143.17 129.63 17.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.802 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -86.27 143.99 27.64 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.143 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.534 HD21 ' HE1' ' A' ' 21' ' ' PHE . 1.6 tm? -62.46 -36.38 82.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.142 -173.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -65.26 -34.18 77.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.933 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.97 -44.08 97.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.106 0.479 . . . . 0.0 110.408 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 70.3 mtp -62.74 -41.69 99.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.116 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -65.72 -31.41 72.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.902 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -76.01 -3.88 38.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.734 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.48 -17.97 45.65 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.972 174.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -91.23 95.57 10.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.155 0.502 . . . . 0.0 110.696 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -100.68 100.93 11.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.579 0.704 . . . . 0.0 110.966 -177.115 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.9 p -165.51 126.96 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.68 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.414 ' HB2' HD13 ' A' ' 54' ' ' ILE . . . -99.99 143.6 30.01 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.018 0.437 . . . . 0.0 110.36 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.43 140.05 44.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.38 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.523 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 11.1 t -109.37 118.04 51.7 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -70.61 156.51 60.98 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.439 2.093 . . . . 0.0 112.135 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.1 t 85.78 -53.53 0.08 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.852 0.861 . . . . 0.0 110.659 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 17.5 p -89.14 -28.39 20.08 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.4 m 66.92 54.69 0.76 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.387 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.45 HD23 ' N ' ' A' ' 53' ' ' MET . 1.7 tt -110.9 136.5 49.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.45 ' N ' HD23 ' A' ' 52' ' ' LEU . 31.9 mtm -123.84 137.99 54.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.742 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.437 ' CG2' ' HB2' ' A' ' 5' ' ' ASP . 0.2 OUTLIER -140.22 153.8 22.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 43.1 m-20 -82.01 159.79 23.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.838 0.351 . . . . 0.0 110.506 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.552 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 49.0 t -130.97 144.19 38.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.09 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.51 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 44.0 t -106.56 108.85 26.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.632 0.253 . . . . 0.0 110.592 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.497 ' HE2' ' HD2' ' A' ' 43' ' ' LYS . 45.2 p90 -112.98 165.24 12.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.041 -177.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.455 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 2.7 t70 -127.4 170.63 12.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.233 0.539 . . . . 0.0 110.234 175.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.411 ' HB2' ' HE2' ' A' ' 60' ' ' LYS . 24.9 mtmm -63.62 -46.25 86.61 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.999 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -72.88 -37.44 67.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.917 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -63.8 -31.48 72.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.773 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 58.9 mt -75.03 -45.31 42.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.605 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.93 -49.63 76.93 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.583 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.61 -40.27 96.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.174 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.411 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 91.2 t80 -69.22 -38.05 78.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.737 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.15 -45.18 83.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.861 0.362 . . . . 0.0 110.794 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -76.45 -25.72 54.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.586 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -79.26 -40.53 30.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.747 0.308 . . . . 0.0 111.64 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.54 -26.4 30.15 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.419 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.446 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 -176.038 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.451 -0.424 0 CA-C-O 121.364 0.602 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -83.18 -20.76 34.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.107 -173.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -132.66 162.81 30.41 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.172 0.51 . . . . 0.0 111.034 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 37.2 tt0 -146.93 108.52 4.32 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.657 171.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.96 155.74 18.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.056 -175.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.527 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 32.3 mp0 -65.32 144.42 57.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.391 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.0 tt -57.54 -29.35 33.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.445 0.64 . . . . 0.0 110.139 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -64.41 -28.8 69.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.927 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -82.1 -31.31 30.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.772 -175.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.458 ' HE2' ' HB2' ' A' ' 23' ' ' TYR . 84.2 mtp -68.65 160.84 29.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.027 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.1 m -85.17 110.89 19.33 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.076 0.465 . . . . 0.0 110.362 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.513 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 35.0 p90 -74.86 139.0 42.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.542 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -126.58 85.4 60.51 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.085 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.456 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 24.5 Cg_endo -62.86 -29.84 76.79 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.609 2.206 . . . . 0.0 111.579 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -63.81 -23.94 67.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.149 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -118.5 5.52 11.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.324 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.454 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 2.0 mp0 57.9 30.95 19.88 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.762 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.404 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 27.5 ptt? -144.36 170.89 15.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.061 0.458 . . . . 0.0 111.234 -175.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.513 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 31.0 m-85 -119.35 140.19 50.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.766 177.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 38.5 p -130.72 148.29 52.48 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.81 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.509 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 2.4 t80 -119.41 122.54 29.3 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.62 116.72 3.71 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.755 2.303 . . . . 0.0 113.383 -175.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 10.7 t -132.98 136.37 27.51 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.19 177.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 9.8 Cg_endo -90.29 118.24 0.68 Allowed 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 121.912 1.741 . . . . 0.0 111.642 174.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.409 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 32.0 p -176.56 -47.07 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.409 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 168.73 -26.89 0.13 Allowed Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.96 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.517 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 3.1 t0 -142.8 176.22 9.23 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -114.0 156.4 24.15 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -177.141 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 22' ' ' THR . 91.1 m-85 -58.39 117.72 4.78 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 172.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 30' ' ' ARG . 49.1 mt-30 -116.9 135.92 53.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.671 0.272 . . . . 0.0 111.105 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.42 HD11 HG12 ' A' ' 56' ' ' VAL . 13.8 tt -148.63 135.04 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.789 174.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -94.24 149.79 20.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.646 0.26 . . . . 0.0 110.62 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -32.11 70.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.488 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -60.51 -41.4 94.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.886 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 64.0 m-20 -66.11 -36.5 83.33 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.246 0.546 . . . . 0.0 110.115 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 57.7 mtp -69.19 -38.92 78.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.368 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -62.84 -30.2 71.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.22 0.533 . . . . 0.0 110.426 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 5.5 mm-40 -64.8 -22.16 66.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.319 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.72 -1.18 55.44 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -174.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -93.18 98.38 11.25 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.648 ' HB3' ' HE2' ' A' ' 58' ' ' PHE . 20.2 pttp -103.44 98.97 8.78 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.627 0.727 . . . . 0.0 111.421 -176.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 2.5 p -169.01 127.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.746 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.35 137.39 39.76 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 176.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.792 HG22 ' HG2' ' A' ' 53' ' ' MET . 40.8 t -111.84 132.4 60.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.022 -178.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.501 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 7.8 t -102.55 112.54 65.69 Favored Pre-proline 0 N--CA 1.448 -0.528 0 CA-C-O 120.991 0.424 . . . . 0.0 110.073 176.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.535 ' O ' ' HB3' ' A' ' 49' ' ' SER . 24.6 Cg_endo -67.81 157.38 62.02 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.27 1.98 . . . . 0.0 110.953 170.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.535 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 41.2 t 90.9 -58.43 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.053 0.941 . . . . 0.0 110.89 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 27.5 p -92.26 -28.25 17.11 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.948 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.8 t 69.65 73.25 0.24 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.399 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.534 HD22 ' HZ ' ' A' ' 31' ' ' PHE . 46.6 tp -134.53 154.41 51.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.354 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.792 ' HG2' HG22 ' A' ' 46' ' ' VAL . 39.4 mtm -139.45 138.37 36.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.294 -177.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -140.17 152.38 21.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.86 177.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 2.1 m-20 -74.48 156.38 36.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.642 0.258 . . . . 0.0 110.32 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 5.0 p -131.15 124.75 56.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.278 0.561 . . . . 0.0 111.165 176.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.527 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 78.4 t -82.58 111.58 19.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.954 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.648 ' HE2' ' HB3' ' A' ' 43' ' ' LYS . 50.2 p90 -112.97 163.03 15.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.19 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.556 ' OD1' ' HG2' ' A' ' 61' ' ' GLU . 5.6 t70 -118.24 157.24 27.38 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.415 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -63.7 -40.49 96.93 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.223 179.087 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.556 ' HG2' ' OD1' ' A' ' 59' ' ' ASP . 10.3 pt-20 -73.34 -37.91 65.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.12 -177.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -63.05 -45.56 91.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.75 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 54.8 mt -56.75 -49.72 74.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.809 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.21 -42.78 86.97 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.974 0.416 . . . . 0.0 111.59 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.9 -46.01 79.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.355 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -66.02 -34.54 78.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.259 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -51.83 -53.1 44.02 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.693 0.283 . . . . 0.0 110.826 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.6 -36.55 81.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.68 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.52 -54.49 19.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.145 0.498 . . . . 0.0 111.436 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.454 ' HB2' ' HA ' ' A' ' 19' ' ' GLN . . . -65.91 -18.38 65.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.895 -176.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.616 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.97 179.239 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -113.22 6.38 17.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.86 0.362 . . . . 0.0 111.079 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -150.5 172.14 15.94 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.511 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 35.3 tt0 -158.9 117.14 2.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.818 0.342 . . . . 0.0 110.326 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.9 OUTLIER -125.99 163.05 28.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.442 ' HG2' ' HB ' ' A' ' 57' ' ' VAL . 46.0 mt-10 -87.88 152.97 21.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.024 0.44 . . . . 0.0 111.145 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.6 tt -60.15 -29.57 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.05 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -69.38 -28.86 66.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.733 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.23 -35.55 35.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.106 0.479 . . . . 0.0 109.769 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 78.5 mmm -57.01 152.28 13.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.41 171.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.6 m -96.85 124.55 40.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.833 0.349 . . . . 0.0 110.816 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -80.9 130.38 35.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.096 0.474 . . . . 0.0 110.507 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -115.43 90.07 24.0 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.47 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 30.9 Cg_endo -63.88 -21.57 68.97 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.959 2.439 . . . . 0.0 112.013 -176.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -59.86 -42.61 94.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.75 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.435 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 0.4 OUTLIER -110.79 5.62 20.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.9 -175.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.533 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 1.9 mp0 59.11 41.22 20.91 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.206 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.435 ' HG2' ' HB3' ' A' ' 18' ' ' ASN . 27.2 ptt? -147.3 173.74 12.3 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.91 -177.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -109.11 138.56 45.27 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.916 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 21.1 p -137.14 162.57 33.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.693 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.42 ' O ' ' HB2' ' A' ' 30' ' ' ARG . 52.3 t80 -144.14 128.16 9.1 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.82 107.96 0.31 Allowed 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.292 2.662 . . . . 0.0 113.774 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.44 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 20.8 t -113.0 140.83 24.61 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.002 174.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 21.0 Cg_endo -91.95 117.5 0.44 Allowed 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.989 1.793 . . . . 0.0 111.837 174.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.436 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 31.6 p 178.36 -46.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.919 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.436 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 164.23 -24.27 0.18 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.917 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.5 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -141.97 175.42 9.75 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.132 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.523 ' HD3' ' HB ' ' A' ' 22' ' ' THR . 7.6 ptp180 -118.33 157.6 26.78 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.326 -178.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.535 ' O ' ' HA ' ' A' ' 22' ' ' THR . 91.5 m-85 -50.04 129.6 20.96 Favored 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 123.831 0.707 . . . . 0.0 110.156 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -130.64 127.48 39.02 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.098 -171.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.465 ' HB ' ' HA ' ' A' ' 45' ' ' ALA . 13.3 tt -146.89 135.92 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.528 175.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.412 ' O ' ' HG3' ' A' ' 38' ' ' MET . 27.0 m-85 -97.48 144.16 27.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.481 -177.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.553 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 3.6 mm? -62.81 -27.83 69.58 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.941 0.4 . . . . 0.0 110.658 176.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -55.43 -43.55 75.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.724 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.4 -31.98 54.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.496 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.596 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 78.2 mtp -70.3 -32.4 70.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.116 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.425 ' HB2' ' HH ' ' A' ' 67' ' ' TYR . 71.1 t80 -68.82 -27.26 65.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.845 177.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -72.85 -7.0 48.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.855 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.0 -0.83 47.83 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.994 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.596 ' O ' ' HA ' ' A' ' 38' ' ' MET . 9.9 tp10 -105.7 155.06 19.62 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.662 ' HD3' ' N ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -147.62 100.99 3.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.769 0.795 . . . . 0.0 110.942 -176.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 p -167.2 131.08 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.98 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.465 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . . . -100.73 135.39 42.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.31 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 p -112.91 136.74 48.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.268 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.7 t -105.07 124.75 35.57 Favored Pre-proline 0 N--CA 1.436 -1.162 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.444 175.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.5 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 58.3 Cg_endo -75.7 156.42 39.93 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.805 2.337 . . . . 0.0 111.094 173.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 33.0 t 89.58 -57.37 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.764 0.826 . . . . 0.0 110.629 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.406 ' HB3' ' CB ' ' A' ' 27' ' ' CYS . 21.5 p -91.25 -30.91 16.36 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.306 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t 70.38 73.23 0.21 Allowed 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.276 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.3 tp -130.35 144.53 51.44 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.458 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 46.3 mtm -135.18 137.86 43.1 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.131 0.491 . . . . 0.0 110.984 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.61 154.86 27.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.663 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.511 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 2.1 t70 -83.4 151.31 25.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.5 HG13 ' HB2' ' A' ' 43' ' ' LYS . 6.1 p -130.04 116.47 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.521 0.677 . . . . 0.0 111.909 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.442 ' HB ' ' HG2' ' A' ' 8' ' ' GLU . 48.4 t -72.76 111.55 7.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.446 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.475 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 28.4 p90 -115.33 164.7 13.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.032 -175.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.515 ' OD1' ' HG2' ' A' ' 61' ' ' GLU . 8.8 t70 -126.05 157.61 37.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 171.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.67 -37.76 88.67 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.629 178.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.515 ' HG2' ' OD1' ' A' ' 59' ' ' ASP . 12.9 pt-20 -73.13 -37.87 66.48 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.355 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.508 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 4.0 m-20 -59.06 -53.13 61.89 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.488 175.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.415 HD21 HD13 ' A' ' 35' ' ' LEU . 28.4 mt -55.42 -50.7 69.1 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.881 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.48 -48.23 81.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.681 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -68.46 -43.56 76.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.867 0.365 . . . . 0.0 110.876 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.508 ' HD1' ' O ' ' A' ' 62' ' ' ASP . 48.1 m-85 -68.13 -32.48 72.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.299 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.553 ' CE1' ' HB3' ' A' ' 35' ' ' LEU . 1.2 m-85 -51.63 -48.13 63.42 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.261 0.553 . . . . 0.0 109.956 170.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.44 -30.87 64.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.776 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 66' ' ' TYR . 67.8 mm-40 -66.73 -45.25 79.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.118 176.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.533 ' HB3' ' HA ' ' A' ' 19' ' ' GLN . . . -75.34 -20.47 59.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.509 -176.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.77 -179.946 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.625 ' HB ' ' OD1' ' A' ' 55' ' ' ASP . 5.7 p . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 120.973 0.416 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -114.08 -21.37 10.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.339 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -121.02 152.64 38.36 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.025 -173.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -144.67 117.65 8.83 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 123.12 0.262 . . . . 0.0 110.492 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -118.17 162.58 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.542 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 41.6 mt-10 -69.29 148.85 49.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.956 0.408 . . . . 0.0 111.254 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.3 tt -62.36 -33.18 57.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.049 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.68 -27.25 61.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.753 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -72.53 -30.33 64.37 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.601 ' HA ' ' HD1' ' A' ' 23' ' ' TYR . 84.5 mtp -69.74 151.06 46.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.06 172.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.1 m -76.86 131.52 38.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.121 0.486 . . . . 0.0 111.578 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -74.92 127.17 32.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.329 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -125.24 85.26 58.48 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.002 0.43 . . . . 0.0 110.304 173.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.68 -34.17 42.15 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.759 2.306 . . . . 0.0 111.949 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.33 -34.11 76.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.478 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.462 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 3.5 t-20 -102.62 -1.6 29.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.875 0.369 . . . . 0.0 111.024 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.405 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 1.5 mp0 62.01 35.96 15.75 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.856 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.536 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 26.2 ptt? -154.0 167.58 29.28 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.544 -177.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -100.36 146.28 27.16 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.477 177.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 23.4 p -138.51 136.82 36.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.86 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.601 ' HD1' ' HA ' ' A' ' 12' ' ' MET . 8.6 t80 -115.38 121.31 34.94 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -50.68 118.73 4.38 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.672 2.915 . . . . 0.0 113.778 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.509 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 16.5 t -135.47 139.98 32.85 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.339 176.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -91.8 120.32 0.56 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.644 2.229 . . . . 0.0 111.947 172.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.6 p 177.61 -39.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.775 0.798 . . . . 0.0 108.958 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 158.14 -26.95 0.44 Allowed Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.627 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.446 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 3.7 t0 -142.04 176.34 9.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.472 ' HE ' ' HB ' ' A' ' 22' ' ' THR . 12.7 ptm180 -117.63 153.7 32.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.584 ' O ' ' HA ' ' A' ' 22' ' ' THR . 99.4 m-85 -51.57 128.24 22.56 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.58 0.55 . . . . 0.0 110.003 177.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -133.55 142.66 48.28 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.065 0.459 . . . . 0.0 110.686 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.536 ' O ' ' HB2' ' A' ' 20' ' ' MET . 14.6 tt -144.44 132.46 17.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.557 -178.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -82.38 128.85 34.64 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.496 -177.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.485 HD12 ' CE1' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -62.59 -34.65 77.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -176.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -65.16 -25.92 67.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.246 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.87 -32.49 27.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.308 0.575 . . . . 0.0 109.76 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 83.6 mtp -67.46 -35.56 79.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.944 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -67.1 -23.6 65.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.154 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -77.69 -9.13 58.82 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.035 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.75 -18.63 34.42 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.058 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.45 121.43 27.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.874 0.369 . . . . 0.0 110.668 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.509 ' HD3' ' CE2' ' A' ' 58' ' ' PHE . 19.7 pttp -120.22 100.56 7.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.675 0.75 . . . . 0.0 112.131 -174.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 p -166.78 126.41 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.573 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.45 142.16 32.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.125 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.94 138.67 51.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.966 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.529 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 23.0 t -107.0 121.69 44.0 Favored Pre-proline 0 N--CA 1.436 -1.15 0 C-N-CA 120.521 -0.471 . . . . 0.0 109.787 176.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' A' ' 49' ' ' SER . 34.0 Cg_endo -68.69 157.1 63.23 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.434 2.089 . . . . 0.0 111.285 174.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 29.5 m 86.51 -60.42 0.05 OUTLIER 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.136 0.975 . . . . 0.0 110.952 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 20.3 p -89.02 -26.88 21.21 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.3 t 69.39 46.45 0.76 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.146 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.541 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 1.7 tt -99.59 129.11 45.72 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 30.4 mtm -120.52 136.79 54.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.102 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.01 162.21 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.625 ' OD1' ' HB ' ' A' ' 3' ' ' THR . 5.0 m-20 -80.29 162.34 24.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.695 0.283 . . . . 0.0 110.382 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.403 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 8.9 p -132.81 137.03 54.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.671 175.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 44.4 t -88.89 112.91 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.556 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.509 ' CE2' ' HD3' ' A' ' 43' ' ' LYS . 39.7 p90 -117.36 165.25 13.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.734 0.302 . . . . 0.0 110.824 -177.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -134.94 151.45 50.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.034 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -56.5 -40.92 75.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.713 175.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.18 -46.91 72.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.268 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.95 -44.73 96.15 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.541 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.417 HD22 HD13 ' A' ' 35' ' ' LEU . 36.4 mt -64.55 -48.21 75.89 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.083 -0.247 . . . . 0.0 111.185 -178.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.66 -41.84 95.83 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.058 0.456 . . . . 0.0 111.01 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -68.48 -42.5 78.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.303 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -66.7 -37.2 84.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.06 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.485 ' CE1' HD12 ' A' ' 35' ' ' LEU . 2.6 m-85 -52.71 -43.45 65.67 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.335 0.588 . . . . 0.0 110.147 174.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -66.66 -52.4 45.31 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.467 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -69.49 -31.63 70.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.782 -175.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.405 ' HB2' ' HA ' ' A' ' 19' ' ' GLN . . . -73.69 -18.29 61.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.748 0.309 . . . . 0.0 111.089 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.711 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.608 178.788 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.0 p . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 120.516 0.198 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -85.23 6.49 25.78 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -166.99 169.64 12.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.632 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -144.34 113.96 7.15 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.442 ' CG2' ' HB3' ' A' ' 11' ' ' ASP . 4.1 mt -120.9 142.07 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -169.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -62.52 140.07 58.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.458 171.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.8 tt -55.42 -33.93 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.518 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -73.36 -28.34 61.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.59 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.442 ' HB3' ' CG2' ' A' ' 7' ' ' ILE . 12.3 t70 -72.01 -29.41 64.17 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 83.0 mmm -69.1 145.02 53.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.373 176.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 50.9 m -90.35 115.76 27.79 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.102 0.477 . . . . 0.0 110.412 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.678 ' HB2' ' HE1' ' A' ' 66' ' ' TYR . 39.2 p90 -74.35 139.13 43.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.554 -176.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -115.38 85.02 12.5 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.223 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.474 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 21.3 Cg_endo -60.33 -28.92 87.76 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.163 2.575 . . . . 0.0 113.799 -170.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.35 -29.45 68.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.875 0.369 . . . . 0.0 110.988 -177.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -108.45 -0.4 20.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.955 -175.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 60.02 40.4 18.77 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.096 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -141.74 170.3 15.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.985 0.421 . . . . 0.0 110.757 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -109.7 144.78 37.59 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.547 174.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 35.5 p -134.66 158.35 44.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.079 -178.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.423 ' HB3' ' CD2' ' A' ' 31' ' ' PHE . 4.4 t80 -137.81 132.81 17.44 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.7 121.81 10.28 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.716 2.277 . . . . 0.0 113.222 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.529 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 28.4 t -132.5 144.66 53.95 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.377 177.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -94.28 118.52 0.29 Allowed 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 122.184 1.923 . . . . 0.0 111.778 173.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.4 p 174.93 -40.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.767 0.794 . . . . 0.0 109.158 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 148.26 -12.53 1.22 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.257 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.58 176.15 9.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.577 0.227 . . . . 0.0 110.461 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.48 ' HD3' ' HB ' ' A' ' 22' ' ' THR . 16.0 ptp180 -121.05 150.35 41.31 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.073 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.643 ' O ' ' HA ' ' A' ' 22' ' ' THR . 98.9 m-85 -51.21 125.46 14.09 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.283 0.364 . . . . 0.0 110.319 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -120.6 133.68 55.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.179 0.514 . . . . 0.0 111.025 -176.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.5 tt -146.54 126.49 5.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.606 175.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -91.44 147.12 23.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.557 -175.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -61.32 -30.63 70.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.345 -177.375 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -55.46 -50.64 69.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.082 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -65.94 -38.4 88.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.45 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 84.0 mtp -63.51 -41.74 98.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.467 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.25 -29.57 69.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.677 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -68.63 -16.73 63.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.215 177.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.73 -9.5 52.06 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.945 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -90.92 92.78 8.92 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -105.46 100.77 10.34 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.255 1.026 . . . . 0.0 111.73 -174.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 p -166.12 130.43 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.036 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.431 ' HB2' HD13 ' A' ' 54' ' ' ILE . . . -99.96 141.95 32.09 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.17 138.02 52.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.905 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.551 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 12.9 t -102.22 121.48 50.13 Favored Pre-proline 0 N--CA 1.432 -1.356 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.471 ' O ' ' HB2' ' A' ' 49' ' ' SER . 45.6 Cg_endo -70.42 155.97 62.62 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.688 2.259 . . . . 0.0 111.846 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 67.5 m 79.78 -51.29 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.519 0.728 . . . . 0.0 111.785 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 13.8 p -91.92 -23.66 19.53 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.053 177.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.4 t 67.59 45.27 1.54 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.231 171.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.535 HD22 ' HZ ' ' A' ' 31' ' ' PHE . 50.5 tp -102.68 137.03 41.44 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.893 -0.504 . . . . 0.0 109.815 176.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 37.1 mtm -123.93 138.21 54.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.949 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.431 HD13 ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -141.64 152.23 19.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.118 179.029 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -78.38 146.14 34.8 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.794 -178.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.608 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 96.8 t -131.42 113.06 22.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.053 0.454 . . . . 0.0 110.704 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.6 t -84.87 124.87 40.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 -175.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.42 ' CD1' HD13 ' A' ' 63' ' ' LEU . 52.8 p90 -118.15 164.9 14.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.906 0.384 . . . . 0.0 111.382 -175.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.43 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -127.69 152.4 47.76 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.834 173.339 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -62.97 -39.4 94.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.468 -176.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -64.64 -43.18 94.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.097 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -68.32 -35.53 77.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.06 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 51.0 mt -60.89 -53.94 51.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.537 177.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.438 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . . . -57.81 -41.75 82.81 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.121 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.92 -47.69 83.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.408 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.678 ' HE1' ' HB2' ' A' ' 14' ' ' PHE . 76.0 t80 -61.98 -35.81 79.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.132 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.438 ' HD2' ' HA ' ' A' ' 64' ' ' ALA . 24.5 m-85 -54.2 -44.26 71.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.032 0.444 . . . . 0.0 110.82 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -76.61 -43.18 39.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.692 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -58.49 -48.08 81.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.825 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.0 -25.52 43.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.252 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.544 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.256 -178.261 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.452 -0.364 0 CA-C-O 121.289 0.566 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -72.46 -36.87 68.59 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.822 -173.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -110.73 162.56 14.64 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.842 0.353 . . . . 0.0 110.891 -171.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -156.67 108.05 2.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.18 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.43 162.41 17.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.0 -175.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.507 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 42.8 mt-10 -71.45 151.58 43.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.262 0.553 . . . . 0.0 110.93 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.5 tt -60.61 -31.18 48.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.509 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.24 -28.05 65.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.313 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -78.71 -29.98 45.72 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.886 0.374 . . . . 0.0 110.584 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 82.4 mmm -58.98 130.44 47.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.387 175.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.3 m -72.92 107.31 5.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.199 0.524 . . . . 0.0 110.48 -176.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.543 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . 43.7 p90 -84.37 133.98 34.5 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.573 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.491 ' HA ' ' OE1' ' A' ' 15' ' ' GLU . 4.9 tp10 -112.04 98.24 41.56 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.747 176.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.02 -22.14 73.7 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.884 2.389 . . . . 0.0 111.692 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -70.16 -25.75 63.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.815 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -114.22 -0.26 13.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.033 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 57.63 42.68 23.6 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.528 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -160.15 172.72 16.93 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.615 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -103.45 137.09 42.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.001 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 30.2 p -136.7 166.63 23.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.438 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.429 ' CB ' ' HB2' ' A' ' 31' ' ' PHE . 0.4 OUTLIER -138.95 121.58 10.53 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.638 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -54.94 122.29 11.41 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.085 2.523 . . . . 0.0 113.414 -177.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 16.3 t -146.32 127.53 7.36 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.267 176.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -85.65 119.28 1.92 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.351 2.034 . . . . 0.0 111.683 174.175 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.8 p -175.63 -43.71 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.1 -30.52 0.17 Allowed Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.342 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.498 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 2.4 t70 -143.2 176.06 9.41 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.94 153.11 25.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.522 ' HZ ' HD22 ' A' ' 52' ' ' LEU . 79.0 m-85 -52.89 124.97 15.51 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -134.31 145.91 49.5 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.09 0.471 . . . . 0.0 111.383 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.3 tt -142.61 135.34 26.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.029 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -91.53 138.8 31.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.785 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.551 ' HA ' ' HG3' ' A' ' 38' ' ' MET . 1.1 mt -68.56 -25.14 64.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.162 -177.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -54.02 -45.48 71.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.542 172.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.66 -44.49 73.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.509 176.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.551 ' HG3' ' HA ' ' A' ' 35' ' ' LEU . 28.3 mtp -60.15 -46.01 91.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -69.24 -22.62 63.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.62 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -76.11 -20.72 57.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.165 0.507 . . . . 0.0 110.11 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.84 -3.3 31.97 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.257 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -83.62 117.32 23.09 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 175.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -126.83 98.52 5.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.072 0.939 . . . . 0.0 111.832 -174.295 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 p -168.54 132.07 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.904 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.25 138.12 38.7 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.0 p -120.23 137.79 52.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.541 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.482 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 10.0 t -104.1 123.88 39.35 Favored Pre-proline 0 N--CA 1.434 -1.24 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 174.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.498 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 35.5 Cg_endo -80.27 157.22 22.82 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.416 2.077 . . . . 0.0 111.451 175.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 23.0 t 88.85 -55.88 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.224 1.01 . . . . 0.0 110.585 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.9 p -89.01 -32.02 17.81 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 47' ' ' CYS . 20.2 m 68.49 74.02 0.28 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.652 176.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.522 HD22 ' HZ ' ' A' ' 31' ' ' PHE . 42.2 tp -132.21 150.28 52.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.428 ' HE3' ' HB2' ' A' ' 53' ' ' MET . 33.0 mtm -135.14 141.12 45.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.076 -175.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.38 148.52 21.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.66 175.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.21 156.66 37.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.837 0.351 . . . . 0.0 110.773 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.46 127.99 57.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.151 0.5 . . . . 0.0 111.098 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.507 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 46.8 t -83.45 105.68 13.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.152 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -113.09 164.65 13.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.572 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.595 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 5.2 t0 -134.12 158.67 43.04 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 173.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.554 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 9.0 mptt -64.24 -38.41 90.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.164 0.507 . . . . 0.0 110.17 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -73.53 -36.93 65.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.083 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.73 -38.44 90.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.794 0.33 . . . . 0.0 110.594 176.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 87.6 mt -63.84 -53.46 50.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.558 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.21 -42.92 66.81 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.673 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -59.07 -49.13 79.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.623 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 70.5 t80 -65.85 -35.96 82.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.28 -177.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -53.66 -44.64 69.83 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.614 0.245 . . . . 0.0 110.787 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -72.32 -39.92 67.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.699 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -63.75 -36.92 85.48 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.152 -0.477 . . . . 0.0 112.279 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.47 -17.64 33.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.648 0.261 . . . . 0.0 111.417 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.794 -178.772 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.45 -0.44 0 CA-C-O 121.16 0.505 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -74.38 -26.77 60.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.369 -171.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -128.98 165.64 20.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.06 0.457 . . . . 0.0 111.635 -174.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 43.9 tt0 -148.45 116.76 6.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.235 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.472 ' CD1' HG13 ' A' ' 54' ' ' ILE . 4.5 mp -113.43 149.7 15.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -173.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.52 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 43.0 mt-10 -67.8 144.17 55.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.8 0.333 . . . . 0.0 110.25 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.3 tt -57.56 -28.57 31.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.161 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -71.69 -35.17 70.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.13 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.465 ' HB3' ' CG2' ' A' ' 7' ' ' ILE . 11.5 t70 -76.84 -40.57 47.37 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 83.7 mmm -49.22 137.18 14.25 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.913 169.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.5 m -79.59 106.87 11.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.403 0.621 . . . . 0.0 110.353 -176.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -75.52 128.2 34.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.558 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -118.03 88.07 30.46 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.822 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.55 -26.04 69.78 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.71 2.274 . . . . 0.0 111.536 -178.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.12 -29.6 70.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.765 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -110.28 5.21 21.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.528 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.531 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 2.3 mp0 58.86 38.33 24.58 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.948 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -160.4 174.68 13.76 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.051 0.453 . . . . 0.0 111.411 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -108.35 140.62 41.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.617 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.55 ' HB ' ' HD3' ' A' ' 30' ' ' ARG . 40.6 p -136.24 169.22 17.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.467 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -140.99 120.45 8.4 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.05 116.28 2.82 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 123.307 2.672 . . . . 0.0 112.975 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 28.4 t -130.29 138.99 34.29 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.422 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 46.3 Cg_endo -91.7 117.87 0.48 Allowed 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 122.049 1.832 . . . . 0.0 111.734 174.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.4 p 178.83 -43.65 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.753 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.89 -25.33 0.24 Allowed Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.994 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.541 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 2.3 t0 -142.76 175.72 9.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.55 ' HD3' ' HB ' ' A' ' 22' ' ' THR . 12.4 ptp180 -114.57 155.54 26.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.587 0.232 . . . . 0.0 111.11 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.627 ' HZ ' HD22 ' A' ' 52' ' ' LEU . 91.0 m-85 -54.57 127.72 29.11 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.16 175.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -124.5 137.9 54.38 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.099 0.476 . . . . 0.0 110.505 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.4 tt -140.66 140.29 33.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.658 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.485 ' O ' ' HG3' ' A' ' 38' ' ' MET . 17.1 m-85 -103.17 136.15 43.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.921 -172.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -56.5 -35.54 68.12 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.103 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.466 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 11.9 t70 -54.34 -51.72 63.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.088 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.97 -29.6 58.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.556 -174.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.485 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 90.4 mtp -65.76 -39.58 91.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.051 176.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -69.71 -23.49 63.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.385 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 36' ' ' ASP . 17.3 mm-40 -73.45 -16.08 61.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.588 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.8 -10.76 38.11 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.883 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -94.04 109.0 20.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.187 0.518 . . . . 0.0 110.331 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.663 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -108.0 102.47 11.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.799 0.809 . . . . 0.0 111.722 -176.11 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 p -164.43 129.3 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.263 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.27 143.52 31.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.134 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.09 139.4 47.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.974 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.518 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 17.4 t -107.73 124.02 36.14 Favored Pre-proline 0 N--CA 1.439 -0.982 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.31 175.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.553 ' O ' ' HB3' ' A' ' 49' ' ' SER . 58.5 Cg_endo -74.86 156.84 43.63 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.758 2.306 . . . . 0.0 111.023 173.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.553 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 40.1 t 88.66 -57.46 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.752 0.821 . . . . 0.0 110.906 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.0 p -91.63 -29.14 17.06 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.514 -0.475 . . . . 0.0 109.724 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 47' ' ' CYS . 33.7 t 66.92 70.13 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.517 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.627 HD22 ' HZ ' ' A' ' 31' ' ' PHE . 53.7 tp -125.51 151.32 46.48 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.427 ' HE2' ' HB2' ' A' ' 53' ' ' MET . 32.7 mtm -134.26 138.23 44.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.383 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.472 HG13 ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -142.72 154.43 17.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 177.579 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.552 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 2.4 m-20 -77.09 158.29 30.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.762 0.315 . . . . 0.0 110.403 177.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 86.0 t -132.79 125.3 52.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.847 0.356 . . . . 0.0 111.123 178.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.52 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 89.2 t -77.75 126.42 38.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.084 177.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -142.71 165.11 28.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.713 0.292 . . . . 0.0 111.154 -175.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.552 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 9.6 t70 -132.2 151.83 51.61 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 171.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -63.61 -33.2 75.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.046 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -65.61 -49.51 68.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.12 176.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -60.47 -39.56 88.06 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.086 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 40.9 mt -58.17 -57.15 14.12 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.766 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.5 -40.81 75.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.268 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -66.19 -37.54 85.85 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.434 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -77.81 -33.86 52.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -51.09 -44.84 61.32 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.893 0.377 . . . . 0.0 110.611 172.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -63.03 -45.64 91.34 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.661 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.79 -40.49 88.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.828 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.531 ' HB3' ' HA ' ' A' ' 19' ' ' GLN . . . -78.93 -12.56 60.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.529 -177.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.596 177.321 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.8 p . . . . . 0 N--CA 1.449 -0.496 0 CA-C-O 120.843 0.354 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -96.12 -24.62 16.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.72 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.402 ' HB3' ' CG2' ' A' ' 54' ' ' ILE . 47.1 t0 -120.62 167.04 12.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 33.2 tt0 -156.72 110.86 2.72 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.565 ' CD1' HG13 ' A' ' 54' ' ' ILE . 4.2 mp -109.9 147.79 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.003 0.43 . . . . 0.0 111.469 -173.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -65.33 147.01 54.18 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.129 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.67 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 21.0 tt -65.17 -28.46 44.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.371 0.605 . . . . 0.0 110.011 177.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -62.97 -39.13 93.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.618 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.489 ' HB3' ' CG2' ' A' ' 7' ' ' ILE . 19.2 t70 -80.63 -36.03 33.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.515 -175.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 79.9 mmm -54.03 144.81 18.28 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.86 170.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.7 m -91.73 127.34 37.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.688 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.664 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . 47.3 p90 -81.76 138.0 35.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.998 0.427 . . . . 0.0 110.669 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -124.39 84.25 56.67 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.605 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.2 -22.0 54.44 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.03 2.487 . . . . 0.0 112.973 -172.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -68.29 -33.3 74.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.973 0.416 . . . . 0.0 110.586 -178.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -105.61 -5.16 20.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.965 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 64.5 36.3 8.81 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.296 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -145.15 167.98 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.597 -177.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.425 ' HB2' HG23 ' A' ' 33' ' ' ILE . 71.2 m-85 -96.89 146.76 24.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.871 0.367 . . . . 0.0 110.336 177.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 22.3 p -136.82 164.46 28.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.503 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.431 ' HB3' ' CD2' ' A' ' 31' ' ' PHE . 10.1 t80 -147.59 127.02 6.45 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.91 120.42 7.87 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.414 2.742 . . . . 0.0 113.655 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.543 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 11.6 t -136.28 135.98 21.83 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.305 174.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -84.39 118.4 2.23 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 121.901 1.734 . . . . 0.0 111.572 175.19 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 32.0 p 177.14 -46.17 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 164.08 -27.11 0.21 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.326 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.556 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 2.5 t0 -139.63 175.22 9.75 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -113.58 153.17 29.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.496 -177.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.623 ' CD1' ' HB2' ' A' ' 47' ' ' CYS . 97.2 m-85 -50.19 130.66 23.06 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.194 0.309 . . . . 0.0 110.752 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.6 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 4.2 pt20 -117.85 134.67 54.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.918 0.389 . . . . 0.0 110.638 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.425 HG23 ' HB2' ' A' ' 21' ' ' PHE . 12.9 tt -147.56 133.87 12.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.288 176.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.416 ' HB2' ' OD2' ' A' ' 37' ' ' ASP . 90.5 m-85 -96.13 147.4 23.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.857 -177.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 35' ' ' LEU . 4.1 mm? -61.0 -33.92 74.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.062 178.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -56.7 -43.38 80.49 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.155 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.416 ' OD2' ' HB2' ' A' ' 34' ' ' TYR . 25.0 m-20 -67.77 -44.39 77.56 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.111 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.412 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 76.1 mtp -61.84 -44.28 97.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.643 -177.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -69.53 -29.23 66.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.68 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -72.94 -18.13 61.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.056 0.455 . . . . 0.0 110.589 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.11 1.41 33.72 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.61 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -108.16 100.61 9.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.153 0.501 . . . . 0.0 109.714 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.504 ' HD2' ' HE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -108.63 101.32 10.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.841 0.829 . . . . 0.0 111.03 -171.409 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 54' ' ' ILE . 1.8 p -163.43 131.38 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.003 -177.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.1 134.78 42.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.059 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.777 HG22 ' HG2' ' A' ' 53' ' ' MET . 46.7 t -114.74 122.99 69.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.623 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 26.1 t -83.49 124.86 75.14 Favored Pre-proline 0 C--N 1.318 -0.779 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.008 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.556 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 58.8 Cg_endo -73.2 156.64 51.09 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.832 2.355 . . . . 0.0 110.746 173.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.518 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 42.8 t 86.79 -60.38 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.447 0.699 . . . . 0.0 110.876 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 15.7 p -92.56 -24.76 18.62 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.207 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 t 64.48 79.61 0.25 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.535 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.4 tt -131.09 131.01 43.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.777 ' HG2' HG22 ' A' ' 46' ' ' VAL . 27.7 mtm -118.94 136.62 53.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.683 0.277 . . . . 0.0 111.265 -175.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.565 HG13 ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -145.52 155.43 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.66 177.143 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.539 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -76.79 152.24 35.65 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.583 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.7 t -132.7 120.05 40.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.964 0.411 . . . . 0.0 110.291 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.67 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 21.1 t -75.71 149.54 6.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.504 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 55.1 p90 -146.84 164.64 32.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.364 0.126 . . . . 0.0 110.694 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.579 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 14.4 t70 -125.98 156.76 39.32 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.861 0.362 . . . . 0.0 110.625 174.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.867 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 0.8 OUTLIER -60.63 -46.55 89.85 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.08 178.722 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -72.89 -40.67 65.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.726 -177.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -63.77 -39.6 94.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.3 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 66.8 mt -64.21 -52.42 58.91 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.498 176.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.14 -45.12 71.89 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.273 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.48 -44.73 95.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.354 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.664 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 54.6 t80 -66.36 -40.83 90.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.586 -176.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -51.31 -48.43 62.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.923 0.392 . . . . 0.0 110.679 175.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -71.15 -35.68 71.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.833 -177.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -70.14 -45.22 67.26 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.75 -12.68 59.42 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -174.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.618 0 C-N-CA 120.424 -0.894 . . . . 0.0 111.387 -179.523 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 N--CA 1.448 -0.551 0 CA-C-O 120.99 0.424 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -88.14 -14.2 39.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.157 -172.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -142.7 174.76 10.36 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.294 -177.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.541 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 33.5 tt0 -155.67 116.59 3.86 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.466 0.479 . . . . 0.0 109.747 -176.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.417 ' CD1' HG13 ' A' ' 54' ' ' ILE . 1.6 mp -129.33 146.44 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.79 -177.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.526 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 46.4 mt-10 -69.82 145.75 51.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.951 0.405 . . . . 0.0 110.463 174.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.2 tt -55.26 -28.89 22.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.474 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -63.1 -33.61 75.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.721 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -86.16 -31.62 21.71 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.164 -174.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.519 ' HA ' ' HD1' ' A' ' 23' ' ' TYR . 80.2 mtp -65.16 145.33 56.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 110.974 177.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.6 m -72.84 120.32 18.3 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.484 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -79.83 133.98 36.31 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.209 177.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -122.54 89.93 49.61 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.125 0.488 . . . . 0.0 110.061 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.77 -14.89 43.02 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.898 2.398 . . . . 0.0 111.917 -177.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -66.46 -40.3 89.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.488 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.545 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 2.8 t-20 -110.73 0.79 17.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.247 -177.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.704 HE21 ' N ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER 59.83 42.32 16.73 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.834 -179.753 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.545 ' HG2' ' HB3' ' A' ' 18' ' ' ASN . 26.9 ptt? -146.96 174.3 11.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.076 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -114.46 142.27 46.6 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 38.6 p -133.2 145.99 51.09 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.519 ' HD1' ' HA ' ' A' ' 12' ' ' MET . 9.6 t80 -119.61 131.15 24.5 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.55 122.79 12.25 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 123.016 2.477 . . . . 0.0 113.096 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.559 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 22.4 t -139.45 138.76 20.92 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.926 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -91.87 117.99 0.47 Allowed 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.19 1.927 . . . . 0.0 111.859 174.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.464 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 30.7 p -178.54 -52.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.745 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.464 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 172.43 -27.89 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.883 -178.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.563 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 2.5 t70 -142.41 176.52 8.94 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.412 ' HE ' ' CB ' ' A' ' 22' ' ' THR . 10.6 ptm180 -114.7 147.51 39.56 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.633 ' O ' ' HA ' ' A' ' 22' ' ' THR . 97.7 m-85 -46.97 121.27 3.54 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.517 0.511 . . . . 0.0 110.18 178.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -120.49 131.52 54.77 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.897 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 20' ' ' MET . 14.7 tt -132.54 132.5 60.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.936 176.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.439 ' O ' ' HG3' ' A' ' 38' ' ' MET . 30.5 m-85 -90.27 134.83 34.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.756 -173.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.413 ' O ' HD11 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -61.46 -30.54 70.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.012 -178.315 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -54.04 -44.82 71.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.943 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.522 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . 16.3 m-20 -77.26 -37.67 52.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.768 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.439 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 79.1 mtp -59.88 -42.43 93.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.544 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -60.49 -37.73 82.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.7 176.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.83 -22.22 64.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.768 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.51 7.06 32.66 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.653 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 8.0 tp10 -93.17 107.01 18.9 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.809 ' HD2' ' HE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -120.48 98.97 6.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.015 0.912 . . . . 0.0 111.68 -174.737 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 p -167.23 130.14 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.261 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.439 ' HB1' HD13 ' A' ' 54' ' ' ILE . . . -100.82 136.04 41.32 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.864 0.364 . . . . 0.0 110.406 -178.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.745 HG23 ' HG2' ' A' ' 53' ' ' MET . 44.7 t -114.07 129.84 69.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.535 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.554 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 13.0 t -99.25 119.46 60.46 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.778 178.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.563 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 34.4 Cg_endo -69.23 155.93 66.22 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.136 1.89 . . . . 0.0 111.162 175.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 44.5 t 85.36 -56.19 0.09 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.692 0.797 . . . . 0.0 111.366 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 52' ' ' LEU . 16.3 p -93.65 -18.56 22.03 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.4 t 67.23 43.06 2.13 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.839 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.628 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -94.21 148.55 22.08 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.676 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.745 ' HG2' HG23 ' A' ' 46' ' ' VAL . 48.9 mtm -140.36 135.73 32.45 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.032 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.439 HD13 ' HB1' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -144.75 152.65 14.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.957 179.43 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 0.4 OUTLIER -76.04 152.95 36.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.879 178.703 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.78 143.37 39.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 56.5 t -103.07 107.99 23.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.809 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 24.3 p90 -113.57 164.53 13.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.099 -177.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -136.46 158.26 44.86 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' A' ' 60' ' ' LYS . 12.4 mptt -64.02 -33.97 76.96 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.764 176.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -60.13 -54.08 50.19 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.232 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -61.46 -43.9 98.06 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.511 -176.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 35.2 mt -59.86 -49.62 77.0 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.285 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.45 80.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.775 0.321 . . . . 0.0 111.381 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -65.72 -53.73 36.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.452 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -68.91 -33.76 74.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.462 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.94 -46.23 64.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.916 175.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -67.25 -45.78 75.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.938 0.399 . . . . 0.0 110.983 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -61.51 -49.58 76.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.882 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.84 -20.34 53.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.113 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -177.995 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.0 p . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 121.054 0.454 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -92.0 -28.18 17.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.439 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -135.81 171.69 14.09 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.067 -171.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 39.7 tt0 -150.58 109.84 3.96 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.02 158.11 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 -175.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.497 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 57.3 mm-40 -61.63 150.59 35.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.138 0.494 . . . . 0.0 111.21 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.683 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 20.6 tt -62.4 -28.7 45.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.227 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -63.2 -29.96 71.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.397 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -79.16 -34.63 43.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.259 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.647 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 90.6 mmm -62.11 118.13 6.93 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 173.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.3 m -71.59 107.86 4.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.406 0.622 . . . . 0.0 110.442 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.585 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 39.0 p90 -74.54 137.6 42.53 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.183 -177.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -114.75 101.93 54.61 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.14 175.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.66 -9.15 23.39 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.072 2.515 . . . . 0.0 112.432 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -93.05 -38.53 11.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.121 0.486 . . . . 0.0 109.877 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.545 ' OD1' ' HE2' ' A' ' 20' ' ' MET . 1.3 t-20 -89.39 -5.85 57.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.464 -175.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 73.46 18.2 3.67 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.608 171.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.573 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 27.3 ptt? -161.75 175.71 11.69 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.081 -173.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.647 ' HB3' ' HB3' ' A' ' 12' ' ' MET . 87.3 m-85 -95.76 131.08 42.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.133 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 23.8 p -129.04 137.8 51.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.779 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 36.0 t80 -109.64 122.6 38.81 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.21 121.31 9.18 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.229 2.62 . . . . 0.0 113.193 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.401 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 30.7 t -138.29 141.11 30.61 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.3 177.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -94.69 118.18 0.25 Allowed 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 122.157 1.905 . . . . 0.0 112.004 173.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.1 p -179.75 -44.95 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.391 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.71 -24.64 0.23 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.143 -177.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.458 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 4.3 t70 -141.91 177.01 8.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.94 151.04 32.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.933 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.779 ' HB2' ' HB3' ' A' ' 23' ' ' TYR . 75.6 m-85 -54.8 114.67 1.8 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 175.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.41 137.06 52.74 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.992 0.425 . . . . 0.0 110.98 -174.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.573 ' O ' ' HB2' ' A' ' 20' ' ' MET . 14.5 tt -139.64 129.13 29.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.827 173.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.431 ' O ' ' HG3' ' A' ' 38' ' ' MET . 14.1 m-85 -79.59 135.86 36.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.162 -173.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.455 HD11 ' CD2' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -66.88 -36.66 82.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.007 0.432 . . . . 0.0 110.049 -176.751 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 17.3 t70 -61.13 -35.44 77.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.454 176.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -69.54 -42.8 74.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.215 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.607 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 75.5 mtp -65.4 -37.72 87.83 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.5 178.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -69.53 -23.48 63.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.471 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 36' ' ' ASP . 70.4 mm-40 -75.05 -12.51 60.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 176.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.15 -5.42 33.97 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.529 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.607 ' O ' ' HA ' ' A' ' 38' ' ' MET . 0.7 OUTLIER -85.34 146.89 26.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 177.605 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 32.2 pttt -144.89 97.59 3.04 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.586 0.708 . . . . 0.0 111.2 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 p -167.74 126.67 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.036 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 53' ' ' MET . . . -100.54 131.15 46.6 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.966 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.9 p -111.91 139.29 37.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.995 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.42 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 8.6 t -116.34 115.02 40.39 Favored Pre-proline 0 N--CA 1.435 -1.178 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.117 175.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.55 ' O ' ' HB3' ' A' ' 49' ' ' SER . 34.2 Cg_endo -69.0 157.38 62.09 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.601 2.201 . . . . 0.0 111.452 174.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.55 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 35.9 t 88.51 -57.33 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.027 0.931 . . . . 0.0 110.586 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.7 p -90.43 -28.29 18.72 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.003 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.8 t 68.87 54.76 0.46 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.898 177.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.464 HD21 ' N ' ' A' ' 53' ' ' MET . 1.9 tt -114.76 137.2 52.21 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.464 ' N ' HD21 ' A' ' 52' ' ' LEU . 35.6 mtm -132.61 138.23 47.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.021 -178.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.49 156.37 18.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.502 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 39.9 m-20 -80.21 159.95 25.78 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.575 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 11.2 p -136.32 138.07 47.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.993 0.425 . . . . 0.0 111.052 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.683 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 61.8 t -72.12 141.57 16.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -150.03 155.94 40.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.854 0.359 . . . . 0.0 110.908 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -134.88 155.5 50.57 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -63.73 -34.67 78.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.178 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -73.93 -40.93 62.76 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.035 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -59.4 -46.39 88.84 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.16 0.505 . . . . 0.0 110.269 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 72.9 mt -69.51 -44.55 70.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.412 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.78 -46.69 88.4 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.66 0.267 . . . . 0.0 111.259 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.572 ' O ' ' HG3' ' A' ' 69' ' ' GLU . 23.8 tt0 -64.95 -49.55 69.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.861 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.468 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 80.0 t80 -62.22 -34.81 77.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.151 -178.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.455 ' CD2' HD11 ' A' ' 35' ' ' LEU . 2.0 t80 -54.18 -44.94 71.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.679 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -76.96 -33.84 57.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.105 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 48.2 mt-10 -61.17 -49.74 76.01 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.974 0.416 . . . . 0.0 110.859 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.23 -25.95 63.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.158 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.57 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.657 177.502 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.448 -0.565 0 CA-C-O 120.841 0.353 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -102.9 -26.64 13.04 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.74 154.06 24.43 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.956 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . 42.3 tt0 -146.3 122.89 11.12 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.613 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 mp -122.61 156.0 27.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.554 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 47.0 mt-10 -73.21 151.93 41.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.266 0.555 . . . . 0.0 111.19 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.434 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 20.4 tt -59.64 -28.59 40.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.59 -178.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -58.8 -38.53 78.78 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.26 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -73.18 -36.56 66.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.98 -174.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 89.5 mmm -58.37 149.92 23.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.188 176.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.4 m -100.9 108.02 19.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.959 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.431 ' HD2' ' HD3' ' A' ' 16' ' ' PRO . 44.6 p90 -74.08 136.03 43.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.011 0.434 . . . . 0.0 111.116 -176.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -115.21 86.7 14.64 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.623 176.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.431 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 20.7 Cg_endo -61.31 -28.2 84.2 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.01 2.473 . . . . 0.0 112.455 -174.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -69.53 -20.28 63.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.117 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.418 ' CB ' ' HE2' ' A' ' 20' ' ' MET . 0.9 OUTLIER -111.72 -1.06 15.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.702 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 57.64 43.07 22.95 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.292 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.418 ' HE2' ' CB ' ' A' ' 18' ' ' ASN . 26.9 ptt? -154.16 165.89 34.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.846 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.474 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 88.0 m-85 -103.87 139.59 38.85 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.6 ' HB ' ' HD3' ' A' ' 30' ' ' ARG . 77.5 p -130.59 169.86 15.04 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 121.141 -0.223 . . . . 0.0 110.929 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -152.77 127.23 4.57 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.36 126.31 21.79 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 123.144 2.563 . . . . 0.0 112.655 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.592 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 9.5 t -135.51 144.3 48.71 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.027 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -86.06 117.92 1.66 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.772 1.648 . . . . 0.0 111.949 173.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.437 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 30.3 p 172.48 -49.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.57 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.437 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 163.19 -24.48 0.19 Allowed Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.398 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.418 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 1.3 t0 -134.61 176.41 8.66 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.351 -0.241 . . . . 0.0 110.351 -177.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.6 ' HD3' ' HB ' ' A' ' 22' ' ' THR . 15.4 ptp180 -109.18 150.77 27.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.942 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.614 ' CD1' ' HB2' ' A' ' 47' ' ' CYS . 97.2 m-85 -55.39 140.46 39.77 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -137.16 134.14 36.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.181 0.515 . . . . 0.0 110.666 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.474 ' CG2' ' HB2' ' A' ' 21' ' ' PHE . 12.4 tt -131.16 130.39 63.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.679 177.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.483 ' O ' ' HG3' ' A' ' 38' ' ' MET . 24.4 m-85 -87.67 147.57 25.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.243 -174.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.422 ' O ' HD11 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -66.7 -35.36 79.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.956 -176.16 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.1 -44.78 79.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.803 178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -64.08 -43.04 96.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.628 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.483 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 55.3 mtp -63.57 -37.59 87.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.488 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -65.32 -35.45 81.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.272 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -70.92 -15.94 62.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.655 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.31 -3.63 59.91 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -81.84 81.64 7.78 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.31 0.576 . . . . 0.0 109.522 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.711 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.64 98.39 11.61 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.358 1.075 . . . . 0.0 110.439 -179.563 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 2.0 p -167.09 129.46 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.802 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 53' ' ' MET . . . -99.46 130.21 45.71 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -107.05 134.36 48.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.147 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.614 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 35.0 t -105.31 123.77 38.57 Favored Pre-proline 0 N--CA 1.433 -1.303 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.093 176.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.615 ' O ' ' HB3' ' A' ' 49' ' ' SER . 33.3 Cg_endo -65.89 156.57 63.6 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.499 2.133 . . . . 0.0 111.044 172.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.615 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 27.4 t 86.21 -61.37 0.05 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.349 0.659 . . . . 0.0 110.963 178.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.4 p -90.99 -23.43 20.4 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.188 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.5 t 68.2 41.57 1.9 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.117 175.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.55 HD22 ' HZ ' ' A' ' 31' ' ' PHE . 54.3 tp -98.79 142.35 30.43 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.112 0.482 . . . . 0.0 109.943 -178.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.464 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 43.5 mtm -132.5 138.01 47.39 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.798 -178.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -141.3 150.38 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 177.305 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 7.3 m-20 -68.85 155.58 39.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.815 0.34 . . . . 0.0 110.181 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 90.7 t -135.29 124.51 41.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.83 176.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.554 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 41.5 t -75.64 104.84 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -108.67 164.78 12.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.909 -175.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.55 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 13.8 t70 -130.13 146.9 51.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.79 175.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -64.07 -32.56 74.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.975 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -73.57 -40.5 63.86 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.663 0.268 . . . . 0.0 110.606 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.73 -41.27 90.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.872 0.367 . . . . 0.0 110.322 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 67.3 mt -63.85 -48.94 74.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.79 178.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.15 -41.95 93.87 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.879 -177.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -63.06 -53.79 48.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.347 0.594 . . . . 0.0 110.466 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.407 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 78.9 t80 -63.81 -36.19 83.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.389 -178.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.14 -44.71 67.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.119 177.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -69.55 -36.18 76.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.625 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -75.96 -34.34 59.82 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.97 -20.27 24.67 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -178.179 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.3 p . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 121.014 0.435 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -98.33 -0.47 43.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.588 -174.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -134.04 162.95 30.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.53 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 40.1 tt0 -159.86 120.28 3.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.86 -177.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.65 161.69 20.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -175.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -74.06 146.81 43.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.371 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.0 tt -59.41 -29.69 42.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.422 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -68.84 -28.26 66.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.923 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -79.4 -31.21 42.73 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.99 0.424 . . . . 0.0 110.3 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 82.3 mmm -63.58 128.07 34.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.986 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 22' ' ' THR . 86.2 m -71.83 119.43 15.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.198 0.523 . . . . 0.0 110.899 -177.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.656 ' HB2' ' HE1' ' A' ' 66' ' ' TYR . 36.2 p90 -74.58 138.81 43.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.035 -177.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -129.23 87.71 53.05 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.914 177.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.416 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 18.7 Cg_endo -59.84 -33.02 96.21 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.274 2.649 . . . . 0.0 112.897 -175.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.63 -28.71 70.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.891 -176.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -113.03 4.95 16.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.707 0.289 . . . . 0.0 111.112 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 59.14 32.0 21.73 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.395 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -144.94 159.01 43.6 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.165 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -93.89 141.81 28.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.726 175.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 20.6 p -137.7 141.57 41.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.642 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.434 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 17.6 t80 -125.52 117.82 24.77 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -178.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -48.44 118.53 3.36 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.47 2.78 . . . . 0.0 113.286 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 19.9 t -130.39 135.66 27.76 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.439 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 5.8 Cg_endo -84.74 118.21 2.09 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.869 1.712 . . . . 0.0 111.442 175.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.409 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 29.9 p 174.62 -45.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -177.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.409 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 159.65 -27.1 0.35 Allowed Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.783 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -138.23 176.0 9.08 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.46 ' HG3' ' HB ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -120.06 156.49 30.86 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.155 -177.078 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.634 ' O ' ' HA ' ' A' ' 22' ' ' THR . 97.3 m-85 -56.4 123.03 13.31 Favored 'General case' 0 CA--C 1.518 -0.258 0 O-C-N 123.384 0.428 . . . . 0.0 110.165 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.572 ' HG2' HG22 ' A' ' 22' ' ' THR . 24.2 mt-30 -120.8 137.63 54.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.823 0.344 . . . . 0.0 110.756 -178.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 45' ' ' ALA . 10.1 tt -145.93 125.22 5.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.419 175.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -87.31 149.49 24.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.252 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.622 ' HA ' ' HG3' ' A' ' 38' ' ' MET . 7.7 tp -71.3 -24.65 62.18 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.12 0.485 . . . . 0.0 110.65 -176.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -54.6 -40.15 68.57 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.429 173.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -68.74 -44.56 73.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.202 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.622 ' HG3' ' HA ' ' A' ' 35' ' ' LEU . 15.2 mtp -62.72 -46.48 87.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.602 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -65.29 -25.19 67.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.095 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.92 -21.86 65.1 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.226 0.536 . . . . 0.0 110.523 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.75 -2.34 34.03 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.012 -177.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.432 ' HG3' HG11 ' A' ' 44' ' ' VAL . 10.2 tp10 -100.19 130.28 46.3 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 20.3 pttp -122.78 101.25 7.34 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.448 0.642 . . . . 0.0 111.068 -176.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 2.6 p -167.3 129.33 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.258 -177.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.482 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . . . -100.74 141.7 33.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.472 175.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.9 p -122.0 134.37 65.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.906 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.432 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 10.9 t -104.33 128.25 27.42 Favored Pre-proline 0 N--CA 1.438 -1.051 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 174.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.82 156.56 20.85 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.734 2.29 . . . . 0.0 111.553 176.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.0 t 85.95 -55.39 0.07 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.699 0.8 . . . . 0.0 110.681 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 15.9 p -87.32 -32.22 19.77 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 47' ' ' CYS . 16.6 m 68.96 76.26 0.24 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.233 174.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.47 HD22 ' HZ ' ' A' ' 31' ' ' PHE . 57.6 tp -133.56 143.75 48.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.627 175.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.436 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 36.2 mtm -132.42 138.26 47.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.578 -177.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -143.31 152.82 16.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.942 178.955 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 2.2 m-20 -70.87 153.3 42.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.648 0.261 . . . . 0.0 110.557 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.513 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 99.9 t -135.46 114.74 16.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.501 176.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.54 117.8 15.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.069 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.501 ' HB3' ' HE1' ' A' ' 38' ' ' MET . 51.5 p90 -111.7 164.86 12.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.819 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.598 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 15.0 t70 -131.74 159.05 39.56 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.355 177.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.689 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 9.2 mptt -58.74 -44.1 90.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.473 178.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -75.53 -37.27 60.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.987 -176.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -62.1 -39.74 93.49 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.671 177.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 80.7 mt -68.83 -44.23 73.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.468 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.36 -51.27 70.21 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.779 -176.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -70.89 -33.39 70.53 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.362 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.656 ' HE1' ' HB2' ' A' ' 14' ' ' PHE . 56.4 t80 -67.16 -35.71 80.27 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.208 176.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.52 -46.1 66.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.623 174.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -71.51 -43.85 65.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.014 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -72.82 -34.11 66.64 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.05 -17.4 43.38 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.147 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.462 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.524 178.892 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 53' ' ' MET . 12.3 p . . . . . 0 N--CA 1.446 -0.648 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -95.27 -1.61 51.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.643 -171.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -143.19 171.92 13.43 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 44.3 tt0 -162.19 108.54 1.28 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -177.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.442 ' CD1' HG13 ' A' ' 54' ' ' ILE . 2.2 mp -119.67 151.26 22.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.385 -172.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -63.17 144.62 56.76 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 175.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.3 tt -60.54 -33.28 53.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.206 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.69 -27.82 62.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.209 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.426 ' HB3' HG21 ' A' ' 7' ' ' ILE . 17.8 t70 -73.57 -35.89 65.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.581 -176.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.458 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 81.4 mtp -69.2 153.76 43.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.479 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.1 m -82.12 113.22 19.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.82 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.489 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . 33.4 p90 -77.5 138.73 39.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.946 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -113.5 88.98 14.17 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.47 -29.51 88.82 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.215 2.61 . . . . 0.0 113.901 -169.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.94 -32.52 73.02 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.883 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.452 ' HB2' ' HG2' ' A' ' 20' ' ' MET . 46.6 m-80 -105.02 1.38 28.55 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.466 -173.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 57.28 39.05 28.85 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.032 0.444 . . . . 0.0 110.383 -178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.452 ' HG2' ' HB2' ' A' ' 18' ' ' ASN . 27.1 ptt? -137.71 170.66 15.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.934 0.397 . . . . 0.0 111.004 -175.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.507 ' HE1' HD21 ' A' ' 35' ' ' LEU . 52.8 m-85 -119.47 144.67 46.86 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.867 176.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 35.6 p -133.03 158.37 42.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.376 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.458 ' CD1' ' HA ' ' A' ' 12' ' ' MET . 4.5 t80 -141.31 129.52 12.21 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -57.7 119.43 6.68 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.985 2.457 . . . . 0.0 113.361 -175.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 17.3 t -133.21 131.8 21.86 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.304 176.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 1.3 Cg_endo -85.31 117.83 1.87 Allowed 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.949 1.766 . . . . 0.0 111.487 173.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 28.4 p -179.15 -47.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.648 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.45 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 168.19 -25.4 0.12 Allowed Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.227 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.538 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 2.5 t70 -143.29 176.35 9.21 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -117.48 154.33 31.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.326 0.108 . . . . 0.0 110.769 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 22' ' ' THR . 94.3 m-85 -48.4 131.32 16.93 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.528 0.517 . . . . 0.0 111.342 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -127.15 126.87 43.64 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.977 -173.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.447 ' HB ' ' HA ' ' A' ' 45' ' ' ALA . 11.5 tt -148.84 136.4 13.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.321 176.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.442 ' O ' ' HG3' ' A' ' 38' ' ' MET . 91.3 m-85 -98.61 147.06 25.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.954 0.406 . . . . 0.0 111.36 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.507 HD21 ' HE1' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -65.62 -33.91 77.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.297 -178.244 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.79 -42.31 71.63 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.962 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -68.96 -40.53 78.85 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.97 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 75.2 mtp -63.8 -31.39 72.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.342 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -72.94 -21.19 60.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.624 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -79.1 -6.78 57.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.221 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.08 -18.2 34.03 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.089 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 38' ' ' MET . 33.0 tt0 -94.62 135.09 36.49 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.688 ' HD2' ' HE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -133.22 101.04 5.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.608 0.718 . . . . 0.0 110.983 -177.365 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 p -165.65 128.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.73 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . . . -100.07 135.86 40.85 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.004 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p -109.74 134.2 52.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.117 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.526 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 24.6 t -101.17 118.47 60.18 Favored Pre-proline 0 N--CA 1.433 -1.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.896 176.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.558 ' O ' ' HB3' ' A' ' 49' ' ' SER . 24.6 Cg_endo -65.38 156.54 62.79 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.397 2.065 . . . . 0.0 111.034 173.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.558 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 35.6 t 87.13 -56.91 0.04 OUTLIER 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.621 0.768 . . . . 0.0 111.035 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.0 p -92.96 -26.97 17.33 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.132 177.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.7 t 70.27 44.07 0.78 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.927 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.441 HD21 ' N ' ' A' ' 53' ' ' MET . 2.1 tt -101.33 136.22 41.54 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.486 ' O ' ' HA ' ' A' ' 3' ' ' THR . 36.9 mtm -125.07 138.56 54.19 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 -177.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.442 HG13 ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -140.45 155.39 23.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.865 178.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.544 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 15.1 m-20 -80.92 159.15 25.04 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.2 t -130.94 126.28 59.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.71 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.7 t -87.49 101.74 11.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.066 0.46 . . . . 0.0 110.642 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.688 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 47.5 p90 -104.48 164.72 11.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.418 -178.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.494 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 20.3 t70 -128.47 159.5 35.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.944 0.402 . . . . 0.0 110.72 175.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.768 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -59.95 -47.55 85.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.416 177.208 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.13 -36.9 80.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.501 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -69.87 -40.66 75.58 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.618 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 42.8 mt -61.57 -44.81 96.34 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.73 177.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.17 -34.4 76.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.932 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -64.84 -54.07 36.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.701 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.489 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 77.0 t80 -65.0 -34.64 78.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.448 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -51.46 -47.14 63.21 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.165 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.81 -45.15 62.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.149 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.54 -43.89 88.53 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.12 -25.69 36.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.744 0.307 . . . . 0.0 111.407 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.673 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -176.656 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.475 0.655 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m -152.31 179.17 8.78 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.178 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.645 ' HB ' ' HB2' ' A' ' 55' ' ' ASP . 5.1 p -82.12 100.78 10.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 0.0 111.615 -178.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -103.06 -16.83 15.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.478 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -102.1 138.35 39.16 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -137.72 114.94 10.95 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -175.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.631 HD11 HD11 ' A' ' 54' ' ' ILE . 4.3 mp -111.36 138.75 38.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.889 0.376 . . . . 0.0 110.235 -176.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.534 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 31.6 mt-10 -66.69 141.6 57.71 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.156 175.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.1 tt -57.07 -28.33 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.995 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -68.14 -28.76 67.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.355 -0.384 . . . . 0.0 112.014 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -82.2 -38.77 24.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.91 0.386 . . . . 0.0 109.995 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 81.1 mmm -53.33 127.07 23.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.496 170.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.3 m -79.1 123.24 27.16 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.659 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 35.7 p90 -94.65 134.47 37.2 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.636 -176.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -107.24 94.26 10.93 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.559 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.9 -27.99 86.16 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.113 2.542 . . . . 0.0 112.763 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -73.74 -27.52 61.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.969 0.414 . . . . 0.0 110.329 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -96.91 -10.08 27.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.895 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 62.66 36.66 13.36 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.833 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -151.78 169.23 22.74 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.456 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.659 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 30.0 m-85 -110.05 140.68 43.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.267 175.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 79.7 p -127.96 163.54 24.28 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.037 0.446 . . . . 0.0 110.759 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -134.8 126.7 18.06 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.31 115.3 1.98 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 123.18 2.587 . . . . 0.0 113.254 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.481 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 41.9 t -128.67 137.37 30.79 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.866 177.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 9.0 Cg_endo -90.3 120.14 0.8 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.487 2.125 . . . . 0.0 111.369 172.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 28.7 p 175.54 -43.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.41 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 160.15 -23.38 0.27 Allowed Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.51 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.423 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 2.8 t0 -142.49 175.71 9.58 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.523 ' HG3' HH11 ' A' ' 30' ' ' ARG . 9.3 ptt85 -113.26 152.96 29.16 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 122.799 0.439 . . . . 0.0 110.706 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' A' ' 22' ' ' THR . 86.7 m-85 -55.4 136.26 49.6 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.334 0.397 . . . . 0.0 110.227 176.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -128.83 124.1 34.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.093 0.473 . . . . 0.0 111.524 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.477 ' HB ' ' HB3' ' A' ' 45' ' ' ALA . 12.0 tt -127.46 127.1 68.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.661 174.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.525 ' O ' ' HG3' ' A' ' 38' ' ' MET . 36.7 m-85 -93.96 131.07 39.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.001 -172.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.27 -31.63 69.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.187 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -54.28 -47.2 72.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.12 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -83.37 -24.53 31.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.271 -176.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.585 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 93.9 mtp -65.1 -38.76 91.76 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.66 174.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -65.61 -29.43 70.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.225 175.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -71.15 -12.32 61.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.214 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.44 -6.86 36.45 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.623 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.585 ' O ' ' HA ' ' A' ' 38' ' ' MET . 9.2 tp10 -94.86 138.39 32.69 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.639 ' HD2' ' HE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -138.71 101.51 4.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 122.103 0.954 . . . . 0.0 111.553 -179.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.3 p -165.23 130.87 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.735 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.487 ' HB2' HD13 ' A' ' 54' ' ' ILE . . . -100.51 131.07 46.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.717 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.76 139.44 34.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.752 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 51' ' ' SER . 18.5 t -108.27 134.45 20.19 Favored Pre-proline 0 N--CA 1.436 -1.129 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.006 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.536 ' O ' ' HB2' ' A' ' 49' ' ' SER . 47.1 Cg_endo -83.0 157.18 15.34 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.16 2.573 . . . . 0.0 111.848 175.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.536 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 75.4 m 84.73 -55.8 0.1 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.889 0.876 . . . . 0.0 110.772 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.2 p -87.67 -33.06 18.92 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 174.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 47' ' ' CYS . 59.3 m 67.42 64.07 0.42 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.613 177.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.454 ' HB3' ' HE1' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -114.54 154.62 27.95 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.277 176.068 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.42 ' HE2' ' HB2' ' A' ' 53' ' ' MET . 41.1 mtm -132.52 137.09 47.03 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.446 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.631 HD11 HD11 ' A' ' 7' ' ' ILE . 2.8 pp -143.68 148.16 19.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.471 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.645 ' HB2' ' HB ' ' A' ' 3' ' ' THR . 4.7 t70 -85.15 152.95 22.99 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -175.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.2 t -134.12 117.79 26.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.54 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.534 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 26.9 t -71.35 108.14 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.605 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.639 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 25.8 p90 -109.77 164.86 12.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.618 0.247 . . . . 0.0 110.407 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.618 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 5.7 t70 -134.09 160.31 38.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.111 0.482 . . . . 0.0 110.647 175.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.53 ' HB3' HG21 ' A' ' 78' ' ' ILE . 21.0 mtmm -62.54 -44.58 96.01 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.755 177.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -69.39 -35.58 75.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.801 -176.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -67.91 -44.04 77.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.174 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 81.6 mt -59.34 -49.23 78.63 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.183 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.57 -41.63 95.01 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.236 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -66.67 -45.92 77.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.295 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.511 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 84.1 t80 -67.57 -35.7 79.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.082 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.538 ' CE2' ' HB ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -53.8 -41.31 67.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 110.442 178.469 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -70.14 -38.77 75.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.088 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -70.15 -45.89 65.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.3 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.9 -15.48 63.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.197 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.58 52.97 10.69 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.823 -0.704 . . . . 0.0 111.593 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.538 ' HB ' ' CE2' ' A' ' 67' ' ' TYR . 0.4 OUTLIER -106.42 162.95 5.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -62.4 131.02 93.71 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.754 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -42.17 120.41 1.56 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 124.103 3.202 . . . . 0.0 114.072 -175.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -81.68 165.49 17.96 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.628 2.885 . . . . 0.0 111.614 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -72.79 133.02 82.59 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.62 146.89 94.04 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 123.096 2.53 . . . . 0.0 112.934 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.53 HG21 ' HB3' ' A' ' 60' ' ' LYS . 32.1 pt -85.15 169.45 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.23 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.82 52.93 1.55 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.922 0.392 . . . . 0.0 111.33 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.62 94.07 2.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.041 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.76 105.9 4.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.718 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.86 176.535 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.5 mtp . . . . . 0 C--O 1.234 0.271 0 CA-C-O 121.275 0.559 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 p -154.99 166.1 34.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.0 -173.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.4 p -73.75 102.35 3.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.27 177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -83.53 1.42 42.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.157 -177.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -146.0 163.98 33.51 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.555 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 34.6 tt0 -156.96 108.81 2.42 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -176.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 mp -116.16 145.45 21.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.281 -173.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.564 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 44.4 mt-10 -63.33 138.26 58.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 173.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.1 tt -51.51 -29.38 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.715 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -60.19 -34.06 73.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.218 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -81.33 -28.77 34.4 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.52 -172.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.561 ' HA ' ' HD1' ' A' ' 23' ' ' TYR . 84.2 mtp -66.3 156.41 34.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.139 0.495 . . . . 0.0 110.967 176.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.7 m -93.39 110.36 21.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.35 0.595 . . . . 0.0 110.207 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.547 ' HD2' ' HD3' ' A' ' 16' ' ' PRO . 38.8 p90 -74.86 140.08 43.62 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.894 -177.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -124.14 89.06 52.22 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 121.229 0.537 . . . . 0.0 109.943 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.547 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 26.4 Cg_endo -62.23 -26.26 77.4 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.369 2.713 . . . . 0.0 112.747 -173.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -69.34 -21.34 63.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.504 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -116.24 7.94 14.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.839 0.352 . . . . 0.0 110.698 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 57.39 43.1 23.76 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.751 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -154.0 171.72 18.6 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.451 -0.499 . . . . 0.0 111.403 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.518 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 57.6 m-85 -112.86 141.93 46.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.412 176.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 17.2 p -133.63 135.4 44.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.993 0.425 . . . . 0.0 111.107 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.561 ' HD1' ' HA ' ' A' ' 12' ' ' MET . 7.6 t80 -106.36 117.47 57.11 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -56.38 113.37 1.42 Allowed 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.028 2.486 . . . . 0.0 113.717 -173.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 12.2 t -126.86 132.14 24.19 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.65 175.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 2.1 Cg_endo -86.08 118.16 1.68 Allowed 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 121.802 1.668 . . . . 0.0 111.582 174.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 29.3 p -177.09 -46.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.414 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 169.29 -27.46 0.13 Allowed Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.367 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.462 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 3.5 t70 -142.02 175.09 10.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -123.26 147.82 46.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.639 0.2 . . . . 0.0 110.619 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 22' ' ' THR . 96.7 m-85 -46.51 111.35 0.37 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.597 0.561 . . . . 0.0 111.221 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -111.37 135.39 51.99 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.089 0.471 . . . . 0.0 111.073 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.44 ' HB ' ' HB2' ' A' ' 45' ' ' ALA . 16.9 tt -132.62 136.7 55.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.754 177.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.532 ' O ' ' HG3' ' A' ' 38' ' ' MET . 30.0 m-85 -95.02 126.37 40.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.369 -174.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.405 ' O ' HD11 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -55.3 -34.73 64.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.123 0.487 . . . . 0.0 110.625 -178.12 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -57.3 -48.74 78.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.414 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -70.78 -32.16 69.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.909 -178.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.532 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 81.2 mtp -61.18 -43.67 98.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.307 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -66.64 -31.15 71.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.192 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -72.37 -14.23 61.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.427 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.74 0.78 36.74 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.632 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -99.54 93.89 6.11 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.515 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -106.19 101.06 10.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 122.001 0.905 . . . . 0.0 111.265 -176.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 p -166.55 131.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.839 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.44 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -100.39 138.93 36.79 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.323 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.07 139.22 43.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.17 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.564 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 7.0 t -110.6 116.02 53.02 Favored Pre-proline 0 C--N 1.313 -0.989 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.133 176.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.496 ' O ' ' HB3' ' A' ' 49' ' ' SER . 35.1 Cg_endo -71.59 157.14 56.65 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.373 2.049 . . . . 0.0 111.192 172.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 46.2 t 89.93 -59.36 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.045 0.938 . . . . 0.0 110.322 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.9 p -89.46 -29.19 19.18 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.677 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 t 69.01 74.53 0.25 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.621 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.439 HD21 ' HZ ' ' A' ' 31' ' ' PHE . 53.9 tp -138.68 152.02 47.68 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.6 mtm -133.44 137.94 45.98 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.587 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.56 153.5 28.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.155 178.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.555 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 3.8 t70 -80.05 151.81 29.72 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.23 115.59 26.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.976 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.564 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 42.5 t -70.12 118.07 14.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.509 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.405 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 19.8 p90 -122.78 159.96 26.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.571 -177.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.485 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.8 t70 -131.35 167.44 19.25 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.413 ' HB2' ' HE2' ' A' ' 60' ' ' LYS . 23.2 mtmm -63.05 -45.32 92.81 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.342 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -68.69 -40.31 80.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.038 -1.437 . . . . 0.0 111.14 -175.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.47 -42.11 99.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.761 0.315 . . . . 0.0 110.994 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 75.9 mt -63.83 -46.28 85.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.241 177.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.544 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . . . -57.38 -47.21 82.27 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.38 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.18 -46.38 79.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.06 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -67.83 -36.05 79.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.641 -176.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.68 ' HD1' ' HB ' ' A' ' 72' ' ' ILE . 26.3 m-85 -53.49 -48.6 68.78 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.007 0.432 . . . . 0.0 110.378 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -67.52 -43.02 81.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.402 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -74.65 -29.71 61.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -174.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.88 -21.41 26.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.617 0.246 . . . . 0.0 111.103 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.83 38.45 6.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.893 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.68 ' HB ' ' HD1' ' A' ' 67' ' ' TYR . 2.0 mt -99.9 -179.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.674 ' H ' HG22 ' A' ' 72' ' ' ILE . 36.3 m80 -63.45 141.41 97.85 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -57.6 132.69 51.88 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.361 2.041 . . . . 0.0 111.065 173.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.49 164.53 20.39 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.297 2.665 . . . . 0.0 113.115 -175.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.16 139.9 79.63 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -50.8 133.94 40.37 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.329 2.686 . . . . 0.0 113.185 -174.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.3 pt -142.43 171.58 10.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.121 -175.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.75 78.9 9.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.952 0.406 . . . . 0.0 110.2 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -134.12 61.79 1.67 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.233 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.84 168.82 21.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.717 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.785 -0.626 . . . . 0.0 110.358 -179.336 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.837 0.351 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.2 m 63.24 -165.33 0.24 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.835 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.2 p -90.08 101.53 14.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.348 0.594 . . . . 0.0 110.812 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -80.13 -35.09 37.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.241 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -114.85 159.2 20.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.362 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.543 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 34.9 tt0 -143.11 110.73 5.85 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.39 139.45 43.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.251 -170.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.562 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 39.0 mt-10 -58.2 135.52 57.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.062 0.458 . . . . 0.0 110.34 173.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.411 ' CG2' ' HA ' ' A' ' 58' ' ' PHE . 15.5 tt -54.54 -29.45 20.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.771 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.9 -27.94 68.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.967 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -83.93 -39.91 19.19 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.464 -175.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 83.0 mtp -60.84 142.78 55.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.708 0.29 . . . . 0.0 111.021 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.0 m -79.69 124.68 28.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.973 -176.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.48 ' HB2' ' HE1' ' A' ' 66' ' ' TYR . 39.2 p90 -84.27 141.65 30.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.099 0.476 . . . . 0.0 111.783 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -125.7 92.05 47.26 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 173.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.62 -26.38 53.88 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 123.094 2.529 . . . . 0.0 113.253 -172.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -69.57 -28.93 66.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.007 0.432 . . . . 0.0 110.918 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -107.41 4.54 26.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.838 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 58.56 37.93 25.4 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.993 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -143.12 171.46 14.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.292 0.568 . . . . 0.0 111.841 -174.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.461 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 41.8 m-85 -116.0 148.18 40.41 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.392 173.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 41.5 p -136.27 167.24 21.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.894 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.446 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 84.3 t80 -144.08 118.07 5.9 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -56.97 109.83 0.51 Allowed 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.201 2.601 . . . . 0.0 113.19 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.1 t -127.22 131.3 23.78 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.712 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 5.2 Cg_exo -80.2 119.42 3.85 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.951 1.768 . . . . 0.0 111.472 176.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.448 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 30.6 p -179.4 -52.72 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.448 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 174.44 -28.57 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.215 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.588 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 1.2 t70 -142.8 175.93 9.44 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -115.71 154.87 28.78 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.582 ' O ' ' HA ' ' A' ' 22' ' ' THR . 80.4 m-85 -50.29 134.75 22.61 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.519 0.512 . . . . 0.0 110.61 178.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -131.77 133.29 44.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.168 0.509 . . . . 0.0 111.066 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tt -151.28 126.11 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.009 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -87.29 138.16 31.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.79 0.329 . . . . 0.0 110.895 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.591 ' HG ' ' HD2' ' A' ' 66' ' ' TYR . 1.2 tm? -64.19 -31.73 73.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.018 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -61.92 -29.92 70.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.792 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 1.1 m-20 -82.17 -32.63 29.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.419 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.549 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 84.6 mtp -67.6 -34.12 76.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.145 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -64.64 -24.44 67.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.398 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 52.2 mt-10 -76.93 -12.21 59.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.025 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.91 -11.49 41.26 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.402 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 38' ' ' MET . 9.3 tp10 -89.41 133.77 34.38 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -142.08 100.13 3.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.115 0.96 . . . . 0.0 111.503 -177.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.4 p -167.27 127.7 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.424 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.511 ' HB3' HD12 ' A' ' 54' ' ' ILE . . . -100.73 141.55 33.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.106 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.6 137.42 51.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.687 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.0 t -99.68 111.88 62.53 Favored Pre-proline 0 N--CA 1.431 -1.408 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.588 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 14.7 Cg_endo -62.6 156.6 51.57 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.935 1.757 . . . . 0.0 110.794 174.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 37.4 m 85.5 -55.75 0.08 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.197 0.999 . . . . 0.0 111.192 -176.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.406 ' SG ' ' HB2' ' A' ' 52' ' ' LEU . 16.6 p -98.13 -17.09 19.24 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.836 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.8 t 70.23 29.77 3.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.423 0.689 . . . . 0.0 111.975 172.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.425 HD11 ' HZ ' ' A' ' 31' ' ' PHE . 1.6 tt -86.56 130.57 34.44 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -174.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.4 mtm -115.35 137.39 52.09 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.85 -176.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 45' ' ' ALA . 2.8 pp -141.88 144.21 25.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.543 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 4.9 t0 -84.27 156.06 22.15 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.73 125.32 55.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.045 0.45 . . . . 0.0 112.068 -174.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.562 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 21.8 t -88.86 100.03 10.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.411 ' HA ' ' CG2' ' A' ' 9' ' ' ILE . 50.6 p90 -94.52 160.3 14.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.843 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.568 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 27.3 t70 -116.14 151.65 35.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.857 0.36 . . . . 0.0 110.515 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.44 ' HE2' ' HB2' ' A' ' 60' ' ' LYS . 22.2 mtmm -58.56 -46.36 87.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.14 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -81.09 -32.19 34.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.346 -174.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.4 ' CB ' ' HB3' ' A' ' 59' ' ' ASP . 15.9 t70 -64.44 -43.66 93.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.324 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 54.4 mt -61.03 -47.38 86.67 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.82 0.343 . . . . 0.0 110.391 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.16 -43.01 77.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.185 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -62.99 -44.87 94.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.688 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.591 ' HD2' ' HG ' ' A' ' 35' ' ' LEU . 84.1 t80 -70.54 -35.3 73.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.07 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.5 -42.95 79.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.446 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -74.98 -30.08 61.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.09 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -63.54 -57.83 8.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.264 0.555 . . . . 0.0 110.793 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.62 -25.48 60.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.656 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.61 49.88 4.69 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.612 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.801 HG23 ' H ' ' A' ' 73' ' ' HIS . 5.1 mt -83.69 -175.78 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.801 ' H ' HG23 ' A' ' 72' ' ' ILE . 49.7 m80 -76.11 130.2 78.55 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.553 0.216 . . . . 0.0 110.462 -177.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.32 116.33 3.83 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.996 2.464 . . . . 0.0 113.149 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -89.68 164.57 5.17 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.622 2.881 . . . . 0.0 111.638 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -75.1 155.52 86.32 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.4 140.01 73.87 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.619 2.212 . . . . 0.0 112.658 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.5 pt -91.13 153.72 3.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.352 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.95 80.37 9.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.498 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -149.61 29.78 0.76 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.292 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.79 -8.95 32.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.202 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.499 -0.762 . . . . 0.0 110.159 -179.162 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptp . . . . . 0 N--CA 1.463 0.21 0 CA-C-O 120.821 0.343 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.0 m -144.5 176.39 9.42 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.668 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.4 p -90.75 103.91 16.56 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.237 0.541 . . . . 0.0 110.677 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -94.89 -12.35 27.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.822 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -125.94 155.16 41.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.776 174.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.569 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 33.9 tt0 -151.44 114.43 4.73 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -176.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -127.55 161.8 34.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.591 -173.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -78.57 148.68 33.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.86 0.362 . . . . 0.0 110.388 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.6 tt -57.02 -28.95 30.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.5 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -63.55 -28.19 69.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.993 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -77.49 -31.21 53.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.947 0.403 . . . . 0.0 111.052 -175.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.581 ' HA ' ' HD1' ' A' ' 23' ' ' TYR . 84.4 mtp -69.5 170.52 10.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.951 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.3 m -106.76 121.25 44.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.707 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.529 ' HB2' ' HE1' ' A' ' 66' ' ' TYR . 44.0 p90 -74.56 142.58 44.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.624 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -139.95 93.7 9.27 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 121.356 0.598 . . . . 0.0 110.649 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -66.22 -19.05 56.68 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.69 2.26 . . . . 0.0 112.279 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.83 -35.1 77.27 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.206 0.526 . . . . 0.0 110.603 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -111.61 5.95 19.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.874 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.536 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 2.1 mp0 57.91 31.58 20.77 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.809 178.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 27.4 ptt? -152.33 162.95 40.43 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.462 -174.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -91.39 138.3 31.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.635 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 21.9 p -129.29 143.58 50.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.709 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.581 ' HD1' ' HA ' ' A' ' 12' ' ' MET . 9.8 t80 -112.94 117.15 46.62 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.48 115.97 2.55 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.235 2.623 . . . . 0.0 113.622 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.6 t -135.94 125.65 16.21 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.07 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.96 119.21 2.82 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 121.897 1.732 . . . . 0.0 111.48 174.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.3 p -176.71 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 164.18 -29.15 0.23 Allowed Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 113.968 -1.469 . . . . 0.0 110.237 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.533 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 3.3 t70 -143.2 174.69 10.49 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -119.93 146.23 45.99 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 23' ' ' TYR . 88.5 m-85 -44.33 118.39 1.51 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.679 0.612 . . . . 0.0 111.361 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -114.24 136.94 52.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.019 0.437 . . . . 0.0 110.337 -177.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 20' ' ' MET . 18.4 tt -134.83 129.67 51.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.578 ' O ' ' HG3' ' A' ' 38' ' ' MET . 48.2 m-85 -84.23 126.78 33.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.836 -174.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -33.39 74.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.894 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -58.25 -34.57 70.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.257 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -87.08 -31.16 20.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.578 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 82.9 mtp -64.86 -41.52 95.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.73 0.3 . . . . 0.0 110.983 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -63.04 -25.4 68.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.577 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -77.3 -10.64 59.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.801 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.26 -5.61 38.76 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.689 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 38' ' ' MET . 7.4 tp10 -89.4 130.97 35.68 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.59 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -137.68 100.27 4.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.25 1.024 . . . . 0.0 111.784 -175.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.0 p -166.82 128.98 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.807 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 53' ' ' MET . . . -100.27 139.76 35.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.032 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.54 135.81 57.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.176 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.544 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 8.1 t -104.23 116.78 60.8 Favored Pre-proline 0 N--CA 1.435 -1.208 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.846 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.533 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 49.9 Cg_endo -70.41 156.74 60.99 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.582 2.188 . . . . 0.0 110.98 173.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 33.3 m 86.97 -56.72 0.05 OUTLIER 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.161 0.984 . . . . 0.0 111.398 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.7 p -91.12 -27.29 18.66 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.87 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.6 t 69.05 72.78 0.26 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.183 174.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.529 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 51.7 tp -134.57 148.49 50.47 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 174.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.428 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 35.2 mtm -131.06 137.75 49.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.426 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -138.98 152.46 24.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.254 178.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.569 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 8.2 t70 -80.87 145.63 31.25 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.5 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 83.9 t -134.12 115.34 20.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.223 0.535 . . . . 0.0 111.715 -177.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.8 t -74.17 107.35 4.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.93 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -96.18 165.24 12.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.455 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.537 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 14.7 t70 -115.14 146.16 41.64 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.968 173.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.02 -40.06 96.6 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -76.76 -40.87 46.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.302 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 59' ' ' ASP . 8.7 m-20 -66.59 -32.03 73.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.192 -177.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 48.0 mt -66.96 -53.34 32.61 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.751 176.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 67' ' ' TYR . . . -58.94 -46.05 88.93 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.03 0.443 . . . . 0.0 111.163 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.22 -41.4 88.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.27 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.529 ' HE1' ' HB2' ' A' ' 14' ' ' PHE . 57.5 t80 -65.75 -35.37 80.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.203 -178.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.45 ' HD1' ' HB ' ' A' ' 72' ' ' ILE . 12.7 m-85 -52.29 -47.91 65.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.958 0.409 . . . . 0.0 110.342 174.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -74.28 -26.7 60.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.362 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -75.41 -44.0 46.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 0.0 111.303 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.536 ' HB3' ' HA ' ' A' ' 19' ' ' GLN . . . -80.2 -12.85 59.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.411 -176.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.3 40.22 11.59 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.792 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.569 HG21 ' H ' ' A' ' 73' ' ' HIS . 1.5 mt -94.89 178.44 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.569 ' H ' HG21 ' A' ' 72' ' ' ILE . 51.3 m80 -71.09 137.53 84.63 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.05 120.91 6.7 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.391 2.727 . . . . 0.0 112.425 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.33 164.16 35.93 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.042 2.495 . . . . 0.0 111.862 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -73.65 134.4 78.98 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.12 139.54 52.39 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 123.058 2.505 . . . . 0.0 113.209 -175.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.0 pt -104.12 168.24 2.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.783 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.68 87.15 7.29 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.071 0.462 . . . . 0.0 110.769 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.8 101.42 11.02 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.671 176.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.05 -24.67 14.82 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.016 -176.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.148 -0.929 . . . . 0.0 110.395 -178.93 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.962 0.41 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.2 m -149.58 174.59 12.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.702 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.1 p -81.86 120.92 25.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.005 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -100.09 5.95 44.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.758 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -162.2 172.5 15.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.544 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 36.0 tt0 -154.13 111.7 3.47 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 3.5 mp -116.91 151.04 18.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.029 -177.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.557 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 57.7 mt-10 -78.34 149.97 33.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.886 0.374 . . . . 0.0 110.567 176.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.7 tt -59.01 -28.82 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.886 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -68.82 -29.98 68.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.381 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.438 ' HB3' HG22 ' A' ' 7' ' ' ILE . 31.9 t70 -84.74 -36.16 21.98 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.322 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.551 ' SD ' ' HB2' ' A' ' 23' ' ' TYR . 4.1 tpt -49.25 141.69 8.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.058 170.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 m -87.48 108.99 19.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.982 0.42 . . . . 0.0 110.069 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.5 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 40.0 p90 -74.17 137.7 43.3 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.976 0.417 . . . . 0.0 110.78 -177.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -115.34 93.9 37.6 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.649 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 70' ' ' ALA . 49.2 Cg_endo -68.86 -22.39 36.54 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.739 2.293 . . . . 0.0 112.449 -174.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -77.09 -18.83 57.71 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.075 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.519 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 4.3 t-20 -116.26 -6.7 11.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.516 0.198 . . . . 0.0 111.247 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.479 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 1.8 mp0 64.35 42.35 5.3 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.08 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.531 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 26.2 ptt? -151.46 174.07 13.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.46 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.5 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 36.0 m-85 -109.86 149.12 30.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.955 0.407 . . . . 0.0 110.674 176.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 36.8 p -137.62 159.93 40.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.283 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.551 ' HB2' ' SD ' ' A' ' 12' ' ' MET . 6.1 t80 -141.28 131.39 13.02 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.34 127.06 21.72 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.692 2.261 . . . . 0.0 113.327 -176.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.504 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 20.0 t -140.74 141.37 24.54 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.214 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 12.0 Cg_endo -91.3 117.99 0.52 Allowed 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 122.171 1.914 . . . . 0.0 112.079 174.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.9 p 177.83 -44.38 0.01 OUTLIER 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.208 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.22 -19.86 0.48 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.168 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -140.12 173.63 11.32 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.41 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -122.27 151.63 40.89 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.622 -0.14 . . . . 0.0 110.622 177.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.603 ' O ' ' HA ' ' A' ' 22' ' ' THR . 93.9 m-85 -47.88 126.94 11.27 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 123.802 0.688 . . . . 0.0 110.642 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -127.86 138.64 52.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.857 0.361 . . . . 0.0 110.939 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.531 ' O ' ' HB2' ' A' ' 20' ' ' MET . 12.1 tt -148.88 132.87 8.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.712 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -87.54 142.57 27.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.55 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.422 HD12 HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -67.86 -30.76 70.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.083 0.468 . . . . 0.0 110.741 -177.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -61.26 -31.24 71.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.839 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 6.7 m-20 -80.74 -34.02 34.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.569 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 79.0 mtp -63.99 -35.42 80.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.976 0.417 . . . . 0.0 110.07 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -68.27 -20.77 64.81 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.638 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 44.5 mm-40 -76.59 -13.42 60.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.361 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.49 -3.87 61.6 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.433 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -90.47 105.09 17.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.731 ' HD2' ' HE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -115.4 100.0 7.78 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.995 0.902 . . . . 0.0 110.552 -177.082 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 1.8 p -167.03 129.5 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.727 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.434 ' HB1' HD12 ' A' ' 54' ' ' ILE . . . -100.01 139.0 36.31 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.824 HG21 ' HG2' ' A' ' 53' ' ' MET . 38.4 t -115.67 119.0 60.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.194 -176.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.559 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 6.8 t -90.19 120.88 69.14 Favored Pre-proline 0 C--N 1.317 -0.824 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.43 ' O ' ' HB2' ' A' ' 49' ' ' SER . 58.2 Cg_endo -73.45 154.95 50.76 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.355 2.037 . . . . 0.0 112.578 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 51.4 m 78.09 -54.4 0.5 Allowed 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.963 0.905 . . . . 0.0 111.637 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 12.1 p -82.2 -25.83 33.88 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.4 t 70.49 42.91 0.84 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.04 169.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.507 HD21 ' HZ ' ' A' ' 31' ' ' PHE . 26.7 tp -103.96 128.61 51.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.359 0.599 . . . . 0.0 110.076 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.824 ' HG2' HG21 ' A' ' 46' ' ' VAL . 35.6 mtm -117.07 136.98 52.58 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.918 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -138.68 152.98 25.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.747 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.544 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 4.7 t70 -82.42 151.4 26.6 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.489 HG11 ' HB2' ' A' ' 43' ' ' LYS . 6.3 p -129.7 112.99 25.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.559 0.695 . . . . 0.0 111.378 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.557 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 53.0 t -68.38 118.62 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.709 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.731 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 20.7 p90 -133.37 164.58 26.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.466 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.558 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 11.6 t70 -137.23 159.95 40.44 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.445 ' HD3' ' H ' ' A' ' 60' ' ' LYS . 3.0 mppt? -62.15 -37.64 85.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.028 0.442 . . . . 0.0 109.851 176.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -64.16 -45.16 89.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.523 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.97 -45.54 88.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.667 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 40.8 mt -55.02 -53.68 52.76 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.108 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.13 -43.18 73.88 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.217 0.323 . . . . 0.0 111.368 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -66.2 -49.89 65.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.022 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -67.73 -32.31 72.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.651 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.456 ' CD2' ' HB ' ' A' ' 72' ' ' ILE . 2.2 m-85 -50.87 -44.28 59.62 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 172.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -63.21 -49.57 73.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.667 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -68.86 -32.51 72.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.287 -175.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -81.69 -10.63 59.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.776 0.322 . . . . 0.0 111.105 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.21 37.63 36.59 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.814 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.515 HG23 ' H ' ' A' ' 73' ' ' HIS . 2.2 mt -91.92 172.48 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.515 ' H ' HG23 ' A' ' 72' ' ' ILE . 16.3 t-80 -66.87 119.02 60.63 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 86.0 Cg_exo -47.84 124.72 10.3 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.292 2.661 . . . . 0.0 112.508 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 74' ' ' PRO . 17.4 Cg_exo -66.38 149.87 84.65 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.87 2.38 . . . . 0.0 112.92 -176.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -75.56 165.68 51.53 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.844 173.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.02 138.33 43.54 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.045 1.83 . . . . 0.0 112.13 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.0 pt -119.25 177.52 2.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.169 -173.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.19 12.25 18.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.173 0.511 . . . . 0.0 110.987 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.47 109.01 19.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.107 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.89 10.48 38.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.611 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.303 0 O-C-N 124.52 1.137 . . . . 0.0 110.721 -178.069 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.55 0.691 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -144.27 161.21 39.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.155 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.9 p -90.66 112.36 24.06 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.083 0.468 . . . . 0.0 111.252 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -86.08 -23.24 26.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.972 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.525 ' HB2' HG22 ' A' ' 54' ' ' ILE . 1.6 m-20 -119.46 145.38 46.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.646 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.41 ' HG3' ' CB ' ' A' ' 55' ' ' ASP . 36.5 tt0 -140.36 108.28 5.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.726 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.5 mp -110.95 160.84 9.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -176.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.426 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 5.2 mp0 -79.38 148.99 31.79 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.3 tt -58.15 -29.95 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.129 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -68.07 -27.76 66.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.045 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.28 -39.44 54.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.782 0.325 . . . . 0.0 110.893 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 81.1 mtp -64.2 157.19 26.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.13 0.49 . . . . 0.0 111.154 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.6 m -90.44 109.22 20.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.482 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.586 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 42.1 p90 -78.96 134.63 36.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.192 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.427 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 9.5 tp10 -117.76 97.65 50.95 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.197 177.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 21.9 Cg_endo -61.25 -29.72 86.89 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.981 2.454 . . . . 0.0 111.953 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.62 -23.54 63.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.375 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.81 -11.63 15.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.119 0.485 . . . . 0.0 109.977 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.523 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 1.9 mp0 69.84 35.11 2.41 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.696 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.532 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 25.0 ptt? -157.99 174.71 14.83 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.593 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.586 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 42.8 m-85 -105.33 140.49 38.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.382 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 42.6 p -132.08 163.01 29.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.904 177.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.596 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 45.6 t80 -136.66 118.57 11.48 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.13 118.51 5.25 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 123.23 2.62 . . . . 0.0 112.794 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.0 t -137.55 140.58 30.64 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.57 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -90.94 118.9 0.61 Allowed 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 121.828 1.685 . . . . 0.0 111.973 174.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.2 p 179.52 -41.27 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 160.17 -26.3 0.31 Allowed Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.398 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.556 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 3.5 t0 -142.94 175.23 10.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.21 153.34 25.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.338 0.113 . . . . 0.0 111.137 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.596 ' HB2' ' HB3' ' A' ' 23' ' ' TYR . 81.2 m-85 -52.45 136.12 32.31 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.063 175.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 2.2 pt20 -133.3 136.68 45.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.876 0.37 . . . . 0.0 110.884 -176.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.532 ' O ' ' HB2' ' A' ' 20' ' ' MET . 15.2 tt -151.55 142.5 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.477 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.536 ' O ' ' HG3' ' A' ' 38' ' ' MET . 95.0 m-85 -99.31 147.74 24.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.914 0.388 . . . . 0.0 111.129 -177.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.47 -41.55 93.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.312 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -65.04 -31.99 73.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.186 0.517 . . . . 0.0 110.849 -175.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.01 -44.07 73.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.093 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.536 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 78.5 mtp -62.18 -42.61 99.44 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.684 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -65.93 -16.55 63.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.254 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -81.99 -12.48 58.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.41 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.2 -4.43 35.5 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.749 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -105.77 111.0 23.49 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.424 ' HD3' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -118.75 102.87 9.15 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.842 0.829 . . . . 0.0 110.732 -172.622 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 1.6 p -162.42 126.22 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.665 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.503 ' HB2' HD13 ' A' ' 54' ' ' ILE . . . -99.85 137.2 38.64 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.389 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.756 HG23 ' HG2' ' A' ' 53' ' ' MET . 47.7 t -114.62 123.01 69.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.764 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.516 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 12.0 t -90.73 122.3 67.11 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.556 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 43.2 Cg_endo -74.59 156.31 44.87 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.225 1.95 . . . . 0.0 111.29 175.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 35.5 t 89.28 -58.39 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.857 0.863 . . . . 0.0 110.107 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.4 p -89.3 -26.15 21.28 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 175.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.9 m 67.36 47.99 1.21 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.227 174.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.437 HD21 ' N ' ' A' ' 53' ' ' MET . 1.7 tt -102.71 135.23 44.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.756 ' HG2' HG23 ' A' ' 46' ' ' VAL . 32.3 mtm -117.11 137.14 52.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.466 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.525 HG22 ' HB2' ' A' ' 5' ' ' ASP . 2.8 pp -142.54 146.1 22.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.222 -176.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.41 ' CB ' ' HG3' ' A' ' 6' ' ' GLU . 6.4 m-20 -79.17 151.28 31.37 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.89 109.69 15.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.302 0.572 . . . . 0.0 110.941 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 46.9 t -65.95 112.37 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.423 -177.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -108.09 160.09 16.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.017 0.437 . . . . 0.0 111.651 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.728 ' HB3' ' HB2' ' A' ' 62' ' ' ASP . 20.3 t70 -117.01 146.15 43.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.093 173.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -62.4 -37.66 86.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.881 0.372 . . . . 0.0 110.563 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.39 -26.58 28.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.176 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.728 ' HB2' ' HB3' ' A' ' 59' ' ' ASP . 4.2 m-20 -65.58 -48.39 72.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.071 173.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 83.5 mt -55.08 -49.35 71.91 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.741 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.09 -37.01 83.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.0 0.429 . . . . 0.0 111.534 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -69.16 -52.83 24.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.677 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -64.13 -34.91 79.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.743 0.306 . . . . 0.0 110.934 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.406 ' HD1' ' HB ' ' A' ' 72' ' ' ILE . 0.5 OUTLIER -53.83 -46.73 71.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.056 174.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.28 -41.89 76.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.584 -178.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -59.39 -44.92 92.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.232 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.523 ' HB2' ' HA ' ' A' ' 19' ' ' GLN . . . -81.73 -27.31 33.95 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.27 58.17 3.22 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.827 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.406 ' HB ' ' HD1' ' A' ' 67' ' ' TYR . 5.2 mt -93.35 167.25 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.62 -0.29 . . . . 0.0 110.222 -176.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -56.22 131.98 75.25 Favored Pre-proline 0 N--CA 1.464 0.237 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.403 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 13.1 Cg_endo -56.4 117.11 3.71 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 123.352 2.701 . . . . 0.0 114.155 -176.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 74' ' ' PRO . 4.7 Cg_endo -87.4 168.88 7.29 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.625 3.55 . . . . 0.0 110.738 172.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 43.7 mt-10 -70.14 131.39 88.85 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 76' ' ' GLU . 38.0 Cg_exo -60.03 141.62 96.72 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.851 2.367 . . . . 0.0 113.004 -174.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.0 pt -90.54 150.08 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.756 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.5 90.8 3.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.104 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.54 -13.28 58.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.885 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.02 91.59 2.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.15 176.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.829 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.92 -179.534 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ttt . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 121.993 0.901 . . . . 0.0 109.823 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.1 m -146.94 179.78 7.35 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.399 -1.273 . . . . 0.0 107.818 175.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' A' ' 55' ' ' ASP . 17.4 p -73.64 94.06 2.14 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.642 0.734 . . . . 0.0 110.987 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -110.23 -13.24 14.37 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.509 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.508 ' HB2' HG22 ' A' ' 54' ' ' ILE . 9.5 m-20 -97.42 127.02 43.04 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 176.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -124.46 108.58 12.29 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.717 -173.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.456 HG22 ' HB3' ' A' ' 11' ' ' ASP . 2.7 mp -111.84 150.27 14.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.126 -175.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -71.4 145.32 49.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.985 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.49 HD11 ' HE2' ' A' ' 38' ' ' MET . 20.7 tt -62.36 -27.57 42.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 172.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -56.79 -29.42 62.68 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.573 173.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.456 ' HB3' HG22 ' A' ' 7' ' ' ILE . 27.8 t70 -94.96 -41.13 9.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.794 -0.184 . . . . 0.0 111.224 -175.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.466 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 68.7 mtp -60.78 145.63 49.01 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.17 0.509 . . . . 0.0 110.867 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 m -89.92 124.03 34.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.053 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.423 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . 38.5 p90 -74.27 135.74 42.65 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.291 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -118.3 88.4 32.86 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.131 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.79 -15.91 45.04 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.117 2.544 . . . . 0.0 112.632 -174.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -68.98 -29.7 67.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.866 0.365 . . . . 0.0 111.217 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.569 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 2.0 t-20 -118.47 6.27 11.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.872 0.367 . . . . 0.0 110.571 -177.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 59.43 43.53 16.25 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.007 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.569 ' HG2' ' HB3' ' A' ' 18' ' ' ASN . 22.9 ptt? -145.58 174.45 11.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.975 0.416 . . . . 0.0 110.925 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.442 ' CZ ' HD12 ' A' ' 9' ' ' ILE . 92.0 m-85 -108.14 142.6 38.12 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 73.0 p -137.37 167.07 22.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.716 0.293 . . . . 0.0 111.192 -175.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.466 ' CD1' ' HA ' ' A' ' 12' ' ' MET . 5.6 t80 -146.68 124.04 5.94 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.9 111.71 0.77 Allowed 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.129 2.552 . . . . 0.0 112.993 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.408 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 27.6 t -118.64 137.96 25.39 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.756 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -88.83 116.95 0.85 Allowed 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 121.349 1.366 . . . . 0.0 111.558 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.5 p 175.15 -41.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.497 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 153.66 -15.6 0.63 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.882 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -142.45 176.15 9.23 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.402 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 18.8 ptp180 -113.62 153.62 28.56 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 22' ' ' THR . 91.5 m-85 -55.74 134.28 51.39 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 174.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 30' ' ' ARG . 24.3 mt-30 -129.8 132.18 46.43 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.946 0.403 . . . . 0.0 111.431 -176.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.425 ' O ' ' HB2' ' A' ' 20' ' ' MET . 14.6 tt -141.58 128.14 19.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.731 171.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.421 ' O ' ' HG3' ' A' ' 38' ' ' MET . 69.6 m-85 -91.13 154.56 19.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.904 0.383 . . . . 0.0 110.698 -176.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.76 -34.82 75.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.658 -177.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.522 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 27.4 t70 -59.67 -45.54 91.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.025 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -64.76 -33.74 76.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 110.61 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.49 ' HE2' HD11 ' A' ' 9' ' ' ILE . 59.5 mtp -74.66 -36.12 62.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.987 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -65.08 -29.61 70.51 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.55 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 36' ' ' ASP . 24.6 mm-40 -58.98 -22.94 61.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.617 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.3 8.2 38.84 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.57 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -115.36 157.65 23.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.662 ' HD3' ' N ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -145.47 100.73 3.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.7 0.762 . . . . 0.0 111.566 -174.091 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 1.4 p -166.71 131.41 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.503 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.471 ' HB1' HD12 ' A' ' 54' ' ' ILE . . . -100.57 132.36 45.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.698 HG21 ' HG2' ' A' ' 53' ' ' MET . 47.2 t -115.13 133.89 59.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.437 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 14.2 t -104.38 130.96 22.37 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.411 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.543 ' O ' ' HB2' ' A' ' 49' ' ' SER . 58.4 Cg_endo -79.44 156.45 25.22 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.866 2.377 . . . . 0.0 112.021 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.543 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 41.6 m 83.22 -53.89 0.16 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.196 0.998 . . . . 0.0 111.609 -177.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 18.0 p -90.65 -24.88 20.36 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.631 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.1 t 64.77 49.8 2.16 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.33 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.2 mt -117.32 154.78 30.67 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.366 0.603 . . . . 0.0 111.308 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.698 ' HG2' HG21 ' A' ' 46' ' ' VAL . 25.2 mtm -135.01 138.47 43.99 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.609 -168.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.508 HG22 ' HB2' ' A' ' 5' ' ' ASP . 2.7 pp -140.37 152.49 21.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.319 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.419 ' HB2' ' HB ' ' A' ' 3' ' ' THR . 4.9 t70 -91.81 147.84 22.68 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -173.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 5.1 p -133.9 123.5 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.4 t -79.8 114.76 21.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 122.137 -0.352 . . . . 0.0 110.661 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.557 ' CE1' ' HB3' ' A' ' 43' ' ' LYS . 44.1 p90 -121.63 165.09 16.24 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.707 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.408 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 14.0 t70 -121.26 161.16 22.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.206 0.527 . . . . 0.0 110.086 174.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.537 ' HB3' HD12 ' A' ' 78' ' ' ILE . 3.4 mtmt -61.66 -40.12 93.82 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.46 175.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -78.23 -35.25 48.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.771 -174.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -70.91 -32.1 68.93 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.341 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 61.7 mt -63.51 -48.71 76.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.76 0.314 . . . . 0.0 110.303 172.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.99 -38.92 93.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.326 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -66.49 -48.86 68.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.34 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.423 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 85.4 t80 -62.6 -36.49 82.9 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.945 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.491 ' HA ' HD11 ' A' ' 72' ' ' ILE . 2.2 t80 -51.99 -42.14 62.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.684 175.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.41 -37.75 60.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.611 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -60.4 -54.36 46.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.057 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.88 -22.92 45.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.939 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.96 51.91 6.68 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.491 HD11 ' HA ' ' A' ' 67' ' ' TYR . 29.1 mt -78.58 156.78 4.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.533 -0.333 . . . . 0.0 111.203 -171.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -53.46 131.68 53.85 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.091 174.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -51.73 117.95 4.0 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.562 2.841 . . . . 0.0 113.576 -175.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -90.95 164.59 3.9 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.804 3.003 . . . . 0.0 110.91 172.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -73.03 132.46 82.65 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -46.47 142.55 9.41 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.383 2.722 . . . . 0.0 113.306 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.537 HD12 ' HB3' ' A' ' 60' ' ' LYS . 26.4 pt -109.19 168.39 3.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.995 -176.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.8 71.19 6.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.097 0.475 . . . . 0.0 110.688 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -132.14 110.26 10.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.943 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 63.73 21.75 12.81 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.195 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.186 -179.755 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.6 p -110.97 177.31 4.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.701 0.286 . . . . 0.0 110.257 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.8 p -86.18 122.42 30.16 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.001 0.429 . . . . 0.0 110.611 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -90.11 -11.38 41.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.608 -175.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.437 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 7.3 m-20 -141.99 169.7 17.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.276 176.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 35.5 tt0 -155.86 118.99 4.28 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -134.96 153.89 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.788 -175.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.51 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 45.4 mt-10 -72.81 152.08 41.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.036 0.446 . . . . 0.0 110.813 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.433 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 18.6 tt -55.49 -29.03 23.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.479 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.02 -35.1 80.1 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.402 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -78.08 -27.73 48.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.947 0.403 . . . . 0.0 111.12 -172.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.471 ' HE1' ' HB2' ' A' ' 23' ' ' TYR . 90.4 mtp -75.84 161.18 29.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.283 0.563 . . . . 0.0 111.317 -178.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.8 m -95.12 115.76 27.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.956 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.433 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 44.5 p90 -81.33 138.88 35.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.091 0.472 . . . . 0.0 111.254 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -118.98 91.46 43.31 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.61 -28.36 52.78 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.188 2.592 . . . . 0.0 113.182 -172.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -70.98 -21.56 62.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.8 -175.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -112.97 3.58 16.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.62 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 55.09 44.53 27.84 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.904 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -146.66 165.7 28.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.94 0.4 . . . . 0.0 110.913 -176.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.534 ' HE1' HD21 ' A' ' 35' ' ' LEU . 68.4 m-85 -112.36 145.33 40.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.716 175.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.595 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 36.7 p -133.12 157.87 44.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.75 0.309 . . . . 0.0 110.987 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.478 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 9.6 t80 -140.34 125.17 11.07 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -51.21 127.89 23.47 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.376 2.718 . . . . 0.0 113.743 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.418 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 20.4 t -145.46 135.02 11.48 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.915 177.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 2.5 Cg_endo -87.24 118.09 1.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.026 1.817 . . . . 0.0 111.679 174.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 31.0 p -178.55 -54.05 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.404 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.468 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 169.44 -25.15 0.1 Allowed Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.99 -177.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -136.68 174.43 10.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.5 147.79 43.28 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 122.437 -0.164 . . . . 0.0 110.563 176.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.595 ' O ' ' HA ' ' A' ' 22' ' ' THR . 92.1 m-85 -45.94 128.86 9.38 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.448 0.467 . . . . 0.0 110.445 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -131.51 138.18 48.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.231 0.539 . . . . 0.0 110.884 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.0 tt -143.17 129.63 17.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.802 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -86.27 143.99 27.64 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.143 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.534 HD21 ' HE1' ' A' ' 21' ' ' PHE . 1.6 tm? -62.46 -36.38 82.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.142 -173.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -65.26 -34.18 77.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.933 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.97 -44.08 97.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.106 0.479 . . . . 0.0 110.408 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 70.3 mtp -62.74 -41.69 99.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.116 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -65.72 -31.41 72.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.902 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -76.01 -3.88 38.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.734 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.48 -17.97 45.65 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.972 174.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -91.23 95.57 10.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.155 0.502 . . . . 0.0 110.696 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -100.68 100.93 11.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.579 0.704 . . . . 0.0 110.966 -177.115 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.9 p -165.51 126.96 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.68 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.414 ' HB2' HD13 ' A' ' 54' ' ' ILE . . . -99.99 143.6 30.01 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.018 0.437 . . . . 0.0 110.36 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.43 140.05 44.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.38 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.523 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 11.1 t -109.37 118.04 51.7 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -70.61 156.51 60.98 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.439 2.093 . . . . 0.0 112.135 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.1 t 85.78 -53.53 0.08 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.852 0.861 . . . . 0.0 110.659 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 17.5 p -89.14 -28.39 20.08 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.4 m 66.92 54.69 0.76 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.387 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.45 HD23 ' N ' ' A' ' 53' ' ' MET . 1.7 tt -110.9 136.5 49.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.45 ' N ' HD23 ' A' ' 52' ' ' LEU . 31.9 mtm -123.84 137.99 54.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.742 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.437 ' CG2' ' HB2' ' A' ' 5' ' ' ASP . 0.2 OUTLIER -140.22 153.8 22.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 43.1 m-20 -82.01 159.79 23.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.838 0.351 . . . . 0.0 110.506 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.552 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 49.0 t -130.97 144.19 38.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.09 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.51 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 44.0 t -106.56 108.85 26.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.632 0.253 . . . . 0.0 110.592 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.497 ' HE2' ' HD2' ' A' ' 43' ' ' LYS . 45.2 p90 -112.98 165.24 12.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.041 -177.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.455 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 2.7 t70 -127.4 170.63 12.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.233 0.539 . . . . 0.0 110.234 175.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.411 ' HB2' ' HE2' ' A' ' 60' ' ' LYS . 24.9 mtmm -63.62 -46.25 86.61 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.999 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -72.88 -37.44 67.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.917 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -63.8 -31.48 72.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.773 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 58.9 mt -75.03 -45.31 42.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.605 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.93 -49.63 76.93 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.583 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.61 -40.27 96.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.174 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.411 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 91.2 t80 -69.22 -38.05 78.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.737 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.508 ' HA ' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -57.15 -45.18 83.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.861 0.362 . . . . 0.0 110.794 178.204 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -76.45 -25.72 54.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.586 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -79.26 -40.53 30.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.747 0.308 . . . . 0.0 111.64 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.54 -26.4 30.15 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.419 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.1 53.97 4.63 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 -176.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.508 HD11 ' HA ' ' A' ' 67' ' ' TYR . 51.8 mt -83.26 143.84 11.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.152 -0.524 . . . . 0.0 111.033 -173.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -52.48 122.58 26.26 Favored Pre-proline 0 C--O 1.234 0.259 0 O-C-N 123.522 0.514 . . . . 0.0 109.79 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -34.62 107.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 125.084 3.856 . . . . 0.0 114.589 -171.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -81.07 165.13 19.52 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.762 2.975 . . . . 0.0 110.78 172.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -73.16 149.17 89.3 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.93 138.11 84.64 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.511 2.141 . . . . 0.0 112.434 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.1 pt -101.93 171.23 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.86 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.78 83.58 6.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.081 0.467 . . . . 0.0 110.245 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -143.11 88.78 2.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.24 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.49 108.88 10.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.711 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.537 -0.744 . . . . 0.0 109.882 179.379 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.8 mtt . . . . . 0 CA--C 1.518 -0.283 0 CA-C-O 121.278 0.561 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -132.61 155.63 48.37 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.714 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.4 p -74.52 114.34 12.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.364 0.602 . . . . 0.0 110.405 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -83.18 -20.76 34.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.107 -173.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -132.66 162.81 30.41 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.172 0.51 . . . . 0.0 111.034 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 37.2 tt0 -146.93 108.52 4.32 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.657 171.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.96 155.74 18.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.056 -175.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.527 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 32.3 mp0 -65.32 144.42 57.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.391 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.0 tt -57.54 -29.35 33.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.445 0.64 . . . . 0.0 110.139 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -64.41 -28.8 69.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.927 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -82.1 -31.31 30.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.772 -175.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.458 ' HE2' ' HB2' ' A' ' 23' ' ' TYR . 84.2 mtp -68.65 160.84 29.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.027 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.1 m -85.17 110.89 19.33 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.076 0.465 . . . . 0.0 110.362 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.513 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 35.0 p90 -74.86 139.0 42.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.542 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -126.58 85.4 60.51 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.085 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.456 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 24.5 Cg_endo -62.86 -29.84 76.79 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.609 2.206 . . . . 0.0 111.579 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -63.81 -23.94 67.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.149 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -118.5 5.52 11.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.324 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.454 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 2.0 mp0 57.9 30.95 19.88 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.762 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.404 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 27.5 ptt? -144.36 170.89 15.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.061 0.458 . . . . 0.0 111.234 -175.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.513 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 31.0 m-85 -119.35 140.19 50.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.766 177.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 38.5 p -130.72 148.29 52.48 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.81 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.509 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 2.4 t80 -119.41 122.54 29.3 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.62 116.72 3.71 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.755 2.303 . . . . 0.0 113.383 -175.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 10.7 t -132.98 136.37 27.51 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.19 177.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 9.8 Cg_endo -90.29 118.24 0.68 Allowed 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 121.912 1.741 . . . . 0.0 111.642 174.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.409 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 32.0 p -176.56 -47.07 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.409 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 168.73 -26.89 0.13 Allowed Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.96 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.517 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 3.1 t0 -142.8 176.22 9.23 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -114.0 156.4 24.15 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -177.141 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 22' ' ' THR . 91.1 m-85 -58.39 117.72 4.78 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 172.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 30' ' ' ARG . 49.1 mt-30 -116.9 135.92 53.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.671 0.272 . . . . 0.0 111.105 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.42 HD11 HG12 ' A' ' 56' ' ' VAL . 13.8 tt -148.63 135.04 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.789 174.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -94.24 149.79 20.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.646 0.26 . . . . 0.0 110.62 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -32.11 70.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.488 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -60.51 -41.4 94.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.886 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 64.0 m-20 -66.11 -36.5 83.33 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.246 0.546 . . . . 0.0 110.115 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 57.7 mtp -69.19 -38.92 78.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.368 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -62.84 -30.2 71.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.22 0.533 . . . . 0.0 110.426 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 5.5 mm-40 -64.8 -22.16 66.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.319 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.72 -1.18 55.44 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -174.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -93.18 98.38 11.25 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.648 ' HB3' ' HE2' ' A' ' 58' ' ' PHE . 20.2 pttp -103.44 98.97 8.78 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.627 0.727 . . . . 0.0 111.421 -176.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 2.5 p -169.01 127.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.746 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.35 137.39 39.76 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 176.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.792 HG22 ' HG2' ' A' ' 53' ' ' MET . 40.8 t -111.84 132.4 60.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.022 -178.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.501 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 7.8 t -102.55 112.54 65.69 Favored Pre-proline 0 N--CA 1.448 -0.528 0 CA-C-O 120.991 0.424 . . . . 0.0 110.073 176.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.535 ' O ' ' HB3' ' A' ' 49' ' ' SER . 24.6 Cg_endo -67.81 157.38 62.02 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.27 1.98 . . . . 0.0 110.953 170.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.535 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 41.2 t 90.9 -58.43 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.053 0.941 . . . . 0.0 110.89 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 27.5 p -92.26 -28.25 17.11 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.948 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.8 t 69.65 73.25 0.24 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.399 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.534 HD22 ' HZ ' ' A' ' 31' ' ' PHE . 46.6 tp -134.53 154.41 51.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.354 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.792 ' HG2' HG22 ' A' ' 46' ' ' VAL . 39.4 mtm -139.45 138.37 36.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.294 -177.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -140.17 152.38 21.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.86 177.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 2.1 m-20 -74.48 156.38 36.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.642 0.258 . . . . 0.0 110.32 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 5.0 p -131.15 124.75 56.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.278 0.561 . . . . 0.0 111.165 176.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.527 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 78.4 t -82.58 111.58 19.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.954 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.648 ' HE2' ' HB3' ' A' ' 43' ' ' LYS . 50.2 p90 -112.97 163.03 15.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.19 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.556 ' OD1' ' HG2' ' A' ' 61' ' ' GLU . 5.6 t70 -118.24 157.24 27.38 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.619 ' HB3' HD11 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -63.7 -40.49 96.93 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.223 179.087 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.556 ' HG2' ' OD1' ' A' ' 59' ' ' ASP . 10.3 pt-20 -73.34 -37.91 65.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.12 -177.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -63.05 -45.56 91.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.75 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 54.8 mt -56.75 -49.72 74.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.809 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.21 -42.78 86.97 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.974 0.416 . . . . 0.0 111.59 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.9 -46.01 79.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.355 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -66.02 -34.54 78.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.259 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.627 ' HD1' ' HB ' ' A' ' 72' ' ' ILE . 2.6 m-85 -51.83 -53.1 44.02 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.693 0.283 . . . . 0.0 110.826 174.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.6 -36.55 81.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.68 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.52 -54.49 19.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.145 0.498 . . . . 0.0 111.436 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.454 ' HB2' ' HA ' ' A' ' 19' ' ' GLN . . . -65.91 -18.38 65.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.895 -176.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.47 45.72 4.87 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.97 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.627 ' HB ' ' HD1' ' A' ' 67' ' ' TYR . 1.2 mt -106.29 142.67 18.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 67.7 m170 -64.72 147.2 98.13 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.705 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.422 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 4.0 Cg_endo -45.23 117.29 1.58 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.119 3.213 . . . . 0.0 113.815 -174.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 74' ' ' PRO . 58.8 Cg_endo -71.25 164.75 34.69 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.396 2.731 . . . . 0.0 111.849 176.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -74.26 152.34 88.08 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.94 135.21 57.83 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.756 2.304 . . . . 0.0 112.892 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.619 HD11 ' HB3' ' A' ' 60' ' ' LYS . 38.3 pt -112.56 171.08 3.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.133 -175.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.57 ' O ' ' HG2' ' A' ' 60' ' ' LYS . . . -107.66 107.36 18.13 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 172.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.421 ' HA ' ' CB ' ' A' ' 60' ' ' LYS . . . -70.65 -174.67 0.93 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.754 -176.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.17 106.72 0.35 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.979 0.419 . . . . 0.0 110.65 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.303 -178.642 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 mtm . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.592 0.234 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -117.91 -174.2 2.59 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.1 p -89.43 118.76 29.32 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 175.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -113.22 6.38 17.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.86 0.362 . . . . 0.0 111.079 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -150.5 172.14 15.94 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.511 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 35.3 tt0 -158.9 117.14 2.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.818 0.342 . . . . 0.0 110.326 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.9 OUTLIER -125.99 163.05 28.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.442 ' HG2' ' HB ' ' A' ' 57' ' ' VAL . 46.0 mt-10 -87.88 152.97 21.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.024 0.44 . . . . 0.0 111.145 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.6 tt -60.15 -29.57 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.05 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -69.38 -28.86 66.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.733 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.23 -35.55 35.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.106 0.479 . . . . 0.0 109.769 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 78.5 mmm -57.01 152.28 13.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.41 171.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.6 m -96.85 124.55 40.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.833 0.349 . . . . 0.0 110.816 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -80.9 130.38 35.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.096 0.474 . . . . 0.0 110.507 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -115.43 90.07 24.0 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.47 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 30.9 Cg_endo -63.88 -21.57 68.97 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.959 2.439 . . . . 0.0 112.013 -176.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -59.86 -42.61 94.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.75 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.435 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 0.4 OUTLIER -110.79 5.62 20.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.9 -175.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.533 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 1.9 mp0 59.11 41.22 20.91 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.206 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.435 ' HG2' ' HB3' ' A' ' 18' ' ' ASN . 27.2 ptt? -147.3 173.74 12.3 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.91 -177.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -109.11 138.56 45.27 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.916 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 21.1 p -137.14 162.57 33.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.693 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.42 ' O ' ' HB2' ' A' ' 30' ' ' ARG . 52.3 t80 -144.14 128.16 9.1 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.82 107.96 0.31 Allowed 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.292 2.662 . . . . 0.0 113.774 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.44 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 20.8 t -113.0 140.83 24.61 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.002 174.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 21.0 Cg_endo -91.95 117.5 0.44 Allowed 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.989 1.793 . . . . 0.0 111.837 174.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.436 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 31.6 p 178.36 -46.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.919 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.436 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 164.23 -24.27 0.18 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.917 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.5 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -141.97 175.42 9.75 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.132 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.523 ' HD3' ' HB ' ' A' ' 22' ' ' THR . 7.6 ptp180 -118.33 157.6 26.78 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.326 -178.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.535 ' O ' ' HA ' ' A' ' 22' ' ' THR . 91.5 m-85 -50.04 129.6 20.96 Favored 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 123.831 0.707 . . . . 0.0 110.156 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -130.64 127.48 39.02 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.098 -171.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.465 ' HB ' ' HA ' ' A' ' 45' ' ' ALA . 13.3 tt -146.89 135.92 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.528 175.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.412 ' O ' ' HG3' ' A' ' 38' ' ' MET . 27.0 m-85 -97.48 144.16 27.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.481 -177.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.553 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 3.6 mm? -62.81 -27.83 69.58 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.941 0.4 . . . . 0.0 110.658 176.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -55.43 -43.55 75.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.724 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.4 -31.98 54.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.496 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.596 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 78.2 mtp -70.3 -32.4 70.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.116 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.425 ' HB2' ' HH ' ' A' ' 67' ' ' TYR . 71.1 t80 -68.82 -27.26 65.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.845 177.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -72.85 -7.0 48.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.855 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.0 -0.83 47.83 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.994 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.596 ' O ' ' HA ' ' A' ' 38' ' ' MET . 9.9 tp10 -105.7 155.06 19.62 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.662 ' HD3' ' N ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -147.62 100.99 3.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.769 0.795 . . . . 0.0 110.942 -176.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 p -167.2 131.08 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.98 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.465 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . . . -100.73 135.39 42.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.31 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 p -112.91 136.74 48.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.268 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.7 t -105.07 124.75 35.57 Favored Pre-proline 0 N--CA 1.436 -1.162 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.444 175.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.5 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 58.3 Cg_endo -75.7 156.42 39.93 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.805 2.337 . . . . 0.0 111.094 173.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 33.0 t 89.58 -57.37 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.764 0.826 . . . . 0.0 110.629 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.406 ' HB3' ' CB ' ' A' ' 27' ' ' CYS . 21.5 p -91.25 -30.91 16.36 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.306 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t 70.38 73.23 0.21 Allowed 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.276 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.3 tp -130.35 144.53 51.44 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.458 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 46.3 mtm -135.18 137.86 43.1 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.131 0.491 . . . . 0.0 110.984 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.61 154.86 27.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.663 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.511 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 2.1 t70 -83.4 151.31 25.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.5 HG13 ' HB2' ' A' ' 43' ' ' LYS . 6.1 p -130.04 116.47 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.521 0.677 . . . . 0.0 111.909 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.442 ' HB ' ' HG2' ' A' ' 8' ' ' GLU . 48.4 t -72.76 111.55 7.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.446 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.475 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 28.4 p90 -115.33 164.7 13.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.032 -175.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.515 ' OD1' ' HG2' ' A' ' 61' ' ' GLU . 8.8 t70 -126.05 157.61 37.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 171.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.715 ' HB3' HD11 ' A' ' 78' ' ' ILE . 0.7 OUTLIER -64.67 -37.76 88.67 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.629 178.11 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.515 ' HG2' ' OD1' ' A' ' 59' ' ' ASP . 12.9 pt-20 -73.13 -37.87 66.48 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.355 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.508 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 4.0 m-20 -59.06 -53.13 61.89 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.488 175.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.415 HD21 HD13 ' A' ' 35' ' ' LEU . 28.4 mt -55.42 -50.7 69.1 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.881 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.48 -48.23 81.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.681 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -68.46 -43.56 76.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.867 0.365 . . . . 0.0 110.876 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.508 ' HD1' ' O ' ' A' ' 62' ' ' ASP . 48.1 m-85 -68.13 -32.48 72.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.299 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.553 ' CE1' ' HB3' ' A' ' 35' ' ' LEU . 1.2 m-85 -51.63 -48.13 63.42 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.261 0.553 . . . . 0.0 109.956 170.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.44 -30.87 64.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.776 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 66' ' ' TYR . 67.8 mm-40 -66.73 -45.25 79.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.118 176.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.533 ' HB3' ' HA ' ' A' ' 19' ' ' GLN . . . -75.34 -20.47 59.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.509 -176.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.73 43.4 6.09 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.77 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.541 HG22 ' H ' ' A' ' 73' ' ' HIS . 1.6 mt -97.72 175.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.541 ' H ' HG22 ' A' ' 72' ' ' ILE . 76.0 m-70 -66.16 135.58 95.08 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 73' ' ' HIS . 41.2 Cg_exo -56.27 119.57 6.85 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 123.047 2.498 . . . . 0.0 112.098 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.38 162.46 38.28 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.92 2.414 . . . . 0.0 113.14 -176.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.446 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 5.1 mp0 -74.79 164.19 63.1 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.261 176.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 15.6 Cg_endo -57.41 142.23 95.07 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.544 2.163 . . . . 0.0 112.42 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.715 HD11 ' HB3' ' A' ' 60' ' ' LYS . 17.6 pt -110.65 170.13 3.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.433 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.21 25.3 1.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.99 0.424 . . . . 0.0 110.934 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.35 114.41 9.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.448 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.99 -28.12 6.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.207 0.527 . . . . 0.0 110.203 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.447 179.503 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.464 0.252 0 CA-C-O 121.002 0.429 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.2 p -102.29 -158.04 0.65 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.563 -177.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.625 ' HB ' ' OD1' ' A' ' 55' ' ' ASP . 5.7 p -65.91 111.66 3.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.973 0.416 . . . . 0.0 111.271 177.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -114.08 -21.37 10.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.339 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -121.02 152.64 38.36 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.025 -173.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -144.67 117.65 8.83 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 123.12 0.262 . . . . 0.0 110.492 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -118.17 162.58 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.542 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 41.6 mt-10 -69.29 148.85 49.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.956 0.408 . . . . 0.0 111.254 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.3 tt -62.36 -33.18 57.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.049 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.68 -27.25 61.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.753 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -72.53 -30.33 64.37 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.601 ' HA ' ' HD1' ' A' ' 23' ' ' TYR . 84.5 mtp -69.74 151.06 46.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.06 172.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.1 m -76.86 131.52 38.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.121 0.486 . . . . 0.0 111.578 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -74.92 127.17 32.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.329 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -125.24 85.26 58.48 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.002 0.43 . . . . 0.0 110.304 173.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.68 -34.17 42.15 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.759 2.306 . . . . 0.0 111.949 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.33 -34.11 76.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.478 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.462 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 3.5 t-20 -102.62 -1.6 29.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.875 0.369 . . . . 0.0 111.024 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.405 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 1.5 mp0 62.01 35.96 15.75 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.856 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.536 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 26.2 ptt? -154.0 167.58 29.28 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.544 -177.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -100.36 146.28 27.16 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.477 177.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 23.4 p -138.51 136.82 36.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.86 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.601 ' HD1' ' HA ' ' A' ' 12' ' ' MET . 8.6 t80 -115.38 121.31 34.94 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -50.68 118.73 4.38 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.672 2.915 . . . . 0.0 113.778 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.509 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 16.5 t -135.47 139.98 32.85 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.339 176.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -91.8 120.32 0.56 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.644 2.229 . . . . 0.0 111.947 172.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.6 p 177.61 -39.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.775 0.798 . . . . 0.0 108.958 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 158.14 -26.95 0.44 Allowed Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.627 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.446 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 3.7 t0 -142.04 176.34 9.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.472 ' HE ' ' HB ' ' A' ' 22' ' ' THR . 12.7 ptm180 -117.63 153.7 32.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.584 ' O ' ' HA ' ' A' ' 22' ' ' THR . 99.4 m-85 -51.57 128.24 22.56 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.58 0.55 . . . . 0.0 110.003 177.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -133.55 142.66 48.28 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.065 0.459 . . . . 0.0 110.686 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.536 ' O ' ' HB2' ' A' ' 20' ' ' MET . 14.6 tt -144.44 132.46 17.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.557 -178.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -82.38 128.85 34.64 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.496 -177.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.485 HD12 ' CE1' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -62.59 -34.65 77.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -176.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -65.16 -25.92 67.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.246 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.87 -32.49 27.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.308 0.575 . . . . 0.0 109.76 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 83.6 mtp -67.46 -35.56 79.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.944 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -67.1 -23.6 65.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.154 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -77.69 -9.13 58.82 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.035 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.75 -18.63 34.42 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.058 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.45 121.43 27.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.874 0.369 . . . . 0.0 110.668 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.509 ' HD3' ' CE2' ' A' ' 58' ' ' PHE . 19.7 pttp -120.22 100.56 7.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.675 0.75 . . . . 0.0 112.131 -174.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 p -166.78 126.41 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.573 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.45 142.16 32.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.125 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.94 138.67 51.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.966 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.529 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 23.0 t -107.0 121.69 44.0 Favored Pre-proline 0 N--CA 1.436 -1.15 0 C-N-CA 120.521 -0.471 . . . . 0.0 109.787 176.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' A' ' 49' ' ' SER . 34.0 Cg_endo -68.69 157.1 63.23 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.434 2.089 . . . . 0.0 111.285 174.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 29.5 m 86.51 -60.42 0.05 OUTLIER 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.136 0.975 . . . . 0.0 110.952 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 20.3 p -89.02 -26.88 21.21 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.3 t 69.39 46.45 0.76 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.146 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.541 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 1.7 tt -99.59 129.11 45.72 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 30.4 mtm -120.52 136.79 54.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.102 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.01 162.21 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.625 ' OD1' ' HB ' ' A' ' 3' ' ' THR . 5.0 m-20 -80.29 162.34 24.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.695 0.283 . . . . 0.0 110.382 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.403 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 8.9 p -132.81 137.03 54.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.671 175.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 44.4 t -88.89 112.91 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.556 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.509 ' CE2' ' HD3' ' A' ' 43' ' ' LYS . 39.7 p90 -117.36 165.25 13.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.734 0.302 . . . . 0.0 110.824 -177.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -134.94 151.45 50.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.034 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.66 ' HB3' HD12 ' A' ' 78' ' ' ILE . 93.6 mttt -56.5 -40.92 75.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.713 175.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.18 -46.91 72.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.268 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.95 -44.73 96.15 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.541 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.417 HD22 HD13 ' A' ' 35' ' ' LEU . 36.4 mt -64.55 -48.21 75.89 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.083 -0.247 . . . . 0.0 111.185 -178.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.66 -41.84 95.83 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.058 0.456 . . . . 0.0 111.01 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -68.48 -42.5 78.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.303 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -66.7 -37.2 84.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.06 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.485 ' CE1' HD12 ' A' ' 35' ' ' LEU . 2.6 m-85 -52.71 -43.45 65.67 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.335 0.588 . . . . 0.0 110.147 174.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -66.66 -52.4 45.31 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.467 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -69.49 -31.63 70.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.782 -175.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.405 ' HB2' ' HA ' ' A' ' 19' ' ' GLN . . . -73.69 -18.29 61.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.748 0.309 . . . . 0.0 111.089 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.01 30.0 13.89 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.608 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.601 HG22 ' H ' ' A' ' 73' ' ' HIS . 1.4 mt -93.52 -176.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.601 ' H ' HG22 ' A' ' 72' ' ' ILE . 75.8 m-70 -88.85 135.62 31.79 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.03 128.02 13.29 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.986 2.458 . . . . 0.0 112.361 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.25 156.26 60.62 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.414 2.076 . . . . 0.0 112.017 -177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -73.55 151.77 89.48 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -47.68 131.3 19.8 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.138 2.559 . . . . 0.0 113.33 -173.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.66 HD12 ' HB3' ' A' ' 60' ' ' LYS . 33.5 pt -108.59 167.81 3.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.227 -177.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.47 81.08 8.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.917 0.389 . . . . 0.0 109.957 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -165.83 112.13 0.89 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.72 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.6 -37.34 5.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.944 0.402 . . . . 0.0 110.651 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.74 0 CA-C-O 118.392 -0.813 . . . . 0.0 109.937 -179.49 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptt? . . . . . 0 C--O 1.232 0.168 0 CA-C-O 121.182 0.515 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.0 p -90.39 165.8 13.64 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.121 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.0 p -73.15 122.07 21.28 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.905 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -85.23 6.49 25.78 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -166.99 169.64 12.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.632 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -144.34 113.96 7.15 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.442 ' CG2' ' HB3' ' A' ' 11' ' ' ASP . 4.1 mt -120.9 142.07 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -169.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -62.52 140.07 58.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.458 171.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.8 tt -55.42 -33.93 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.518 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -73.36 -28.34 61.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.59 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.442 ' HB3' ' CG2' ' A' ' 7' ' ' ILE . 12.3 t70 -72.01 -29.41 64.17 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 83.0 mmm -69.1 145.02 53.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.373 176.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 50.9 m -90.35 115.76 27.79 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.102 0.477 . . . . 0.0 110.412 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.678 ' HB2' ' HE1' ' A' ' 66' ' ' TYR . 39.2 p90 -74.35 139.13 43.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.554 -176.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -115.38 85.02 12.5 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.223 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.474 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 21.3 Cg_endo -60.33 -28.92 87.76 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.163 2.575 . . . . 0.0 113.799 -170.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.35 -29.45 68.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.875 0.369 . . . . 0.0 110.988 -177.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -108.45 -0.4 20.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.955 -175.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.43 ' CG ' HG12 ' A' ' 72' ' ' ILE . 1.8 mp0 60.02 40.4 18.77 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.096 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -141.74 170.3 15.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.985 0.421 . . . . 0.0 110.757 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -109.7 144.78 37.59 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.547 174.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 35.5 p -134.66 158.35 44.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.079 -178.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.423 ' HB3' ' CD2' ' A' ' 31' ' ' PHE . 4.4 t80 -137.81 132.81 17.44 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.7 121.81 10.28 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.716 2.277 . . . . 0.0 113.222 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.529 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 28.4 t -132.5 144.66 53.95 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.377 177.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -94.28 118.52 0.29 Allowed 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 122.184 1.923 . . . . 0.0 111.778 173.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.4 p 174.93 -40.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.767 0.794 . . . . 0.0 109.158 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 148.26 -12.53 1.22 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.257 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.58 176.15 9.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.577 0.227 . . . . 0.0 110.461 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.48 ' HD3' ' HB ' ' A' ' 22' ' ' THR . 16.0 ptp180 -121.05 150.35 41.31 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.073 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.643 ' O ' ' HA ' ' A' ' 22' ' ' THR . 98.9 m-85 -51.21 125.46 14.09 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.283 0.364 . . . . 0.0 110.319 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -120.6 133.68 55.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.179 0.514 . . . . 0.0 111.025 -176.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.5 tt -146.54 126.49 5.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.606 175.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -91.44 147.12 23.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.557 -175.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -61.32 -30.63 70.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.345 -177.375 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -55.46 -50.64 69.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.082 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -65.94 -38.4 88.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.45 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 84.0 mtp -63.51 -41.74 98.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.467 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.25 -29.57 69.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.677 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -68.63 -16.73 63.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.215 177.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.73 -9.5 52.06 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.945 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -90.92 92.78 8.92 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -105.46 100.77 10.34 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.255 1.026 . . . . 0.0 111.73 -174.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 p -166.12 130.43 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.036 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.431 ' HB2' HD13 ' A' ' 54' ' ' ILE . . . -99.96 141.95 32.09 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.17 138.02 52.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.905 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.551 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 12.9 t -102.22 121.48 50.13 Favored Pre-proline 0 N--CA 1.432 -1.356 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.471 ' O ' ' HB2' ' A' ' 49' ' ' SER . 45.6 Cg_endo -70.42 155.97 62.62 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.688 2.259 . . . . 0.0 111.846 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 67.5 m 79.78 -51.29 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.519 0.728 . . . . 0.0 111.785 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 13.8 p -91.92 -23.66 19.53 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.053 177.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.4 t 67.59 45.27 1.54 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.231 171.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.535 HD22 ' HZ ' ' A' ' 31' ' ' PHE . 50.5 tp -102.68 137.03 41.44 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.893 -0.504 . . . . 0.0 109.815 176.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 37.1 mtm -123.93 138.21 54.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.949 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.431 HD13 ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -141.64 152.23 19.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.118 179.029 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -78.38 146.14 34.8 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.794 -178.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.608 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 96.8 t -131.42 113.06 22.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.053 0.454 . . . . 0.0 110.704 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.6 t -84.87 124.87 40.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 -175.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.42 ' CD1' HD13 ' A' ' 63' ' ' LEU . 52.8 p90 -118.15 164.9 14.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.906 0.384 . . . . 0.0 111.382 -175.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.43 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -127.69 152.4 47.76 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.834 173.339 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -62.97 -39.4 94.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.468 -176.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -64.64 -43.18 94.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.097 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -68.32 -35.53 77.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.06 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 51.0 mt -60.89 -53.94 51.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.537 177.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.438 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . . . -57.81 -41.75 82.81 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.121 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.92 -47.69 83.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.408 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.678 ' HE1' ' HB2' ' A' ' 14' ' ' PHE . 76.0 t80 -61.98 -35.81 79.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.132 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.534 ' HD1' ' HB ' ' A' ' 72' ' ' ILE . 24.5 m-85 -54.2 -44.26 71.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.032 0.444 . . . . 0.0 110.82 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -76.61 -43.18 39.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.692 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -58.49 -48.08 81.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.825 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.0 -25.52 43.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.252 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.26 55.41 2.76 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.256 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.534 ' HB ' ' HD1' ' A' ' 67' ' ' TYR . 12.2 mt -94.33 153.49 3.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.273 -0.464 . . . . 0.0 109.991 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -56.61 139.21 76.1 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.096 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -35.17 108.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 124.576 3.518 . . . . 0.0 114.189 -177.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -80.89 164.74 20.13 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.42 2.747 . . . . 0.0 112.525 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -73.13 117.9 64.02 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -65.48 140.34 62.79 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.69 2.26 . . . . 0.0 113.177 -174.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.1 pt -95.52 172.69 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.791 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -127.43 102.26 6.8 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.51 110.6 6.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.821 -177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.7 -49.26 7.61 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.629 178.221 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mmt . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 120.763 0.316 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.7 m -139.57 136.21 34.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.939 0.4 . . . . 0.0 111.601 -177.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.6 93.83 7.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.289 0.566 . . . . 0.0 110.078 173.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -72.46 -36.87 68.59 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.822 -173.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -110.73 162.56 14.64 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.842 0.353 . . . . 0.0 110.891 -171.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -156.67 108.05 2.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.18 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.43 162.41 17.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.0 -175.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.507 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 42.8 mt-10 -71.45 151.58 43.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.262 0.553 . . . . 0.0 110.93 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.5 tt -60.61 -31.18 48.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.509 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.24 -28.05 65.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.313 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -78.71 -29.98 45.72 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.886 0.374 . . . . 0.0 110.584 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 82.4 mmm -58.98 130.44 47.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.387 175.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.3 m -72.92 107.31 5.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.199 0.524 . . . . 0.0 110.48 -176.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.543 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . 43.7 p90 -84.37 133.98 34.5 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.573 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.491 ' HA ' ' OE1' ' A' ' 15' ' ' GLU . 4.9 tp10 -112.04 98.24 41.56 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.747 176.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.02 -22.14 73.7 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.884 2.389 . . . . 0.0 111.692 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -70.16 -25.75 63.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.815 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -114.22 -0.26 13.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.033 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 57.63 42.68 23.6 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.528 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -160.15 172.72 16.93 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.615 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -103.45 137.09 42.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.001 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 30.2 p -136.7 166.63 23.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.438 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.429 ' CB ' ' HB2' ' A' ' 31' ' ' PHE . 0.4 OUTLIER -138.95 121.58 10.53 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.638 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -54.94 122.29 11.41 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.085 2.523 . . . . 0.0 113.414 -177.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 16.3 t -146.32 127.53 7.36 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.267 176.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -85.65 119.28 1.92 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.351 2.034 . . . . 0.0 111.683 174.175 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.8 p -175.63 -43.71 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.1 -30.52 0.17 Allowed Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.342 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.498 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 2.4 t70 -143.2 176.06 9.41 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.94 153.11 25.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.522 ' HZ ' HD22 ' A' ' 52' ' ' LEU . 79.0 m-85 -52.89 124.97 15.51 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -134.31 145.91 49.5 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.09 0.471 . . . . 0.0 111.383 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.3 tt -142.61 135.34 26.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.029 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -91.53 138.8 31.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.785 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.551 ' HA ' ' HG3' ' A' ' 38' ' ' MET . 1.1 mt -68.56 -25.14 64.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.162 -177.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -54.02 -45.48 71.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.542 172.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.66 -44.49 73.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.509 176.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.551 ' HG3' ' HA ' ' A' ' 35' ' ' LEU . 28.3 mtp -60.15 -46.01 91.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -69.24 -22.62 63.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.62 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -76.11 -20.72 57.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.165 0.507 . . . . 0.0 110.11 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.84 -3.3 31.97 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.257 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -83.62 117.32 23.09 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 175.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.525 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -126.83 98.52 5.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.072 0.939 . . . . 0.0 111.832 -174.295 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 p -168.54 132.07 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.904 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.25 138.12 38.7 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.0 p -120.23 137.79 52.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.541 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.482 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 10.0 t -104.1 123.88 39.35 Favored Pre-proline 0 N--CA 1.434 -1.24 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 174.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.498 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 35.5 Cg_endo -80.27 157.22 22.82 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.416 2.077 . . . . 0.0 111.451 175.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 23.0 t 88.85 -55.88 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.224 1.01 . . . . 0.0 110.585 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.9 p -89.01 -32.02 17.81 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 47' ' ' CYS . 20.2 m 68.49 74.02 0.28 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.652 176.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.522 HD22 ' HZ ' ' A' ' 31' ' ' PHE . 42.2 tp -132.21 150.28 52.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.428 ' HE3' ' HB2' ' A' ' 53' ' ' MET . 33.0 mtm -135.14 141.12 45.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.076 -175.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.38 148.52 21.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.66 175.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.21 156.66 37.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.837 0.351 . . . . 0.0 110.773 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.46 127.99 57.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.151 0.5 . . . . 0.0 111.098 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.507 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 46.8 t -83.45 105.68 13.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.152 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -113.09 164.65 13.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.572 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.595 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 5.2 t0 -134.12 158.67 43.04 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 173.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.679 ' HB3' HG22 ' A' ' 78' ' ' ILE . 9.0 mptt -64.24 -38.41 90.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.164 0.507 . . . . 0.0 110.17 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -73.53 -36.93 65.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.083 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.73 -38.44 90.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.794 0.33 . . . . 0.0 110.594 176.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 87.6 mt -63.84 -53.46 50.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.558 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.433 ' HA ' ' HG3' ' A' ' 75' ' ' PRO . . . -53.21 -42.92 66.81 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.673 -177.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -59.07 -49.13 79.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.623 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 70.5 t80 -65.85 -35.96 82.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.28 -177.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.57 ' HD1' ' HB ' ' A' ' 72' ' ' ILE . 27.3 m-85 -53.66 -44.64 69.83 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.614 0.245 . . . . 0.0 110.787 178.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -72.32 -39.92 67.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.699 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -63.75 -36.92 85.48 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.152 -0.477 . . . . 0.0 112.279 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.47 -17.64 33.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.648 0.261 . . . . 0.0 111.417 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.8 37.22 9.56 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.794 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.663 HG21 ' H ' ' A' ' 73' ' ' HIS . 2.0 mt -94.1 -176.04 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.663 ' H ' HG21 ' A' ' 72' ' ' ILE . 66.7 m-70 -79.09 134.99 58.76 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.09 131.84 41.28 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.882 2.388 . . . . 0.0 112.61 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.433 ' HG3' ' HA ' ' A' ' 64' ' ' ALA . 61.3 Cg_endo -73.86 164.09 35.46 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.032 2.488 . . . . 0.0 112.106 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.458 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 10.4 pt-20 -73.51 159.33 84.93 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.128 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 76' ' ' GLU . 14.8 Cg_endo -57.86 143.2 96.19 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.616 2.211 . . . . 0.0 112.916 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.679 HG22 ' HB3' ' A' ' 60' ' ' LYS . 36.3 pt -115.71 174.03 3.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.106 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.03 -11.14 31.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.208 0.528 . . . . 0.0 110.235 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 55.53 -162.53 0.15 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.338 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -113.24 -41.83 3.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.114 0.483 . . . . 0.0 110.18 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.465 -0.779 . . . . 0.0 110.413 177.597 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.699 ' HA ' ' HE3' ' A' ' 1' ' ' MET . 3.2 mmt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.212 0.529 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.3 m -104.5 149.91 25.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.222 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.0 p -86.06 101.15 12.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.16 0.505 . . . . 0.0 109.899 173.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -74.38 -26.77 60.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.369 -171.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -128.98 165.64 20.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.06 0.457 . . . . 0.0 111.635 -174.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 43.9 tt0 -148.45 116.76 6.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.235 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.472 ' CD1' HG13 ' A' ' 54' ' ' ILE . 4.5 mp -113.43 149.7 15.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -173.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.52 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 43.0 mt-10 -67.8 144.17 55.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.8 0.333 . . . . 0.0 110.25 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.3 tt -57.56 -28.57 31.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.161 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -71.69 -35.17 70.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.13 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.465 ' HB3' ' CG2' ' A' ' 7' ' ' ILE . 11.5 t70 -76.84 -40.57 47.37 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 83.7 mmm -49.22 137.18 14.25 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.913 169.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.5 m -79.59 106.87 11.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.403 0.621 . . . . 0.0 110.353 -176.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -75.52 128.2 34.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.558 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -118.03 88.07 30.46 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.822 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.55 -26.04 69.78 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.71 2.274 . . . . 0.0 111.536 -178.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.12 -29.6 70.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.765 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -110.28 5.21 21.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.528 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.531 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 2.3 mp0 58.86 38.33 24.58 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.948 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -160.4 174.68 13.76 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.051 0.453 . . . . 0.0 111.411 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -108.35 140.62 41.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.617 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.55 ' HB ' ' HD3' ' A' ' 30' ' ' ARG . 40.6 p -136.24 169.22 17.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.467 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -140.99 120.45 8.4 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.05 116.28 2.82 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 123.307 2.672 . . . . 0.0 112.975 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 28.4 t -130.29 138.99 34.29 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.422 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 46.3 Cg_endo -91.7 117.87 0.48 Allowed 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 122.049 1.832 . . . . 0.0 111.734 174.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.4 p 178.83 -43.65 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.753 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.89 -25.33 0.24 Allowed Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.994 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.541 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 2.3 t0 -142.76 175.72 9.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.55 ' HD3' ' HB ' ' A' ' 22' ' ' THR . 12.4 ptp180 -114.57 155.54 26.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.587 0.232 . . . . 0.0 111.11 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.627 ' HZ ' HD22 ' A' ' 52' ' ' LEU . 91.0 m-85 -54.57 127.72 29.11 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.16 175.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -124.5 137.9 54.38 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.099 0.476 . . . . 0.0 110.505 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.4 tt -140.66 140.29 33.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.658 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.485 ' O ' ' HG3' ' A' ' 38' ' ' MET . 17.1 m-85 -103.17 136.15 43.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.921 -172.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -56.5 -35.54 68.12 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.103 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.466 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 11.9 t70 -54.34 -51.72 63.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.088 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.97 -29.6 58.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.556 -174.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.485 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 90.4 mtp -65.76 -39.58 91.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.051 176.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -69.71 -23.49 63.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.385 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 36' ' ' ASP . 17.3 mm-40 -73.45 -16.08 61.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.588 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.8 -10.76 38.11 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.883 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -94.04 109.0 20.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.187 0.518 . . . . 0.0 110.331 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.663 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -108.0 102.47 11.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.799 0.809 . . . . 0.0 111.722 -176.11 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 p -164.43 129.3 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.263 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.27 143.52 31.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.134 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.09 139.4 47.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.974 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.518 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 17.4 t -107.73 124.02 36.14 Favored Pre-proline 0 N--CA 1.439 -0.982 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.31 175.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.553 ' O ' ' HB3' ' A' ' 49' ' ' SER . 58.5 Cg_endo -74.86 156.84 43.63 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.758 2.306 . . . . 0.0 111.023 173.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.553 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 40.1 t 88.66 -57.46 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.752 0.821 . . . . 0.0 110.906 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.0 p -91.63 -29.14 17.06 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.514 -0.475 . . . . 0.0 109.724 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 47' ' ' CYS . 33.7 t 66.92 70.13 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.517 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.627 HD22 ' HZ ' ' A' ' 31' ' ' PHE . 53.7 tp -125.51 151.32 46.48 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.427 ' HE2' ' HB2' ' A' ' 53' ' ' MET . 32.7 mtm -134.26 138.23 44.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.383 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.472 HG13 ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -142.72 154.43 17.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 177.579 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.552 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 2.4 m-20 -77.09 158.29 30.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.762 0.315 . . . . 0.0 110.403 177.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 86.0 t -132.79 125.3 52.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.847 0.356 . . . . 0.0 111.123 178.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.52 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 89.2 t -77.75 126.42 38.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.084 177.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -142.71 165.11 28.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.713 0.292 . . . . 0.0 111.154 -175.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.552 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 9.6 t70 -132.2 151.83 51.61 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 171.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -63.61 -33.2 75.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.046 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -65.61 -49.51 68.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.12 176.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -60.47 -39.56 88.06 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.086 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 40.9 mt -58.17 -57.15 14.12 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.766 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.5 -40.81 75.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.268 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -66.19 -37.54 85.85 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.434 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -77.81 -33.86 52.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -51.09 -44.84 61.32 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.893 0.377 . . . . 0.0 110.611 172.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -63.03 -45.64 91.34 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.661 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.79 -40.49 88.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.828 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.531 ' HB3' ' HA ' ' A' ' 19' ' ' GLN . . . -78.93 -12.56 60.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.529 -177.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.56 38.3 32.98 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.596 177.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.462 HG23 ' HG2' ' A' ' 19' ' ' GLN . 0.9 OUTLIER -115.66 168.63 7.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 O-C-N 122.892 -0.181 . . . . 0.0 110.709 178.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -57.55 116.34 13.69 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.775 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.446 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 73.3 Cg_endo -76.79 145.64 25.73 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.538 2.158 . . . . 0.0 112.325 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 74' ' ' PRO . 6.9 Cg_exo -73.36 164.71 34.46 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.277 2.651 . . . . 0.0 111.778 176.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -73.73 124.01 89.87 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -47.39 139.97 16.19 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.552 2.835 . . . . 0.0 113.625 -172.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 31.6 pt -120.3 157.44 22.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.658 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -115.89 81.8 1.66 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.963 0.411 . . . . 0.0 110.705 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.4 -3.35 18.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.502 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.74 136.27 33.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.668 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.539 -0.743 . . . . 0.0 110.043 178.987 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.4 mtp . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 121.44 0.638 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.6 p -104.12 173.24 6.39 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.789 176.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.8 p -79.72 126.58 31.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.843 0.354 . . . . 0.0 111.086 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -96.12 -24.62 16.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.72 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.402 ' HB3' ' CG2' ' A' ' 54' ' ' ILE . 47.1 t0 -120.62 167.04 12.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 33.2 tt0 -156.72 110.86 2.72 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.565 ' CD1' HG13 ' A' ' 54' ' ' ILE . 4.2 mp -109.9 147.79 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.003 0.43 . . . . 0.0 111.469 -173.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -65.33 147.01 54.18 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.129 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.67 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 21.0 tt -65.17 -28.46 44.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.371 0.605 . . . . 0.0 110.011 177.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -62.97 -39.13 93.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.618 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.489 ' HB3' ' CG2' ' A' ' 7' ' ' ILE . 19.2 t70 -80.63 -36.03 33.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.515 -175.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 79.9 mmm -54.03 144.81 18.28 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.86 170.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.7 m -91.73 127.34 37.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.688 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.664 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . 47.3 p90 -81.76 138.0 35.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.998 0.427 . . . . 0.0 110.669 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -124.39 84.25 56.67 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.605 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.2 -22.0 54.44 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.03 2.487 . . . . 0.0 112.973 -172.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -68.29 -33.3 74.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.973 0.416 . . . . 0.0 110.586 -178.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -105.61 -5.16 20.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.965 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 64.5 36.3 8.81 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.296 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -145.15 167.98 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.597 -177.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.425 ' HB2' HG23 ' A' ' 33' ' ' ILE . 71.2 m-85 -96.89 146.76 24.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.871 0.367 . . . . 0.0 110.336 177.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 22.3 p -136.82 164.46 28.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.503 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.431 ' HB3' ' CD2' ' A' ' 31' ' ' PHE . 10.1 t80 -147.59 127.02 6.45 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.91 120.42 7.87 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.414 2.742 . . . . 0.0 113.655 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.543 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 11.6 t -136.28 135.98 21.83 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.305 174.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -84.39 118.4 2.23 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 121.901 1.734 . . . . 0.0 111.572 175.19 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 32.0 p 177.14 -46.17 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 164.08 -27.11 0.21 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.326 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.556 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 2.5 t0 -139.63 175.22 9.75 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -113.58 153.17 29.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.496 -177.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.623 ' CD1' ' HB2' ' A' ' 47' ' ' CYS . 97.2 m-85 -50.19 130.66 23.06 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.194 0.309 . . . . 0.0 110.752 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.6 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 4.2 pt20 -117.85 134.67 54.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.918 0.389 . . . . 0.0 110.638 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.425 HG23 ' HB2' ' A' ' 21' ' ' PHE . 12.9 tt -147.56 133.87 12.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.288 176.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.416 ' HB2' ' OD2' ' A' ' 37' ' ' ASP . 90.5 m-85 -96.13 147.4 23.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.857 -177.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 35' ' ' LEU . 4.1 mm? -61.0 -33.92 74.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.062 178.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -56.7 -43.38 80.49 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.155 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.416 ' OD2' ' HB2' ' A' ' 34' ' ' TYR . 25.0 m-20 -67.77 -44.39 77.56 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.111 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.412 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 76.1 mtp -61.84 -44.28 97.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.643 -177.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -69.53 -29.23 66.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.68 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -72.94 -18.13 61.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.056 0.455 . . . . 0.0 110.589 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.11 1.41 33.72 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.61 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -108.16 100.61 9.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.153 0.501 . . . . 0.0 109.714 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.504 ' HD2' ' HE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -108.63 101.32 10.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.841 0.829 . . . . 0.0 111.03 -171.409 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 54' ' ' ILE . 1.8 p -163.43 131.38 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.003 -177.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.1 134.78 42.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.059 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.777 HG22 ' HG2' ' A' ' 53' ' ' MET . 46.7 t -114.74 122.99 69.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.623 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 26.1 t -83.49 124.86 75.14 Favored Pre-proline 0 C--N 1.318 -0.779 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.008 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.556 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 58.8 Cg_endo -73.2 156.64 51.09 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.832 2.355 . . . . 0.0 110.746 173.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.518 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 42.8 t 86.79 -60.38 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.447 0.699 . . . . 0.0 110.876 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 15.7 p -92.56 -24.76 18.62 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.207 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 t 64.48 79.61 0.25 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.535 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.4 tt -131.09 131.01 43.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.777 ' HG2' HG22 ' A' ' 46' ' ' VAL . 27.7 mtm -118.94 136.62 53.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.683 0.277 . . . . 0.0 111.265 -175.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.565 HG13 ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -145.52 155.43 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.66 177.143 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.539 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -76.79 152.24 35.65 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.583 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.7 t -132.7 120.05 40.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.964 0.411 . . . . 0.0 110.291 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.67 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 21.1 t -75.71 149.54 6.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.504 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 55.1 p90 -146.84 164.64 32.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.364 0.126 . . . . 0.0 110.694 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.579 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 14.4 t70 -125.98 156.76 39.32 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.861 0.362 . . . . 0.0 110.625 174.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.867 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 0.8 OUTLIER -60.63 -46.55 89.85 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.08 178.722 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -72.89 -40.67 65.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.726 -177.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -63.77 -39.6 94.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.3 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 66.8 mt -64.21 -52.42 58.91 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.498 176.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.403 ' HA ' ' HG3' ' A' ' 75' ' ' PRO . . . -54.14 -45.12 71.89 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.273 -177.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.48 -44.73 95.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.354 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.664 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 54.6 t80 -66.36 -40.83 90.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.586 -176.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.507 ' HA ' HD13 ' A' ' 72' ' ' ILE . 36.6 m-85 -51.31 -48.43 62.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.923 0.392 . . . . 0.0 110.679 175.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -71.15 -35.68 71.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.833 -177.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -70.14 -45.22 67.26 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.75 -12.68 59.42 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -174.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.8 41.34 8.27 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.424 -0.894 . . . . 0.0 111.387 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.584 HG23 ' H ' ' A' ' 73' ' ' HIS . 2.8 mt -98.2 177.03 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.584 ' H ' HG23 ' A' ' 72' ' ' ILE . 98.5 m-70 -57.36 122.72 56.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 110.324 -0.251 . . . . 0.0 110.324 177.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -52.18 121.76 9.46 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.363 2.708 . . . . 0.0 112.389 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.403 ' HG3' ' HA ' ' A' ' 64' ' ' ALA . 64.0 Cg_endo -74.09 148.1 39.24 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.664 2.242 . . . . 0.0 112.254 -177.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -76.2 148.89 81.58 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.142 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.08 136.0 72.72 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.649 2.233 . . . . 0.0 112.777 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.6 pt -98.3 166.15 2.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.836 -176.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.06 72.99 6.88 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.586 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -159.08 125.03 4.41 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.815 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.55 -48.79 0.9 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.232 173.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.423 177.014 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.942 0.401 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.1 m -94.93 175.29 6.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.013 171.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.2 p -69.71 119.74 14.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.99 0.424 . . . . 0.0 110.752 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -88.14 -14.2 39.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.157 -172.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -142.7 174.76 10.36 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.294 -177.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.541 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 33.5 tt0 -155.67 116.59 3.86 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.466 0.479 . . . . 0.0 109.747 -176.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.417 ' CD1' HG13 ' A' ' 54' ' ' ILE . 1.6 mp -129.33 146.44 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.79 -177.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.526 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 46.4 mt-10 -69.82 145.75 51.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.951 0.405 . . . . 0.0 110.463 174.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.2 tt -55.26 -28.89 22.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.474 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -63.1 -33.61 75.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.721 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -86.16 -31.62 21.71 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.164 -174.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.519 ' HA ' ' HD1' ' A' ' 23' ' ' TYR . 80.2 mtp -65.16 145.33 56.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 110.974 177.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.6 m -72.84 120.32 18.3 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.484 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -79.83 133.98 36.31 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.209 177.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -122.54 89.93 49.61 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.125 0.488 . . . . 0.0 110.061 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.77 -14.89 43.02 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.898 2.398 . . . . 0.0 111.917 -177.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -66.46 -40.3 89.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.488 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.545 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 2.8 t-20 -110.73 0.79 17.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.247 -177.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.704 HE21 ' N ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER 59.83 42.32 16.73 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.834 -179.753 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.545 ' HG2' ' HB3' ' A' ' 18' ' ' ASN . 26.9 ptt? -146.96 174.3 11.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.076 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -114.46 142.27 46.6 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 38.6 p -133.2 145.99 51.09 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.519 ' HD1' ' HA ' ' A' ' 12' ' ' MET . 9.6 t80 -119.61 131.15 24.5 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.55 122.79 12.25 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 123.016 2.477 . . . . 0.0 113.096 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.559 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 22.4 t -139.45 138.76 20.92 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.926 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -91.87 117.99 0.47 Allowed 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.19 1.927 . . . . 0.0 111.859 174.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.464 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 30.7 p -178.54 -52.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.745 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.464 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 172.43 -27.89 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.883 -178.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.563 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 2.5 t70 -142.41 176.52 8.94 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.412 ' HE ' ' CB ' ' A' ' 22' ' ' THR . 10.6 ptm180 -114.7 147.51 39.56 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.633 ' O ' ' HA ' ' A' ' 22' ' ' THR . 97.7 m-85 -46.97 121.27 3.54 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.517 0.511 . . . . 0.0 110.18 178.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -120.49 131.52 54.77 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.897 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 20' ' ' MET . 14.7 tt -132.54 132.5 60.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.936 176.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.439 ' O ' ' HG3' ' A' ' 38' ' ' MET . 30.5 m-85 -90.27 134.83 34.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.756 -173.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.538 ' HG ' HD12 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -61.46 -30.54 70.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.012 -178.315 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -54.04 -44.82 71.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.943 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.522 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . 16.3 m-20 -77.26 -37.67 52.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.768 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.439 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 79.1 mtp -59.88 -42.43 93.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.544 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.453 ' HZ ' ' HG3' ' A' ' 76' ' ' GLU . 47.3 t80 -60.49 -37.73 82.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.7 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.83 -22.22 64.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.768 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.51 7.06 32.66 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.653 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 8.0 tp10 -93.17 107.01 18.9 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.809 ' HD2' ' HE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -120.48 98.97 6.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.015 0.912 . . . . 0.0 111.68 -174.737 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 p -167.23 130.14 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.261 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.439 ' HB1' HD13 ' A' ' 54' ' ' ILE . . . -100.82 136.04 41.32 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.864 0.364 . . . . 0.0 110.406 -178.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.745 HG23 ' HG2' ' A' ' 53' ' ' MET . 44.7 t -114.07 129.84 69.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.535 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.554 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 13.0 t -99.25 119.46 60.46 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.778 178.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.563 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 34.4 Cg_endo -69.23 155.93 66.22 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.136 1.89 . . . . 0.0 111.162 175.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 44.5 t 85.36 -56.19 0.09 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.692 0.797 . . . . 0.0 111.366 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 52' ' ' LEU . 16.3 p -93.65 -18.56 22.03 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.4 t 67.23 43.06 2.13 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.839 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.628 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -94.21 148.55 22.08 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.676 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.745 ' HG2' HG23 ' A' ' 46' ' ' VAL . 48.9 mtm -140.36 135.73 32.45 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.032 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.439 HD13 ' HB1' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -144.75 152.65 14.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.957 179.43 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 0.4 OUTLIER -76.04 152.95 36.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.879 178.703 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.78 143.37 39.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 56.5 t -103.07 107.99 23.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.809 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 24.3 p90 -113.57 164.53 13.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.099 -177.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -136.46 158.26 44.86 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' A' ' 60' ' ' LYS . 12.4 mptt -64.02 -33.97 76.96 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.764 176.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -60.13 -54.08 50.19 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.232 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -61.46 -43.9 98.06 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.511 -176.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 35.2 mt -59.86 -49.62 77.0 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.285 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.45 80.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.775 0.321 . . . . 0.0 111.381 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -65.72 -53.73 36.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.452 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -68.91 -33.76 74.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.462 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.502 ' HA ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -51.94 -46.23 64.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.916 175.681 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -67.25 -45.78 75.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.938 0.399 . . . . 0.0 110.983 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -61.51 -49.58 76.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.882 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.84 -20.34 53.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.113 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.97 46.1 10.99 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -177.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.538 HD12 ' HG ' ' A' ' 35' ' ' LEU . 10.7 mt -81.7 165.65 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.53 -0.335 . . . . 0.0 110.303 -173.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.436 ' N ' HG23 ' A' ' 72' ' ' ILE . 27.9 t60 -61.95 133.53 93.93 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.296 178.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -46.69 120.19 3.81 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.611 2.874 . . . . 0.0 113.302 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -86.68 166.8 8.75 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.954 3.102 . . . . 0.0 112.212 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.453 ' HG3' ' HZ ' ' A' ' 39' ' ' PHE . 39.6 mt-10 -72.52 136.87 80.74 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.21 140.88 24.95 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.213 2.609 . . . . 0.0 113.31 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.2 pt -101.51 151.07 5.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.66 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.97 83.13 4.68 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.125 0.488 . . . . 0.0 110.494 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.34 92.74 7.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.306 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.65 -53.28 2.66 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.656 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.396 179.428 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.6 mtm . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.322 0.582 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 p -118.74 160.02 22.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.365 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.0 p -86.03 130.74 34.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.054 0.454 . . . . 0.0 110.944 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -92.0 -28.18 17.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.439 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -135.81 171.69 14.09 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.067 -171.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 39.7 tt0 -150.58 109.84 3.96 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.02 158.11 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 -175.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.497 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 57.3 mm-40 -61.63 150.59 35.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.138 0.494 . . . . 0.0 111.21 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.683 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 20.6 tt -62.4 -28.7 45.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.227 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -63.2 -29.96 71.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.397 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -79.16 -34.63 43.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.259 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.647 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 90.6 mmm -62.11 118.13 6.93 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 173.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.3 m -71.59 107.86 4.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.406 0.622 . . . . 0.0 110.442 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.585 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 39.0 p90 -74.54 137.6 42.53 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.183 -177.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -114.75 101.93 54.61 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.14 175.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.66 -9.15 23.39 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.072 2.515 . . . . 0.0 112.432 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -93.05 -38.53 11.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.121 0.486 . . . . 0.0 109.877 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.545 ' OD1' ' HE2' ' A' ' 20' ' ' MET . 1.3 t-20 -89.39 -5.85 57.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.464 -175.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 73.46 18.2 3.67 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.608 171.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.573 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 27.3 ptt? -161.75 175.71 11.69 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.081 -173.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.647 ' HB3' ' HB3' ' A' ' 12' ' ' MET . 87.3 m-85 -95.76 131.08 42.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.133 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 23.8 p -129.04 137.8 51.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.779 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 36.0 t80 -109.64 122.6 38.81 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.21 121.31 9.18 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.229 2.62 . . . . 0.0 113.193 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.401 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 30.7 t -138.29 141.11 30.61 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.3 177.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -94.69 118.18 0.25 Allowed 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 122.157 1.905 . . . . 0.0 112.004 173.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.1 p -179.75 -44.95 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.391 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.71 -24.64 0.23 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.143 -177.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.458 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 4.3 t70 -141.91 177.01 8.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.94 151.04 32.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.933 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.779 ' HB2' ' HB3' ' A' ' 23' ' ' TYR . 75.6 m-85 -54.8 114.67 1.8 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 175.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.41 137.06 52.74 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.992 0.425 . . . . 0.0 110.98 -174.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.573 ' O ' ' HB2' ' A' ' 20' ' ' MET . 14.5 tt -139.64 129.13 29.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.827 173.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.431 ' O ' ' HG3' ' A' ' 38' ' ' MET . 14.1 m-85 -79.59 135.86 36.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.162 -173.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.455 HD11 ' CD2' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -66.88 -36.66 82.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.007 0.432 . . . . 0.0 110.049 -176.751 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 17.3 t70 -61.13 -35.44 77.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.454 176.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -69.54 -42.8 74.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.215 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.607 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 75.5 mtp -65.4 -37.72 87.83 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.5 178.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -69.53 -23.48 63.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.471 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 36' ' ' ASP . 70.4 mm-40 -75.05 -12.51 60.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 176.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.15 -5.42 33.97 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.529 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.607 ' O ' ' HA ' ' A' ' 38' ' ' MET . 0.7 OUTLIER -85.34 146.89 26.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 177.605 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 32.2 pttt -144.89 97.59 3.04 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.586 0.708 . . . . 0.0 111.2 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 p -167.74 126.67 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.036 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 53' ' ' MET . . . -100.54 131.15 46.6 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.966 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.9 p -111.91 139.29 37.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.995 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.42 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 8.6 t -116.34 115.02 40.39 Favored Pre-proline 0 N--CA 1.435 -1.178 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.117 175.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.55 ' O ' ' HB3' ' A' ' 49' ' ' SER . 34.2 Cg_endo -69.0 157.38 62.09 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.601 2.201 . . . . 0.0 111.452 174.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.55 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 35.9 t 88.51 -57.33 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.027 0.931 . . . . 0.0 110.586 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.7 p -90.43 -28.29 18.72 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.003 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.8 t 68.87 54.76 0.46 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.898 177.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.464 HD21 ' N ' ' A' ' 53' ' ' MET . 1.9 tt -114.76 137.2 52.21 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.464 ' N ' HD21 ' A' ' 52' ' ' LEU . 35.6 mtm -132.61 138.23 47.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.021 -178.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.49 156.37 18.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.502 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 39.9 m-20 -80.21 159.95 25.78 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.575 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 11.2 p -136.32 138.07 47.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.993 0.425 . . . . 0.0 111.052 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.683 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 61.8 t -72.12 141.57 16.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -150.03 155.94 40.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.854 0.359 . . . . 0.0 110.908 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -134.88 155.5 50.57 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -63.73 -34.67 78.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.178 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -73.93 -40.93 62.76 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.035 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -59.4 -46.39 88.84 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.16 0.505 . . . . 0.0 110.269 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 72.9 mt -69.51 -44.55 70.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.412 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.78 -46.69 88.4 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.66 0.267 . . . . 0.0 111.259 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.572 ' O ' ' HG3' ' A' ' 69' ' ' GLU . 23.8 tt0 -64.95 -49.55 69.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.861 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.468 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 80.0 t80 -62.22 -34.81 77.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.151 -178.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.522 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 2.0 t80 -54.18 -44.94 71.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.679 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -76.96 -33.84 57.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.105 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 48.2 mt-10 -61.17 -49.74 76.01 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.974 0.416 . . . . 0.0 110.859 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.23 -25.95 63.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.158 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.56 33.31 10.33 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.657 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.555 HG22 ' H ' ' A' ' 73' ' ' HIS . 0.6 OUTLIER -72.82 -175.7 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.768 0.318 . . . . 0.0 110.455 177.689 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.555 ' H ' HG22 ' A' ' 72' ' ' ILE . 18.6 m170 -67.32 162.99 50.64 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.071 -173.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.49 115.69 2.09 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.774 2.316 . . . . 0.0 112.771 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.9 158.79 31.1 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.795 2.33 . . . . 0.0 112.604 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -90.57 143.83 29.72 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.641 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -62.23 139.37 77.43 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.374 2.05 . . . . 0.0 112.438 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 40.7 pt -112.65 152.81 14.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.092 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -110.05 95.7 5.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.978 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -129.01 -2.86 5.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.637 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -158.25 -46.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.507 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.18 179.626 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.46 0.069 0 CA-C-O 120.765 0.317 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.6 m -107.18 160.46 15.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.976 0.417 . . . . 0.0 111.184 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.7 p -82.69 127.05 33.04 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.211 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -102.9 -26.64 13.04 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.74 154.06 24.43 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.956 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . 42.3 tt0 -146.3 122.89 11.12 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.613 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 mp -122.61 156.0 27.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.554 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 47.0 mt-10 -73.21 151.93 41.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.266 0.555 . . . . 0.0 111.19 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.434 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 20.4 tt -59.64 -28.59 40.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.59 -178.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -58.8 -38.53 78.78 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.26 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -73.18 -36.56 66.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.98 -174.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 89.5 mmm -58.37 149.92 23.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.188 176.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.4 m -100.9 108.02 19.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.959 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.431 ' HD2' ' HD3' ' A' ' 16' ' ' PRO . 44.6 p90 -74.08 136.03 43.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.011 0.434 . . . . 0.0 111.116 -176.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -115.21 86.7 14.64 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.623 176.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.431 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 20.7 Cg_endo -61.31 -28.2 84.2 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.01 2.473 . . . . 0.0 112.455 -174.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -69.53 -20.28 63.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.117 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.418 ' CB ' ' HE2' ' A' ' 20' ' ' MET . 0.9 OUTLIER -111.72 -1.06 15.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.702 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 57.64 43.07 22.95 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.292 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.418 ' HE2' ' CB ' ' A' ' 18' ' ' ASN . 26.9 ptt? -154.16 165.89 34.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.846 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.474 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 88.0 m-85 -103.87 139.59 38.85 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.6 ' HB ' ' HD3' ' A' ' 30' ' ' ARG . 77.5 p -130.59 169.86 15.04 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 121.141 -0.223 . . . . 0.0 110.929 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -152.77 127.23 4.57 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.36 126.31 21.79 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 123.144 2.563 . . . . 0.0 112.655 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.592 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 9.5 t -135.51 144.3 48.71 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.027 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -86.06 117.92 1.66 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.772 1.648 . . . . 0.0 111.949 173.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.437 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 30.3 p 172.48 -49.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.57 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.437 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 163.19 -24.48 0.19 Allowed Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.398 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.418 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 1.3 t0 -134.61 176.41 8.66 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.351 -0.241 . . . . 0.0 110.351 -177.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.6 ' HD3' ' HB ' ' A' ' 22' ' ' THR . 15.4 ptp180 -109.18 150.77 27.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.942 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.614 ' CD1' ' HB2' ' A' ' 47' ' ' CYS . 97.2 m-85 -55.39 140.46 39.77 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -137.16 134.14 36.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.181 0.515 . . . . 0.0 110.666 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.474 ' CG2' ' HB2' ' A' ' 21' ' ' PHE . 12.4 tt -131.16 130.39 63.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.679 177.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.483 ' O ' ' HG3' ' A' ' 38' ' ' MET . 24.4 m-85 -87.67 147.57 25.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.243 -174.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.471 ' HG ' ' CD1' ' A' ' 72' ' ' ILE . 0.6 OUTLIER -66.7 -35.36 79.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.956 -176.16 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.1 -44.78 79.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.803 178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -64.08 -43.04 96.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.628 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.483 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 55.3 mtp -63.57 -37.59 87.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.488 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -65.32 -35.45 81.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.272 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -70.92 -15.94 62.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.655 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.31 -3.63 59.91 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -81.84 81.64 7.78 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.31 0.576 . . . . 0.0 109.522 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.711 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.64 98.39 11.61 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.358 1.075 . . . . 0.0 110.439 -179.563 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 2.0 p -167.09 129.46 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.802 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 53' ' ' MET . . . -99.46 130.21 45.71 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -107.05 134.36 48.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.147 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.614 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 35.0 t -105.31 123.77 38.57 Favored Pre-proline 0 N--CA 1.433 -1.303 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.093 176.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.615 ' O ' ' HB3' ' A' ' 49' ' ' SER . 33.3 Cg_endo -65.89 156.57 63.6 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.499 2.133 . . . . 0.0 111.044 172.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.615 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 27.4 t 86.21 -61.37 0.05 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.349 0.659 . . . . 0.0 110.963 178.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.4 p -90.99 -23.43 20.4 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.188 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.5 t 68.2 41.57 1.9 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.117 175.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.55 HD22 ' HZ ' ' A' ' 31' ' ' PHE . 54.3 tp -98.79 142.35 30.43 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.112 0.482 . . . . 0.0 109.943 -178.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.464 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 43.5 mtm -132.5 138.01 47.39 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.798 -178.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -141.3 150.38 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 177.305 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 7.3 m-20 -68.85 155.58 39.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.815 0.34 . . . . 0.0 110.181 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 90.7 t -135.29 124.51 41.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.83 176.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.554 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 41.5 t -75.64 104.84 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -108.67 164.78 12.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.909 -175.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.55 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 13.8 t70 -130.13 146.9 51.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.79 175.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -64.07 -32.56 74.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.975 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -73.57 -40.5 63.86 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.663 0.268 . . . . 0.0 110.606 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.73 -41.27 90.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.872 0.367 . . . . 0.0 110.322 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 67.3 mt -63.85 -48.94 74.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.79 178.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.15 -41.95 93.87 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.879 -177.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -63.06 -53.79 48.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.347 0.594 . . . . 0.0 110.466 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.416 ' CE2' HD13 ' A' ' 72' ' ' ILE . 78.9 t80 -63.81 -36.19 83.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.389 -178.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.49 ' HA ' HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -53.14 -44.71 67.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.119 177.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -69.55 -36.18 76.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.625 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -75.96 -34.34 59.82 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.97 -20.27 24.67 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.7 57.08 5.12 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.523 HG21 ' H ' ' A' ' 73' ' ' HIS . 6.6 mt -97.81 172.92 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.625 -0.287 . . . . 0.0 110.712 -173.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.523 ' H ' HG21 ' A' ' 72' ' ' ILE . 79.5 t60 -53.0 125.89 41.73 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.476 173.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.47 114.14 2.4 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.784 2.323 . . . . 0.0 112.774 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.03 163.43 3.86 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.314 2.676 . . . . 0.0 111.316 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.77 118.24 67.6 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.99 147.63 55.38 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.887 2.392 . . . . 0.0 113.192 -173.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.0 pt -94.7 -177.63 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.206 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.11 89.14 3.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.885 0.374 . . . . 0.0 110.755 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.46 82.86 8.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.112 0.482 . . . . 0.0 110.143 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.26 -16.03 20.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.918 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.392 -0.813 . . . . 0.0 110.002 -179.412 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 C--O 1.234 0.258 0 CA-C-O 121.52 0.676 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.0 m -131.37 171.26 13.57 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.272 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.3 p -88.77 108.56 19.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.014 0.435 . . . . 0.0 110.32 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -98.33 -0.47 43.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.588 -174.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -134.04 162.95 30.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.53 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 40.1 tt0 -159.86 120.28 3.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.86 -177.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.65 161.69 20.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -175.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -74.06 146.81 43.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.371 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.0 tt -59.41 -29.69 42.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.422 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -68.84 -28.26 66.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.923 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -79.4 -31.21 42.73 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.99 0.424 . . . . 0.0 110.3 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 82.3 mmm -63.58 128.07 34.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.986 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 22' ' ' THR . 86.2 m -71.83 119.43 15.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.198 0.523 . . . . 0.0 110.899 -177.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.656 ' HB2' ' HE1' ' A' ' 66' ' ' TYR . 36.2 p90 -74.58 138.81 43.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.035 -177.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -129.23 87.71 53.05 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.914 177.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.416 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 18.7 Cg_endo -59.84 -33.02 96.21 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.274 2.649 . . . . 0.0 112.897 -175.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.63 -28.71 70.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.891 -176.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -113.03 4.95 16.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.707 0.289 . . . . 0.0 111.112 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 59.14 32.0 21.73 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.395 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -144.94 159.01 43.6 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.165 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -93.89 141.81 28.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.726 175.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 20.6 p -137.7 141.57 41.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.642 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.434 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 17.6 t80 -125.52 117.82 24.77 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -178.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -48.44 118.53 3.36 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.47 2.78 . . . . 0.0 113.286 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 19.9 t -130.39 135.66 27.76 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.439 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 5.8 Cg_endo -84.74 118.21 2.09 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.869 1.712 . . . . 0.0 111.442 175.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.409 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 29.9 p 174.62 -45.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -177.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.409 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 159.65 -27.1 0.35 Allowed Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.783 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -138.23 176.0 9.08 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.46 ' HG3' ' HB ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -120.06 156.49 30.86 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.155 -177.078 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.634 ' O ' ' HA ' ' A' ' 22' ' ' THR . 97.3 m-85 -56.4 123.03 13.31 Favored 'General case' 0 CA--C 1.518 -0.258 0 O-C-N 123.384 0.428 . . . . 0.0 110.165 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.572 ' HG2' HG22 ' A' ' 22' ' ' THR . 24.2 mt-30 -120.8 137.63 54.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.823 0.344 . . . . 0.0 110.756 -178.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 45' ' ' ALA . 10.1 tt -145.93 125.22 5.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.419 175.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -87.31 149.49 24.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.252 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.622 ' HA ' ' HG3' ' A' ' 38' ' ' MET . 7.7 tp -71.3 -24.65 62.18 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.12 0.485 . . . . 0.0 110.65 -176.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -54.6 -40.15 68.57 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.429 173.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -68.74 -44.56 73.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.202 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.622 ' HG3' ' HA ' ' A' ' 35' ' ' LEU . 15.2 mtp -62.72 -46.48 87.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.602 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.721 ' HZ ' ' HG2' ' A' ' 76' ' ' GLU . 82.3 t80 -65.29 -25.19 67.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.095 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.92 -21.86 65.1 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.226 0.536 . . . . 0.0 110.523 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.75 -2.34 34.03 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.012 -177.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.432 ' HG3' HG11 ' A' ' 44' ' ' VAL . 10.2 tp10 -100.19 130.28 46.3 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 20.3 pttp -122.78 101.25 7.34 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.448 0.642 . . . . 0.0 111.068 -176.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 2.6 p -167.3 129.33 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.258 -177.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.482 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . . . -100.74 141.7 33.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.472 175.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.9 p -122.0 134.37 65.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.906 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.432 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 10.9 t -104.33 128.25 27.42 Favored Pre-proline 0 N--CA 1.438 -1.051 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 174.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.82 156.56 20.85 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.734 2.29 . . . . 0.0 111.553 176.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.0 t 85.95 -55.39 0.07 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.699 0.8 . . . . 0.0 110.681 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 15.9 p -87.32 -32.22 19.77 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 47' ' ' CYS . 16.6 m 68.96 76.26 0.24 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.233 174.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.47 HD22 ' HZ ' ' A' ' 31' ' ' PHE . 57.6 tp -133.56 143.75 48.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.627 175.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.436 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 36.2 mtm -132.42 138.26 47.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.578 -177.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -143.31 152.82 16.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.942 178.955 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 2.2 m-20 -70.87 153.3 42.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.648 0.261 . . . . 0.0 110.557 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.513 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 99.9 t -135.46 114.74 16.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.501 176.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.54 117.8 15.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.069 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.501 ' HB3' ' HE1' ' A' ' 38' ' ' MET . 51.5 p90 -111.7 164.86 12.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.819 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.598 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 15.0 t70 -131.74 159.05 39.56 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.355 177.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.689 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 9.2 mptt -58.74 -44.1 90.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.473 178.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -75.53 -37.27 60.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.987 -176.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -62.1 -39.74 93.49 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.671 177.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 80.7 mt -68.83 -44.23 73.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.468 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.36 -51.27 70.21 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.779 -176.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -70.89 -33.39 70.53 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.362 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.656 ' HE1' ' HB2' ' A' ' 14' ' ' PHE . 56.4 t80 -67.16 -35.71 80.27 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.208 176.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.439 ' HA ' HD11 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -52.52 -46.1 66.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.623 174.269 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -71.51 -43.85 65.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.014 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -72.82 -34.11 66.64 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.05 -17.4 43.38 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.147 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.29 54.52 4.69 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.524 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.579 HG22 ' H ' ' A' ' 73' ' ' HIS . 3.7 mt -104.81 177.94 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.579 ' H ' HG22 ' A' ' 72' ' ' ILE . 13.3 m-70 -92.69 146.53 32.42 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 176.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.33 126.23 21.38 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.659 2.906 . . . . 0.0 114.479 -171.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.94 167.45 22.07 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.997 3.132 . . . . 0.0 110.428 169.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.721 ' HG2' ' HZ ' ' A' ' 39' ' ' PHE . 13.8 pt-20 -71.82 143.48 86.92 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.523 ' HG2' ' HB2' ' A' ' 82' ' ' ALA . 77.4 Cg_exo -48.81 137.45 27.37 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.05 2.5 . . . . 0.0 113.773 -170.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 pp -82.59 107.5 14.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.398 -175.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 56.66 11.99 1.01 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.344 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.94 152.36 24.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.796 -178.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.27 133.79 48.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.523 ' HB2' ' HG2' ' A' ' 77' ' ' PRO . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.121 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 121.2 0.524 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 p -97.55 151.3 20.18 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.118 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 53' ' ' MET . 12.3 p -74.09 112.57 10.35 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.944 175.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -95.27 -1.61 51.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.643 -171.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -143.19 171.92 13.43 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 44.3 tt0 -162.19 108.54 1.28 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -177.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.442 ' CD1' HG13 ' A' ' 54' ' ' ILE . 2.2 mp -119.67 151.26 22.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.385 -172.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -63.17 144.62 56.76 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 175.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.3 tt -60.54 -33.28 53.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.206 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.69 -27.82 62.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.209 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.426 ' HB3' HG21 ' A' ' 7' ' ' ILE . 17.8 t70 -73.57 -35.89 65.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.581 -176.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.458 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 81.4 mtp -69.2 153.76 43.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.479 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.1 m -82.12 113.22 19.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.82 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.489 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . 33.4 p90 -77.5 138.73 39.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.946 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -113.5 88.98 14.17 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.47 -29.51 88.82 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.215 2.61 . . . . 0.0 113.901 -169.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.94 -32.52 73.02 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.883 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.452 ' HB2' ' HG2' ' A' ' 20' ' ' MET . 46.6 m-80 -105.02 1.38 28.55 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.466 -173.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 57.28 39.05 28.85 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.032 0.444 . . . . 0.0 110.383 -178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.452 ' HG2' ' HB2' ' A' ' 18' ' ' ASN . 27.1 ptt? -137.71 170.66 15.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.934 0.397 . . . . 0.0 111.004 -175.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.507 ' HE1' HD21 ' A' ' 35' ' ' LEU . 52.8 m-85 -119.47 144.67 46.86 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.867 176.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 35.6 p -133.03 158.37 42.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.376 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.458 ' CD1' ' HA ' ' A' ' 12' ' ' MET . 4.5 t80 -141.31 129.52 12.21 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -57.7 119.43 6.68 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.985 2.457 . . . . 0.0 113.361 -175.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 17.3 t -133.21 131.8 21.86 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.304 176.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 1.3 Cg_endo -85.31 117.83 1.87 Allowed 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.949 1.766 . . . . 0.0 111.487 173.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 28.4 p -179.15 -47.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.648 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.45 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 168.19 -25.4 0.12 Allowed Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.227 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.538 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 2.5 t70 -143.29 176.35 9.21 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -117.48 154.33 31.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.326 0.108 . . . . 0.0 110.769 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 22' ' ' THR . 94.3 m-85 -48.4 131.32 16.93 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.528 0.517 . . . . 0.0 111.342 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -127.15 126.87 43.64 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.977 -173.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.447 ' HB ' ' HA ' ' A' ' 45' ' ' ALA . 11.5 tt -148.84 136.4 13.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.321 176.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.442 ' O ' ' HG3' ' A' ' 38' ' ' MET . 91.3 m-85 -98.61 147.06 25.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.954 0.406 . . . . 0.0 111.36 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.507 HD21 ' HE1' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -65.62 -33.91 77.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.297 -178.244 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.79 -42.31 71.63 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.962 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -68.96 -40.53 78.85 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.97 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 75.2 mtp -63.8 -31.39 72.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.342 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -72.94 -21.19 60.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.624 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -79.1 -6.78 57.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.221 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.08 -18.2 34.03 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.089 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 38' ' ' MET . 33.0 tt0 -94.62 135.09 36.49 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.688 ' HD2' ' HE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -133.22 101.04 5.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.608 0.718 . . . . 0.0 110.983 -177.365 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 p -165.65 128.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.73 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . . . -100.07 135.86 40.85 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.004 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p -109.74 134.2 52.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.117 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.526 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 24.6 t -101.17 118.47 60.18 Favored Pre-proline 0 N--CA 1.433 -1.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.896 176.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.558 ' O ' ' HB3' ' A' ' 49' ' ' SER . 24.6 Cg_endo -65.38 156.54 62.79 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.397 2.065 . . . . 0.0 111.034 173.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.558 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 35.6 t 87.13 -56.91 0.04 OUTLIER 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.621 0.768 . . . . 0.0 111.035 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.0 p -92.96 -26.97 17.33 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.132 177.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.7 t 70.27 44.07 0.78 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.927 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.441 HD21 ' N ' ' A' ' 53' ' ' MET . 2.1 tt -101.33 136.22 41.54 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.486 ' O ' ' HA ' ' A' ' 3' ' ' THR . 36.9 mtm -125.07 138.56 54.19 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 -177.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.442 HG13 ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -140.45 155.39 23.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.865 178.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.544 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 15.1 m-20 -80.92 159.15 25.04 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.2 t -130.94 126.28 59.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.71 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.7 t -87.49 101.74 11.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.066 0.46 . . . . 0.0 110.642 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.688 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 47.5 p90 -104.48 164.72 11.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.418 -178.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.494 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 20.3 t70 -128.47 159.5 35.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.944 0.402 . . . . 0.0 110.72 175.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.768 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -59.95 -47.55 85.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.416 177.208 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.13 -36.9 80.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.501 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -69.87 -40.66 75.58 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.618 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 42.8 mt -61.57 -44.81 96.34 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.73 177.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.17 -34.4 76.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.932 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -64.84 -54.07 36.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.701 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.489 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 77.0 t80 -65.0 -34.64 78.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.448 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.626 ' HD1' ' HB ' ' A' ' 72' ' ' ILE . 10.4 t80 -51.46 -47.14 63.21 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.165 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.81 -45.15 62.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.149 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.54 -43.89 88.53 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.12 -25.69 36.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.744 0.307 . . . . 0.0 111.407 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.95 59.06 2.51 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.626 ' HB ' ' HD1' ' A' ' 67' ' ' TYR . 18.4 mt -87.6 162.36 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.503 -0.349 . . . . 0.0 110.137 -176.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.419 ' N ' HG23 ' A' ' 72' ' ' ILE . 21.6 p-80 -61.2 146.25 88.79 Favored Pre-proline 0 C--O 1.232 0.164 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.19 115.46 2.3 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.993 2.462 . . . . 0.0 111.8 176.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.587 ' HD3' ' CE1' ' A' ' 67' ' ' TYR . 86.1 Cg_endo -92.65 164.54 2.8 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.507 2.804 . . . . 0.0 112.595 -175.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -74.55 138.26 74.25 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.34 144.3 50.12 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.27 2.647 . . . . 0.0 114.188 -172.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.642 HD13 ' HB3' ' A' ' 60' ' ' LYS . 45.3 pt -122.54 152.16 26.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.295 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.94 85.8 3.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.044 0.449 . . . . 0.0 110.341 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.97 -14.23 37.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.008 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -128.55 105.6 8.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.628 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.677 -0.678 . . . . 0.0 110.193 -179.651 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.664 ' HB ' ' HB2' ' A' ' 55' ' ' ASP . 5.1 p . . . . . 0 N--CA 1.45 -0.47 0 CA-C-O 121.251 0.548 . . . . 0.0 111.615 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -103.06 -16.83 15.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.478 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -102.1 138.35 39.16 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -137.72 114.94 10.95 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -175.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.681 HD13 HD13 ' A' ' 54' ' ' ILE . 4.3 mp -111.36 138.75 38.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.889 0.376 . . . . 0.0 110.235 -176.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.562 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 31.6 mt-10 -66.69 141.6 57.71 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.156 175.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.1 tt -57.07 -28.33 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.995 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -68.14 -28.76 67.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.355 -0.384 . . . . 0.0 112.014 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -82.2 -38.77 24.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.91 0.386 . . . . 0.0 109.995 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 81.1 mmm -53.33 127.07 23.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.496 170.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.3 m -79.1 123.24 27.16 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.666 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 35.7 p90 -94.65 134.47 37.2 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.636 -176.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -107.24 94.26 10.93 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.559 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.9 -27.99 86.16 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.113 2.542 . . . . 0.0 112.763 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -73.74 -27.52 61.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.969 0.414 . . . . 0.0 110.329 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -96.91 -10.08 27.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.895 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 62.66 36.66 13.36 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.833 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -151.78 169.23 22.74 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.456 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.666 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 30.0 m-85 -110.05 140.68 43.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.267 175.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 79.7 p -127.96 163.54 24.28 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.037 0.446 . . . . 0.0 110.759 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -134.8 126.7 18.06 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.31 115.3 1.98 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 123.18 2.587 . . . . 0.0 113.254 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.498 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 41.9 t -128.67 137.37 30.79 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.866 177.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 9.0 Cg_endo -90.3 120.14 0.8 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.487 2.125 . . . . 0.0 111.369 172.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 28.7 p 175.54 -43.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.41 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 160.15 -23.38 0.27 Allowed Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.51 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.424 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 2.8 t0 -142.49 175.71 9.58 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.543 ' HG3' HH11 ' A' ' 30' ' ' ARG . 9.3 ptt85 -113.26 152.96 29.16 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 122.799 0.439 . . . . 0.0 110.706 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 22' ' ' THR . 86.7 m-85 -55.4 136.26 49.6 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.334 0.397 . . . . 0.0 110.227 176.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -128.83 124.1 34.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.093 0.473 . . . . 0.0 111.524 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' A' ' 45' ' ' ALA . 12.0 tt -127.46 127.1 68.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.661 174.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.525 ' O ' ' HG3' ' A' ' 38' ' ' MET . 36.7 m-85 -93.96 131.07 39.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.001 -172.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -59.27 -31.63 69.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.187 -178.692 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -54.28 -47.2 72.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.12 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -83.37 -24.53 31.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.271 -176.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.59 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 93.9 mtp -65.1 -38.76 91.76 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.66 174.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -65.61 -29.43 70.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.225 175.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -71.15 -12.32 61.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.214 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.44 -6.86 36.45 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.623 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 38' ' ' MET . 9.2 tp10 -94.86 138.39 32.69 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.635 ' HD2' ' HE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -138.71 101.51 4.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 122.103 0.954 . . . . 0.0 111.553 -179.757 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.3 p -165.23 130.87 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.735 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.564 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -100.51 131.07 46.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.717 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.76 139.44 34.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.752 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 51' ' ' SER . 18.5 t -108.27 134.45 20.19 Favored Pre-proline 0 N--CA 1.436 -1.129 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.006 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.521 ' O ' ' HB2' ' A' ' 49' ' ' SER . 47.1 Cg_endo -83.0 157.18 15.34 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.16 2.573 . . . . 0.0 111.848 175.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.521 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 75.4 m 84.73 -55.8 0.1 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.889 0.876 . . . . 0.0 110.772 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.2 p -87.67 -33.06 18.92 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 174.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 47' ' ' CYS . 59.3 m 67.42 64.07 0.42 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.613 177.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.465 ' HB3' ' HE1' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -114.54 154.62 27.95 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.277 176.068 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 41.1 mtm -132.52 137.09 47.03 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.446 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.681 HD13 HD13 ' A' ' 7' ' ' ILE . 2.8 pp -143.68 148.16 19.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.471 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.664 ' HB2' ' HB ' ' A' ' 3' ' ' THR . 4.7 t70 -85.15 152.95 22.99 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -175.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.2 t -134.12 117.79 26.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.54 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.562 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 26.9 t -71.35 108.14 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.605 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.635 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 25.8 p90 -109.77 164.86 12.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.618 0.247 . . . . 0.0 110.407 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.629 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 5.7 t70 -134.09 160.31 38.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.111 0.482 . . . . 0.0 110.647 175.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -62.54 -44.58 96.01 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.755 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -69.39 -35.58 75.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.801 -176.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -67.91 -44.04 77.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.174 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 81.6 mt -59.34 -49.23 78.63 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.183 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.57 -41.63 95.01 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.236 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -66.67 -45.92 77.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.295 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.518 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 84.1 t80 -67.57 -35.7 79.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.082 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.8 -41.31 67.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 110.442 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -70.14 -38.77 75.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.088 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -70.15 -45.89 65.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.3 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.9 -15.48 63.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.197 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.783 0 C-N-CA 120.823 -0.704 . . . . 0.0 111.593 178.527 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.448 -0.57 0 CA-C-O 121.023 0.44 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -83.53 1.42 42.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.157 -177.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -146.0 163.98 33.51 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 34.6 tt0 -156.96 108.81 2.42 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -176.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 mp -116.16 145.45 21.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.281 -173.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.587 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 44.4 mt-10 -63.33 138.26 58.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 173.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.401 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 14.1 tt -51.51 -29.38 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.715 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -60.19 -34.06 73.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.218 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -81.33 -28.77 34.4 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.52 -172.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.578 ' HA ' ' HD1' ' A' ' 23' ' ' TYR . 84.2 mtp -66.3 156.41 34.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.139 0.495 . . . . 0.0 110.967 176.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.7 m -93.39 110.36 21.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.35 0.595 . . . . 0.0 110.207 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.553 ' HD2' ' HD3' ' A' ' 16' ' ' PRO . 38.8 p90 -74.86 140.08 43.62 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.894 -177.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -124.14 89.06 52.22 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 121.229 0.537 . . . . 0.0 109.943 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.553 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 26.4 Cg_endo -62.23 -26.26 77.4 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.369 2.713 . . . . 0.0 112.747 -173.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -69.34 -21.34 63.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.504 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -116.24 7.94 14.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.839 0.352 . . . . 0.0 110.698 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 57.39 43.1 23.76 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.751 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -154.0 171.72 18.6 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.451 -0.499 . . . . 0.0 111.403 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.534 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 57.6 m-85 -112.86 141.93 46.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.412 176.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 17.2 p -133.63 135.4 44.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.993 0.425 . . . . 0.0 111.107 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.588 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 7.6 t80 -106.36 117.47 57.11 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -56.38 113.37 1.42 Allowed 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.028 2.486 . . . . 0.0 113.717 -173.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 12.2 t -126.86 132.14 24.19 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.65 175.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 2.1 Cg_endo -86.08 118.16 1.68 Allowed 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 121.802 1.668 . . . . 0.0 111.582 174.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 29.3 p -177.09 -46.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.414 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 169.29 -27.46 0.13 Allowed Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.367 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.468 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 3.5 t70 -142.02 175.09 10.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -123.26 147.82 46.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.639 0.2 . . . . 0.0 110.619 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.588 ' HB2' ' HB3' ' A' ' 23' ' ' TYR . 96.7 m-85 -46.51 111.35 0.37 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.597 0.561 . . . . 0.0 111.221 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -111.37 135.39 51.99 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.089 0.471 . . . . 0.0 111.073 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' A' ' 45' ' ' ALA . 16.9 tt -132.62 136.7 55.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.754 177.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.538 ' O ' ' HG3' ' A' ' 38' ' ' MET . 30.0 m-85 -95.02 126.37 40.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.369 -174.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 35' ' ' LEU . 0.5 OUTLIER -55.3 -34.73 64.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.123 0.487 . . . . 0.0 110.625 -178.12 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -57.3 -48.74 78.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.414 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -70.78 -32.16 69.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.909 -178.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.538 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 81.2 mtp -61.18 -43.67 98.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.307 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -66.64 -31.15 71.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.192 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -72.37 -14.23 61.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.427 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.74 0.78 36.74 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.632 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -99.54 93.89 6.11 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -106.19 101.06 10.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 122.001 0.905 . . . . 0.0 111.265 -176.629 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 p -166.55 131.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.839 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.462 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -100.39 138.93 36.79 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.323 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.07 139.22 43.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.17 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.581 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 7.0 t -110.6 116.02 53.02 Favored Pre-proline 0 C--N 1.313 -0.989 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.133 176.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.51 ' O ' ' HB3' ' A' ' 49' ' ' SER . 35.1 Cg_endo -71.59 157.14 56.65 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.373 2.049 . . . . 0.0 111.192 172.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.51 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 46.2 t 89.93 -59.36 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.045 0.938 . . . . 0.0 110.322 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.9 p -89.46 -29.19 19.18 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.677 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 t 69.01 74.53 0.25 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.621 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.448 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 53.9 tp -138.68 152.02 47.68 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.6 mtm -133.44 137.94 45.98 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.587 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.479 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -137.56 153.5 28.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.155 178.257 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 3.8 t70 -80.05 151.81 29.72 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.23 115.59 26.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.976 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.587 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 42.5 t -70.12 118.07 14.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.509 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -122.78 159.96 26.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.571 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.494 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.8 t70 -131.35 167.44 19.25 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.405 ' H ' ' HG3' ' A' ' 60' ' ' LYS . 23.2 mtmm -63.05 -45.32 92.81 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.342 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -68.69 -40.31 80.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.038 -1.437 . . . . 0.0 111.14 -175.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.47 -42.11 99.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.761 0.315 . . . . 0.0 110.994 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 75.9 mt -63.83 -46.28 85.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.241 177.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.558 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . . . -57.38 -47.21 82.27 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.38 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.18 -46.38 79.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.06 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -67.83 -36.05 79.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.641 -176.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.558 ' HD2' ' HA ' ' A' ' 64' ' ' ALA . 26.3 m-85 -53.49 -48.6 68.78 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.007 0.432 . . . . 0.0 110.378 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -67.52 -43.02 81.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.402 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -74.65 -29.71 61.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -174.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.88 -21.41 26.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.617 0.246 . . . . 0.0 111.103 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.893 -179.325 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.448 -0.547 0 CA-C-O 121.348 0.594 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -80.13 -35.09 37.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.241 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -114.85 159.2 20.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.362 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.532 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 34.9 tt0 -143.11 110.73 5.85 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.39 139.45 43.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.251 -170.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.583 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 39.0 mt-10 -58.2 135.52 57.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.062 0.458 . . . . 0.0 110.34 173.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.422 ' CG2' ' HA ' ' A' ' 58' ' ' PHE . 15.5 tt -54.54 -29.45 20.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.771 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.9 -27.94 68.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.967 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -83.93 -39.91 19.19 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.464 -175.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 83.0 mtp -60.84 142.78 55.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.708 0.29 . . . . 0.0 111.021 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.0 m -79.69 124.68 28.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.973 -176.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.484 ' HB2' ' HE1' ' A' ' 66' ' ' TYR . 39.2 p90 -84.27 141.65 30.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.099 0.476 . . . . 0.0 111.783 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -125.7 92.05 47.26 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 173.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.62 -26.38 53.88 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 123.094 2.529 . . . . 0.0 113.253 -172.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -69.57 -28.93 66.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.007 0.432 . . . . 0.0 110.918 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -107.41 4.54 26.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.838 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 58.56 37.93 25.4 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.993 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 26.0 ptt? -143.12 171.46 14.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.292 0.568 . . . . 0.0 111.841 -174.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.479 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 41.8 m-85 -116.0 148.18 40.41 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.392 173.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 41.5 p -136.27 167.24 21.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.894 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.462 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 84.3 t80 -144.08 118.07 5.9 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -56.97 109.83 0.51 Allowed 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.201 2.601 . . . . 0.0 113.19 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.1 t -127.22 131.3 23.78 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.712 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 5.2 Cg_exo -80.2 119.42 3.85 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.951 1.768 . . . . 0.0 111.472 176.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.448 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 30.6 p -179.4 -52.72 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.448 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 174.44 -28.57 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.215 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.588 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 1.2 t70 -142.8 175.93 9.44 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -115.71 154.87 28.78 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.578 ' O ' ' HA ' ' A' ' 22' ' ' THR . 80.4 m-85 -50.29 134.75 22.61 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.519 0.512 . . . . 0.0 110.61 178.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -131.77 133.29 44.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.168 0.509 . . . . 0.0 111.066 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 20' ' ' MET . 10.9 tt -151.28 126.11 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.009 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -87.29 138.16 31.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.79 0.329 . . . . 0.0 110.895 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.6 ' HG ' ' HD2' ' A' ' 66' ' ' TYR . 1.2 tm? -64.19 -31.73 73.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.018 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -61.92 -29.92 70.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.792 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.17 -32.63 29.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.419 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.553 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 84.6 mtp -67.6 -34.12 76.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.145 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -64.64 -24.44 67.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.398 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -76.93 -12.21 59.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.025 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.91 -11.49 41.26 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.402 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.553 ' O ' ' HA ' ' A' ' 38' ' ' MET . 9.3 tp10 -89.41 133.77 34.38 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -142.08 100.13 3.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.115 0.96 . . . . 0.0 111.503 -177.0 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.4 p -167.27 127.7 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.424 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.58 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -100.73 141.55 33.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.106 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.6 137.42 51.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.687 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.41 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 18.0 t -99.68 111.88 62.53 Favored Pre-proline 0 N--CA 1.431 -1.408 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.588 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 14.7 Cg_endo -62.6 156.6 51.57 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.935 1.757 . . . . 0.0 110.794 174.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 37.4 m 85.5 -55.75 0.08 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.197 0.999 . . . . 0.0 111.192 -176.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 52' ' ' LEU . 16.6 p -98.13 -17.09 19.24 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.836 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.8 t 70.23 29.77 3.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.423 0.689 . . . . 0.0 111.975 172.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.433 HD13 ' HZ ' ' A' ' 31' ' ' PHE . 1.6 tt -86.56 130.57 34.44 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -174.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.4 mtm -115.35 137.39 52.09 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.85 -176.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.58 HD11 ' HB3' ' A' ' 45' ' ' ALA . 2.8 pp -141.88 144.21 25.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.532 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 4.9 t0 -84.27 156.06 22.15 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.73 125.32 55.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.045 0.45 . . . . 0.0 112.068 -174.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.583 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 21.8 t -88.86 100.03 10.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.422 ' HA ' ' CG2' ' A' ' 9' ' ' ILE . 50.6 p90 -94.52 160.3 14.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.843 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.579 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 27.3 t70 -116.14 151.65 35.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.857 0.36 . . . . 0.0 110.515 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.455 ' HE2' ' HB2' ' A' ' 60' ' ' LYS . 22.2 mtmm -58.56 -46.36 87.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.14 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -81.09 -32.19 34.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.346 -174.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.411 ' CB ' ' HB3' ' A' ' 59' ' ' ASP . 15.9 t70 -64.44 -43.66 93.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.324 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 54.4 mt -61.03 -47.38 86.67 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.82 0.343 . . . . 0.0 110.391 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.16 -43.01 77.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.185 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -62.99 -44.87 94.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.688 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.6 ' HD2' ' HG ' ' A' ' 35' ' ' LEU . 84.1 t80 -70.54 -35.3 73.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.07 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.5 -42.95 79.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.446 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -74.98 -30.08 61.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.09 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -63.54 -57.83 8.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.264 0.555 . . . . 0.0 110.793 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.62 -25.48 60.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.656 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.516 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.612 -178.88 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.448 -0.558 0 CA-C-O 121.237 0.541 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -94.89 -12.35 27.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.822 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -125.94 155.16 41.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.776 174.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.558 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 33.9 tt0 -151.44 114.43 4.73 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -176.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -127.55 161.8 34.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.591 -173.688 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -78.57 148.68 33.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.86 0.362 . . . . 0.0 110.388 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.6 tt -57.02 -28.95 30.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.5 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -63.55 -28.19 69.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.993 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -77.49 -31.21 53.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.947 0.403 . . . . 0.0 111.052 -175.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.593 ' HA ' ' HD1' ' A' ' 23' ' ' TYR . 84.4 mtp -69.5 170.52 10.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.951 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.3 m -106.76 121.25 44.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.707 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.533 ' HB2' ' HE1' ' A' ' 66' ' ' TYR . 44.0 p90 -74.56 142.58 44.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.624 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.421 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 17.8 tt0 -139.95 93.7 9.27 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 121.356 0.598 . . . . 0.0 110.649 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 25.1 Cg_endo -66.22 -19.05 56.68 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.69 2.26 . . . . 0.0 112.279 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.83 -35.1 77.27 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.206 0.526 . . . . 0.0 110.603 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -111.61 5.95 19.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.874 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.554 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 2.1 mp0 57.91 31.58 20.77 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.809 178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 27.4 ptt? -152.33 162.95 40.43 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.462 -174.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -91.39 138.3 31.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.635 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 21.9 p -129.29 143.58 50.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.709 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.609 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 9.8 t80 -112.94 117.15 46.62 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.48 115.97 2.55 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.235 2.623 . . . . 0.0 113.622 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 13.6 t -135.94 125.65 16.21 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.07 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 2.2 Cg_endo -82.96 119.21 2.82 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 121.897 1.732 . . . . 0.0 111.48 174.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.3 p -176.71 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 164.18 -29.15 0.23 Allowed Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 113.968 -1.469 . . . . 0.0 110.237 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.534 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 3.3 t70 -143.2 174.69 10.49 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -119.93 146.23 45.99 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.609 ' HB2' ' HB3' ' A' ' 23' ' ' TYR . 88.5 m-85 -44.33 118.39 1.51 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.679 0.612 . . . . 0.0 111.361 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -114.24 136.94 52.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.019 0.437 . . . . 0.0 110.337 -177.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 20' ' ' MET . 18.4 tt -134.83 129.67 51.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.586 ' O ' ' HG3' ' A' ' 38' ' ' MET . 48.2 m-85 -84.23 126.78 33.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.836 -174.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -33.39 74.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.894 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -58.25 -34.57 70.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.257 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -87.08 -31.16 20.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.586 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 82.9 mtp -64.86 -41.52 95.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.73 0.3 . . . . 0.0 110.983 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -63.04 -25.4 68.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.577 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -77.3 -10.64 59.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.801 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.26 -5.61 38.76 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.689 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 38' ' ' MET . 7.4 tp10 -89.4 130.97 35.68 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.584 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -137.68 100.27 4.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.25 1.024 . . . . 0.0 111.784 -175.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.0 p -166.82 128.98 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.807 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.451 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -100.27 139.76 35.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.032 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.54 135.81 57.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.176 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.559 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 8.1 t -104.23 116.78 60.8 Favored Pre-proline 0 N--CA 1.435 -1.208 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.846 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.534 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 49.9 Cg_endo -70.41 156.74 60.99 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.582 2.188 . . . . 0.0 110.98 173.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 33.3 m 86.97 -56.72 0.05 OUTLIER 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.161 0.984 . . . . 0.0 111.398 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.7 p -91.12 -27.29 18.66 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.87 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.6 t 69.05 72.78 0.26 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.183 174.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.533 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 51.7 tp -134.57 148.49 50.47 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 174.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.439 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 35.2 mtm -131.06 137.75 49.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.426 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.46 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -138.98 152.46 24.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.254 178.587 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.558 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 8.2 t70 -80.87 145.63 31.25 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 83.9 t -134.12 115.34 20.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.223 0.535 . . . . 0.0 111.715 -177.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.8 t -74.17 107.35 4.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.93 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -96.18 165.24 12.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.455 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.547 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 14.7 t70 -115.14 146.16 41.64 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.968 173.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.02 -40.06 96.6 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -76.76 -40.87 46.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.302 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.408 ' HB2' ' HB3' ' A' ' 59' ' ' ASP . 8.7 m-20 -66.59 -32.03 73.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.192 -177.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 48.0 mt -66.96 -53.34 32.61 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.751 176.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 67' ' ' TYR . . . -58.94 -46.05 88.93 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.03 0.443 . . . . 0.0 111.163 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.22 -41.4 88.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.27 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.533 ' HE1' ' HB2' ' A' ' 14' ' ' PHE . 57.5 t80 -65.75 -35.37 80.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.203 -178.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' A' ' 64' ' ' ALA . 12.7 m-85 -52.29 -47.91 65.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.958 0.409 . . . . 0.0 110.342 174.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -74.28 -26.7 60.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.362 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -75.41 -44.0 46.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 0.0 111.303 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.554 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -80.2 -12.85 59.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.411 -176.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.792 178.128 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 120.862 0.363 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -100.09 5.95 44.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.758 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -162.2 172.5 15.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.55 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 36.0 tt0 -154.13 111.7 3.47 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 3.5 mp -116.91 151.04 18.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.029 -177.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.576 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 57.7 mt-10 -78.34 149.97 33.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.886 0.374 . . . . 0.0 110.567 176.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.7 tt -59.01 -28.82 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.886 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -68.82 -29.98 68.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.381 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.444 ' HB3' HG22 ' A' ' 7' ' ' ILE . 31.9 t70 -84.74 -36.16 21.98 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.322 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.55 ' SD ' ' HB2' ' A' ' 23' ' ' TYR . 4.1 tpt -49.25 141.69 8.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.058 170.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 m -87.48 108.99 19.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.982 0.42 . . . . 0.0 110.069 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.513 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 40.0 p90 -74.17 137.7 43.3 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.976 0.417 . . . . 0.0 110.78 -177.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -115.34 93.9 37.6 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.649 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 70' ' ' ALA . 49.2 Cg_endo -68.86 -22.39 36.54 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.739 2.293 . . . . 0.0 112.449 -174.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -77.09 -18.83 57.71 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.075 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.53 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 4.3 t-20 -116.26 -6.7 11.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.516 0.198 . . . . 0.0 111.247 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.512 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 1.8 mp0 64.35 42.35 5.3 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.08 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.543 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 26.2 ptt? -151.46 174.07 13.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.46 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.513 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 36.0 m-85 -109.86 149.12 30.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.955 0.407 . . . . 0.0 110.674 176.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 36.8 p -137.62 159.93 40.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.283 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.55 ' HB2' ' SD ' ' A' ' 12' ' ' MET . 6.1 t80 -141.28 131.39 13.02 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.34 127.06 21.72 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.692 2.261 . . . . 0.0 113.327 -176.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.511 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 20.0 t -140.74 141.37 24.54 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.214 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 12.0 Cg_endo -91.3 117.99 0.52 Allowed 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 122.171 1.914 . . . . 0.0 112.079 174.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.9 p 177.83 -44.38 0.01 OUTLIER 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.208 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.22 -19.86 0.48 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.168 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -140.12 173.63 11.32 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.432 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -122.27 151.63 40.89 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.622 -0.14 . . . . 0.0 110.622 177.62 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.601 ' O ' ' HA ' ' A' ' 22' ' ' THR . 93.9 m-85 -47.88 126.94 11.27 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 123.802 0.688 . . . . 0.0 110.642 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -127.86 138.64 52.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.857 0.361 . . . . 0.0 110.939 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.543 ' O ' ' HB2' ' A' ' 20' ' ' MET . 12.1 tt -148.88 132.87 8.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.712 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -87.54 142.57 27.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.55 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.43 HD11 HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -67.86 -30.76 70.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.083 0.468 . . . . 0.0 110.741 -177.736 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -61.26 -31.24 71.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.839 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 6.7 m-20 -80.74 -34.02 34.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.569 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 79.0 mtp -63.99 -35.42 80.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.976 0.417 . . . . 0.0 110.07 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -68.27 -20.77 64.81 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.638 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 44.5 mm-40 -76.59 -13.42 60.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.361 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.49 -3.87 61.6 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.433 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -90.47 105.09 17.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.743 ' HD2' ' HE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -115.4 100.0 7.78 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.995 0.902 . . . . 0.0 110.552 -177.082 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 1.8 p -167.03 129.5 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.727 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.497 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -100.01 139.0 36.31 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.84 HG22 ' HG2' ' A' ' 53' ' ' MET . 38.4 t -115.67 119.0 60.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.194 -176.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.57 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 6.8 t -90.19 120.88 69.14 Favored Pre-proline 0 C--N 1.317 -0.824 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' A' ' 49' ' ' SER . 58.2 Cg_endo -73.45 154.95 50.76 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.355 2.037 . . . . 0.0 112.578 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 51.4 m 78.09 -54.4 0.5 Allowed 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.963 0.905 . . . . 0.0 111.637 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 12.1 p -82.2 -25.83 33.88 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.4 t 70.49 42.91 0.84 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.04 169.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.499 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 26.7 tp -103.96 128.61 51.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.359 0.599 . . . . 0.0 110.076 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.84 ' HG2' HG22 ' A' ' 46' ' ' VAL . 35.6 mtm -117.07 136.98 52.58 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.918 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.497 HD11 ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -138.68 152.98 25.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.747 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.55 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 4.7 t70 -82.42 151.4 26.6 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.533 HG13 ' HB2' ' A' ' 43' ' ' LYS . 6.3 p -129.7 112.99 25.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.559 0.695 . . . . 0.0 111.378 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.576 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 53.0 t -68.38 118.62 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.709 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.743 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 20.7 p90 -133.37 164.58 26.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.466 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.569 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 11.6 t70 -137.23 159.95 40.44 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.502 ' HD3' ' H ' ' A' ' 60' ' ' LYS . 3.0 mppt? -62.15 -37.64 85.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.028 0.442 . . . . 0.0 109.851 176.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -64.16 -45.16 89.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.523 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.97 -45.54 88.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.667 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 40.8 mt -55.02 -53.68 52.76 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.108 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.13 -43.18 73.88 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.217 0.323 . . . . 0.0 111.368 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -66.2 -49.89 65.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.022 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -67.73 -32.31 72.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.651 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.432 ' HD1' ' O ' ' A' ' 63' ' ' LEU . 2.2 m-85 -50.87 -44.28 59.62 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 172.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -63.21 -49.57 73.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.667 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -68.86 -32.51 72.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.287 -175.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.512 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -81.69 -10.63 59.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.776 0.322 . . . . 0.0 111.105 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.62 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.814 177.106 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.448 -0.57 0 CA-C-O 121.083 0.468 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -86.08 -23.24 26.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.972 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.637 ' HB2' HG22 ' A' ' 54' ' ' ILE . 1.6 m-20 -119.46 145.38 46.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.646 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.408 ' HG3' ' CB ' ' A' ' 55' ' ' ASP . 36.5 tt0 -140.36 108.28 5.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.726 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.5 mp -110.95 160.84 9.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -176.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.446 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 5.2 mp0 -79.38 148.99 31.79 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.3 tt -58.15 -29.95 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.129 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -68.07 -27.76 66.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.045 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.28 -39.44 54.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.782 0.325 . . . . 0.0 110.893 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 81.1 mtp -64.2 157.19 26.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.13 0.49 . . . . 0.0 111.154 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.6 m -90.44 109.22 20.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.482 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.602 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 42.1 p90 -78.96 134.63 36.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.192 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 9.5 tp10 -117.76 97.65 50.95 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.197 177.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 21.9 Cg_endo -61.25 -29.72 86.89 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.981 2.454 . . . . 0.0 111.953 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.62 -23.54 63.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.375 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.81 -11.63 15.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.119 0.485 . . . . 0.0 109.977 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.55 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 1.9 mp0 69.84 35.11 2.41 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.696 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.549 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 25.0 ptt? -157.99 174.71 14.83 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.593 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.602 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 42.8 m-85 -105.33 140.49 38.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.382 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 42.6 p -132.08 163.01 29.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.904 177.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.614 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 45.6 t80 -136.66 118.57 11.48 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.13 118.51 5.25 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 123.23 2.62 . . . . 0.0 112.794 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.0 t -137.55 140.58 30.64 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.57 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -90.94 118.9 0.61 Allowed 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 121.828 1.685 . . . . 0.0 111.973 174.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.2 p 179.52 -41.27 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 160.17 -26.3 0.31 Allowed Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.398 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.562 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 3.5 t0 -142.94 175.23 10.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.21 153.34 25.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.338 0.113 . . . . 0.0 111.137 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.614 ' HB2' ' HB3' ' A' ' 23' ' ' TYR . 81.2 m-85 -52.45 136.12 32.31 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.063 175.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 12.6 pt20 -133.3 136.68 45.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.876 0.37 . . . . 0.0 110.884 -176.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.549 ' O ' ' HB2' ' A' ' 20' ' ' MET . 15.2 tt -151.55 142.5 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.477 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.546 ' O ' ' HG3' ' A' ' 38' ' ' MET . 95.0 m-85 -99.31 147.74 24.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.914 0.388 . . . . 0.0 111.129 -177.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.47 -41.55 93.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.312 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -65.04 -31.99 73.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.186 0.517 . . . . 0.0 110.849 -175.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.01 -44.07 73.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.093 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.546 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 78.5 mtp -62.18 -42.61 99.44 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.684 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -65.93 -16.55 63.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.254 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -81.99 -12.48 58.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.41 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.2 -4.43 35.5 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.749 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -105.77 111.0 23.49 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.549 ' HD3' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -118.75 102.87 9.15 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.842 0.829 . . . . 0.0 110.732 -172.622 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 1.6 p -162.42 126.22 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.665 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.552 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -99.85 137.2 38.64 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.389 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.764 HG22 ' HG2' ' A' ' 53' ' ' MET . 47.7 t -114.62 123.01 69.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.764 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.532 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 12.0 t -90.73 122.3 67.11 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.562 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 43.2 Cg_endo -74.59 156.31 44.87 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.225 1.95 . . . . 0.0 111.29 175.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 35.5 t 89.28 -58.39 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.857 0.863 . . . . 0.0 110.107 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.4 p -89.3 -26.15 21.28 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 175.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.9 m 67.36 47.99 1.21 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.227 174.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 53' ' ' MET . 1.7 tt -102.71 135.23 44.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.764 ' HG2' HG22 ' A' ' 46' ' ' VAL . 32.3 mtm -117.11 137.14 52.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.466 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.637 HG22 ' HB2' ' A' ' 5' ' ' ASP . 2.8 pp -142.54 146.1 22.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.222 -176.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.408 ' CB ' ' HG3' ' A' ' 6' ' ' GLU . 6.4 m-20 -79.17 151.28 31.37 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.89 109.69 15.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.302 0.572 . . . . 0.0 110.941 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.446 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 46.9 t -65.95 112.37 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.423 -177.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -108.09 160.09 16.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.017 0.437 . . . . 0.0 111.651 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.734 ' HB3' ' HB2' ' A' ' 62' ' ' ASP . 20.3 t70 -117.01 146.15 43.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.093 173.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.418 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 12.3 mptt -62.4 -37.66 86.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.881 0.372 . . . . 0.0 110.563 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.39 -26.58 28.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.176 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.734 ' HB2' ' HB3' ' A' ' 59' ' ' ASP . 4.2 m-20 -65.58 -48.39 72.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.071 173.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 83.5 mt -55.08 -49.35 71.91 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.741 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.09 -37.01 83.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.0 0.429 . . . . 0.0 111.534 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -69.16 -52.83 24.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.677 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -64.13 -34.91 79.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.743 0.306 . . . . 0.0 110.934 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -53.83 -46.73 71.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.056 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.28 -41.89 76.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.584 -178.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -59.39 -44.92 92.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.232 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.55 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -81.73 -27.31 33.95 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.521 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.827 -179.824 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 55' ' ' ASP . 17.4 p . . . . . 0 N--CA 1.45 -0.471 0 CA-C-O 121.642 0.734 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -110.23 -13.24 14.37 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.509 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.512 ' HB2' HG22 ' A' ' 54' ' ' ILE . 9.5 m-20 -97.42 127.02 43.04 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 176.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -124.46 108.58 12.29 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.717 -173.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.468 HG22 ' HB3' ' A' ' 11' ' ' ASP . 2.7 mp -111.84 150.27 14.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.126 -175.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -71.4 145.32 49.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.985 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.439 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 20.7 tt -62.36 -27.57 42.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 172.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -56.79 -29.42 62.68 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.573 173.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.468 ' HB3' HG22 ' A' ' 7' ' ' ILE . 27.8 t70 -94.96 -41.13 9.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.794 -0.184 . . . . 0.0 111.224 -175.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.477 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 68.7 mtp -60.78 145.63 49.01 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.17 0.509 . . . . 0.0 110.867 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 m -89.92 124.03 34.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.053 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.434 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . 38.5 p90 -74.27 135.74 42.65 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.291 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -118.3 88.4 32.86 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.131 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.79 -15.91 45.04 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.117 2.544 . . . . 0.0 112.632 -174.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -68.98 -29.7 67.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.866 0.365 . . . . 0.0 111.217 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.583 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 2.0 t-20 -118.47 6.27 11.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.872 0.367 . . . . 0.0 110.571 -177.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 59.43 43.53 16.25 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.007 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.583 ' HG2' ' HB3' ' A' ' 18' ' ' ASN . 22.9 ptt? -145.58 174.45 11.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.975 0.416 . . . . 0.0 110.925 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.439 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 92.0 m-85 -108.14 142.6 38.12 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 73.0 p -137.37 167.07 22.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.716 0.293 . . . . 0.0 111.192 -175.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.477 ' CD1' ' HA ' ' A' ' 12' ' ' MET . 5.6 t80 -146.68 124.04 5.94 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.9 111.71 0.77 Allowed 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.129 2.552 . . . . 0.0 112.993 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.405 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 27.6 t -118.64 137.96 25.39 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.756 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -88.83 116.95 0.85 Allowed 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 121.349 1.366 . . . . 0.0 111.558 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.5 p 175.15 -41.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.497 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 153.66 -15.6 0.63 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.882 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -142.45 176.15 9.23 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.412 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 18.8 ptp180 -113.62 153.62 28.56 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 22' ' ' THR . 91.5 m-85 -55.74 134.28 51.39 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 174.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 30' ' ' ARG . 98.2 mt-30 -129.8 132.18 46.43 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.946 0.403 . . . . 0.0 111.431 -176.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 20' ' ' MET . 14.6 tt -141.58 128.14 19.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.731 171.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.431 ' O ' ' HG3' ' A' ' 38' ' ' MET . 69.6 m-85 -91.13 154.56 19.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.904 0.383 . . . . 0.0 110.698 -176.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.76 -34.82 75.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.658 -177.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.53 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 27.4 t70 -59.67 -45.54 91.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.025 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.406 ' OD2' ' HB2' ' A' ' 34' ' ' TYR . 21.0 m-20 -64.76 -33.74 76.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 110.61 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 59.5 mtp -74.66 -36.12 62.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.987 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -65.08 -29.61 70.51 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.55 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 36' ' ' ASP . 24.6 mm-40 -58.98 -22.94 61.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.617 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.3 8.2 38.84 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.57 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -115.36 157.65 23.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.666 ' HD3' ' N ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -145.47 100.73 3.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.7 0.762 . . . . 0.0 111.566 -174.091 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 1.4 p -166.71 131.41 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.503 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.537 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -100.57 132.36 45.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.699 HG22 ' HG2' ' A' ' 53' ' ' MET . 47.2 t -115.13 133.89 59.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.454 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 14.2 t -104.38 130.96 22.37 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.411 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.542 ' O ' ' HB2' ' A' ' 49' ' ' SER . 58.4 Cg_endo -79.44 156.45 25.22 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.866 2.377 . . . . 0.0 112.021 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.542 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 41.6 m 83.22 -53.89 0.16 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.196 0.998 . . . . 0.0 111.609 -177.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 18.0 p -90.65 -24.88 20.36 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.631 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.1 t 64.77 49.8 2.16 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.33 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.2 mt -117.32 154.78 30.67 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.366 0.603 . . . . 0.0 111.308 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.699 ' HG2' HG22 ' A' ' 46' ' ' VAL . 25.2 mtm -135.01 138.47 43.99 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.609 -168.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.537 HD11 ' HB3' ' A' ' 45' ' ' ALA . 2.7 pp -140.37 152.49 21.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.319 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.438 ' HB2' ' HB ' ' A' ' 3' ' ' THR . 4.9 t70 -91.81 147.84 22.68 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -173.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 5.1 p -133.9 123.5 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.4 t -79.8 114.76 21.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 122.137 -0.352 . . . . 0.0 110.661 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.566 ' CE1' ' HB3' ' A' ' 43' ' ' LYS . 44.1 p90 -121.63 165.09 16.24 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.707 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.417 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 14.0 t70 -121.26 161.16 22.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.206 0.527 . . . . 0.0 110.086 174.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -61.66 -40.12 93.82 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.46 175.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -78.23 -35.25 48.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.771 -174.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -70.91 -32.1 68.93 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.341 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 61.7 mt -63.51 -48.71 76.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.76 0.314 . . . . 0.0 110.303 172.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.99 -38.92 93.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.326 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -66.49 -48.86 68.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.34 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.434 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 85.4 t80 -62.6 -36.49 82.9 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.945 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -51.99 -42.14 62.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.684 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.41 -37.75 60.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.611 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -60.4 -54.36 46.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.057 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.88 -22.92 45.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.939 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -177.937 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.8 p . . . . . 0 N--CA 1.447 -0.601 0 CA-C-O 121.001 0.429 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -90.11 -11.38 41.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.608 -175.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.448 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 7.3 m-20 -141.99 169.7 17.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.276 176.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 35.5 tt0 -155.86 118.99 4.28 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -134.96 153.89 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.788 -175.863 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.531 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 45.4 mt-10 -72.81 152.08 41.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.036 0.446 . . . . 0.0 110.813 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.439 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 18.6 tt -55.49 -29.03 23.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.479 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.02 -35.1 80.1 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.402 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -78.08 -27.73 48.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.947 0.403 . . . . 0.0 111.12 -172.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 90.4 mtp -75.84 161.18 29.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.283 0.563 . . . . 0.0 111.317 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.8 m -95.12 115.76 27.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.956 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.454 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 44.5 p90 -81.33 138.88 35.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.091 0.472 . . . . 0.0 111.254 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -118.98 91.46 43.31 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.61 -28.36 52.78 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.188 2.592 . . . . 0.0 113.182 -172.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -70.98 -21.56 62.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.8 -175.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -112.97 3.58 16.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.62 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 55.09 44.53 27.84 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.904 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -146.66 165.7 28.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.94 0.4 . . . . 0.0 110.913 -176.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.543 ' HE1' HD23 ' A' ' 35' ' ' LEU . 68.4 m-85 -112.36 145.33 40.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.716 175.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 36.7 p -133.12 157.87 44.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.75 0.309 . . . . 0.0 110.987 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.496 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 9.6 t80 -140.34 125.17 11.07 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -51.21 127.89 23.47 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.376 2.718 . . . . 0.0 113.743 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 20.4 t -145.46 135.02 11.48 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.915 177.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 2.5 Cg_endo -87.24 118.09 1.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.026 1.817 . . . . 0.0 111.679 174.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 31.0 p -178.55 -54.05 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.404 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.468 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 169.44 -25.15 0.1 Allowed Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.99 -177.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -136.68 174.43 10.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.5 147.79 43.28 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 122.437 -0.164 . . . . 0.0 110.563 176.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' A' ' 22' ' ' THR . 92.1 m-85 -45.94 128.86 9.38 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.448 0.467 . . . . 0.0 110.445 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -131.51 138.18 48.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.231 0.539 . . . . 0.0 110.884 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.0 tt -143.17 129.63 17.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.802 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -86.27 143.99 27.64 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.143 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.543 HD23 ' HE1' ' A' ' 21' ' ' PHE . 1.6 tm? -62.46 -36.38 82.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.142 -173.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -65.26 -34.18 77.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.933 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.97 -44.08 97.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.106 0.479 . . . . 0.0 110.408 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 70.3 mtp -62.74 -41.69 99.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.116 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -65.72 -31.41 72.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.902 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -76.01 -3.88 38.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.734 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.48 -17.97 45.65 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.972 174.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -91.23 95.57 10.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.155 0.502 . . . . 0.0 110.696 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -100.68 100.93 11.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.579 0.704 . . . . 0.0 110.966 -177.115 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.9 p -165.51 126.96 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.68 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.454 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -99.99 143.6 30.01 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.018 0.437 . . . . 0.0 110.36 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.43 140.05 44.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.38 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.539 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 11.1 t -109.37 118.04 51.7 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -70.61 156.51 60.98 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.439 2.093 . . . . 0.0 112.135 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.1 t 85.78 -53.53 0.08 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.852 0.861 . . . . 0.0 110.659 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 17.5 p -89.14 -28.39 20.08 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.4 m 66.92 54.69 0.76 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.387 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 53' ' ' MET . 1.7 tt -110.9 136.5 49.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.443 ' N ' HD23 ' A' ' 52' ' ' LEU . 31.9 mtm -123.84 137.99 54.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.742 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.454 HD11 ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -140.22 153.8 22.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.915 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 43.1 m-20 -82.01 159.79 23.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.838 0.351 . . . . 0.0 110.506 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.56 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 49.0 t -130.97 144.19 38.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.09 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.531 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 44.0 t -106.56 108.85 26.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.632 0.253 . . . . 0.0 110.592 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.513 ' HE2' ' HD2' ' A' ' 43' ' ' LYS . 45.2 p90 -112.98 165.24 12.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.041 -177.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.464 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 2.7 t70 -127.4 170.63 12.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.233 0.539 . . . . 0.0 110.234 175.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -63.62 -46.25 86.61 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.999 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -72.88 -37.44 67.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.917 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -63.8 -31.48 72.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.773 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 58.9 mt -75.03 -45.31 42.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.605 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.93 -49.63 76.93 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.583 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.61 -40.27 96.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.174 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.421 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 91.2 t80 -69.22 -38.05 78.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.737 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.15 -45.18 83.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.861 0.362 . . . . 0.0 110.794 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -76.45 -25.72 54.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.586 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -79.26 -40.53 30.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.747 0.308 . . . . 0.0 111.64 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.54 -26.4 30.15 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.419 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.446 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 -176.038 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.451 -0.424 0 CA-C-O 121.364 0.602 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -83.18 -20.76 34.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.107 -173.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -132.66 162.81 30.41 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.172 0.51 . . . . 0.0 111.034 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 37.2 tt0 -146.93 108.52 4.32 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.657 171.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.96 155.74 18.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.056 -175.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.553 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 32.3 mp0 -65.32 144.42 57.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.391 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.0 tt -57.54 -29.35 33.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.445 0.64 . . . . 0.0 110.139 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -64.41 -28.8 69.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.927 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -82.1 -31.31 30.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.772 -175.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 84.2 mtp -68.65 160.84 29.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.027 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.1 m -85.17 110.89 19.33 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.076 0.465 . . . . 0.0 110.362 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.531 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 35.0 p90 -74.86 139.0 42.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.542 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -126.58 85.4 60.51 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.085 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.476 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 24.5 Cg_endo -62.86 -29.84 76.79 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.609 2.206 . . . . 0.0 111.579 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -63.81 -23.94 67.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.149 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -118.5 5.52 11.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.324 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.461 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 2.0 mp0 57.9 30.95 19.88 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.762 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 27.5 ptt? -144.36 170.89 15.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.061 0.458 . . . . 0.0 111.234 -175.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.531 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 31.0 m-85 -119.35 140.19 50.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.766 177.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 38.5 p -130.72 148.29 52.48 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.81 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.535 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 2.4 t80 -119.41 122.54 29.3 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.62 116.72 3.71 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.755 2.303 . . . . 0.0 113.383 -175.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 10.7 t -132.98 136.37 27.51 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.19 177.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 9.8 Cg_endo -90.29 118.24 0.68 Allowed 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 121.912 1.741 . . . . 0.0 111.642 174.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.409 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 32.0 p -176.56 -47.07 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.409 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 168.73 -26.89 0.13 Allowed Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.96 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.52 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 3.1 t0 -142.8 176.22 9.23 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.483 ' H ' ' HD2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -114.0 156.4 24.15 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -177.141 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 22' ' ' THR . 91.1 m-85 -58.39 117.72 4.78 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 172.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 30' ' ' ARG . 49.1 mt-30 -116.9 135.92 53.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.671 0.272 . . . . 0.0 111.105 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.421 HD13 HG11 ' A' ' 56' ' ' VAL . 13.8 tt -148.63 135.04 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.789 174.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -94.24 149.79 20.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.646 0.26 . . . . 0.0 110.62 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -32.11 70.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.488 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -60.51 -41.4 94.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.886 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 64.0 m-20 -66.11 -36.5 83.33 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.246 0.546 . . . . 0.0 110.115 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.532 ' HE2' ' HB3' ' A' ' 58' ' ' PHE . 57.7 mtp -69.19 -38.92 78.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.368 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -62.84 -30.2 71.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.22 0.533 . . . . 0.0 110.426 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 5.5 mm-40 -64.8 -22.16 66.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.319 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.72 -1.18 55.44 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -174.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -93.18 98.38 11.25 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.654 ' HB3' ' HE2' ' A' ' 58' ' ' PHE . 20.2 pttp -103.44 98.97 8.78 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.627 0.727 . . . . 0.0 111.421 -176.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 2.5 p -169.01 127.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.746 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.35 137.39 39.76 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 176.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.794 HG22 ' HG2' ' A' ' 53' ' ' MET . 40.8 t -111.84 132.4 60.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.022 -178.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.518 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 7.8 t -102.55 112.54 65.69 Favored Pre-proline 0 N--CA 1.448 -0.528 0 CA-C-O 120.991 0.424 . . . . 0.0 110.073 176.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.546 ' O ' ' HB3' ' A' ' 49' ' ' SER . 24.6 Cg_endo -67.81 157.38 62.02 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.27 1.98 . . . . 0.0 110.953 170.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.546 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 41.2 t 90.9 -58.43 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.053 0.941 . . . . 0.0 110.89 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 27.5 p -92.26 -28.25 17.11 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.948 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.8 t 69.65 73.25 0.24 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.399 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.543 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 46.6 tp -134.53 154.41 51.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.354 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.794 ' HG2' HG22 ' A' ' 46' ' ' VAL . 39.4 mtm -139.45 138.37 36.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.294 -177.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -140.17 152.38 21.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.86 177.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 2.1 m-20 -74.48 156.38 36.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.642 0.258 . . . . 0.0 110.32 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 5.0 p -131.15 124.75 56.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.278 0.561 . . . . 0.0 111.165 176.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.553 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 78.4 t -82.58 111.58 19.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.954 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.654 ' HE2' ' HB3' ' A' ' 43' ' ' LYS . 50.2 p90 -112.97 163.03 15.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.19 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.57 ' OD1' ' HG2' ' A' ' 61' ' ' GLU . 5.6 t70 -118.24 157.24 27.38 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.499 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -63.7 -40.49 96.93 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.223 179.087 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.57 ' HG2' ' OD1' ' A' ' 59' ' ' ASP . 10.3 pt-20 -73.34 -37.91 65.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.12 -177.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -63.05 -45.56 91.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.75 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 54.8 mt -56.75 -49.72 74.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.809 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.21 -42.78 86.97 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.974 0.416 . . . . 0.0 111.59 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.9 -46.01 79.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.355 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -66.02 -34.54 78.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.259 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -51.83 -53.1 44.02 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.693 0.283 . . . . 0.0 110.826 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.6 -36.55 81.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.68 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.52 -54.49 19.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.145 0.498 . . . . 0.0 111.436 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.461 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -65.91 -18.38 65.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.895 -176.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.616 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.97 179.239 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -113.22 6.38 17.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.86 0.362 . . . . 0.0 111.079 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -150.5 172.14 15.94 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.501 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 35.3 tt0 -158.9 117.14 2.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.818 0.342 . . . . 0.0 110.326 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.9 OUTLIER -125.99 163.05 28.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.457 ' HG2' ' HB ' ' A' ' 57' ' ' VAL . 46.0 mt-10 -87.88 152.97 21.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.024 0.44 . . . . 0.0 111.145 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.6 tt -60.15 -29.57 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.05 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -69.38 -28.86 66.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.733 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.23 -35.55 35.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.106 0.479 . . . . 0.0 109.769 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 78.5 mmm -57.01 152.28 13.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.41 171.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.6 m -96.85 124.55 40.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.833 0.349 . . . . 0.0 110.816 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -80.9 130.38 35.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.096 0.474 . . . . 0.0 110.507 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -115.43 90.07 24.0 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 30.9 Cg_endo -63.88 -21.57 68.97 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.959 2.439 . . . . 0.0 112.013 -176.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -59.86 -42.61 94.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.75 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.453 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 0.4 OUTLIER -110.79 5.62 20.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.9 -175.847 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.548 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 1.9 mp0 59.11 41.22 20.91 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.206 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.453 ' HG2' ' HB3' ' A' ' 18' ' ' ASN . 27.2 ptt? -147.3 173.74 12.3 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.91 -177.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -109.11 138.56 45.27 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.916 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.535 ' HB ' ' HD3' ' A' ' 30' ' ' ARG . 21.1 p -137.14 162.57 33.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.693 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.438 ' O ' ' HB2' ' A' ' 30' ' ' ARG . 52.3 t80 -144.14 128.16 9.1 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.82 107.96 0.31 Allowed 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.292 2.662 . . . . 0.0 113.774 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.46 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 20.8 t -113.0 140.83 24.61 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.002 174.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 21.0 Cg_endo -91.95 117.5 0.44 Allowed 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.989 1.793 . . . . 0.0 111.837 174.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.436 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 31.6 p 178.36 -46.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.919 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.436 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 164.23 -24.27 0.18 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.917 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.504 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -141.97 175.42 9.75 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.132 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.535 ' HD3' ' HB ' ' A' ' 22' ' ' THR . 7.6 ptp180 -118.33 157.6 26.78 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.326 -178.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.534 ' O ' ' HA ' ' A' ' 22' ' ' THR . 91.5 m-85 -50.04 129.6 20.96 Favored 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 123.831 0.707 . . . . 0.0 110.156 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -130.64 127.48 39.02 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.098 -171.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.479 ' HB ' ' HA ' ' A' ' 45' ' ' ALA . 13.3 tt -146.89 135.92 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.528 175.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.416 ' O ' ' HG3' ' A' ' 38' ' ' MET . 27.0 m-85 -97.48 144.16 27.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.481 -177.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.565 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 3.6 mm? -62.81 -27.83 69.58 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.941 0.4 . . . . 0.0 110.658 176.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -55.43 -43.55 75.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.724 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.4 -31.98 54.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.496 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.603 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 78.2 mtp -70.3 -32.4 70.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.116 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -68.82 -27.26 65.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.845 177.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -72.85 -7.0 48.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.855 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.0 -0.83 47.83 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.994 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.603 ' O ' ' HA ' ' A' ' 38' ' ' MET . 9.9 tp10 -105.7 155.06 19.62 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.664 ' HD3' ' N ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -147.62 100.99 3.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.769 0.795 . . . . 0.0 110.942 -176.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 p -167.2 131.08 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.98 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.479 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . . . -100.73 135.39 42.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.31 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 p -112.91 136.74 48.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.268 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.409 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 18.7 t -105.07 124.75 35.57 Favored Pre-proline 0 N--CA 1.436 -1.162 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.444 175.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.504 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 58.3 Cg_endo -75.7 156.42 39.93 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.805 2.337 . . . . 0.0 111.094 173.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 33.0 t 89.58 -57.37 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.764 0.826 . . . . 0.0 110.629 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.413 ' HB3' ' CB ' ' A' ' 27' ' ' CYS . 21.5 p -91.25 -30.91 16.36 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.306 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t 70.38 73.23 0.21 Allowed 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.276 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.3 tp -130.35 144.53 51.44 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.458 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.406 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 46.3 mtm -135.18 137.86 43.1 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.131 0.491 . . . . 0.0 110.984 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.469 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -138.61 154.86 27.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.663 179.43 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.501 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 2.1 t70 -83.4 151.31 25.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 43' ' ' LYS . 6.1 p -130.04 116.47 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.521 0.677 . . . . 0.0 111.909 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.457 ' HB ' ' HG2' ' A' ' 8' ' ' GLU . 48.4 t -72.76 111.55 7.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.446 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.486 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 28.4 p90 -115.33 164.7 13.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.032 -175.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.52 ' OD1' ' HG2' ' A' ' 61' ' ' GLU . 8.8 t70 -126.05 157.61 37.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 171.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.67 -37.76 88.67 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.629 178.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.52 ' HG2' ' OD1' ' A' ' 59' ' ' ASP . 12.9 pt-20 -73.13 -37.87 66.48 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.355 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.506 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 4.0 m-20 -59.06 -53.13 61.89 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.488 175.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.422 HD22 HD12 ' A' ' 35' ' ' LEU . 28.4 mt -55.42 -50.7 69.1 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.881 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.48 -48.23 81.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.681 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -68.46 -43.56 76.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.867 0.365 . . . . 0.0 110.876 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.506 ' HD1' ' O ' ' A' ' 62' ' ' ASP . 48.1 m-85 -68.13 -32.48 72.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.299 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.565 ' CE1' ' HB3' ' A' ' 35' ' ' LEU . 1.2 m-85 -51.63 -48.13 63.42 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.261 0.553 . . . . 0.0 109.956 170.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.44 -30.87 64.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.776 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 66' ' ' TYR . 67.8 mm-40 -66.73 -45.25 79.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.118 176.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.548 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -75.34 -20.47 59.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.509 -176.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.77 -179.946 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.634 ' HB ' ' OD1' ' A' ' 55' ' ' ASP . 5.7 p . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 120.973 0.416 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -114.08 -21.37 10.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.339 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -121.02 152.64 38.36 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.025 -173.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -144.67 117.65 8.83 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 123.12 0.262 . . . . 0.0 110.492 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.4 ' CD1' HG13 ' A' ' 54' ' ' ILE . 0.6 OUTLIER -118.17 162.58 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.564 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 41.6 mt-10 -69.29 148.85 49.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.956 0.408 . . . . 0.0 111.254 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.3 tt -62.36 -33.18 57.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.049 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.68 -27.25 61.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.753 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -72.53 -30.33 64.37 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.613 ' HA ' ' HD1' ' A' ' 23' ' ' TYR . 84.5 mtp -69.74 151.06 46.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.06 172.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.1 m -76.86 131.52 38.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.121 0.486 . . . . 0.0 111.578 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -74.92 127.17 32.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.329 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -125.24 85.26 58.48 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.002 0.43 . . . . 0.0 110.304 173.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.68 -34.17 42.15 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.759 2.306 . . . . 0.0 111.949 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.33 -34.11 76.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.478 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.476 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 3.5 t-20 -102.62 -1.6 29.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.875 0.369 . . . . 0.0 111.024 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.404 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 1.5 mp0 62.01 35.96 15.75 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.856 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.551 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 26.2 ptt? -154.0 167.58 29.28 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.544 -177.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -100.36 146.28 27.16 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.477 177.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 23.4 p -138.51 136.82 36.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.86 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.613 ' HD1' ' HA ' ' A' ' 12' ' ' MET . 8.6 t80 -115.38 121.31 34.94 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -50.68 118.73 4.38 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.672 2.915 . . . . 0.0 113.778 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.515 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 16.5 t -135.47 139.98 32.85 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.339 176.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -91.8 120.32 0.56 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.644 2.229 . . . . 0.0 111.947 172.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.6 p 177.61 -39.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.775 0.798 . . . . 0.0 108.958 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 158.14 -26.95 0.44 Allowed Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.627 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.452 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 3.7 t0 -142.04 176.34 9.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.464 ' HE ' ' HB ' ' A' ' 22' ' ' THR . 12.7 ptm180 -117.63 153.7 32.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.582 ' O ' ' HA ' ' A' ' 22' ' ' THR . 99.4 m-85 -51.57 128.24 22.56 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.58 0.55 . . . . 0.0 110.003 177.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -133.55 142.66 48.28 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.065 0.459 . . . . 0.0 110.686 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.551 ' O ' ' HB2' ' A' ' 20' ' ' MET . 14.6 tt -144.44 132.46 17.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.557 -178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -82.38 128.85 34.64 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.496 -177.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.494 HD12 ' CE1' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -62.59 -34.65 77.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -176.788 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -65.16 -25.92 67.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.246 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.87 -32.49 27.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.308 0.575 . . . . 0.0 109.76 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 83.6 mtp -67.46 -35.56 79.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.944 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -67.1 -23.6 65.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.154 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -77.69 -9.13 58.82 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.035 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.75 -18.63 34.42 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.058 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.45 121.43 27.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.874 0.369 . . . . 0.0 110.668 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.515 ' HD3' ' CE2' ' A' ' 58' ' ' PHE . 19.7 pttp -120.22 100.56 7.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.675 0.75 . . . . 0.0 112.131 -174.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 p -166.78 126.41 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.573 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.45 142.16 32.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.125 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.94 138.67 51.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.966 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.546 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 23.0 t -107.0 121.69 44.0 Favored Pre-proline 0 N--CA 1.436 -1.15 0 C-N-CA 120.521 -0.471 . . . . 0.0 109.787 176.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 34.0 Cg_endo -68.69 157.1 63.23 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.434 2.089 . . . . 0.0 111.285 174.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 29.5 m 86.51 -60.42 0.05 OUTLIER 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.136 0.975 . . . . 0.0 110.952 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 20.3 p -89.02 -26.88 21.21 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.3 t 69.39 46.45 0.76 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.146 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.548 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 1.7 tt -99.59 129.11 45.72 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 30.4 mtm -120.52 136.79 54.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.102 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.4 HG13 ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -147.01 162.21 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.705 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.634 ' OD1' ' HB ' ' A' ' 3' ' ' THR . 5.0 m-20 -80.29 162.34 24.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.695 0.283 . . . . 0.0 110.382 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.419 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 8.9 p -132.81 137.03 54.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.671 175.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.564 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 44.4 t -88.89 112.91 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.556 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.515 ' CE2' ' HD3' ' A' ' 43' ' ' LYS . 39.7 p90 -117.36 165.25 13.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.734 0.302 . . . . 0.0 110.824 -177.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -134.94 151.45 50.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.034 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -56.5 -40.92 75.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.713 175.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.18 -46.91 72.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.268 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.95 -44.73 96.15 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.541 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.42 HD22 HD11 ' A' ' 35' ' ' LEU . 36.4 mt -64.55 -48.21 75.89 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.083 -0.247 . . . . 0.0 111.185 -178.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.66 -41.84 95.83 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.058 0.456 . . . . 0.0 111.01 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -68.48 -42.5 78.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.303 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -66.7 -37.2 84.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.06 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.494 ' CE1' HD12 ' A' ' 35' ' ' LEU . 2.6 m-85 -52.71 -43.45 65.67 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.335 0.588 . . . . 0.0 110.147 174.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -66.66 -52.4 45.31 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.467 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -69.49 -31.63 70.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.782 -175.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.404 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -73.69 -18.29 61.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.748 0.309 . . . . 0.0 111.089 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.711 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.608 178.788 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.0 p . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 120.516 0.198 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -85.23 6.49 25.78 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -166.99 169.64 12.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.632 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -144.34 113.96 7.15 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.451 HG22 ' HB3' ' A' ' 11' ' ' ASP . 4.1 mt -120.9 142.07 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -169.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -62.52 140.07 58.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.458 171.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.8 tt -55.42 -33.93 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.518 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -73.36 -28.34 61.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.59 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.451 ' HB3' HG22 ' A' ' 7' ' ' ILE . 12.3 t70 -72.01 -29.41 64.17 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 83.0 mmm -69.1 145.02 53.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.373 176.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 50.9 m -90.35 115.76 27.79 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.102 0.477 . . . . 0.0 110.412 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.693 ' HB2' ' HE1' ' A' ' 66' ' ' TYR . 39.2 p90 -74.35 139.13 43.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.554 -176.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -115.38 85.02 12.5 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.223 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 21.3 Cg_endo -60.33 -28.92 87.76 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.163 2.575 . . . . 0.0 113.799 -170.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.35 -29.45 68.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.875 0.369 . . . . 0.0 110.988 -177.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -108.45 -0.4 20.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.955 -175.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 60.02 40.4 18.77 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.096 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -141.74 170.3 15.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.985 0.421 . . . . 0.0 110.757 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -109.7 144.78 37.59 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.547 174.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 35.5 p -134.66 158.35 44.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.079 -178.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.435 ' HB3' ' CD2' ' A' ' 31' ' ' PHE . 4.4 t80 -137.81 132.81 17.44 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.7 121.81 10.28 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.716 2.277 . . . . 0.0 113.222 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.53 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 28.4 t -132.5 144.66 53.95 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.377 177.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 41.3 Cg_endo -94.28 118.52 0.29 Allowed 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 122.184 1.923 . . . . 0.0 111.778 173.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.4 p 174.93 -40.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.767 0.794 . . . . 0.0 109.158 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 148.26 -12.53 1.22 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.257 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.58 176.15 9.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.577 0.227 . . . . 0.0 110.461 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.483 ' HD3' ' HB ' ' A' ' 22' ' ' THR . 16.0 ptp180 -121.05 150.35 41.31 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.073 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.645 ' O ' ' HA ' ' A' ' 22' ' ' THR . 98.9 m-85 -51.21 125.46 14.09 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.283 0.364 . . . . 0.0 110.319 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 14.0 pt20 -120.6 133.68 55.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.179 0.514 . . . . 0.0 111.025 -176.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.5 tt -146.54 126.49 5.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.606 175.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -91.44 147.12 23.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.557 -175.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.42 ' HA ' HD22 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -61.32 -30.63 70.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.345 -177.375 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -55.46 -50.64 69.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.082 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -65.94 -38.4 88.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.45 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 84.0 mtp -63.51 -41.74 98.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.467 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.25 -29.57 69.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.677 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -68.63 -16.73 63.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.215 177.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.73 -9.5 52.06 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.945 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -90.92 92.78 8.92 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.619 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -105.46 100.77 10.34 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.255 1.026 . . . . 0.0 111.73 -174.929 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 p -166.12 130.43 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.036 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.516 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -99.96 141.95 32.09 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.412 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 7.4 p -120.17 138.02 52.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.905 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.569 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 12.9 t -102.22 121.48 50.13 Favored Pre-proline 0 N--CA 1.432 -1.356 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 49' ' ' SER . 45.6 Cg_endo -70.42 155.97 62.62 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.688 2.259 . . . . 0.0 111.846 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 67.5 m 79.78 -51.29 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.519 0.728 . . . . 0.0 111.785 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 13.8 p -91.92 -23.66 19.53 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.053 177.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.4 t 67.59 45.27 1.54 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.231 171.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.537 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 50.5 tp -102.68 137.03 41.44 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.893 -0.504 . . . . 0.0 109.815 176.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 37.1 mtm -123.93 138.21 54.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.949 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.516 HD11 ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -141.64 152.23 19.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.118 179.029 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -78.38 146.14 34.8 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.794 -178.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.619 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 96.8 t -131.42 113.06 22.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.053 0.454 . . . . 0.0 110.704 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.6 t -84.87 124.87 40.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 -175.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.419 ' CD1' HD11 ' A' ' 63' ' ' LEU . 52.8 p90 -118.15 164.9 14.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.906 0.384 . . . . 0.0 111.382 -175.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.441 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -127.69 152.4 47.76 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.834 173.339 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -62.97 -39.4 94.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.468 -176.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -64.64 -43.18 94.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.097 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -68.32 -35.53 77.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.06 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 51.0 mt -60.89 -53.94 51.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.537 177.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.451 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . . . -57.81 -41.75 82.81 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.121 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.92 -47.69 83.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.408 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.693 ' HE1' ' HB2' ' A' ' 14' ' ' PHE . 76.0 t80 -61.98 -35.81 79.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.132 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.451 ' HD2' ' HA ' ' A' ' 64' ' ' ALA . 24.5 m-85 -54.2 -44.26 71.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.032 0.444 . . . . 0.0 110.82 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -76.61 -43.18 39.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.692 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -58.49 -48.08 81.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.825 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.0 -25.52 43.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.252 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.544 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.256 -178.261 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.452 -0.364 0 CA-C-O 121.289 0.566 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -72.46 -36.87 68.59 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.822 -173.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -110.73 162.56 14.64 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.842 0.353 . . . . 0.0 110.891 -171.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -156.67 108.05 2.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.18 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.43 162.41 17.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.0 -175.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.523 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 42.8 mt-10 -71.45 151.58 43.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.262 0.553 . . . . 0.0 110.93 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.5 tt -60.61 -31.18 48.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.509 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.24 -28.05 65.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.313 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -78.71 -29.98 45.72 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.886 0.374 . . . . 0.0 110.584 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 82.4 mmm -58.98 130.44 47.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.387 175.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.3 m -72.92 107.31 5.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.199 0.524 . . . . 0.0 110.48 -176.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.549 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . 43.7 p90 -84.37 133.98 34.5 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.573 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.523 ' HA ' ' OE1' ' A' ' 15' ' ' GLU . 4.9 tp10 -112.04 98.24 41.56 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.747 176.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.02 -22.14 73.7 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.884 2.389 . . . . 0.0 111.692 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -70.16 -25.75 63.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.815 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -114.22 -0.26 13.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.033 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 57.63 42.68 23.6 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.528 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -160.15 172.72 16.93 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.615 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 14' ' ' PHE . 95.8 m-85 -103.45 137.09 42.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.001 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 30.2 p -136.7 166.63 23.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.438 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.441 ' CB ' ' HB2' ' A' ' 31' ' ' PHE . 0.4 OUTLIER -138.95 121.58 10.53 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.638 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -54.94 122.29 11.41 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.085 2.523 . . . . 0.0 113.414 -177.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 16.3 t -146.32 127.53 7.36 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.267 176.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -85.65 119.28 1.92 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.351 2.034 . . . . 0.0 111.683 174.175 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.8 p -175.63 -43.71 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.1 -30.52 0.17 Allowed Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.342 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.5 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 2.4 t70 -143.2 176.06 9.41 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.94 153.11 25.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.531 ' HZ ' HD23 ' A' ' 52' ' ' LEU . 79.0 m-85 -52.89 124.97 15.51 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -134.31 145.91 49.5 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.09 0.471 . . . . 0.0 111.383 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.3 tt -142.61 135.34 26.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.029 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -91.53 138.8 31.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.785 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.541 ' HA ' ' HG3' ' A' ' 38' ' ' MET . 1.1 mt -68.56 -25.14 64.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.162 -177.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -54.02 -45.48 71.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.542 172.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.66 -44.49 73.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.509 176.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.541 ' HG3' ' HA ' ' A' ' 35' ' ' LEU . 28.3 mtp -60.15 -46.01 91.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -69.24 -22.62 63.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.62 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -76.11 -20.72 57.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.165 0.507 . . . . 0.0 110.11 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.84 -3.3 31.97 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.257 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -83.62 117.32 23.09 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 175.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.52 ' HD3' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -126.83 98.52 5.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.072 0.939 . . . . 0.0 111.832 -174.295 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 p -168.54 132.07 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.904 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.25 138.12 38.7 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.0 p -120.23 137.79 52.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.541 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.499 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 10.0 t -104.1 123.88 39.35 Favored Pre-proline 0 N--CA 1.434 -1.24 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 174.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.5 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 35.5 Cg_endo -80.27 157.22 22.82 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.416 2.077 . . . . 0.0 111.451 175.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 23.0 t 88.85 -55.88 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.224 1.01 . . . . 0.0 110.585 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.9 p -89.01 -32.02 17.81 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 47' ' ' CYS . 20.2 m 68.49 74.02 0.28 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.652 176.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.531 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 42.2 tp -132.21 150.28 52.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.0 mtm -135.14 141.12 45.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.076 -175.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.38 148.52 21.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.66 175.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.21 156.66 37.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.837 0.351 . . . . 0.0 110.773 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.407 HG13 ' HB2' ' A' ' 43' ' ' LYS . 7.5 p -132.46 127.99 57.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.151 0.5 . . . . 0.0 111.098 176.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 46.8 t -83.45 105.68 13.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.152 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -113.09 164.65 13.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.572 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.605 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 5.2 t0 -134.12 158.67 43.04 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 173.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.652 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 9.0 mptt -64.24 -38.41 90.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.164 0.507 . . . . 0.0 110.17 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -73.53 -36.93 65.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.083 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.73 -38.44 90.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.794 0.33 . . . . 0.0 110.594 176.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 87.6 mt -63.84 -53.46 50.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.558 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.21 -42.92 66.81 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.673 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -59.07 -49.13 79.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.623 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.549 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 70.5 t80 -65.85 -35.96 82.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.28 -177.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -53.66 -44.64 69.83 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.614 0.245 . . . . 0.0 110.787 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -72.32 -39.92 67.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.699 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -63.75 -36.92 85.48 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.152 -0.477 . . . . 0.0 112.279 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.47 -17.64 33.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.648 0.261 . . . . 0.0 111.417 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.794 -178.772 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.45 -0.44 0 CA-C-O 121.16 0.505 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -74.38 -26.77 60.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.369 -171.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -128.98 165.64 20.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.06 0.457 . . . . 0.0 111.635 -174.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.569 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 43.9 tt0 -148.45 116.76 6.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.235 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.489 ' CD1' HG13 ' A' ' 54' ' ' ILE . 4.5 mp -113.43 149.7 15.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -173.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.543 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 43.0 mt-10 -67.8 144.17 55.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.8 0.333 . . . . 0.0 110.25 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.403 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 19.3 tt -57.56 -28.57 31.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.161 177.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -71.69 -35.17 70.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.13 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.474 ' HB3' ' CG2' ' A' ' 7' ' ' ILE . 11.5 t70 -76.84 -40.57 47.37 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 83.7 mmm -49.22 137.18 14.25 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.913 169.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.5 m -79.59 106.87 11.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.403 0.621 . . . . 0.0 110.353 -176.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -75.52 128.2 34.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.558 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 37.4 tp10 -118.03 88.07 30.46 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.822 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 31.7 Cg_endo -63.55 -26.04 69.78 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.71 2.274 . . . . 0.0 111.536 -178.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.12 -29.6 70.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.765 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -110.28 5.21 21.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.528 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.54 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 2.3 mp0 58.86 38.33 24.58 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.948 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -160.4 174.68 13.76 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.051 0.453 . . . . 0.0 111.411 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.403 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 72.0 m-85 -108.35 140.62 41.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.617 177.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.555 ' HB ' ' HD3' ' A' ' 30' ' ' ARG . 40.6 p -136.24 169.22 17.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.467 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.414 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 5.4 t80 -140.99 120.45 8.4 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.05 116.28 2.82 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 123.307 2.672 . . . . 0.0 112.975 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 28.4 t -130.29 138.99 34.29 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.422 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 46.3 Cg_endo -91.7 117.87 0.48 Allowed 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 122.049 1.832 . . . . 0.0 111.734 174.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.4 p 178.83 -43.65 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.753 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.89 -25.33 0.24 Allowed Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.994 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.54 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 2.3 t0 -142.76 175.72 9.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.555 ' HD3' ' HB ' ' A' ' 22' ' ' THR . 12.4 ptp180 -114.57 155.54 26.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.587 0.232 . . . . 0.0 111.11 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.636 ' HZ ' HD23 ' A' ' 52' ' ' LEU . 91.0 m-85 -54.57 127.72 29.11 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.16 175.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -124.5 137.9 54.38 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.099 0.476 . . . . 0.0 110.505 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.4 tt -140.66 140.29 33.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.658 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.488 ' O ' ' HG3' ' A' ' 38' ' ' MET . 17.1 m-85 -103.17 136.15 43.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.921 -172.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -56.5 -35.54 68.12 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.103 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.484 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 11.9 t70 -54.34 -51.72 63.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.088 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.97 -29.6 58.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.556 -174.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.488 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 90.4 mtp -65.76 -39.58 91.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.051 176.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -69.71 -23.49 63.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.385 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 36' ' ' ASP . 17.3 mm-40 -73.45 -16.08 61.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.588 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.8 -10.76 38.11 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.883 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -94.04 109.0 20.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.187 0.518 . . . . 0.0 110.331 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.679 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -108.0 102.47 11.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.799 0.809 . . . . 0.0 111.722 -176.11 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 p -164.43 129.3 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.263 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 53' ' ' MET . . . -101.27 143.52 31.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.134 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.09 139.4 47.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.974 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.534 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 17.4 t -107.73 124.02 36.14 Favored Pre-proline 0 N--CA 1.439 -0.982 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.31 175.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.563 ' O ' ' HB3' ' A' ' 49' ' ' SER . 58.5 Cg_endo -74.86 156.84 43.63 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.758 2.306 . . . . 0.0 111.023 173.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.563 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 40.1 t 88.66 -57.46 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.752 0.821 . . . . 0.0 110.906 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.0 p -91.63 -29.14 17.06 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.514 -0.475 . . . . 0.0 109.724 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 47' ' ' CYS . 33.7 t 66.92 70.13 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.517 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.636 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 53.7 tp -125.51 151.32 46.48 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.401 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 32.7 mtm -134.26 138.23 44.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.383 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.489 HG13 ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -142.72 154.43 17.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 177.579 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.569 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 2.4 m-20 -77.09 158.29 30.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.762 0.315 . . . . 0.0 110.403 177.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 86.0 t -132.79 125.3 52.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.847 0.356 . . . . 0.0 111.123 178.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.543 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 89.2 t -77.75 126.42 38.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.084 177.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -142.71 165.11 28.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.713 0.292 . . . . 0.0 111.154 -175.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.564 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 9.6 t70 -132.2 151.83 51.61 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 171.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -63.61 -33.2 75.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.046 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -65.61 -49.51 68.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.12 176.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -60.47 -39.56 88.06 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.086 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 40.9 mt -58.17 -57.15 14.12 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.766 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.5 -40.81 75.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.268 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -66.19 -37.54 85.85 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.434 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -77.81 -33.86 52.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -51.09 -44.84 61.32 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.893 0.377 . . . . 0.0 110.611 172.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -63.03 -45.64 91.34 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.661 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.79 -40.49 88.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.828 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.54 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -78.93 -12.56 60.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.529 -177.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.596 177.321 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.8 p . . . . . 0 N--CA 1.449 -0.496 0 CA-C-O 120.843 0.354 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -96.12 -24.62 16.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.72 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.418 ' HB3' ' CG2' ' A' ' 54' ' ' ILE . 47.1 t0 -120.62 167.04 12.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 33.2 tt0 -156.72 110.86 2.72 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.584 ' CD1' HG13 ' A' ' 54' ' ' ILE . 4.2 mp -109.9 147.79 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.003 0.43 . . . . 0.0 111.469 -173.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -65.33 147.01 54.18 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.129 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.676 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 21.0 tt -65.17 -28.46 44.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.371 0.605 . . . . 0.0 110.011 177.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -62.97 -39.13 93.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.618 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.49 ' HB3' ' CG2' ' A' ' 7' ' ' ILE . 19.2 t70 -80.63 -36.03 33.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.515 -175.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 79.9 mmm -54.03 144.81 18.28 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.86 170.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.7 m -91.73 127.34 37.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.688 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.679 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . 47.3 p90 -81.76 138.0 35.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.998 0.427 . . . . 0.0 110.669 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -124.39 84.25 56.67 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.605 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.2 -22.0 54.44 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.03 2.487 . . . . 0.0 112.973 -172.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -68.29 -33.3 74.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.973 0.416 . . . . 0.0 110.586 -178.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -105.61 -5.16 20.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.965 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 64.5 36.3 8.81 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.296 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -145.15 167.98 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.597 -177.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.445 ' HB2' HG23 ' A' ' 33' ' ' ILE . 71.2 m-85 -96.89 146.76 24.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.871 0.367 . . . . 0.0 110.336 177.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 22.3 p -136.82 164.46 28.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.503 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.436 ' HB3' ' CD2' ' A' ' 31' ' ' PHE . 10.1 t80 -147.59 127.02 6.45 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.91 120.42 7.87 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.414 2.742 . . . . 0.0 113.655 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.551 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 11.6 t -136.28 135.98 21.83 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.305 174.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -84.39 118.4 2.23 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 121.901 1.734 . . . . 0.0 111.572 175.19 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 32.0 p 177.14 -46.17 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 164.08 -27.11 0.21 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.326 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.565 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 2.5 t0 -139.63 175.22 9.75 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -113.58 153.17 29.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.496 -177.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.636 ' CD1' ' HB2' ' A' ' 47' ' ' CYS . 97.2 m-85 -50.19 130.66 23.06 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.194 0.309 . . . . 0.0 110.752 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 27.8 pt20 -117.85 134.67 54.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.918 0.389 . . . . 0.0 110.638 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.445 HG23 ' HB2' ' A' ' 21' ' ' PHE . 12.9 tt -147.56 133.87 12.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.288 176.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.422 ' HB2' ' OD2' ' A' ' 37' ' ' ASP . 90.5 m-85 -96.13 147.4 23.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.857 -177.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 35' ' ' LEU . 4.1 mm? -61.0 -33.92 74.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.062 178.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -56.7 -43.38 80.49 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.155 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.422 ' OD2' ' HB2' ' A' ' 34' ' ' TYR . 25.0 m-20 -67.77 -44.39 77.56 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.111 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.414 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 76.1 mtp -61.84 -44.28 97.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.643 -177.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -69.53 -29.23 66.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.68 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -72.94 -18.13 61.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.056 0.455 . . . . 0.0 110.589 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.11 1.41 33.72 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.61 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -108.16 100.61 9.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.153 0.501 . . . . 0.0 109.714 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.549 ' HD3' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -108.63 101.32 10.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.841 0.829 . . . . 0.0 111.03 -171.409 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.8 p -163.43 131.38 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.003 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.1 134.78 42.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.059 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.799 HG22 ' HG2' ' A' ' 53' ' ' MET . 46.7 t -114.74 122.99 69.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.636 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 26.1 t -83.49 124.86 75.14 Favored Pre-proline 0 C--N 1.318 -0.779 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.008 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.565 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 58.8 Cg_endo -73.2 156.64 51.09 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.832 2.355 . . . . 0.0 110.746 173.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.529 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 42.8 t 86.79 -60.38 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.447 0.699 . . . . 0.0 110.876 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 15.7 p -92.56 -24.76 18.62 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.207 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 t 64.48 79.61 0.25 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.535 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.411 HD23 ' N ' ' A' ' 53' ' ' MET . 3.4 tt -131.09 131.01 43.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.799 ' HG2' HG22 ' A' ' 46' ' ' VAL . 27.7 mtm -118.94 136.62 53.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.683 0.277 . . . . 0.0 111.265 -175.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.584 HG13 ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -145.52 155.43 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.66 177.143 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.553 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -76.79 152.24 35.65 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.583 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.7 t -132.7 120.05 40.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.964 0.411 . . . . 0.0 110.291 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.676 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 21.1 t -75.71 149.54 6.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.5 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 55.1 p90 -146.84 164.64 32.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.364 0.126 . . . . 0.0 110.694 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.59 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 14.4 t70 -125.98 156.76 39.32 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.861 0.362 . . . . 0.0 110.625 174.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.889 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 0.8 OUTLIER -60.63 -46.55 89.85 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.08 178.722 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -72.89 -40.67 65.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.726 -177.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -63.77 -39.6 94.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.3 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 66.8 mt -64.21 -52.42 58.91 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.498 176.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.14 -45.12 71.89 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.273 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.48 -44.73 95.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.354 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.679 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 54.6 t80 -66.36 -40.83 90.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.586 -176.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -51.31 -48.43 62.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.923 0.392 . . . . 0.0 110.679 175.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -71.15 -35.68 71.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.833 -177.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -70.14 -45.22 67.26 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.75 -12.68 59.42 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -174.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.618 0 C-N-CA 120.424 -0.894 . . . . 0.0 111.387 -179.523 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 N--CA 1.448 -0.551 0 CA-C-O 120.99 0.424 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -88.14 -14.2 39.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.157 -172.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -142.7 174.76 10.36 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.294 -177.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.554 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 33.5 tt0 -155.67 116.59 3.86 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.466 0.479 . . . . 0.0 109.747 -176.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.434 ' CD1' HG13 ' A' ' 54' ' ' ILE . 1.6 mp -129.33 146.44 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.79 -177.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.552 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 46.4 mt-10 -69.82 145.75 51.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.951 0.405 . . . . 0.0 110.463 174.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.2 tt -55.26 -28.89 22.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.474 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -63.1 -33.61 75.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.721 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -86.16 -31.62 21.71 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.164 -174.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.533 ' HA ' ' HD1' ' A' ' 23' ' ' TYR . 80.2 mtp -65.16 145.33 56.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 110.974 177.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.6 m -72.84 120.32 18.3 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.484 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -79.83 133.98 36.31 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.209 177.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -122.54 89.93 49.61 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.125 0.488 . . . . 0.0 110.061 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.77 -14.89 43.02 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.898 2.398 . . . . 0.0 111.917 -177.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -66.46 -40.3 89.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.488 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.557 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 2.8 t-20 -110.73 0.79 17.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.247 -177.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 59.83 42.32 16.73 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.834 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.557 ' HG2' ' HB3' ' A' ' 18' ' ' ASN . 26.9 ptt? -146.96 174.3 11.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.076 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -114.46 142.27 46.6 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 38.6 p -133.2 145.99 51.09 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.533 ' HD1' ' HA ' ' A' ' 12' ' ' MET . 9.6 t80 -119.61 131.15 24.5 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.55 122.79 12.25 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 123.016 2.477 . . . . 0.0 113.096 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.561 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 22.4 t -139.45 138.76 20.92 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.926 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -91.87 117.99 0.47 Allowed 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.19 1.927 . . . . 0.0 111.859 174.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.464 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 30.7 p -178.54 -52.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.745 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.464 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 172.43 -27.89 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.883 -178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.571 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 2.5 t70 -142.41 176.52 8.94 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.439 ' HE ' ' CB ' ' A' ' 22' ' ' THR . 10.6 ptm180 -114.7 147.51 39.56 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.641 ' CE1' ' HB3' ' A' ' 52' ' ' LEU . 97.7 m-85 -46.97 121.27 3.54 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.517 0.511 . . . . 0.0 110.18 178.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -120.49 131.52 54.77 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.897 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 20' ' ' MET . 14.7 tt -132.54 132.5 60.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.936 176.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.445 ' O ' ' HG3' ' A' ' 38' ' ' MET . 30.5 m-85 -90.27 134.83 34.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.756 -173.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 35' ' ' LEU . 0.5 OUTLIER -61.46 -30.54 70.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.012 -178.315 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -54.04 -44.82 71.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.943 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . 16.3 m-20 -77.26 -37.67 52.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.768 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.445 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 79.1 mtp -59.88 -42.43 93.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.544 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -60.49 -37.73 82.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.7 176.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.83 -22.22 64.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.768 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.51 7.06 32.66 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.653 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.535 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 8.0 tp10 -93.17 107.01 18.9 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.813 ' HD2' ' HE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -120.48 98.97 6.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.015 0.912 . . . . 0.0 111.68 -174.737 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 p -167.23 130.14 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.261 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.489 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -100.82 136.04 41.32 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.864 0.364 . . . . 0.0 110.406 -178.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.765 HG22 ' HG2' ' A' ' 53' ' ' MET . 44.7 t -114.07 129.84 69.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.535 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.572 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 13.0 t -99.25 119.46 60.46 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.778 178.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.571 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 34.4 Cg_endo -69.23 155.93 66.22 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.136 1.89 . . . . 0.0 111.162 175.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.51 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 44.5 t 85.36 -56.19 0.09 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.692 0.797 . . . . 0.0 111.366 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 52' ' ' LEU . 16.3 p -93.65 -18.56 22.03 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.4 t 67.23 43.06 2.13 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.839 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.641 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -94.21 148.55 22.08 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.676 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.765 ' HG2' HG22 ' A' ' 46' ' ' VAL . 48.9 mtm -140.36 135.73 32.45 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.032 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.489 HD11 ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -144.75 152.65 14.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.957 179.43 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 0.4 OUTLIER -76.04 152.95 36.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.879 178.703 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.78 143.37 39.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.552 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 56.5 t -103.07 107.99 23.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.813 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 24.3 p90 -113.57 164.53 13.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.099 -177.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -136.46 158.26 44.86 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.482 ' HD2' ' N ' ' A' ' 60' ' ' LYS . 12.4 mptt -64.02 -33.97 76.96 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.764 176.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -60.13 -54.08 50.19 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.232 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -61.46 -43.9 98.06 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.511 -176.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 35.2 mt -59.86 -49.62 77.0 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.285 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.45 80.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.775 0.321 . . . . 0.0 111.381 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -65.72 -53.73 36.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.452 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -68.91 -33.76 74.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.462 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.94 -46.23 64.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.916 175.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -67.25 -45.78 75.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.938 0.399 . . . . 0.0 110.983 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -61.51 -49.58 76.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.882 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.84 -20.34 53.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.113 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -177.995 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.0 p . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 121.054 0.454 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -92.0 -28.18 17.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.439 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -135.81 171.69 14.09 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.067 -171.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 39.7 tt0 -150.58 109.84 3.96 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.02 158.11 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 -175.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.519 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 57.3 mm-40 -61.63 150.59 35.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.138 0.494 . . . . 0.0 111.21 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.691 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 20.6 tt -62.4 -28.7 45.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.227 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -63.2 -29.96 71.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.397 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -79.16 -34.63 43.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.259 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.679 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 90.6 mmm -62.11 118.13 6.93 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 173.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.3 m -71.59 107.86 4.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.406 0.622 . . . . 0.0 110.442 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.597 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 39.0 p90 -74.54 137.6 42.53 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.183 -177.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -114.75 101.93 54.61 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.14 175.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.66 -9.15 23.39 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.072 2.515 . . . . 0.0 112.432 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -93.05 -38.53 11.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.121 0.486 . . . . 0.0 109.877 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.44 HD22 ' HA ' ' A' ' 18' ' ' ASN . 1.3 t-20 -89.39 -5.85 57.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.464 -175.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 73.46 18.2 3.67 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.608 171.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.583 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 27.3 ptt? -161.75 175.71 11.69 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.081 -173.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.679 ' HB3' ' HB3' ' A' ' 12' ' ' MET . 87.3 m-85 -95.76 131.08 42.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.133 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 23.8 p -129.04 137.8 51.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.795 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 36.0 t80 -109.64 122.6 38.81 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.21 121.31 9.18 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.229 2.62 . . . . 0.0 113.193 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.7 t -138.29 141.11 30.61 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.3 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -94.69 118.18 0.25 Allowed 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 122.157 1.905 . . . . 0.0 112.004 173.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.1 p -179.75 -44.95 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.391 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.71 -24.64 0.23 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.143 -177.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.461 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 4.3 t70 -141.91 177.01 8.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.94 151.04 32.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.933 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.795 ' HB2' ' HB3' ' A' ' 23' ' ' TYR . 75.6 m-85 -54.8 114.67 1.8 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 175.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.41 137.06 52.74 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.992 0.425 . . . . 0.0 110.98 -174.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.583 ' O ' ' HB2' ' A' ' 20' ' ' MET . 14.5 tt -139.64 129.13 29.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.827 173.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.439 ' O ' ' HG3' ' A' ' 38' ' ' MET . 14.1 m-85 -79.59 135.86 36.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.162 -173.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.471 HD12 ' CD2' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -66.88 -36.66 82.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.007 0.432 . . . . 0.0 110.049 -176.751 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 17.3 t70 -61.13 -35.44 77.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.454 176.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -69.54 -42.8 74.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.215 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.616 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 75.5 mtp -65.4 -37.72 87.83 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.5 178.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -69.53 -23.48 63.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.471 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 36' ' ' ASP . 70.4 mm-40 -75.05 -12.51 60.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 176.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.15 -5.42 33.97 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.529 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.616 ' O ' ' HA ' ' A' ' 38' ' ' MET . 0.7 OUTLIER -85.34 146.89 26.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 177.605 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 32.2 pttt -144.89 97.59 3.04 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.586 0.708 . . . . 0.0 111.2 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 p -167.74 126.67 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.036 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 53' ' ' MET . . . -100.54 131.15 46.6 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.966 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.9 p -111.91 139.29 37.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.995 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.436 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 8.6 t -116.34 115.02 40.39 Favored Pre-proline 0 N--CA 1.435 -1.178 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.117 175.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.563 ' O ' ' HB3' ' A' ' 49' ' ' SER . 34.2 Cg_endo -69.0 157.38 62.09 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.601 2.201 . . . . 0.0 111.452 174.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.563 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 35.9 t 88.51 -57.33 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.027 0.931 . . . . 0.0 110.586 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.7 p -90.43 -28.29 18.72 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.003 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.8 t 68.87 54.76 0.46 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.898 177.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 53' ' ' MET . 1.9 tt -114.76 137.2 52.21 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.469 ' N ' HD23 ' A' ' 52' ' ' LEU . 35.6 mtm -132.61 138.23 47.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.021 -178.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -142.49 156.37 18.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.778 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 39.9 m-20 -80.21 159.95 25.78 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.59 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 11.2 p -136.32 138.07 47.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.993 0.425 . . . . 0.0 111.052 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.691 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 61.8 t -72.12 141.57 16.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -150.03 155.94 40.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.854 0.359 . . . . 0.0 110.908 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -134.88 155.5 50.57 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -63.73 -34.67 78.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.178 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -73.93 -40.93 62.76 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.035 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -59.4 -46.39 88.84 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.16 0.505 . . . . 0.0 110.269 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 72.9 mt -69.51 -44.55 70.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.412 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.78 -46.69 88.4 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.66 0.267 . . . . 0.0 111.259 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.574 ' O ' ' HG3' ' A' ' 69' ' ' GLU . 23.8 tt0 -64.95 -49.55 69.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.861 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.477 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 80.0 t80 -62.22 -34.81 77.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.151 -178.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.471 ' CD2' HD12 ' A' ' 35' ' ' LEU . 2.0 t80 -54.18 -44.94 71.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.679 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -76.96 -33.84 57.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.105 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.574 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 48.2 mt-10 -61.17 -49.74 76.01 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.974 0.416 . . . . 0.0 110.859 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.23 -25.95 63.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.158 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.57 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.657 177.502 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.448 -0.565 0 CA-C-O 120.841 0.353 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -102.9 -26.64 13.04 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.74 154.06 24.43 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.956 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . 42.3 tt0 -146.3 122.89 11.12 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.613 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 mp -122.61 156.0 27.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.574 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 47.0 mt-10 -73.21 151.93 41.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.266 0.555 . . . . 0.0 111.19 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.442 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 20.4 tt -59.64 -28.59 40.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.59 -178.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -58.8 -38.53 78.78 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.26 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -73.18 -36.56 66.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.98 -174.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 89.5 mmm -58.37 149.92 23.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.188 176.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.4 m -100.9 108.02 19.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.959 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.419 ' HD2' ' HD3' ' A' ' 16' ' ' PRO . 44.6 p90 -74.08 136.03 43.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.011 0.434 . . . . 0.0 111.116 -176.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.426 ' HA ' ' OE1' ' A' ' 15' ' ' GLU . 6.4 tp10 -115.21 86.7 14.64 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.623 176.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.419 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 20.7 Cg_endo -61.31 -28.2 84.2 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.01 2.473 . . . . 0.0 112.455 -174.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -69.53 -20.28 63.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.117 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -111.72 -1.06 15.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.702 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 57.64 43.07 22.95 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.292 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -154.16 165.89 34.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.846 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.49 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 88.0 m-85 -103.87 139.59 38.85 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.609 ' HB ' ' HD3' ' A' ' 30' ' ' ARG . 77.5 p -130.59 169.86 15.04 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 121.141 -0.223 . . . . 0.0 110.929 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -152.77 127.23 4.57 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.36 126.31 21.79 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 123.144 2.563 . . . . 0.0 112.655 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.591 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 9.5 t -135.51 144.3 48.71 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.027 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -86.06 117.92 1.66 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.772 1.648 . . . . 0.0 111.949 173.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.437 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 30.3 p 172.48 -49.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.57 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.437 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 163.19 -24.48 0.19 Allowed Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.398 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.419 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 1.3 t0 -134.61 176.41 8.66 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.351 -0.241 . . . . 0.0 110.351 -177.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.609 ' HD3' ' HB ' ' A' ' 22' ' ' THR . 15.4 ptp180 -109.18 150.77 27.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.942 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.631 ' CD1' ' HB2' ' A' ' 47' ' ' CYS . 97.2 m-85 -55.39 140.46 39.77 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -137.16 134.14 36.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.181 0.515 . . . . 0.0 110.666 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.49 ' CG2' ' HB2' ' A' ' 21' ' ' PHE . 12.4 tt -131.16 130.39 63.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.679 177.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.492 ' O ' ' HG3' ' A' ' 38' ' ' MET . 24.4 m-85 -87.67 147.57 25.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.243 -174.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.429 ' HA ' HD22 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -66.7 -35.36 79.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.956 -176.16 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.1 -44.78 79.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.803 178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.401 ' OD1' ' HB2' ' A' ' 34' ' ' TYR . 3.4 m-20 -64.08 -43.04 96.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.628 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.492 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 55.3 mtp -63.57 -37.59 87.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.488 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -65.32 -35.45 81.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.272 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -70.92 -15.94 62.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.655 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.31 -3.63 59.91 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -81.84 81.64 7.78 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.31 0.576 . . . . 0.0 109.522 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.72 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.64 98.39 11.61 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.358 1.075 . . . . 0.0 110.439 -179.563 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 2.0 p -167.09 129.46 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.802 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 53' ' ' MET . . . -99.46 130.21 45.71 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -107.05 134.36 48.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.147 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.631 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 35.0 t -105.31 123.77 38.57 Favored Pre-proline 0 N--CA 1.433 -1.303 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.093 176.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.626 ' O ' ' HB3' ' A' ' 49' ' ' SER . 33.3 Cg_endo -65.89 156.57 63.6 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.499 2.133 . . . . 0.0 111.044 172.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.626 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 27.4 t 86.21 -61.37 0.05 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.349 0.659 . . . . 0.0 110.963 178.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.4 p -90.99 -23.43 20.4 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.188 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.5 t 68.2 41.57 1.9 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.117 175.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.556 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 54.3 tp -98.79 142.35 30.43 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.112 0.482 . . . . 0.0 109.943 -178.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.476 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 43.5 mtm -132.5 138.01 47.39 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.798 -178.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -141.3 150.38 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 177.305 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 7.3 m-20 -68.85 155.58 39.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.815 0.34 . . . . 0.0 110.181 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 90.7 t -135.29 124.51 41.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.83 176.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.574 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 41.5 t -75.64 104.84 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -108.67 164.78 12.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.909 -175.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.562 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 13.8 t70 -130.13 146.9 51.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.79 175.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -64.07 -32.56 74.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.975 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -73.57 -40.5 63.86 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.663 0.268 . . . . 0.0 110.606 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.73 -41.27 90.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.872 0.367 . . . . 0.0 110.322 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 67.3 mt -63.85 -48.94 74.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.79 178.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.15 -41.95 93.87 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.879 -177.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -63.06 -53.79 48.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.347 0.594 . . . . 0.0 110.466 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.411 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 78.9 t80 -63.81 -36.19 83.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.389 -178.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.14 -44.71 67.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.119 177.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -69.55 -36.18 76.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.625 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -75.96 -34.34 59.82 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.97 -20.27 24.67 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -178.179 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.3 p . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 121.014 0.435 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -98.33 -0.47 43.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.588 -174.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -134.04 162.95 30.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.53 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 40.1 tt0 -159.86 120.28 3.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.86 -177.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 8' ' ' GLU . 1.8 mp -120.65 161.69 20.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -175.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.402 ' N ' HG22 ' A' ' 7' ' ' ILE . 40.9 mt-10 -74.06 146.81 43.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.371 177.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.0 tt -59.41 -29.69 42.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.422 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -68.84 -28.26 66.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.923 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -79.4 -31.21 42.73 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.99 0.424 . . . . 0.0 110.3 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 82.3 mmm -63.58 128.07 34.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.986 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 22' ' ' THR . 86.2 m -71.83 119.43 15.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.198 0.523 . . . . 0.0 110.899 -177.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.672 ' HB2' ' HE1' ' A' ' 66' ' ' TYR . 36.2 p90 -74.58 138.81 43.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.035 -177.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -129.23 87.71 53.05 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.914 177.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.431 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 18.7 Cg_endo -59.84 -33.02 96.21 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.274 2.649 . . . . 0.0 112.897 -175.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.63 -28.71 70.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.891 -176.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -113.03 4.95 16.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.707 0.289 . . . . 0.0 111.112 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.418 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 2.1 mp0 59.14 32.0 21.73 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.395 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -144.94 159.01 43.6 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.165 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -93.89 141.81 28.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.726 175.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 20.6 p -137.7 141.57 41.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.642 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.456 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 17.6 t80 -125.52 117.82 24.77 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -178.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -48.44 118.53 3.36 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.47 2.78 . . . . 0.0 113.286 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 19.9 t -130.39 135.66 27.76 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.439 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 5.8 Cg_endo -84.74 118.21 2.09 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.869 1.712 . . . . 0.0 111.442 175.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.409 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 29.9 p 174.62 -45.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -177.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.409 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 159.65 -27.1 0.35 Allowed Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.783 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -138.23 176.0 9.08 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.476 ' HG3' ' HB ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -120.06 156.49 30.86 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.155 -177.078 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.64 ' O ' ' HA ' ' A' ' 22' ' ' THR . 97.3 m-85 -56.4 123.03 13.31 Favored 'General case' 0 CA--C 1.518 -0.258 0 O-C-N 123.384 0.428 . . . . 0.0 110.165 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.579 ' HG2' HG22 ' A' ' 22' ' ' THR . 98.3 mt-30 -120.8 137.63 54.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.823 0.344 . . . . 0.0 110.756 -178.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.5 ' HB ' ' HA ' ' A' ' 45' ' ' ALA . 10.1 tt -145.93 125.22 5.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.419 175.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -87.31 149.49 24.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.252 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.625 ' HA ' ' HG3' ' A' ' 38' ' ' MET . 7.7 tp -71.3 -24.65 62.18 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.12 0.485 . . . . 0.0 110.65 -176.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -54.6 -40.15 68.57 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.429 173.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -68.74 -44.56 73.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.202 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.625 ' HG3' ' HA ' ' A' ' 35' ' ' LEU . 15.2 mtp -62.72 -46.48 87.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.602 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -65.29 -25.19 67.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.095 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.92 -21.86 65.1 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.226 0.536 . . . . 0.0 110.523 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.75 -2.34 34.03 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.012 -177.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.459 ' HG3' HG12 ' A' ' 44' ' ' VAL . 10.2 tp10 -100.19 130.28 46.3 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 20.3 pttp -122.78 101.25 7.34 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.448 0.642 . . . . 0.0 111.068 -176.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 2.6 p -167.3 129.33 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.258 -177.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.5 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . . . -100.74 141.7 33.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.472 175.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.9 p -122.0 134.37 65.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.906 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.451 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 10.9 t -104.33 128.25 27.42 Favored Pre-proline 0 N--CA 1.438 -1.051 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 174.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.82 156.56 20.85 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.734 2.29 . . . . 0.0 111.553 176.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.0 t 85.95 -55.39 0.07 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.699 0.8 . . . . 0.0 110.681 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 15.9 p -87.32 -32.22 19.77 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 47' ' ' CYS . 16.6 m 68.96 76.26 0.24 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.233 174.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.485 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 57.6 tp -133.56 143.75 48.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.627 175.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.446 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 36.2 mtm -132.42 138.26 47.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.578 -177.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -143.31 152.82 16.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.942 178.955 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.532 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 2.2 m-20 -70.87 153.3 42.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.648 0.261 . . . . 0.0 110.557 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.526 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 99.9 t -135.46 114.74 16.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.501 176.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.54 117.8 15.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.069 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 43' ' ' LYS . 51.5 p90 -111.7 164.86 12.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.819 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.609 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 15.0 t70 -131.74 159.05 39.56 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.355 177.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.75 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 9.2 mptt -58.74 -44.1 90.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.473 178.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -75.53 -37.27 60.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.987 -176.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -62.1 -39.74 93.49 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.671 177.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 80.7 mt -68.83 -44.23 73.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.468 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.36 -51.27 70.21 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.779 -176.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -70.89 -33.39 70.53 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.362 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.672 ' HE1' ' HB2' ' A' ' 14' ' ' PHE . 56.4 t80 -67.16 -35.71 80.27 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.208 176.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.52 -46.1 66.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.623 174.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -71.51 -43.85 65.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.014 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -72.82 -34.11 66.64 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -83.05 -17.4 43.38 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.147 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.462 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.524 178.892 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 53' ' ' MET . 12.3 p . . . . . 0 N--CA 1.446 -0.648 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -95.27 -1.61 51.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.643 -171.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -143.19 171.92 13.43 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 44.3 tt0 -162.19 108.54 1.28 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -177.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.46 ' CD1' HG13 ' A' ' 54' ' ' ILE . 2.2 mp -119.67 151.26 22.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.385 -172.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -63.17 144.62 56.76 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 175.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.3 tt -60.54 -33.28 53.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.206 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.69 -27.82 62.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.209 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.453 ' HB3' HG22 ' A' ' 7' ' ' ILE . 17.8 t70 -73.57 -35.89 65.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.581 -176.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.465 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 81.4 mtp -69.2 153.76 43.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.479 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.1 m -82.12 113.22 19.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.82 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.498 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . 33.4 p90 -77.5 138.73 39.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.946 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -113.5 88.98 14.17 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.47 -29.51 88.82 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.215 2.61 . . . . 0.0 113.901 -169.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.94 -32.52 73.02 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.883 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.473 ' HB2' ' HG2' ' A' ' 20' ' ' MET . 46.6 m-80 -105.02 1.38 28.55 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.466 -173.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 57.28 39.05 28.85 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.032 0.444 . . . . 0.0 110.383 -178.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.473 ' HG2' ' HB2' ' A' ' 18' ' ' ASN . 27.1 ptt? -137.71 170.66 15.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.934 0.397 . . . . 0.0 111.004 -175.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.522 ' HE1' HD23 ' A' ' 35' ' ' LEU . 52.8 m-85 -119.47 144.67 46.86 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.867 176.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 35.6 p -133.03 158.37 42.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.376 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.465 ' CD1' ' HA ' ' A' ' 12' ' ' MET . 4.5 t80 -141.31 129.52 12.21 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -57.7 119.43 6.68 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.985 2.457 . . . . 0.0 113.361 -175.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.465 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 17.3 t -133.21 131.8 21.86 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.304 176.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 1.3 Cg_endo -85.31 117.83 1.87 Allowed 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.949 1.766 . . . . 0.0 111.487 173.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 28.4 p -179.15 -47.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.648 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.45 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 168.19 -25.4 0.12 Allowed Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.227 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.54 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 2.5 t70 -143.29 176.35 9.21 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -117.48 154.33 31.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.326 0.108 . . . . 0.0 110.769 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 22' ' ' THR . 94.3 m-85 -48.4 131.32 16.93 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.528 0.517 . . . . 0.0 111.342 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -127.15 126.87 43.64 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.977 -173.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.462 ' HB ' ' HA ' ' A' ' 45' ' ' ALA . 11.5 tt -148.84 136.4 13.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.321 176.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.448 ' O ' ' HG3' ' A' ' 38' ' ' MET . 91.3 m-85 -98.61 147.06 25.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.954 0.406 . . . . 0.0 111.36 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.522 HD23 ' HE1' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -65.62 -33.91 77.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.297 -178.244 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.79 -42.31 71.63 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.962 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -68.96 -40.53 78.85 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.97 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.448 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 75.2 mtp -63.8 -31.39 72.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.342 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -72.94 -21.19 60.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.624 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -79.1 -6.78 57.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.221 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.08 -18.2 34.03 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.089 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 38' ' ' MET . 33.0 tt0 -94.62 135.09 36.49 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.688 ' HD2' ' HE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -133.22 101.04 5.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.608 0.718 . . . . 0.0 110.983 -177.365 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 p -165.65 128.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.73 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.462 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . . . -100.07 135.86 40.85 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.004 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p -109.74 134.2 52.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.117 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.544 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 24.6 t -101.17 118.47 60.18 Favored Pre-proline 0 N--CA 1.433 -1.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.896 176.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.571 ' O ' ' HB3' ' A' ' 49' ' ' SER . 24.6 Cg_endo -65.38 156.54 62.79 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.397 2.065 . . . . 0.0 111.034 173.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.571 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 35.6 t 87.13 -56.91 0.04 OUTLIER 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.621 0.768 . . . . 0.0 111.035 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.0 p -92.96 -26.97 17.33 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.132 177.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.7 t 70.27 44.07 0.78 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.927 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 53' ' ' MET . 2.1 tt -101.33 136.22 41.54 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' A' ' 3' ' ' THR . 36.9 mtm -125.07 138.56 54.19 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 -177.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.46 HG13 ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -140.45 155.39 23.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.865 178.934 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.557 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 15.1 m-20 -80.92 159.15 25.04 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.2 t -130.94 126.28 59.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.71 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.7 t -87.49 101.74 11.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.066 0.46 . . . . 0.0 110.642 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.688 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 47.5 p90 -104.48 164.72 11.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.418 -178.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.506 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 20.3 t70 -128.47 159.5 35.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.944 0.402 . . . . 0.0 110.72 175.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.815 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -59.95 -47.55 85.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.416 177.208 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.13 -36.9 80.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.501 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -69.87 -40.66 75.58 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.618 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 42.8 mt -61.57 -44.81 96.34 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.73 177.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.17 -34.4 76.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.932 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -64.84 -54.07 36.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.701 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.498 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 77.0 t80 -65.0 -34.64 78.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.448 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -51.46 -47.14 63.21 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.165 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.81 -45.15 62.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.149 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.54 -43.89 88.53 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.12 -25.69 36.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.744 0.307 . . . . 0.0 111.407 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.673 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -176.656 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.475 0.655 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m -152.31 179.17 8.78 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.178 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.664 ' HB ' ' HB2' ' A' ' 55' ' ' ASP . 5.1 p -82.12 100.78 10.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 0.0 111.615 -178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -103.06 -16.83 15.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.478 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -102.1 138.35 39.16 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -137.72 114.94 10.95 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -175.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.681 HD13 HD13 ' A' ' 54' ' ' ILE . 4.3 mp -111.36 138.75 38.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.889 0.376 . . . . 0.0 110.235 -176.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.562 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 31.6 mt-10 -66.69 141.6 57.71 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.156 175.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.1 tt -57.07 -28.33 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.995 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -68.14 -28.76 67.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.355 -0.384 . . . . 0.0 112.014 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -82.2 -38.77 24.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.91 0.386 . . . . 0.0 109.995 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 81.1 mmm -53.33 127.07 23.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.496 170.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.3 m -79.1 123.24 27.16 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.666 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 35.7 p90 -94.65 134.47 37.2 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.636 -176.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -107.24 94.26 10.93 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.559 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.9 -27.99 86.16 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.113 2.542 . . . . 0.0 112.763 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -73.74 -27.52 61.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.969 0.414 . . . . 0.0 110.329 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -96.91 -10.08 27.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.895 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 62.66 36.66 13.36 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.833 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -151.78 169.23 22.74 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.456 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.666 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 30.0 m-85 -110.05 140.68 43.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.267 175.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 79.7 p -127.96 163.54 24.28 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.037 0.446 . . . . 0.0 110.759 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -134.8 126.7 18.06 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.31 115.3 1.98 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 123.18 2.587 . . . . 0.0 113.254 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.498 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 41.9 t -128.67 137.37 30.79 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.866 177.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 9.0 Cg_endo -90.3 120.14 0.8 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.487 2.125 . . . . 0.0 111.369 172.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 28.7 p 175.54 -43.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.41 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 160.15 -23.38 0.27 Allowed Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.51 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.424 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 2.8 t0 -142.49 175.71 9.58 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.543 ' HG3' HH11 ' A' ' 30' ' ' ARG . 9.3 ptt85 -113.26 152.96 29.16 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 122.799 0.439 . . . . 0.0 110.706 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 22' ' ' THR . 86.7 m-85 -55.4 136.26 49.6 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.334 0.397 . . . . 0.0 110.227 176.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -128.83 124.1 34.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.093 0.473 . . . . 0.0 111.524 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' A' ' 45' ' ' ALA . 12.0 tt -127.46 127.1 68.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.661 174.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.525 ' O ' ' HG3' ' A' ' 38' ' ' MET . 36.7 m-85 -93.96 131.07 39.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.001 -172.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -59.27 -31.63 69.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.187 -178.692 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -54.28 -47.2 72.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.12 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -83.37 -24.53 31.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.271 -176.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.59 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 93.9 mtp -65.1 -38.76 91.76 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.66 174.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -65.61 -29.43 70.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.225 175.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -71.15 -12.32 61.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.214 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.44 -6.86 36.45 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.623 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 38' ' ' MET . 9.2 tp10 -94.86 138.39 32.69 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.635 ' HD2' ' HE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -138.71 101.51 4.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 122.103 0.954 . . . . 0.0 111.553 -179.757 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.3 p -165.23 130.87 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.735 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.564 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -100.51 131.07 46.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.717 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.76 139.44 34.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.752 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 51' ' ' SER . 18.5 t -108.27 134.45 20.19 Favored Pre-proline 0 N--CA 1.436 -1.129 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.006 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.521 ' O ' ' HB2' ' A' ' 49' ' ' SER . 47.1 Cg_endo -83.0 157.18 15.34 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.16 2.573 . . . . 0.0 111.848 175.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.521 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 75.4 m 84.73 -55.8 0.1 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.889 0.876 . . . . 0.0 110.772 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.2 p -87.67 -33.06 18.92 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 174.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 47' ' ' CYS . 59.3 m 67.42 64.07 0.42 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.613 177.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.465 ' HB3' ' HE1' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -114.54 154.62 27.95 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.277 176.068 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 41.1 mtm -132.52 137.09 47.03 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.446 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.681 HD13 HD13 ' A' ' 7' ' ' ILE . 2.8 pp -143.68 148.16 19.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.471 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.664 ' HB2' ' HB ' ' A' ' 3' ' ' THR . 4.7 t70 -85.15 152.95 22.99 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -175.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.2 t -134.12 117.79 26.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.54 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.562 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 26.9 t -71.35 108.14 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.605 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.635 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 25.8 p90 -109.77 164.86 12.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.618 0.247 . . . . 0.0 110.407 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.629 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 5.7 t70 -134.09 160.31 38.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.111 0.482 . . . . 0.0 110.647 175.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.565 ' HB3' HG21 ' A' ' 78' ' ' ILE . 21.0 mtmm -62.54 -44.58 96.01 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.755 177.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -69.39 -35.58 75.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.801 -176.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -67.91 -44.04 77.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.174 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 81.6 mt -59.34 -49.23 78.63 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.183 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.57 -41.63 95.01 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.236 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -66.67 -45.92 77.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.295 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.518 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 84.1 t80 -67.57 -35.7 79.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.082 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.543 ' CE2' ' HB ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -53.8 -41.31 67.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 110.442 178.469 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -70.14 -38.77 75.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.088 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -70.15 -45.89 65.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.3 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.9 -15.48 63.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.197 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.58 52.97 10.69 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.823 -0.704 . . . . 0.0 111.593 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.543 ' HB ' ' CE2' ' A' ' 67' ' ' TYR . 0.4 OUTLIER -106.42 162.95 5.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -62.4 131.02 93.71 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.754 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -42.17 120.41 1.56 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 124.103 3.202 . . . . 0.0 114.072 -175.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -81.68 165.49 17.96 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.628 2.885 . . . . 0.0 111.614 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -72.79 133.02 82.59 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.62 146.89 94.04 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 123.096 2.53 . . . . 0.0 112.934 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.565 HG21 ' HB3' ' A' ' 60' ' ' LYS . 32.1 pt -85.15 169.45 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.23 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.82 52.93 1.55 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.922 0.392 . . . . 0.0 111.33 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.62 94.07 2.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.041 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.76 105.9 4.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.718 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.86 176.535 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.5 mtp . . . . . 0 C--O 1.234 0.271 0 CA-C-O 121.275 0.559 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 p -154.99 166.1 34.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.0 -173.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.4 p -73.75 102.35 3.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.27 177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -83.53 1.42 42.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.157 -177.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -146.0 163.98 33.51 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 34.6 tt0 -156.96 108.81 2.42 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -176.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 mp -116.16 145.45 21.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.281 -173.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.587 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 44.4 mt-10 -63.33 138.26 58.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 173.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.401 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 14.1 tt -51.51 -29.38 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.715 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -60.19 -34.06 73.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.218 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -81.33 -28.77 34.4 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.52 -172.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.578 ' HA ' ' HD1' ' A' ' 23' ' ' TYR . 84.2 mtp -66.3 156.41 34.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.139 0.495 . . . . 0.0 110.967 176.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.7 m -93.39 110.36 21.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.35 0.595 . . . . 0.0 110.207 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.553 ' HD2' ' HD3' ' A' ' 16' ' ' PRO . 38.8 p90 -74.86 140.08 43.62 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.894 -177.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -124.14 89.06 52.22 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 121.229 0.537 . . . . 0.0 109.943 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.553 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 26.4 Cg_endo -62.23 -26.26 77.4 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.369 2.713 . . . . 0.0 112.747 -173.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -69.34 -21.34 63.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.504 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -116.24 7.94 14.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.839 0.352 . . . . 0.0 110.698 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 57.39 43.1 23.76 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.751 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -154.0 171.72 18.6 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.451 -0.499 . . . . 0.0 111.403 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.534 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 57.6 m-85 -112.86 141.93 46.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.412 176.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 17.2 p -133.63 135.4 44.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.993 0.425 . . . . 0.0 111.107 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.588 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 7.6 t80 -106.36 117.47 57.11 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -56.38 113.37 1.42 Allowed 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.028 2.486 . . . . 0.0 113.717 -173.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 12.2 t -126.86 132.14 24.19 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.65 175.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 2.1 Cg_endo -86.08 118.16 1.68 Allowed 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 121.802 1.668 . . . . 0.0 111.582 174.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 29.3 p -177.09 -46.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.414 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 169.29 -27.46 0.13 Allowed Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.367 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.468 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 3.5 t70 -142.02 175.09 10.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -123.26 147.82 46.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.639 0.2 . . . . 0.0 110.619 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.588 ' HB2' ' HB3' ' A' ' 23' ' ' TYR . 96.7 m-85 -46.51 111.35 0.37 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.597 0.561 . . . . 0.0 111.221 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -111.37 135.39 51.99 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.089 0.471 . . . . 0.0 111.073 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' A' ' 45' ' ' ALA . 16.9 tt -132.62 136.7 55.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.754 177.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.538 ' O ' ' HG3' ' A' ' 38' ' ' MET . 30.0 m-85 -95.02 126.37 40.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.369 -174.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 35' ' ' LEU . 0.5 OUTLIER -55.3 -34.73 64.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.123 0.487 . . . . 0.0 110.625 -178.12 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -57.3 -48.74 78.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.414 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -70.78 -32.16 69.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.909 -178.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.538 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 81.2 mtp -61.18 -43.67 98.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.307 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -66.64 -31.15 71.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.192 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -72.37 -14.23 61.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.427 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.74 0.78 36.74 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.632 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -99.54 93.89 6.11 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -106.19 101.06 10.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 122.001 0.905 . . . . 0.0 111.265 -176.629 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 p -166.55 131.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.839 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.462 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -100.39 138.93 36.79 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.323 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.07 139.22 43.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.17 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.581 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 7.0 t -110.6 116.02 53.02 Favored Pre-proline 0 C--N 1.313 -0.989 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.133 176.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.51 ' O ' ' HB3' ' A' ' 49' ' ' SER . 35.1 Cg_endo -71.59 157.14 56.65 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.373 2.049 . . . . 0.0 111.192 172.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.51 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 46.2 t 89.93 -59.36 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.045 0.938 . . . . 0.0 110.322 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.9 p -89.46 -29.19 19.18 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.677 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 t 69.01 74.53 0.25 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.621 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.448 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 53.9 tp -138.68 152.02 47.68 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.6 mtm -133.44 137.94 45.98 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.587 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.479 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -137.56 153.5 28.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.155 178.257 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 3.8 t70 -80.05 151.81 29.72 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.23 115.59 26.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.976 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.587 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 42.5 t -70.12 118.07 14.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.509 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -122.78 159.96 26.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.571 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.494 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.8 t70 -131.35 167.44 19.25 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.405 ' H ' ' HG3' ' A' ' 60' ' ' LYS . 23.2 mtmm -63.05 -45.32 92.81 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.342 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -68.69 -40.31 80.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.038 -1.437 . . . . 0.0 111.14 -175.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.47 -42.11 99.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.761 0.315 . . . . 0.0 110.994 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 75.9 mt -63.83 -46.28 85.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.241 177.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.558 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . . . -57.38 -47.21 82.27 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.38 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.18 -46.38 79.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.06 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -67.83 -36.05 79.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.641 -176.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.684 ' HD1' ' HB ' ' A' ' 72' ' ' ILE . 26.3 m-85 -53.49 -48.6 68.78 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.007 0.432 . . . . 0.0 110.378 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -67.52 -43.02 81.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.402 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -74.65 -29.71 61.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -174.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.88 -21.41 26.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.617 0.246 . . . . 0.0 111.103 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.83 38.45 6.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.893 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.684 ' HB ' ' HD1' ' A' ' 67' ' ' TYR . 2.0 mt -99.9 -179.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.651 ' H ' HG22 ' A' ' 72' ' ' ILE . 36.3 m80 -63.45 141.41 97.85 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -57.6 132.69 51.88 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.361 2.041 . . . . 0.0 111.065 173.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.49 164.53 20.39 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.297 2.665 . . . . 0.0 113.115 -175.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.16 139.9 79.63 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -50.8 133.94 40.37 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.329 2.686 . . . . 0.0 113.185 -174.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.3 pt -142.43 171.58 10.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.121 -175.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.75 78.9 9.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.952 0.406 . . . . 0.0 110.2 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -134.12 61.79 1.67 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.233 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.84 168.82 21.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.717 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.785 -0.626 . . . . 0.0 110.358 -179.336 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.837 0.351 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.2 m 63.24 -165.33 0.24 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.835 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.2 p -90.08 101.53 14.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.348 0.594 . . . . 0.0 110.812 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -80.13 -35.09 37.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.241 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -114.85 159.2 20.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.362 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.532 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 34.9 tt0 -143.11 110.73 5.85 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.39 139.45 43.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.251 -170.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.583 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 39.0 mt-10 -58.2 135.52 57.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.062 0.458 . . . . 0.0 110.34 173.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.422 ' CG2' ' HA ' ' A' ' 58' ' ' PHE . 15.5 tt -54.54 -29.45 20.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.771 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.9 -27.94 68.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.967 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -83.93 -39.91 19.19 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.464 -175.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 83.0 mtp -60.84 142.78 55.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.708 0.29 . . . . 0.0 111.021 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.0 m -79.69 124.68 28.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.973 -176.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.484 ' HB2' ' HE1' ' A' ' 66' ' ' TYR . 39.2 p90 -84.27 141.65 30.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.099 0.476 . . . . 0.0 111.783 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -125.7 92.05 47.26 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 173.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.62 -26.38 53.88 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 123.094 2.529 . . . . 0.0 113.253 -172.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -69.57 -28.93 66.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.007 0.432 . . . . 0.0 110.918 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -107.41 4.54 26.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.838 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 58.56 37.93 25.4 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.993 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 26.0 ptt? -143.12 171.46 14.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.292 0.568 . . . . 0.0 111.841 -174.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.479 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 41.8 m-85 -116.0 148.18 40.41 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.392 173.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 41.5 p -136.27 167.24 21.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.894 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.462 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 84.3 t80 -144.08 118.07 5.9 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -56.97 109.83 0.51 Allowed 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.201 2.601 . . . . 0.0 113.19 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.1 t -127.22 131.3 23.78 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.712 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 5.2 Cg_exo -80.2 119.42 3.85 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.951 1.768 . . . . 0.0 111.472 176.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.448 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 30.6 p -179.4 -52.72 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.448 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 174.44 -28.57 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.215 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.588 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 1.2 t70 -142.8 175.93 9.44 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -115.71 154.87 28.78 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.578 ' O ' ' HA ' ' A' ' 22' ' ' THR . 80.4 m-85 -50.29 134.75 22.61 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.519 0.512 . . . . 0.0 110.61 178.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -131.77 133.29 44.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.168 0.509 . . . . 0.0 111.066 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 20' ' ' MET . 10.9 tt -151.28 126.11 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.009 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -87.29 138.16 31.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.79 0.329 . . . . 0.0 110.895 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.6 ' HG ' ' HD2' ' A' ' 66' ' ' TYR . 1.2 tm? -64.19 -31.73 73.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.018 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -61.92 -29.92 70.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.792 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.17 -32.63 29.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.419 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.553 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 84.6 mtp -67.6 -34.12 76.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.145 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -64.64 -24.44 67.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.398 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -76.93 -12.21 59.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.025 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.91 -11.49 41.26 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.402 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.553 ' O ' ' HA ' ' A' ' 38' ' ' MET . 9.3 tp10 -89.41 133.77 34.38 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -142.08 100.13 3.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.115 0.96 . . . . 0.0 111.503 -177.0 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.4 p -167.27 127.7 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.424 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.58 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -100.73 141.55 33.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.106 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.6 137.42 51.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.687 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.41 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 18.0 t -99.68 111.88 62.53 Favored Pre-proline 0 N--CA 1.431 -1.408 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.588 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 14.7 Cg_endo -62.6 156.6 51.57 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.935 1.757 . . . . 0.0 110.794 174.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 37.4 m 85.5 -55.75 0.08 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.197 0.999 . . . . 0.0 111.192 -176.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 52' ' ' LEU . 16.6 p -98.13 -17.09 19.24 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.836 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.8 t 70.23 29.77 3.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.423 0.689 . . . . 0.0 111.975 172.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.433 HD13 ' HZ ' ' A' ' 31' ' ' PHE . 1.6 tt -86.56 130.57 34.44 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -174.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.4 mtm -115.35 137.39 52.09 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.85 -176.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.58 HD11 ' HB3' ' A' ' 45' ' ' ALA . 2.8 pp -141.88 144.21 25.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.532 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 4.9 t0 -84.27 156.06 22.15 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.73 125.32 55.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.045 0.45 . . . . 0.0 112.068 -174.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.583 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 21.8 t -88.86 100.03 10.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.422 ' HA ' ' CG2' ' A' ' 9' ' ' ILE . 50.6 p90 -94.52 160.3 14.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.843 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.579 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 27.3 t70 -116.14 151.65 35.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.857 0.36 . . . . 0.0 110.515 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.455 ' HE2' ' HB2' ' A' ' 60' ' ' LYS . 22.2 mtmm -58.56 -46.36 87.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.14 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -81.09 -32.19 34.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.346 -174.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.411 ' CB ' ' HB3' ' A' ' 59' ' ' ASP . 15.9 t70 -64.44 -43.66 93.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.324 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 54.4 mt -61.03 -47.38 86.67 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.82 0.343 . . . . 0.0 110.391 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.16 -43.01 77.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.185 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -62.99 -44.87 94.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.688 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.6 ' HD2' ' HG ' ' A' ' 35' ' ' LEU . 84.1 t80 -70.54 -35.3 73.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.07 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.5 -42.95 79.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.446 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -74.98 -30.08 61.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.09 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -63.54 -57.83 8.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.264 0.555 . . . . 0.0 110.793 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.62 -25.48 60.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.656 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.61 49.88 4.69 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.612 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.779 HG22 ' H ' ' A' ' 73' ' ' HIS . 5.1 mt -83.69 -175.78 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.779 ' H ' HG22 ' A' ' 72' ' ' ILE . 49.7 m80 -76.11 130.2 78.55 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.553 0.216 . . . . 0.0 110.462 -177.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 36.2 Cg_endo -65.32 116.33 3.83 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.996 2.464 . . . . 0.0 113.149 -176.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 74' ' ' PRO . 15.8 Cg_endo -89.68 164.57 5.17 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.622 2.881 . . . . 0.0 111.638 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -75.1 155.52 86.32 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.4 140.01 73.87 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.619 2.212 . . . . 0.0 112.658 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.5 pt -91.13 153.72 3.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.352 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.95 80.37 9.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.498 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -149.61 29.78 0.76 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.292 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.79 -8.95 32.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.202 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.499 -0.762 . . . . 0.0 110.159 -179.162 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptp . . . . . 0 N--CA 1.463 0.21 0 CA-C-O 120.821 0.343 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.0 m -144.5 176.39 9.42 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.668 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.4 p -90.75 103.91 16.56 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.237 0.541 . . . . 0.0 110.677 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -94.89 -12.35 27.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.822 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -125.94 155.16 41.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.776 174.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.558 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 33.9 tt0 -151.44 114.43 4.73 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -176.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -127.55 161.8 34.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.591 -173.688 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -78.57 148.68 33.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.86 0.362 . . . . 0.0 110.388 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.6 tt -57.02 -28.95 30.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.5 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -63.55 -28.19 69.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.993 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -77.49 -31.21 53.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.947 0.403 . . . . 0.0 111.052 -175.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.593 ' HA ' ' HD1' ' A' ' 23' ' ' TYR . 84.4 mtp -69.5 170.52 10.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.951 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.3 m -106.76 121.25 44.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.707 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.533 ' HB2' ' HE1' ' A' ' 66' ' ' TYR . 44.0 p90 -74.56 142.58 44.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.624 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.421 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 17.8 tt0 -139.95 93.7 9.27 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 121.356 0.598 . . . . 0.0 110.649 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 25.1 Cg_endo -66.22 -19.05 56.68 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.69 2.26 . . . . 0.0 112.279 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.83 -35.1 77.27 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.206 0.526 . . . . 0.0 110.603 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -111.61 5.95 19.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.874 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.554 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 2.1 mp0 57.91 31.58 20.77 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.809 178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 27.4 ptt? -152.33 162.95 40.43 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.462 -174.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -91.39 138.3 31.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.635 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 21.9 p -129.29 143.58 50.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.709 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.609 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 9.8 t80 -112.94 117.15 46.62 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.48 115.97 2.55 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.235 2.623 . . . . 0.0 113.622 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 13.6 t -135.94 125.65 16.21 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.07 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 2.2 Cg_endo -82.96 119.21 2.82 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 121.897 1.732 . . . . 0.0 111.48 174.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.3 p -176.71 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 164.18 -29.15 0.23 Allowed Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 113.968 -1.469 . . . . 0.0 110.237 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.534 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 3.3 t70 -143.2 174.69 10.49 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -119.93 146.23 45.99 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.609 ' HB2' ' HB3' ' A' ' 23' ' ' TYR . 88.5 m-85 -44.33 118.39 1.51 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.679 0.612 . . . . 0.0 111.361 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -114.24 136.94 52.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.019 0.437 . . . . 0.0 110.337 -177.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 20' ' ' MET . 18.4 tt -134.83 129.67 51.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.586 ' O ' ' HG3' ' A' ' 38' ' ' MET . 48.2 m-85 -84.23 126.78 33.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.836 -174.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -33.39 74.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.894 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -58.25 -34.57 70.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.257 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -87.08 -31.16 20.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.586 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 82.9 mtp -64.86 -41.52 95.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.73 0.3 . . . . 0.0 110.983 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -63.04 -25.4 68.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.577 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -77.3 -10.64 59.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.801 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.26 -5.61 38.76 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.689 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 38' ' ' MET . 7.4 tp10 -89.4 130.97 35.68 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.584 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -137.68 100.27 4.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.25 1.024 . . . . 0.0 111.784 -175.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.0 p -166.82 128.98 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.807 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.451 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -100.27 139.76 35.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.032 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.54 135.81 57.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.176 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.559 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 8.1 t -104.23 116.78 60.8 Favored Pre-proline 0 N--CA 1.435 -1.208 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.846 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.534 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 49.9 Cg_endo -70.41 156.74 60.99 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.582 2.188 . . . . 0.0 110.98 173.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 33.3 m 86.97 -56.72 0.05 OUTLIER 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.161 0.984 . . . . 0.0 111.398 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.7 p -91.12 -27.29 18.66 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.87 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.6 t 69.05 72.78 0.26 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.183 174.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.533 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 51.7 tp -134.57 148.49 50.47 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 174.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.439 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 35.2 mtm -131.06 137.75 49.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.426 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.46 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -138.98 152.46 24.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.254 178.587 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.558 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 8.2 t70 -80.87 145.63 31.25 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 83.9 t -134.12 115.34 20.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.223 0.535 . . . . 0.0 111.715 -177.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.8 t -74.17 107.35 4.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.93 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -96.18 165.24 12.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.455 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.547 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 14.7 t70 -115.14 146.16 41.64 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.968 173.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.02 -40.06 96.6 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -76.76 -40.87 46.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.302 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.408 ' HB2' ' HB3' ' A' ' 59' ' ' ASP . 8.7 m-20 -66.59 -32.03 73.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.192 -177.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 48.0 mt -66.96 -53.34 32.61 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.751 176.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 67' ' ' TYR . . . -58.94 -46.05 88.93 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.03 0.443 . . . . 0.0 111.163 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.22 -41.4 88.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.27 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.533 ' HE1' ' HB2' ' A' ' 14' ' ' PHE . 57.5 t80 -65.75 -35.37 80.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.203 -178.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.458 ' HD1' ' HB ' ' A' ' 72' ' ' ILE . 12.7 m-85 -52.29 -47.91 65.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.958 0.409 . . . . 0.0 110.342 174.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -74.28 -26.7 60.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.362 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -75.41 -44.0 46.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 0.0 111.303 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.554 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -80.2 -12.85 59.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.411 -176.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.3 40.22 11.59 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.792 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.535 HG22 ' H ' ' A' ' 73' ' ' HIS . 1.5 mt -94.89 178.44 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.535 ' H ' HG22 ' A' ' 72' ' ' ILE . 51.3 m80 -71.09 137.53 84.63 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.05 120.91 6.7 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.391 2.727 . . . . 0.0 112.425 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.33 164.16 35.93 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.042 2.495 . . . . 0.0 111.862 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -73.65 134.4 78.98 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.12 139.54 52.39 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 123.058 2.505 . . . . 0.0 113.209 -175.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.0 pt -104.12 168.24 2.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.783 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.68 87.15 7.29 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.071 0.462 . . . . 0.0 110.769 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.8 101.42 11.02 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.671 176.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.05 -24.67 14.82 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.016 -176.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.148 -0.929 . . . . 0.0 110.395 -178.93 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.962 0.41 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.2 m -149.58 174.59 12.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.702 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.1 p -81.86 120.92 25.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.005 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -100.09 5.95 44.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.758 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -162.2 172.5 15.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.55 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 36.0 tt0 -154.13 111.7 3.47 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 3.5 mp -116.91 151.04 18.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.029 -177.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.576 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 57.7 mt-10 -78.34 149.97 33.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.886 0.374 . . . . 0.0 110.567 176.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.7 tt -59.01 -28.82 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.886 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -68.82 -29.98 68.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.381 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.444 ' HB3' HG22 ' A' ' 7' ' ' ILE . 31.9 t70 -84.74 -36.16 21.98 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.322 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.55 ' SD ' ' HB2' ' A' ' 23' ' ' TYR . 4.1 tpt -49.25 141.69 8.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.058 170.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 m -87.48 108.99 19.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.982 0.42 . . . . 0.0 110.069 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.513 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 40.0 p90 -74.17 137.7 43.3 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.976 0.417 . . . . 0.0 110.78 -177.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -115.34 93.9 37.6 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.649 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 70' ' ' ALA . 49.2 Cg_endo -68.86 -22.39 36.54 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.739 2.293 . . . . 0.0 112.449 -174.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -77.09 -18.83 57.71 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.075 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.53 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 4.3 t-20 -116.26 -6.7 11.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.516 0.198 . . . . 0.0 111.247 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.512 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 1.8 mp0 64.35 42.35 5.3 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.08 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.543 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 26.2 ptt? -151.46 174.07 13.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.46 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.513 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 36.0 m-85 -109.86 149.12 30.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.955 0.407 . . . . 0.0 110.674 176.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 36.8 p -137.62 159.93 40.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.283 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.55 ' HB2' ' SD ' ' A' ' 12' ' ' MET . 6.1 t80 -141.28 131.39 13.02 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.34 127.06 21.72 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.692 2.261 . . . . 0.0 113.327 -176.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.511 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 20.0 t -140.74 141.37 24.54 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.214 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 12.0 Cg_endo -91.3 117.99 0.52 Allowed 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 122.171 1.914 . . . . 0.0 112.079 174.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.9 p 177.83 -44.38 0.01 OUTLIER 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.208 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.22 -19.86 0.48 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.168 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -140.12 173.63 11.32 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.432 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -122.27 151.63 40.89 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.622 -0.14 . . . . 0.0 110.622 177.62 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.601 ' O ' ' HA ' ' A' ' 22' ' ' THR . 93.9 m-85 -47.88 126.94 11.27 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 123.802 0.688 . . . . 0.0 110.642 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -127.86 138.64 52.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.857 0.361 . . . . 0.0 110.939 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.543 ' O ' ' HB2' ' A' ' 20' ' ' MET . 12.1 tt -148.88 132.87 8.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.712 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -87.54 142.57 27.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.55 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.43 HD11 HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -67.86 -30.76 70.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.083 0.468 . . . . 0.0 110.741 -177.736 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -61.26 -31.24 71.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.839 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 6.7 m-20 -80.74 -34.02 34.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.569 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 79.0 mtp -63.99 -35.42 80.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.976 0.417 . . . . 0.0 110.07 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -68.27 -20.77 64.81 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.638 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 44.5 mm-40 -76.59 -13.42 60.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.361 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.49 -3.87 61.6 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.433 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -90.47 105.09 17.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.743 ' HD2' ' HE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -115.4 100.0 7.78 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.995 0.902 . . . . 0.0 110.552 -177.082 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 1.8 p -167.03 129.5 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.727 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.497 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -100.01 139.0 36.31 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.84 HG22 ' HG2' ' A' ' 53' ' ' MET . 38.4 t -115.67 119.0 60.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.194 -176.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.57 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 6.8 t -90.19 120.88 69.14 Favored Pre-proline 0 C--N 1.317 -0.824 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' A' ' 49' ' ' SER . 58.2 Cg_endo -73.45 154.95 50.76 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.355 2.037 . . . . 0.0 112.578 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 51.4 m 78.09 -54.4 0.5 Allowed 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.963 0.905 . . . . 0.0 111.637 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 12.1 p -82.2 -25.83 33.88 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.4 t 70.49 42.91 0.84 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.04 169.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.499 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 26.7 tp -103.96 128.61 51.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.359 0.599 . . . . 0.0 110.076 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.84 ' HG2' HG22 ' A' ' 46' ' ' VAL . 35.6 mtm -117.07 136.98 52.58 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.918 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.497 HD11 ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -138.68 152.98 25.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.747 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.55 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 4.7 t70 -82.42 151.4 26.6 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.533 HG13 ' HB2' ' A' ' 43' ' ' LYS . 6.3 p -129.7 112.99 25.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.559 0.695 . . . . 0.0 111.378 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.576 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 53.0 t -68.38 118.62 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.709 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.743 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 20.7 p90 -133.37 164.58 26.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.466 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.569 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 11.6 t70 -137.23 159.95 40.44 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.502 ' HD3' ' H ' ' A' ' 60' ' ' LYS . 3.0 mppt? -62.15 -37.64 85.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.028 0.442 . . . . 0.0 109.851 176.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -64.16 -45.16 89.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.523 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.97 -45.54 88.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.667 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 40.8 mt -55.02 -53.68 52.76 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.108 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.13 -43.18 73.88 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.217 0.323 . . . . 0.0 111.368 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -66.2 -49.89 65.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.022 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -67.73 -32.31 72.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.651 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.46 ' CD2' ' HB ' ' A' ' 72' ' ' ILE . 2.2 m-85 -50.87 -44.28 59.62 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 172.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -63.21 -49.57 73.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.667 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -68.86 -32.51 72.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.287 -175.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.512 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -81.69 -10.63 59.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.776 0.322 . . . . 0.0 111.105 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.21 37.63 36.59 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.814 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.496 HG22 ' H ' ' A' ' 73' ' ' HIS . 2.2 mt -91.92 172.48 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.496 ' H ' HG22 ' A' ' 72' ' ' ILE . 16.3 t-80 -66.87 119.02 60.63 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.512 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 86.0 Cg_exo -47.84 124.72 10.3 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.292 2.661 . . . . 0.0 112.508 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' ' 74' ' ' PRO . 17.4 Cg_exo -66.38 149.87 84.65 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.87 2.38 . . . . 0.0 112.92 -176.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -75.56 165.68 51.53 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.844 173.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.02 138.33 43.54 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.045 1.83 . . . . 0.0 112.13 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.0 pt -119.25 177.52 2.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.169 -173.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.19 12.25 18.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.173 0.511 . . . . 0.0 110.987 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.47 109.01 19.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.107 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.89 10.48 38.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.611 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.303 0 O-C-N 124.52 1.137 . . . . 0.0 110.721 -178.069 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.55 0.691 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -144.27 161.21 39.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.155 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.9 p -90.66 112.36 24.06 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.083 0.468 . . . . 0.0 111.252 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -86.08 -23.24 26.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.972 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.637 ' HB2' HG22 ' A' ' 54' ' ' ILE . 1.6 m-20 -119.46 145.38 46.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.646 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.408 ' HG3' ' CB ' ' A' ' 55' ' ' ASP . 36.5 tt0 -140.36 108.28 5.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.726 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.5 mp -110.95 160.84 9.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -176.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.446 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 5.2 mp0 -79.38 148.99 31.79 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.3 tt -58.15 -29.95 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.129 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -68.07 -27.76 66.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.045 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.28 -39.44 54.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.782 0.325 . . . . 0.0 110.893 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 81.1 mtp -64.2 157.19 26.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.13 0.49 . . . . 0.0 111.154 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.6 m -90.44 109.22 20.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.482 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.602 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 42.1 p90 -78.96 134.63 36.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.192 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 9.5 tp10 -117.76 97.65 50.95 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.197 177.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 21.9 Cg_endo -61.25 -29.72 86.89 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.981 2.454 . . . . 0.0 111.953 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.62 -23.54 63.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.375 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.81 -11.63 15.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.119 0.485 . . . . 0.0 109.977 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.55 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 1.9 mp0 69.84 35.11 2.41 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.696 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.549 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 25.0 ptt? -157.99 174.71 14.83 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.593 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.602 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 42.8 m-85 -105.33 140.49 38.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.382 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 42.6 p -132.08 163.01 29.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.904 177.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.614 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 45.6 t80 -136.66 118.57 11.48 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.13 118.51 5.25 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 123.23 2.62 . . . . 0.0 112.794 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.0 t -137.55 140.58 30.64 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.57 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -90.94 118.9 0.61 Allowed 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 121.828 1.685 . . . . 0.0 111.973 174.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.2 p 179.52 -41.27 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 160.17 -26.3 0.31 Allowed Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.398 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.562 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 3.5 t0 -142.94 175.23 10.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.21 153.34 25.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.338 0.113 . . . . 0.0 111.137 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.614 ' HB2' ' HB3' ' A' ' 23' ' ' TYR . 81.2 m-85 -52.45 136.12 32.31 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.063 175.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 12.6 pt20 -133.3 136.68 45.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.876 0.37 . . . . 0.0 110.884 -176.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.549 ' O ' ' HB2' ' A' ' 20' ' ' MET . 15.2 tt -151.55 142.5 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.477 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.546 ' O ' ' HG3' ' A' ' 38' ' ' MET . 95.0 m-85 -99.31 147.74 24.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.914 0.388 . . . . 0.0 111.129 -177.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.47 -41.55 93.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.312 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -65.04 -31.99 73.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.186 0.517 . . . . 0.0 110.849 -175.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.01 -44.07 73.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.093 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.546 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 78.5 mtp -62.18 -42.61 99.44 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.684 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -65.93 -16.55 63.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.254 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -81.99 -12.48 58.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.41 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.2 -4.43 35.5 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.749 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -105.77 111.0 23.49 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.549 ' HD3' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -118.75 102.87 9.15 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.842 0.829 . . . . 0.0 110.732 -172.622 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 1.6 p -162.42 126.22 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.665 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.552 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -99.85 137.2 38.64 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.389 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.764 HG22 ' HG2' ' A' ' 53' ' ' MET . 47.7 t -114.62 123.01 69.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.764 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.532 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 12.0 t -90.73 122.3 67.11 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.562 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 43.2 Cg_endo -74.59 156.31 44.87 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.225 1.95 . . . . 0.0 111.29 175.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 35.5 t 89.28 -58.39 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.857 0.863 . . . . 0.0 110.107 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.4 p -89.3 -26.15 21.28 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 175.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.9 m 67.36 47.99 1.21 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.227 174.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 53' ' ' MET . 1.7 tt -102.71 135.23 44.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.764 ' HG2' HG22 ' A' ' 46' ' ' VAL . 32.3 mtm -117.11 137.14 52.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.466 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.637 HG22 ' HB2' ' A' ' 5' ' ' ASP . 2.8 pp -142.54 146.1 22.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.222 -176.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.408 ' CB ' ' HG3' ' A' ' 6' ' ' GLU . 6.4 m-20 -79.17 151.28 31.37 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.89 109.69 15.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.302 0.572 . . . . 0.0 110.941 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.446 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 46.9 t -65.95 112.37 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.423 -177.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -108.09 160.09 16.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.017 0.437 . . . . 0.0 111.651 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.734 ' HB3' ' HB2' ' A' ' 62' ' ' ASP . 20.3 t70 -117.01 146.15 43.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.093 173.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.418 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 12.3 mptt -62.4 -37.66 86.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.881 0.372 . . . . 0.0 110.563 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.39 -26.58 28.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.176 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.734 ' HB2' ' HB3' ' A' ' 59' ' ' ASP . 4.2 m-20 -65.58 -48.39 72.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.071 173.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 83.5 mt -55.08 -49.35 71.91 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.741 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.09 -37.01 83.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.0 0.429 . . . . 0.0 111.534 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -69.16 -52.83 24.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.677 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -64.13 -34.91 79.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.743 0.306 . . . . 0.0 110.934 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.424 ' CE1' ' HD3' ' A' ' 75' ' ' PRO . 0.5 OUTLIER -53.83 -46.73 71.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.056 174.962 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.28 -41.89 76.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.584 -178.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -59.39 -44.92 92.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.232 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.55 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -81.73 -27.31 33.95 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.27 58.17 3.22 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.827 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.419 ' HB ' ' HD1' ' A' ' 67' ' ' TYR . 5.2 mt -93.35 167.25 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.62 -0.29 . . . . 0.0 110.222 -176.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -56.22 131.98 75.25 Favored Pre-proline 0 N--CA 1.464 0.237 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 13.1 Cg_endo -56.4 117.11 3.71 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 123.352 2.701 . . . . 0.0 114.155 -176.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 74' ' ' PRO . 4.7 Cg_endo -87.4 168.88 7.29 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.625 3.55 . . . . 0.0 110.738 172.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 43.7 mt-10 -70.14 131.39 88.85 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 76' ' ' GLU . 38.0 Cg_exo -60.03 141.62 96.72 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.851 2.367 . . . . 0.0 113.004 -174.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.0 pt -90.54 150.08 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.756 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.5 90.8 3.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.104 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.54 -13.28 58.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.885 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.02 91.59 2.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.15 176.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.829 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.92 -179.534 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ttt . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 121.993 0.901 . . . . 0.0 109.823 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.1 m -146.94 179.78 7.35 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.399 -1.273 . . . . 0.0 107.818 175.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 55' ' ' ASP . 17.4 p -73.64 94.06 2.14 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.642 0.734 . . . . 0.0 110.987 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -110.23 -13.24 14.37 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.509 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.512 ' HB2' HG22 ' A' ' 54' ' ' ILE . 9.5 m-20 -97.42 127.02 43.04 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 176.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -124.46 108.58 12.29 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.717 -173.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.468 HG22 ' HB3' ' A' ' 11' ' ' ASP . 2.7 mp -111.84 150.27 14.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.126 -175.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -71.4 145.32 49.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.985 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.439 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 20.7 tt -62.36 -27.57 42.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 172.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -56.79 -29.42 62.68 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.573 173.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.468 ' HB3' HG22 ' A' ' 7' ' ' ILE . 27.8 t70 -94.96 -41.13 9.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.794 -0.184 . . . . 0.0 111.224 -175.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.477 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 68.7 mtp -60.78 145.63 49.01 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.17 0.509 . . . . 0.0 110.867 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 m -89.92 124.03 34.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.053 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.434 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . 38.5 p90 -74.27 135.74 42.65 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.291 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -118.3 88.4 32.86 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.131 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.79 -15.91 45.04 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.117 2.544 . . . . 0.0 112.632 -174.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -68.98 -29.7 67.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.866 0.365 . . . . 0.0 111.217 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.583 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 2.0 t-20 -118.47 6.27 11.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.872 0.367 . . . . 0.0 110.571 -177.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 59.43 43.53 16.25 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.007 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.583 ' HG2' ' HB3' ' A' ' 18' ' ' ASN . 22.9 ptt? -145.58 174.45 11.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.975 0.416 . . . . 0.0 110.925 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.439 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 92.0 m-85 -108.14 142.6 38.12 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 73.0 p -137.37 167.07 22.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.716 0.293 . . . . 0.0 111.192 -175.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.477 ' CD1' ' HA ' ' A' ' 12' ' ' MET . 5.6 t80 -146.68 124.04 5.94 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.9 111.71 0.77 Allowed 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.129 2.552 . . . . 0.0 112.993 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.405 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 27.6 t -118.64 137.96 25.39 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.756 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -88.83 116.95 0.85 Allowed 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 121.349 1.366 . . . . 0.0 111.558 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.5 p 175.15 -41.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.497 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 153.66 -15.6 0.63 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.882 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -142.45 176.15 9.23 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.412 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 18.8 ptp180 -113.62 153.62 28.56 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 22' ' ' THR . 91.5 m-85 -55.74 134.28 51.39 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 174.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 30' ' ' ARG . 98.2 mt-30 -129.8 132.18 46.43 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.946 0.403 . . . . 0.0 111.431 -176.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 20' ' ' MET . 14.6 tt -141.58 128.14 19.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.731 171.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.431 ' O ' ' HG3' ' A' ' 38' ' ' MET . 69.6 m-85 -91.13 154.56 19.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.904 0.383 . . . . 0.0 110.698 -176.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.76 -34.82 75.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.658 -177.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.53 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 27.4 t70 -59.67 -45.54 91.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.025 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.406 ' OD2' ' HB2' ' A' ' 34' ' ' TYR . 21.0 m-20 -64.76 -33.74 76.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 110.61 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 59.5 mtp -74.66 -36.12 62.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.987 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -65.08 -29.61 70.51 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.55 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 36' ' ' ASP . 24.6 mm-40 -58.98 -22.94 61.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.617 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.3 8.2 38.84 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.57 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -115.36 157.65 23.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.666 ' HD3' ' N ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -145.47 100.73 3.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.7 0.762 . . . . 0.0 111.566 -174.091 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 1.4 p -166.71 131.41 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.503 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.537 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -100.57 132.36 45.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.699 HG22 ' HG2' ' A' ' 53' ' ' MET . 47.2 t -115.13 133.89 59.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.454 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 14.2 t -104.38 130.96 22.37 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.411 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.542 ' O ' ' HB2' ' A' ' 49' ' ' SER . 58.4 Cg_endo -79.44 156.45 25.22 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.866 2.377 . . . . 0.0 112.021 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.542 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 41.6 m 83.22 -53.89 0.16 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.196 0.998 . . . . 0.0 111.609 -177.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 18.0 p -90.65 -24.88 20.36 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.631 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.1 t 64.77 49.8 2.16 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.33 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.2 mt -117.32 154.78 30.67 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.366 0.603 . . . . 0.0 111.308 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.699 ' HG2' HG22 ' A' ' 46' ' ' VAL . 25.2 mtm -135.01 138.47 43.99 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.609 -168.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.537 HD11 ' HB3' ' A' ' 45' ' ' ALA . 2.7 pp -140.37 152.49 21.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.319 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.438 ' HB2' ' HB ' ' A' ' 3' ' ' THR . 4.9 t70 -91.81 147.84 22.68 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -173.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 5.1 p -133.9 123.5 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.4 t -79.8 114.76 21.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 122.137 -0.352 . . . . 0.0 110.661 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.566 ' CE1' ' HB3' ' A' ' 43' ' ' LYS . 44.1 p90 -121.63 165.09 16.24 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.707 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.417 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 14.0 t70 -121.26 161.16 22.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.206 0.527 . . . . 0.0 110.086 174.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.569 ' HB3' HD12 ' A' ' 78' ' ' ILE . 3.4 mtmt -61.66 -40.12 93.82 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.46 175.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -78.23 -35.25 48.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.771 -174.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -70.91 -32.1 68.93 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.341 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 61.7 mt -63.51 -48.71 76.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.76 0.314 . . . . 0.0 110.303 172.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.99 -38.92 93.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.326 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -66.49 -48.86 68.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.34 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.434 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 85.4 t80 -62.6 -36.49 82.9 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.945 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.507 ' HA ' HD12 ' A' ' 72' ' ' ILE . 2.2 t80 -51.99 -42.14 62.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.684 175.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.41 -37.75 60.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.611 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -60.4 -54.36 46.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.057 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.88 -22.92 45.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.939 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.96 51.91 6.68 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.507 HD12 ' HA ' ' A' ' 67' ' ' TYR . 29.1 mt -78.58 156.78 4.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.533 -0.333 . . . . 0.0 111.203 -171.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -53.46 131.68 53.85 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.091 174.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -51.73 117.95 4.0 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.562 2.841 . . . . 0.0 113.576 -175.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -90.95 164.59 3.9 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.804 3.003 . . . . 0.0 110.91 172.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -73.03 132.46 82.65 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -46.47 142.55 9.41 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.383 2.722 . . . . 0.0 113.306 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.569 HD12 ' HB3' ' A' ' 60' ' ' LYS . 26.4 pt -109.19 168.39 3.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.995 -176.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.8 71.19 6.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.097 0.475 . . . . 0.0 110.688 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -132.14 110.26 10.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.943 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 63.73 21.75 12.81 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.195 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.186 -179.755 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.6 p -110.97 177.31 4.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.701 0.286 . . . . 0.0 110.257 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.8 p -86.18 122.42 30.16 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.001 0.429 . . . . 0.0 110.611 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -90.11 -11.38 41.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.608 -175.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.448 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 7.3 m-20 -141.99 169.7 17.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.276 176.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 35.5 tt0 -155.86 118.99 4.28 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -134.96 153.89 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.788 -175.863 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.531 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 45.4 mt-10 -72.81 152.08 41.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.036 0.446 . . . . 0.0 110.813 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.439 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 18.6 tt -55.49 -29.03 23.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.479 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.02 -35.1 80.1 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.402 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -78.08 -27.73 48.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.947 0.403 . . . . 0.0 111.12 -172.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 90.4 mtp -75.84 161.18 29.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.283 0.563 . . . . 0.0 111.317 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.8 m -95.12 115.76 27.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.956 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.454 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 44.5 p90 -81.33 138.88 35.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.091 0.472 . . . . 0.0 111.254 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -118.98 91.46 43.31 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.61 -28.36 52.78 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.188 2.592 . . . . 0.0 113.182 -172.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -70.98 -21.56 62.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.8 -175.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -112.97 3.58 16.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.62 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 55.09 44.53 27.84 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.904 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -146.66 165.7 28.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.94 0.4 . . . . 0.0 110.913 -176.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.543 ' HE1' HD23 ' A' ' 35' ' ' LEU . 68.4 m-85 -112.36 145.33 40.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.716 175.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 36.7 p -133.12 157.87 44.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.75 0.309 . . . . 0.0 110.987 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.496 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 9.6 t80 -140.34 125.17 11.07 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -51.21 127.89 23.47 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.376 2.718 . . . . 0.0 113.743 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 20.4 t -145.46 135.02 11.48 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.915 177.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 2.5 Cg_endo -87.24 118.09 1.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.026 1.817 . . . . 0.0 111.679 174.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 31.0 p -178.55 -54.05 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.404 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.468 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 169.44 -25.15 0.1 Allowed Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.99 -177.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -136.68 174.43 10.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.5 147.79 43.28 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 122.437 -0.164 . . . . 0.0 110.563 176.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' A' ' 22' ' ' THR . 92.1 m-85 -45.94 128.86 9.38 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.448 0.467 . . . . 0.0 110.445 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -131.51 138.18 48.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.231 0.539 . . . . 0.0 110.884 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.0 tt -143.17 129.63 17.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.802 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -86.27 143.99 27.64 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.143 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.543 HD23 ' HE1' ' A' ' 21' ' ' PHE . 1.6 tm? -62.46 -36.38 82.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.142 -173.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -65.26 -34.18 77.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.933 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.97 -44.08 97.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.106 0.479 . . . . 0.0 110.408 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 70.3 mtp -62.74 -41.69 99.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.116 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -65.72 -31.41 72.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.902 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -76.01 -3.88 38.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.734 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.48 -17.97 45.65 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.972 174.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -91.23 95.57 10.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.155 0.502 . . . . 0.0 110.696 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -100.68 100.93 11.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.579 0.704 . . . . 0.0 110.966 -177.115 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.9 p -165.51 126.96 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.68 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.454 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -99.99 143.6 30.01 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.018 0.437 . . . . 0.0 110.36 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.43 140.05 44.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.38 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.539 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 11.1 t -109.37 118.04 51.7 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -70.61 156.51 60.98 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.439 2.093 . . . . 0.0 112.135 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.1 t 85.78 -53.53 0.08 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.852 0.861 . . . . 0.0 110.659 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 17.5 p -89.14 -28.39 20.08 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.4 m 66.92 54.69 0.76 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.387 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 53' ' ' MET . 1.7 tt -110.9 136.5 49.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.443 ' N ' HD23 ' A' ' 52' ' ' LEU . 31.9 mtm -123.84 137.99 54.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.742 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.454 HD11 ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -140.22 153.8 22.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.915 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 43.1 m-20 -82.01 159.79 23.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.838 0.351 . . . . 0.0 110.506 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.56 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 49.0 t -130.97 144.19 38.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.09 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.531 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 44.0 t -106.56 108.85 26.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.632 0.253 . . . . 0.0 110.592 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.513 ' HE2' ' HD2' ' A' ' 43' ' ' LYS . 45.2 p90 -112.98 165.24 12.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.041 -177.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.464 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 2.7 t70 -127.4 170.63 12.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.233 0.539 . . . . 0.0 110.234 175.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -63.62 -46.25 86.61 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.999 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -72.88 -37.44 67.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.917 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -63.8 -31.48 72.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.773 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 58.9 mt -75.03 -45.31 42.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.605 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.93 -49.63 76.93 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.583 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.61 -40.27 96.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.174 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.421 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 91.2 t80 -69.22 -38.05 78.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.737 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.547 ' HA ' HD12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -57.15 -45.18 83.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.861 0.362 . . . . 0.0 110.794 178.204 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -76.45 -25.72 54.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.586 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -79.26 -40.53 30.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.747 0.308 . . . . 0.0 111.64 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.54 -26.4 30.15 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.419 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.1 53.97 4.63 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 -176.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 67' ' ' TYR . 51.8 mt -83.26 143.84 11.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.152 -0.524 . . . . 0.0 111.033 -173.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -52.48 122.58 26.26 Favored Pre-proline 0 C--O 1.234 0.259 0 O-C-N 123.522 0.514 . . . . 0.0 109.79 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -34.62 107.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 125.084 3.856 . . . . 0.0 114.589 -171.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -81.07 165.13 19.52 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.762 2.975 . . . . 0.0 110.78 172.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -73.16 149.17 89.3 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.93 138.11 84.64 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.511 2.141 . . . . 0.0 112.434 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.1 pt -101.93 171.23 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.86 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.78 83.58 6.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.081 0.467 . . . . 0.0 110.245 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -143.11 88.78 2.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.24 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.49 108.88 10.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.711 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.537 -0.744 . . . . 0.0 109.882 179.379 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.8 mtt . . . . . 0 CA--C 1.518 -0.283 0 CA-C-O 121.278 0.561 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -132.61 155.63 48.37 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.714 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.4 p -74.52 114.34 12.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.364 0.602 . . . . 0.0 110.405 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -83.18 -20.76 34.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.107 -173.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -132.66 162.81 30.41 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.172 0.51 . . . . 0.0 111.034 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 37.2 tt0 -146.93 108.52 4.32 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.657 171.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.96 155.74 18.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.056 -175.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.553 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 32.3 mp0 -65.32 144.42 57.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.391 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.0 tt -57.54 -29.35 33.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.445 0.64 . . . . 0.0 110.139 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -64.41 -28.8 69.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.927 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -82.1 -31.31 30.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.772 -175.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 84.2 mtp -68.65 160.84 29.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.027 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.1 m -85.17 110.89 19.33 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.076 0.465 . . . . 0.0 110.362 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.531 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 35.0 p90 -74.86 139.0 42.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.542 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -126.58 85.4 60.51 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.085 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.476 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 24.5 Cg_endo -62.86 -29.84 76.79 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.609 2.206 . . . . 0.0 111.579 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -63.81 -23.94 67.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.149 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -118.5 5.52 11.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.324 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.461 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 2.0 mp0 57.9 30.95 19.88 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.762 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 27.5 ptt? -144.36 170.89 15.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.061 0.458 . . . . 0.0 111.234 -175.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.531 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 31.0 m-85 -119.35 140.19 50.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.766 177.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 38.5 p -130.72 148.29 52.48 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.81 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.535 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 2.4 t80 -119.41 122.54 29.3 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.62 116.72 3.71 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.755 2.303 . . . . 0.0 113.383 -175.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 10.7 t -132.98 136.37 27.51 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.19 177.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 9.8 Cg_endo -90.29 118.24 0.68 Allowed 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 121.912 1.741 . . . . 0.0 111.642 174.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.409 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 32.0 p -176.56 -47.07 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.409 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 168.73 -26.89 0.13 Allowed Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.96 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.52 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 3.1 t0 -142.8 176.22 9.23 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.483 ' H ' ' HD2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -114.0 156.4 24.15 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -177.141 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 22' ' ' THR . 91.1 m-85 -58.39 117.72 4.78 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 172.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 30' ' ' ARG . 49.1 mt-30 -116.9 135.92 53.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.671 0.272 . . . . 0.0 111.105 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.421 HD13 HG11 ' A' ' 56' ' ' VAL . 13.8 tt -148.63 135.04 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.789 174.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -94.24 149.79 20.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.646 0.26 . . . . 0.0 110.62 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -32.11 70.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.488 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -60.51 -41.4 94.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.886 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 64.0 m-20 -66.11 -36.5 83.33 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.246 0.546 . . . . 0.0 110.115 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.532 ' HE2' ' HB3' ' A' ' 58' ' ' PHE . 57.7 mtp -69.19 -38.92 78.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.368 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -62.84 -30.2 71.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.22 0.533 . . . . 0.0 110.426 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 5.5 mm-40 -64.8 -22.16 66.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.319 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.72 -1.18 55.44 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -174.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -93.18 98.38 11.25 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.654 ' HB3' ' HE2' ' A' ' 58' ' ' PHE . 20.2 pttp -103.44 98.97 8.78 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.627 0.727 . . . . 0.0 111.421 -176.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 2.5 p -169.01 127.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.746 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.35 137.39 39.76 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 176.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.794 HG22 ' HG2' ' A' ' 53' ' ' MET . 40.8 t -111.84 132.4 60.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.022 -178.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.518 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 7.8 t -102.55 112.54 65.69 Favored Pre-proline 0 N--CA 1.448 -0.528 0 CA-C-O 120.991 0.424 . . . . 0.0 110.073 176.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.546 ' O ' ' HB3' ' A' ' 49' ' ' SER . 24.6 Cg_endo -67.81 157.38 62.02 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.27 1.98 . . . . 0.0 110.953 170.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.546 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 41.2 t 90.9 -58.43 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.053 0.941 . . . . 0.0 110.89 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 27.5 p -92.26 -28.25 17.11 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.948 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.8 t 69.65 73.25 0.24 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.399 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.543 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 46.6 tp -134.53 154.41 51.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.354 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.794 ' HG2' HG22 ' A' ' 46' ' ' VAL . 39.4 mtm -139.45 138.37 36.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.294 -177.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -140.17 152.38 21.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.86 177.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 2.1 m-20 -74.48 156.38 36.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.642 0.258 . . . . 0.0 110.32 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 5.0 p -131.15 124.75 56.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.278 0.561 . . . . 0.0 111.165 176.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.553 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 78.4 t -82.58 111.58 19.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.954 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.654 ' HE2' ' HB3' ' A' ' 43' ' ' LYS . 50.2 p90 -112.97 163.03 15.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.19 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.57 ' OD1' ' HG2' ' A' ' 61' ' ' GLU . 5.6 t70 -118.24 157.24 27.38 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.622 ' HB3' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -63.7 -40.49 96.93 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.223 179.087 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.57 ' HG2' ' OD1' ' A' ' 59' ' ' ASP . 10.3 pt-20 -73.34 -37.91 65.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.12 -177.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -63.05 -45.56 91.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.75 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 54.8 mt -56.75 -49.72 74.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.809 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.21 -42.78 86.97 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.974 0.416 . . . . 0.0 111.59 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.9 -46.01 79.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.355 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -66.02 -34.54 78.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.259 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.636 ' HD1' ' HB ' ' A' ' 72' ' ' ILE . 2.6 m-85 -51.83 -53.1 44.02 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.693 0.283 . . . . 0.0 110.826 174.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.6 -36.55 81.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.68 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.52 -54.49 19.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.145 0.498 . . . . 0.0 111.436 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.461 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -65.91 -18.38 65.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.895 -176.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.47 45.72 4.87 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.97 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.636 ' HB ' ' HD1' ' A' ' 67' ' ' TYR . 1.2 mt -106.29 142.67 18.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 67.7 m170 -64.72 147.2 98.13 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.705 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.477 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 4.0 Cg_endo -45.23 117.29 1.58 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.119 3.213 . . . . 0.0 113.815 -174.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.477 ' HD2' ' HA ' ' A' ' 74' ' ' PRO . 58.8 Cg_endo -71.25 164.75 34.69 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.396 2.731 . . . . 0.0 111.849 176.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -74.26 152.34 88.08 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.94 135.21 57.83 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.756 2.304 . . . . 0.0 112.892 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.622 HD12 ' HB3' ' A' ' 60' ' ' LYS . 38.3 pt -112.56 171.08 3.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.133 -175.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.581 ' O ' ' HG2' ' A' ' 60' ' ' LYS . . . -107.66 107.36 18.13 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 172.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.428 ' HA ' ' CB ' ' A' ' 60' ' ' LYS . . . -70.65 -174.67 0.93 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.754 -176.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.17 106.72 0.35 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.979 0.419 . . . . 0.0 110.65 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.303 -178.642 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 mtm . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.592 0.234 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -117.91 -174.2 2.59 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.1 p -89.43 118.76 29.32 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 175.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -113.22 6.38 17.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.86 0.362 . . . . 0.0 111.079 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -150.5 172.14 15.94 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.501 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 35.3 tt0 -158.9 117.14 2.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.818 0.342 . . . . 0.0 110.326 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.9 OUTLIER -125.99 163.05 28.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.457 ' HG2' ' HB ' ' A' ' 57' ' ' VAL . 46.0 mt-10 -87.88 152.97 21.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.024 0.44 . . . . 0.0 111.145 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.6 tt -60.15 -29.57 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.05 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -69.38 -28.86 66.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.733 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.23 -35.55 35.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.106 0.479 . . . . 0.0 109.769 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 78.5 mmm -57.01 152.28 13.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.41 171.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.6 m -96.85 124.55 40.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.833 0.349 . . . . 0.0 110.816 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -80.9 130.38 35.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.096 0.474 . . . . 0.0 110.507 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -115.43 90.07 24.0 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 30.9 Cg_endo -63.88 -21.57 68.97 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.959 2.439 . . . . 0.0 112.013 -176.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -59.86 -42.61 94.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.75 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.453 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 0.4 OUTLIER -110.79 5.62 20.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.9 -175.847 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.548 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 1.9 mp0 59.11 41.22 20.91 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.206 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.453 ' HG2' ' HB3' ' A' ' 18' ' ' ASN . 27.2 ptt? -147.3 173.74 12.3 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.91 -177.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -109.11 138.56 45.27 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.916 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.535 ' HB ' ' HD3' ' A' ' 30' ' ' ARG . 21.1 p -137.14 162.57 33.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.693 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.438 ' O ' ' HB2' ' A' ' 30' ' ' ARG . 52.3 t80 -144.14 128.16 9.1 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.82 107.96 0.31 Allowed 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.292 2.662 . . . . 0.0 113.774 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.46 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 20.8 t -113.0 140.83 24.61 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.002 174.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 21.0 Cg_endo -91.95 117.5 0.44 Allowed 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.989 1.793 . . . . 0.0 111.837 174.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.436 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 31.6 p 178.36 -46.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.919 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.436 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 164.23 -24.27 0.18 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.917 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.504 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -141.97 175.42 9.75 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.132 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.535 ' HD3' ' HB ' ' A' ' 22' ' ' THR . 7.6 ptp180 -118.33 157.6 26.78 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.326 -178.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.534 ' O ' ' HA ' ' A' ' 22' ' ' THR . 91.5 m-85 -50.04 129.6 20.96 Favored 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 123.831 0.707 . . . . 0.0 110.156 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -130.64 127.48 39.02 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.098 -171.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.479 ' HB ' ' HA ' ' A' ' 45' ' ' ALA . 13.3 tt -146.89 135.92 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.528 175.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.416 ' O ' ' HG3' ' A' ' 38' ' ' MET . 27.0 m-85 -97.48 144.16 27.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.481 -177.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.565 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 3.6 mm? -62.81 -27.83 69.58 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.941 0.4 . . . . 0.0 110.658 176.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -55.43 -43.55 75.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.724 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.4 -31.98 54.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.496 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.603 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 78.2 mtp -70.3 -32.4 70.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.116 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -68.82 -27.26 65.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.845 177.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -72.85 -7.0 48.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.855 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.0 -0.83 47.83 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.994 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.603 ' O ' ' HA ' ' A' ' 38' ' ' MET . 9.9 tp10 -105.7 155.06 19.62 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.664 ' HD3' ' N ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -147.62 100.99 3.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.769 0.795 . . . . 0.0 110.942 -176.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 p -167.2 131.08 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.98 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.479 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . . . -100.73 135.39 42.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.31 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 p -112.91 136.74 48.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.268 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.409 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 18.7 t -105.07 124.75 35.57 Favored Pre-proline 0 N--CA 1.436 -1.162 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.444 175.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.504 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 58.3 Cg_endo -75.7 156.42 39.93 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.805 2.337 . . . . 0.0 111.094 173.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 33.0 t 89.58 -57.37 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.764 0.826 . . . . 0.0 110.629 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.413 ' HB3' ' CB ' ' A' ' 27' ' ' CYS . 21.5 p -91.25 -30.91 16.36 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.306 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t 70.38 73.23 0.21 Allowed 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.276 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.3 tp -130.35 144.53 51.44 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.458 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.406 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 46.3 mtm -135.18 137.86 43.1 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.131 0.491 . . . . 0.0 110.984 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.469 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -138.61 154.86 27.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.663 179.43 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.501 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 2.1 t70 -83.4 151.31 25.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 43' ' ' LYS . 6.1 p -130.04 116.47 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.521 0.677 . . . . 0.0 111.909 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.457 ' HB ' ' HG2' ' A' ' 8' ' ' GLU . 48.4 t -72.76 111.55 7.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.446 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.486 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 28.4 p90 -115.33 164.7 13.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.032 -175.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.52 ' OD1' ' HG2' ' A' ' 61' ' ' GLU . 8.8 t70 -126.05 157.61 37.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 171.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.704 ' HB3' HD12 ' A' ' 78' ' ' ILE . 0.7 OUTLIER -64.67 -37.76 88.67 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.629 178.11 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.52 ' HG2' ' OD1' ' A' ' 59' ' ' ASP . 12.9 pt-20 -73.13 -37.87 66.48 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.355 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.506 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 4.0 m-20 -59.06 -53.13 61.89 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.488 175.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.422 HD22 HD12 ' A' ' 35' ' ' LEU . 28.4 mt -55.42 -50.7 69.1 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.881 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.48 -48.23 81.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.681 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -68.46 -43.56 76.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.867 0.365 . . . . 0.0 110.876 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.506 ' HD1' ' O ' ' A' ' 62' ' ' ASP . 48.1 m-85 -68.13 -32.48 72.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.299 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.565 ' CE1' ' HB3' ' A' ' 35' ' ' LEU . 1.2 m-85 -51.63 -48.13 63.42 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.261 0.553 . . . . 0.0 109.956 170.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.44 -30.87 64.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.776 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 66' ' ' TYR . 67.8 mm-40 -66.73 -45.25 79.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.118 176.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.548 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -75.34 -20.47 59.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.509 -176.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.73 43.4 6.09 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.77 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.541 HG22 ' H ' ' A' ' 73' ' ' HIS . 1.6 mt -97.72 175.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.541 ' H ' HG22 ' A' ' 72' ' ' ILE . 76.0 m-70 -66.16 135.58 95.08 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 73' ' ' HIS . 41.2 Cg_exo -56.27 119.57 6.85 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 123.047 2.498 . . . . 0.0 112.098 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.38 162.46 38.28 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.92 2.414 . . . . 0.0 113.14 -176.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.436 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 5.1 mp0 -74.79 164.19 63.1 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.261 176.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 15.6 Cg_endo -57.41 142.23 95.07 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.544 2.163 . . . . 0.0 112.42 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.704 HD12 ' HB3' ' A' ' 60' ' ' LYS . 17.6 pt -110.65 170.13 3.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.433 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.21 25.3 1.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.99 0.424 . . . . 0.0 110.934 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.35 114.41 9.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.448 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.99 -28.12 6.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.207 0.527 . . . . 0.0 110.203 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.447 179.503 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.464 0.252 0 CA-C-O 121.002 0.429 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.2 p -102.29 -158.04 0.65 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.563 -177.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.634 ' HB ' ' OD1' ' A' ' 55' ' ' ASP . 5.7 p -65.91 111.66 3.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.973 0.416 . . . . 0.0 111.271 177.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -114.08 -21.37 10.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.339 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -121.02 152.64 38.36 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.025 -173.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -144.67 117.65 8.83 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 123.12 0.262 . . . . 0.0 110.492 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.4 ' CD1' HG13 ' A' ' 54' ' ' ILE . 0.6 OUTLIER -118.17 162.58 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.564 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 41.6 mt-10 -69.29 148.85 49.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.956 0.408 . . . . 0.0 111.254 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.3 tt -62.36 -33.18 57.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.049 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.68 -27.25 61.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.753 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -72.53 -30.33 64.37 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.613 ' HA ' ' HD1' ' A' ' 23' ' ' TYR . 84.5 mtp -69.74 151.06 46.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.06 172.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.1 m -76.86 131.52 38.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.121 0.486 . . . . 0.0 111.578 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -74.92 127.17 32.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.329 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -125.24 85.26 58.48 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.002 0.43 . . . . 0.0 110.304 173.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.68 -34.17 42.15 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.759 2.306 . . . . 0.0 111.949 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.33 -34.11 76.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.478 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.476 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 3.5 t-20 -102.62 -1.6 29.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.875 0.369 . . . . 0.0 111.024 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.404 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 1.5 mp0 62.01 35.96 15.75 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.856 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.551 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 26.2 ptt? -154.0 167.58 29.28 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.544 -177.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -100.36 146.28 27.16 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.477 177.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 23.4 p -138.51 136.82 36.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.86 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.613 ' HD1' ' HA ' ' A' ' 12' ' ' MET . 8.6 t80 -115.38 121.31 34.94 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -50.68 118.73 4.38 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.672 2.915 . . . . 0.0 113.778 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.515 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 16.5 t -135.47 139.98 32.85 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.339 176.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -91.8 120.32 0.56 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.644 2.229 . . . . 0.0 111.947 172.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.6 p 177.61 -39.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.775 0.798 . . . . 0.0 108.958 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 158.14 -26.95 0.44 Allowed Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.627 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.452 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 3.7 t0 -142.04 176.34 9.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.464 ' HE ' ' HB ' ' A' ' 22' ' ' THR . 12.7 ptm180 -117.63 153.7 32.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.582 ' O ' ' HA ' ' A' ' 22' ' ' THR . 99.4 m-85 -51.57 128.24 22.56 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.58 0.55 . . . . 0.0 110.003 177.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -133.55 142.66 48.28 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.065 0.459 . . . . 0.0 110.686 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.551 ' O ' ' HB2' ' A' ' 20' ' ' MET . 14.6 tt -144.44 132.46 17.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.557 -178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -82.38 128.85 34.64 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.496 -177.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.494 HD12 ' CE1' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -62.59 -34.65 77.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -176.788 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -65.16 -25.92 67.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.246 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.87 -32.49 27.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.308 0.575 . . . . 0.0 109.76 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 83.6 mtp -67.46 -35.56 79.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.944 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -67.1 -23.6 65.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.154 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -77.69 -9.13 58.82 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.035 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.75 -18.63 34.42 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.058 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.45 121.43 27.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.874 0.369 . . . . 0.0 110.668 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.515 ' HD3' ' CE2' ' A' ' 58' ' ' PHE . 19.7 pttp -120.22 100.56 7.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.675 0.75 . . . . 0.0 112.131 -174.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 p -166.78 126.41 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.573 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.45 142.16 32.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.125 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.94 138.67 51.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.966 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.546 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 23.0 t -107.0 121.69 44.0 Favored Pre-proline 0 N--CA 1.436 -1.15 0 C-N-CA 120.521 -0.471 . . . . 0.0 109.787 176.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 34.0 Cg_endo -68.69 157.1 63.23 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.434 2.089 . . . . 0.0 111.285 174.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 29.5 m 86.51 -60.42 0.05 OUTLIER 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.136 0.975 . . . . 0.0 110.952 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 20.3 p -89.02 -26.88 21.21 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.3 t 69.39 46.45 0.76 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.146 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.548 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 1.7 tt -99.59 129.11 45.72 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 30.4 mtm -120.52 136.79 54.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.102 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.4 HG13 ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -147.01 162.21 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.705 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.634 ' OD1' ' HB ' ' A' ' 3' ' ' THR . 5.0 m-20 -80.29 162.34 24.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.695 0.283 . . . . 0.0 110.382 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.419 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 8.9 p -132.81 137.03 54.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.671 175.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.564 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 44.4 t -88.89 112.91 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.556 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.515 ' CE2' ' HD3' ' A' ' 43' ' ' LYS . 39.7 p90 -117.36 165.25 13.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.734 0.302 . . . . 0.0 110.824 -177.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -134.94 151.45 50.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.034 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.674 ' HB3' HD12 ' A' ' 78' ' ' ILE . 93.6 mttt -56.5 -40.92 75.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.713 175.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.18 -46.91 72.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.268 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.95 -44.73 96.15 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.541 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.42 HD22 HD11 ' A' ' 35' ' ' LEU . 36.4 mt -64.55 -48.21 75.89 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.083 -0.247 . . . . 0.0 111.185 -178.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.414 ' HA ' ' HG3' ' A' ' 75' ' ' PRO . . . -60.66 -41.84 95.83 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.058 0.456 . . . . 0.0 111.01 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -68.48 -42.5 78.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.303 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -66.7 -37.2 84.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.06 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.494 ' CE1' HD12 ' A' ' 35' ' ' LEU . 2.6 m-85 -52.71 -43.45 65.67 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.335 0.588 . . . . 0.0 110.147 174.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -66.66 -52.4 45.31 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.467 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -69.49 -31.63 70.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.782 -175.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.404 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -73.69 -18.29 61.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.748 0.309 . . . . 0.0 111.089 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.01 30.0 13.89 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.608 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.59 HG22 ' H ' ' A' ' 73' ' ' HIS . 1.4 mt -93.52 -176.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.59 ' H ' HG22 ' A' ' 72' ' ' ILE . 75.8 m-70 -88.85 135.62 31.79 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.03 128.02 13.29 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.986 2.458 . . . . 0.0 112.361 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.414 ' HG3' ' HA ' ' A' ' 64' ' ' ALA . 29.7 Cg_endo -64.25 156.26 60.62 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.414 2.076 . . . . 0.0 112.017 -177.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -73.55 151.77 89.48 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -47.68 131.3 19.8 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.138 2.559 . . . . 0.0 113.33 -173.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.674 HD12 ' HB3' ' A' ' 60' ' ' LYS . 33.5 pt -108.59 167.81 3.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.227 -177.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.47 81.08 8.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.917 0.389 . . . . 0.0 109.957 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -165.83 112.13 0.89 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.72 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.6 -37.34 5.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.944 0.402 . . . . 0.0 110.651 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.74 0 CA-C-O 118.392 -0.813 . . . . 0.0 109.937 -179.49 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptt? . . . . . 0 C--O 1.232 0.168 0 CA-C-O 121.182 0.515 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.0 p -90.39 165.8 13.64 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.121 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.0 p -73.15 122.07 21.28 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.905 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -85.23 6.49 25.78 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -166.99 169.64 12.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.632 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -144.34 113.96 7.15 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.451 HG22 ' HB3' ' A' ' 11' ' ' ASP . 4.1 mt -120.9 142.07 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -169.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -62.52 140.07 58.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.458 171.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.8 tt -55.42 -33.93 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.518 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -73.36 -28.34 61.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.59 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.451 ' HB3' HG22 ' A' ' 7' ' ' ILE . 12.3 t70 -72.01 -29.41 64.17 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 83.0 mmm -69.1 145.02 53.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.373 176.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 50.9 m -90.35 115.76 27.79 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.102 0.477 . . . . 0.0 110.412 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.693 ' HB2' ' HE1' ' A' ' 66' ' ' TYR . 39.2 p90 -74.35 139.13 43.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.554 -176.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -115.38 85.02 12.5 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.223 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 21.3 Cg_endo -60.33 -28.92 87.76 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.163 2.575 . . . . 0.0 113.799 -170.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.35 -29.45 68.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.875 0.369 . . . . 0.0 110.988 -177.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -108.45 -0.4 20.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.955 -175.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.44 ' CG ' HG12 ' A' ' 72' ' ' ILE . 1.8 mp0 60.02 40.4 18.77 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.096 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -141.74 170.3 15.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.985 0.421 . . . . 0.0 110.757 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -109.7 144.78 37.59 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.547 174.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 35.5 p -134.66 158.35 44.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.079 -178.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.435 ' HB3' ' CD2' ' A' ' 31' ' ' PHE . 4.4 t80 -137.81 132.81 17.44 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.7 121.81 10.28 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.716 2.277 . . . . 0.0 113.222 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.53 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 28.4 t -132.5 144.66 53.95 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.377 177.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 41.3 Cg_endo -94.28 118.52 0.29 Allowed 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 122.184 1.923 . . . . 0.0 111.778 173.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.4 p 174.93 -40.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.767 0.794 . . . . 0.0 109.158 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 148.26 -12.53 1.22 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.257 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.58 176.15 9.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.577 0.227 . . . . 0.0 110.461 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.483 ' HD3' ' HB ' ' A' ' 22' ' ' THR . 16.0 ptp180 -121.05 150.35 41.31 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.073 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.645 ' O ' ' HA ' ' A' ' 22' ' ' THR . 98.9 m-85 -51.21 125.46 14.09 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.283 0.364 . . . . 0.0 110.319 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 14.0 pt20 -120.6 133.68 55.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.179 0.514 . . . . 0.0 111.025 -176.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.5 tt -146.54 126.49 5.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.606 175.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -91.44 147.12 23.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.557 -175.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.42 ' HA ' HD22 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -61.32 -30.63 70.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.345 -177.375 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -55.46 -50.64 69.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.082 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -65.94 -38.4 88.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.45 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 84.0 mtp -63.51 -41.74 98.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.467 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.25 -29.57 69.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.677 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -68.63 -16.73 63.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.215 177.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.73 -9.5 52.06 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.945 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -90.92 92.78 8.92 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.619 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -105.46 100.77 10.34 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.255 1.026 . . . . 0.0 111.73 -174.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 p -166.12 130.43 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.036 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.516 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -99.96 141.95 32.09 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.412 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 7.4 p -120.17 138.02 52.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.905 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.569 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 12.9 t -102.22 121.48 50.13 Favored Pre-proline 0 N--CA 1.432 -1.356 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 49' ' ' SER . 45.6 Cg_endo -70.42 155.97 62.62 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.688 2.259 . . . . 0.0 111.846 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 67.5 m 79.78 -51.29 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.519 0.728 . . . . 0.0 111.785 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 13.8 p -91.92 -23.66 19.53 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.053 177.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.4 t 67.59 45.27 1.54 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.231 171.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.537 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 50.5 tp -102.68 137.03 41.44 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.893 -0.504 . . . . 0.0 109.815 176.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 37.1 mtm -123.93 138.21 54.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.949 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.516 HD11 ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -141.64 152.23 19.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.118 179.029 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -78.38 146.14 34.8 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.794 -178.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.619 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 96.8 t -131.42 113.06 22.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.053 0.454 . . . . 0.0 110.704 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.6 t -84.87 124.87 40.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 -175.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.419 ' CD1' HD11 ' A' ' 63' ' ' LEU . 52.8 p90 -118.15 164.9 14.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.906 0.384 . . . . 0.0 111.382 -175.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.441 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -127.69 152.4 47.76 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.834 173.339 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -62.97 -39.4 94.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.468 -176.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -64.64 -43.18 94.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.097 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -68.32 -35.53 77.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.06 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 51.0 mt -60.89 -53.94 51.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.537 177.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.451 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . . . -57.81 -41.75 82.81 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.121 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.92 -47.69 83.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.408 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.693 ' HE1' ' HB2' ' A' ' 14' ' ' PHE . 76.0 t80 -61.98 -35.81 79.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.132 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.542 ' HD1' ' HB ' ' A' ' 72' ' ' ILE . 24.5 m-85 -54.2 -44.26 71.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.032 0.444 . . . . 0.0 110.82 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -76.61 -43.18 39.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.692 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -58.49 -48.08 81.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.825 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.0 -25.52 43.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.252 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.26 55.41 2.76 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.256 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.542 ' HB ' ' HD1' ' A' ' 67' ' ' TYR . 12.2 mt -94.33 153.49 3.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.273 -0.464 . . . . 0.0 109.991 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -56.61 139.21 76.1 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.096 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -35.17 108.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 124.576 3.518 . . . . 0.0 114.189 -177.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -80.89 164.74 20.13 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.42 2.747 . . . . 0.0 112.525 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -73.13 117.9 64.02 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -65.48 140.34 62.79 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.69 2.26 . . . . 0.0 113.177 -174.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.1 pt -95.52 172.69 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.791 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -127.43 102.26 6.8 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.51 110.6 6.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.821 -177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.7 -49.26 7.61 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.629 178.221 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mmt . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 120.763 0.316 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.7 m -139.57 136.21 34.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.939 0.4 . . . . 0.0 111.601 -177.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.6 93.83 7.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.289 0.566 . . . . 0.0 110.078 173.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -72.46 -36.87 68.59 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.822 -173.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -110.73 162.56 14.64 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.842 0.353 . . . . 0.0 110.891 -171.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -156.67 108.05 2.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.18 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.43 162.41 17.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.0 -175.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.523 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 42.8 mt-10 -71.45 151.58 43.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.262 0.553 . . . . 0.0 110.93 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.5 tt -60.61 -31.18 48.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.509 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.24 -28.05 65.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.313 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -78.71 -29.98 45.72 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.886 0.374 . . . . 0.0 110.584 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 82.4 mmm -58.98 130.44 47.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.387 175.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.3 m -72.92 107.31 5.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.199 0.524 . . . . 0.0 110.48 -176.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.549 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . 43.7 p90 -84.37 133.98 34.5 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.573 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.523 ' HA ' ' OE1' ' A' ' 15' ' ' GLU . 4.9 tp10 -112.04 98.24 41.56 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.747 176.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.02 -22.14 73.7 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.884 2.389 . . . . 0.0 111.692 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -70.16 -25.75 63.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.815 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -114.22 -0.26 13.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.033 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 57.63 42.68 23.6 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.528 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -160.15 172.72 16.93 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.615 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 14' ' ' PHE . 95.8 m-85 -103.45 137.09 42.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.001 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 30.2 p -136.7 166.63 23.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.438 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.441 ' CB ' ' HB2' ' A' ' 31' ' ' PHE . 0.4 OUTLIER -138.95 121.58 10.53 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.638 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -54.94 122.29 11.41 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.085 2.523 . . . . 0.0 113.414 -177.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 16.3 t -146.32 127.53 7.36 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.267 176.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -85.65 119.28 1.92 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.351 2.034 . . . . 0.0 111.683 174.175 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.8 p -175.63 -43.71 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.1 -30.52 0.17 Allowed Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.342 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.5 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 2.4 t70 -143.2 176.06 9.41 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.94 153.11 25.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.531 ' HZ ' HD23 ' A' ' 52' ' ' LEU . 79.0 m-85 -52.89 124.97 15.51 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -134.31 145.91 49.5 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.09 0.471 . . . . 0.0 111.383 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.3 tt -142.61 135.34 26.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.029 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -91.53 138.8 31.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.785 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.541 ' HA ' ' HG3' ' A' ' 38' ' ' MET . 1.1 mt -68.56 -25.14 64.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.162 -177.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -54.02 -45.48 71.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.542 172.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.66 -44.49 73.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.509 176.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.541 ' HG3' ' HA ' ' A' ' 35' ' ' LEU . 28.3 mtp -60.15 -46.01 91.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.407 ' HZ ' ' HG2' ' A' ' 76' ' ' GLU . 43.0 t80 -69.24 -22.62 63.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.62 -177.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -76.11 -20.72 57.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.165 0.507 . . . . 0.0 110.11 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.84 -3.3 31.97 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.257 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -83.62 117.32 23.09 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 175.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.52 ' HD3' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -126.83 98.52 5.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.072 0.939 . . . . 0.0 111.832 -174.295 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 p -168.54 132.07 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.904 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.25 138.12 38.7 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.0 p -120.23 137.79 52.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.541 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.499 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 10.0 t -104.1 123.88 39.35 Favored Pre-proline 0 N--CA 1.434 -1.24 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 174.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.5 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 35.5 Cg_endo -80.27 157.22 22.82 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.416 2.077 . . . . 0.0 111.451 175.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 23.0 t 88.85 -55.88 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.224 1.01 . . . . 0.0 110.585 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.9 p -89.01 -32.02 17.81 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 47' ' ' CYS . 20.2 m 68.49 74.02 0.28 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.652 176.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.531 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 42.2 tp -132.21 150.28 52.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.0 mtm -135.14 141.12 45.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.076 -175.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.38 148.52 21.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.66 175.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.21 156.66 37.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.837 0.351 . . . . 0.0 110.773 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.407 HG13 ' HB2' ' A' ' 43' ' ' LYS . 7.5 p -132.46 127.99 57.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.151 0.5 . . . . 0.0 111.098 176.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 46.8 t -83.45 105.68 13.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.152 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -113.09 164.65 13.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.572 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.605 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 5.2 t0 -134.12 158.67 43.04 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 173.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.727 ' HB3' HG21 ' A' ' 78' ' ' ILE . 9.0 mptt -64.24 -38.41 90.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.164 0.507 . . . . 0.0 110.17 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -73.53 -36.93 65.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.083 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.73 -38.44 90.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.794 0.33 . . . . 0.0 110.594 176.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 87.6 mt -63.84 -53.46 50.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.558 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.444 ' HA ' ' HG3' ' A' ' 75' ' ' PRO . . . -53.21 -42.92 66.81 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.673 -177.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -59.07 -49.13 79.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.623 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.549 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 70.5 t80 -65.85 -35.96 82.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.28 -177.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.576 ' HD1' ' HB ' ' A' ' 72' ' ' ILE . 27.3 m-85 -53.66 -44.64 69.83 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.614 0.245 . . . . 0.0 110.787 178.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -72.32 -39.92 67.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.699 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -63.75 -36.92 85.48 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.152 -0.477 . . . . 0.0 112.279 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.47 -17.64 33.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.648 0.261 . . . . 0.0 111.417 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.8 37.22 9.56 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.794 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.642 HG22 ' H ' ' A' ' 73' ' ' HIS . 2.0 mt -94.1 -176.04 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.642 ' H ' HG22 ' A' ' 72' ' ' ILE . 66.7 m-70 -79.09 134.99 58.76 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.09 131.84 41.28 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.882 2.388 . . . . 0.0 112.61 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.444 ' HG3' ' HA ' ' A' ' 64' ' ' ALA . 61.3 Cg_endo -73.86 164.09 35.46 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.032 2.488 . . . . 0.0 112.106 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.462 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 10.4 pt-20 -73.51 159.33 84.93 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.128 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 76' ' ' GLU . 14.8 Cg_endo -57.86 143.2 96.19 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.616 2.211 . . . . 0.0 112.916 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.727 HG21 ' HB3' ' A' ' 60' ' ' LYS . 36.3 pt -115.71 174.03 3.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.106 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.03 -11.14 31.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.208 0.528 . . . . 0.0 110.235 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 55.53 -162.53 0.15 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.338 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -113.24 -41.83 3.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.114 0.483 . . . . 0.0 110.18 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.465 -0.779 . . . . 0.0 110.413 177.597 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.459 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 3.2 mmt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.212 0.529 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.3 m -104.5 149.91 25.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.222 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.0 p -86.06 101.15 12.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.16 0.505 . . . . 0.0 109.899 173.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -74.38 -26.77 60.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.369 -171.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -128.98 165.64 20.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.06 0.457 . . . . 0.0 111.635 -174.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.569 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 43.9 tt0 -148.45 116.76 6.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.235 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.489 ' CD1' HG13 ' A' ' 54' ' ' ILE . 4.5 mp -113.43 149.7 15.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -173.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.543 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 43.0 mt-10 -67.8 144.17 55.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.8 0.333 . . . . 0.0 110.25 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.403 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 19.3 tt -57.56 -28.57 31.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.161 177.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -71.69 -35.17 70.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.13 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.474 ' HB3' ' CG2' ' A' ' 7' ' ' ILE . 11.5 t70 -76.84 -40.57 47.37 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 83.7 mmm -49.22 137.18 14.25 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.913 169.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.5 m -79.59 106.87 11.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.403 0.621 . . . . 0.0 110.353 -176.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -75.52 128.2 34.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.558 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 37.4 tp10 -118.03 88.07 30.46 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.822 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 31.7 Cg_endo -63.55 -26.04 69.78 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.71 2.274 . . . . 0.0 111.536 -178.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.12 -29.6 70.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.765 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -110.28 5.21 21.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.528 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.54 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 2.3 mp0 58.86 38.33 24.58 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.948 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -160.4 174.68 13.76 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.051 0.453 . . . . 0.0 111.411 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.403 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 72.0 m-85 -108.35 140.62 41.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.617 177.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.555 ' HB ' ' HD3' ' A' ' 30' ' ' ARG . 40.6 p -136.24 169.22 17.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.467 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.414 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 5.4 t80 -140.99 120.45 8.4 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.05 116.28 2.82 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 123.307 2.672 . . . . 0.0 112.975 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 28.4 t -130.29 138.99 34.29 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.422 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 46.3 Cg_endo -91.7 117.87 0.48 Allowed 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 122.049 1.832 . . . . 0.0 111.734 174.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.4 p 178.83 -43.65 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.753 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.89 -25.33 0.24 Allowed Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.994 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.54 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 2.3 t0 -142.76 175.72 9.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.555 ' HD3' ' HB ' ' A' ' 22' ' ' THR . 12.4 ptp180 -114.57 155.54 26.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.587 0.232 . . . . 0.0 111.11 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.636 ' HZ ' HD23 ' A' ' 52' ' ' LEU . 91.0 m-85 -54.57 127.72 29.11 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.16 175.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -124.5 137.9 54.38 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.099 0.476 . . . . 0.0 110.505 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.4 tt -140.66 140.29 33.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.658 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.488 ' O ' ' HG3' ' A' ' 38' ' ' MET . 17.1 m-85 -103.17 136.15 43.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.921 -172.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -56.5 -35.54 68.12 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.103 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.484 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 11.9 t70 -54.34 -51.72 63.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.088 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.97 -29.6 58.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.556 -174.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.488 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 90.4 mtp -65.76 -39.58 91.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.051 176.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -69.71 -23.49 63.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.385 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 36' ' ' ASP . 17.3 mm-40 -73.45 -16.08 61.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.588 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.8 -10.76 38.11 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.883 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -94.04 109.0 20.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.187 0.518 . . . . 0.0 110.331 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.679 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -108.0 102.47 11.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.799 0.809 . . . . 0.0 111.722 -176.11 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 p -164.43 129.3 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.263 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 53' ' ' MET . . . -101.27 143.52 31.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.134 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.09 139.4 47.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.974 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.534 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 17.4 t -107.73 124.02 36.14 Favored Pre-proline 0 N--CA 1.439 -0.982 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.31 175.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.563 ' O ' ' HB3' ' A' ' 49' ' ' SER . 58.5 Cg_endo -74.86 156.84 43.63 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.758 2.306 . . . . 0.0 111.023 173.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.563 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 40.1 t 88.66 -57.46 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.752 0.821 . . . . 0.0 110.906 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.0 p -91.63 -29.14 17.06 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.514 -0.475 . . . . 0.0 109.724 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 47' ' ' CYS . 33.7 t 66.92 70.13 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.517 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.636 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 53.7 tp -125.51 151.32 46.48 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.401 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 32.7 mtm -134.26 138.23 44.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.383 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.489 HG13 ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -142.72 154.43 17.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 177.579 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.569 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 2.4 m-20 -77.09 158.29 30.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.762 0.315 . . . . 0.0 110.403 177.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 86.0 t -132.79 125.3 52.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.847 0.356 . . . . 0.0 111.123 178.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.543 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 89.2 t -77.75 126.42 38.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.084 177.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -142.71 165.11 28.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.713 0.292 . . . . 0.0 111.154 -175.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.564 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 9.6 t70 -132.2 151.83 51.61 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 171.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -63.61 -33.2 75.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.046 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -65.61 -49.51 68.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.12 176.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -60.47 -39.56 88.06 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.086 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 40.9 mt -58.17 -57.15 14.12 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.766 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.5 -40.81 75.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.268 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -66.19 -37.54 85.85 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.434 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -77.81 -33.86 52.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -51.09 -44.84 61.32 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.893 0.377 . . . . 0.0 110.611 172.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -63.03 -45.64 91.34 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.661 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.79 -40.49 88.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.828 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.54 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -78.93 -12.56 60.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.529 -177.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.56 38.3 32.98 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.596 177.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.496 HG23 ' HG2' ' A' ' 19' ' ' GLN . 0.9 OUTLIER -115.66 168.63 7.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 O-C-N 122.892 -0.181 . . . . 0.0 110.709 178.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -57.55 116.34 13.69 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.775 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.506 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 73.3 Cg_endo -76.79 145.64 25.73 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.538 2.158 . . . . 0.0 112.325 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 74' ' ' PRO . 6.9 Cg_exo -73.36 164.71 34.46 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.277 2.651 . . . . 0.0 111.778 176.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -73.73 124.01 89.87 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -47.39 139.97 16.19 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.552 2.835 . . . . 0.0 113.625 -172.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 31.6 pt -120.3 157.44 22.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.658 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -115.89 81.8 1.66 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.963 0.411 . . . . 0.0 110.705 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.4 -3.35 18.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.502 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.74 136.27 33.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.668 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.539 -0.743 . . . . 0.0 110.043 178.987 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.4 mtp . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 121.44 0.638 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.6 p -104.12 173.24 6.39 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.789 176.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.8 p -79.72 126.58 31.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.843 0.354 . . . . 0.0 111.086 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -96.12 -24.62 16.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.72 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.418 ' HB3' ' CG2' ' A' ' 54' ' ' ILE . 47.1 t0 -120.62 167.04 12.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 33.2 tt0 -156.72 110.86 2.72 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.584 ' CD1' HG13 ' A' ' 54' ' ' ILE . 4.2 mp -109.9 147.79 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.003 0.43 . . . . 0.0 111.469 -173.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -65.33 147.01 54.18 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.129 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.676 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 21.0 tt -65.17 -28.46 44.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.371 0.605 . . . . 0.0 110.011 177.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -62.97 -39.13 93.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.618 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.49 ' HB3' ' CG2' ' A' ' 7' ' ' ILE . 19.2 t70 -80.63 -36.03 33.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.515 -175.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 79.9 mmm -54.03 144.81 18.28 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.86 170.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.7 m -91.73 127.34 37.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.688 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.679 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . 47.3 p90 -81.76 138.0 35.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.998 0.427 . . . . 0.0 110.669 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -124.39 84.25 56.67 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.605 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.2 -22.0 54.44 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.03 2.487 . . . . 0.0 112.973 -172.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -68.29 -33.3 74.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.973 0.416 . . . . 0.0 110.586 -178.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -105.61 -5.16 20.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.965 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 64.5 36.3 8.81 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.296 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -145.15 167.98 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.597 -177.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.445 ' HB2' HG23 ' A' ' 33' ' ' ILE . 71.2 m-85 -96.89 146.76 24.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.871 0.367 . . . . 0.0 110.336 177.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 22.3 p -136.82 164.46 28.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.503 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.436 ' HB3' ' CD2' ' A' ' 31' ' ' PHE . 10.1 t80 -147.59 127.02 6.45 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.91 120.42 7.87 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.414 2.742 . . . . 0.0 113.655 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.551 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 11.6 t -136.28 135.98 21.83 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.305 174.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -84.39 118.4 2.23 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 121.901 1.734 . . . . 0.0 111.572 175.19 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 32.0 p 177.14 -46.17 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 164.08 -27.11 0.21 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.326 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.565 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 2.5 t0 -139.63 175.22 9.75 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -113.58 153.17 29.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.496 -177.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.636 ' CD1' ' HB2' ' A' ' 47' ' ' CYS . 97.2 m-85 -50.19 130.66 23.06 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.194 0.309 . . . . 0.0 110.752 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 27.8 pt20 -117.85 134.67 54.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.918 0.389 . . . . 0.0 110.638 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.445 HG23 ' HB2' ' A' ' 21' ' ' PHE . 12.9 tt -147.56 133.87 12.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.288 176.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.422 ' HB2' ' OD2' ' A' ' 37' ' ' ASP . 90.5 m-85 -96.13 147.4 23.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.857 -177.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 35' ' ' LEU . 4.1 mm? -61.0 -33.92 74.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.062 178.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -56.7 -43.38 80.49 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.155 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.422 ' OD2' ' HB2' ' A' ' 34' ' ' TYR . 25.0 m-20 -67.77 -44.39 77.56 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.111 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.414 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 76.1 mtp -61.84 -44.28 97.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.643 -177.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -69.53 -29.23 66.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.68 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -72.94 -18.13 61.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.056 0.455 . . . . 0.0 110.589 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.11 1.41 33.72 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.61 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -108.16 100.61 9.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.153 0.501 . . . . 0.0 109.714 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.549 ' HD3' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -108.63 101.32 10.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.841 0.829 . . . . 0.0 111.03 -171.409 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.8 p -163.43 131.38 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.003 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.1 134.78 42.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.059 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.799 HG22 ' HG2' ' A' ' 53' ' ' MET . 46.7 t -114.74 122.99 69.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.636 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 26.1 t -83.49 124.86 75.14 Favored Pre-proline 0 C--N 1.318 -0.779 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.008 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.565 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 58.8 Cg_endo -73.2 156.64 51.09 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.832 2.355 . . . . 0.0 110.746 173.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.529 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 42.8 t 86.79 -60.38 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.447 0.699 . . . . 0.0 110.876 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 15.7 p -92.56 -24.76 18.62 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.207 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 t 64.48 79.61 0.25 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.535 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.411 HD23 ' N ' ' A' ' 53' ' ' MET . 3.4 tt -131.09 131.01 43.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.799 ' HG2' HG22 ' A' ' 46' ' ' VAL . 27.7 mtm -118.94 136.62 53.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.683 0.277 . . . . 0.0 111.265 -175.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.584 HG13 ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -145.52 155.43 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.66 177.143 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.553 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -76.79 152.24 35.65 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.583 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.7 t -132.7 120.05 40.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.964 0.411 . . . . 0.0 110.291 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.676 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 21.1 t -75.71 149.54 6.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.5 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 55.1 p90 -146.84 164.64 32.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.364 0.126 . . . . 0.0 110.694 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.59 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 14.4 t70 -125.98 156.76 39.32 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.861 0.362 . . . . 0.0 110.625 174.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.889 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 0.8 OUTLIER -60.63 -46.55 89.85 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.08 178.722 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -72.89 -40.67 65.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.726 -177.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -63.77 -39.6 94.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.3 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 66.8 mt -64.21 -52.42 58.91 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.498 176.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.429 ' HA ' ' HG3' ' A' ' 75' ' ' PRO . . . -54.14 -45.12 71.89 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.273 -177.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.48 -44.73 95.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.354 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.679 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 54.6 t80 -66.36 -40.83 90.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.586 -176.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.532 ' HA ' HD12 ' A' ' 72' ' ' ILE . 36.6 m-85 -51.31 -48.43 62.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.923 0.392 . . . . 0.0 110.679 175.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -71.15 -35.68 71.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.833 -177.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -70.14 -45.22 67.26 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.75 -12.68 59.42 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -174.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.8 41.34 8.27 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.424 -0.894 . . . . 0.0 111.387 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.561 HG22 ' H ' ' A' ' 73' ' ' HIS . 2.8 mt -98.2 177.03 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.561 ' H ' HG22 ' A' ' 72' ' ' ILE . 98.5 m-70 -57.36 122.72 56.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 110.324 -0.251 . . . . 0.0 110.324 177.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -52.18 121.76 9.46 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.363 2.708 . . . . 0.0 112.389 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.429 ' HG3' ' HA ' ' A' ' 64' ' ' ALA . 64.0 Cg_endo -74.09 148.1 39.24 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.664 2.242 . . . . 0.0 112.254 -177.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -76.2 148.89 81.58 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.142 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.08 136.0 72.72 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.649 2.233 . . . . 0.0 112.777 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.6 pt -98.3 166.15 2.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.836 -176.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.06 72.99 6.88 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.586 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -159.08 125.03 4.41 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.815 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.55 -48.79 0.9 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.232 173.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.423 177.014 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.942 0.401 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.1 m -94.93 175.29 6.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.013 171.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.2 p -69.71 119.74 14.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.99 0.424 . . . . 0.0 110.752 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -88.14 -14.2 39.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.157 -172.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -142.7 174.76 10.36 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.294 -177.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.554 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 33.5 tt0 -155.67 116.59 3.86 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.466 0.479 . . . . 0.0 109.747 -176.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.434 ' CD1' HG13 ' A' ' 54' ' ' ILE . 1.6 mp -129.33 146.44 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.79 -177.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.552 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 46.4 mt-10 -69.82 145.75 51.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.951 0.405 . . . . 0.0 110.463 174.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.2 tt -55.26 -28.89 22.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.474 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -63.1 -33.61 75.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.721 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -86.16 -31.62 21.71 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.164 -174.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.533 ' HA ' ' HD1' ' A' ' 23' ' ' TYR . 80.2 mtp -65.16 145.33 56.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 110.974 177.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.6 m -72.84 120.32 18.3 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.484 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -79.83 133.98 36.31 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.209 177.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -122.54 89.93 49.61 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.125 0.488 . . . . 0.0 110.061 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.77 -14.89 43.02 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.898 2.398 . . . . 0.0 111.917 -177.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -66.46 -40.3 89.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.488 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.557 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 2.8 t-20 -110.73 0.79 17.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.247 -177.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 59.83 42.32 16.73 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.834 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.557 ' HG2' ' HB3' ' A' ' 18' ' ' ASN . 26.9 ptt? -146.96 174.3 11.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.076 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -114.46 142.27 46.6 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 38.6 p -133.2 145.99 51.09 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.533 ' HD1' ' HA ' ' A' ' 12' ' ' MET . 9.6 t80 -119.61 131.15 24.5 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.55 122.79 12.25 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 123.016 2.477 . . . . 0.0 113.096 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.561 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 22.4 t -139.45 138.76 20.92 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.926 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -91.87 117.99 0.47 Allowed 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.19 1.927 . . . . 0.0 111.859 174.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.464 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 30.7 p -178.54 -52.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.745 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.464 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 172.43 -27.89 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.883 -178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.571 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 2.5 t70 -142.41 176.52 8.94 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.439 ' HE ' ' CB ' ' A' ' 22' ' ' THR . 10.6 ptm180 -114.7 147.51 39.56 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.641 ' CE1' ' HB3' ' A' ' 52' ' ' LEU . 97.7 m-85 -46.97 121.27 3.54 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.517 0.511 . . . . 0.0 110.18 178.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -120.49 131.52 54.77 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.897 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 20' ' ' MET . 14.7 tt -132.54 132.5 60.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.936 176.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.445 ' O ' ' HG3' ' A' ' 38' ' ' MET . 30.5 m-85 -90.27 134.83 34.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.756 -173.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.566 ' HG ' HD13 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -61.46 -30.54 70.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.012 -178.315 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -54.04 -44.82 71.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.943 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . 16.3 m-20 -77.26 -37.67 52.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.768 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.445 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 79.1 mtp -59.88 -42.43 93.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.544 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.437 ' HZ ' ' HG3' ' A' ' 76' ' ' GLU . 47.3 t80 -60.49 -37.73 82.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.7 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.83 -22.22 64.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.768 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.51 7.06 32.66 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.653 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.535 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 8.0 tp10 -93.17 107.01 18.9 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.813 ' HD2' ' HE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -120.48 98.97 6.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.015 0.912 . . . . 0.0 111.68 -174.737 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 p -167.23 130.14 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.261 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.489 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -100.82 136.04 41.32 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.864 0.364 . . . . 0.0 110.406 -178.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.765 HG22 ' HG2' ' A' ' 53' ' ' MET . 44.7 t -114.07 129.84 69.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.535 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.572 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 13.0 t -99.25 119.46 60.46 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.778 178.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.571 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 34.4 Cg_endo -69.23 155.93 66.22 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.136 1.89 . . . . 0.0 111.162 175.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.51 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 44.5 t 85.36 -56.19 0.09 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.692 0.797 . . . . 0.0 111.366 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 52' ' ' LEU . 16.3 p -93.65 -18.56 22.03 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.4 t 67.23 43.06 2.13 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.839 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.641 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -94.21 148.55 22.08 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.676 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.765 ' HG2' HG22 ' A' ' 46' ' ' VAL . 48.9 mtm -140.36 135.73 32.45 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.032 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.489 HD11 ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -144.75 152.65 14.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.957 179.43 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 0.4 OUTLIER -76.04 152.95 36.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.879 178.703 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.78 143.37 39.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.552 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 56.5 t -103.07 107.99 23.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.813 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 24.3 p90 -113.57 164.53 13.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.099 -177.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -136.46 158.26 44.86 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.482 ' HD2' ' N ' ' A' ' 60' ' ' LYS . 12.4 mptt -64.02 -33.97 76.96 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.764 176.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -60.13 -54.08 50.19 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.232 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -61.46 -43.9 98.06 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.511 -176.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 35.2 mt -59.86 -49.62 77.0 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.285 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.45 80.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.775 0.321 . . . . 0.0 111.381 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -65.72 -53.73 36.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.452 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -68.91 -33.76 74.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.462 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.518 ' HA ' HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -51.94 -46.23 64.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.916 175.681 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -67.25 -45.78 75.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.938 0.399 . . . . 0.0 110.983 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -61.51 -49.58 76.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.882 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.84 -20.34 53.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.113 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.97 46.1 10.99 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -177.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.566 HD13 ' HG ' ' A' ' 35' ' ' LEU . 10.7 mt -81.7 165.65 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.53 -0.335 . . . . 0.0 110.303 -173.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.437 ' N ' HG22 ' A' ' 72' ' ' ILE . 27.9 t60 -61.95 133.53 93.93 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.296 178.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -46.69 120.19 3.81 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.611 2.874 . . . . 0.0 113.302 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.402 ' HD3' ' CE1' ' A' ' 67' ' ' TYR . 81.2 Cg_endo -86.68 166.8 8.75 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.954 3.102 . . . . 0.0 112.212 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.437 ' HG3' ' HZ ' ' A' ' 39' ' ' PHE . 39.6 mt-10 -72.52 136.87 80.74 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.21 140.88 24.95 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.213 2.609 . . . . 0.0 113.31 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.2 pt -101.51 151.07 5.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.66 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.97 83.13 4.68 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.125 0.488 . . . . 0.0 110.494 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.34 92.74 7.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.306 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.65 -53.28 2.66 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.656 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.396 179.428 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.6 mtm . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.322 0.582 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 p -118.74 160.02 22.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.365 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.0 p -86.03 130.74 34.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.054 0.454 . . . . 0.0 110.944 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -92.0 -28.18 17.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.439 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -135.81 171.69 14.09 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.067 -171.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 39.7 tt0 -150.58 109.84 3.96 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.02 158.11 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 -175.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.519 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 57.3 mm-40 -61.63 150.59 35.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.138 0.494 . . . . 0.0 111.21 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.691 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 20.6 tt -62.4 -28.7 45.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.227 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -63.2 -29.96 71.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.397 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -79.16 -34.63 43.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.259 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.679 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 90.6 mmm -62.11 118.13 6.93 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 173.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.3 m -71.59 107.86 4.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.406 0.622 . . . . 0.0 110.442 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.597 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 39.0 p90 -74.54 137.6 42.53 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.183 -177.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -114.75 101.93 54.61 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.14 175.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.66 -9.15 23.39 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.072 2.515 . . . . 0.0 112.432 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -93.05 -38.53 11.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.121 0.486 . . . . 0.0 109.877 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.44 HD22 ' HA ' ' A' ' 18' ' ' ASN . 1.3 t-20 -89.39 -5.85 57.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.464 -175.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 73.46 18.2 3.67 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.608 171.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.583 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 27.3 ptt? -161.75 175.71 11.69 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.081 -173.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.679 ' HB3' ' HB3' ' A' ' 12' ' ' MET . 87.3 m-85 -95.76 131.08 42.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.133 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 23.8 p -129.04 137.8 51.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.795 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 36.0 t80 -109.64 122.6 38.81 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.21 121.31 9.18 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.229 2.62 . . . . 0.0 113.193 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.7 t -138.29 141.11 30.61 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.3 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -94.69 118.18 0.25 Allowed 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 122.157 1.905 . . . . 0.0 112.004 173.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.1 p -179.75 -44.95 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.391 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.71 -24.64 0.23 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.143 -177.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.461 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 4.3 t70 -141.91 177.01 8.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.94 151.04 32.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.933 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.795 ' HB2' ' HB3' ' A' ' 23' ' ' TYR . 75.6 m-85 -54.8 114.67 1.8 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 175.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.41 137.06 52.74 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.992 0.425 . . . . 0.0 110.98 -174.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.583 ' O ' ' HB2' ' A' ' 20' ' ' MET . 14.5 tt -139.64 129.13 29.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.827 173.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.439 ' O ' ' HG3' ' A' ' 38' ' ' MET . 14.1 m-85 -79.59 135.86 36.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.162 -173.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.471 HD12 ' CD2' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -66.88 -36.66 82.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.007 0.432 . . . . 0.0 110.049 -176.751 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 17.3 t70 -61.13 -35.44 77.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.454 176.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -69.54 -42.8 74.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.215 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.616 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 75.5 mtp -65.4 -37.72 87.83 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.5 178.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -69.53 -23.48 63.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.471 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 36' ' ' ASP . 70.4 mm-40 -75.05 -12.51 60.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 176.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.15 -5.42 33.97 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.529 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.616 ' O ' ' HA ' ' A' ' 38' ' ' MET . 0.7 OUTLIER -85.34 146.89 26.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 177.605 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 32.2 pttt -144.89 97.59 3.04 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.586 0.708 . . . . 0.0 111.2 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 p -167.74 126.67 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.036 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 53' ' ' MET . . . -100.54 131.15 46.6 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.966 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.9 p -111.91 139.29 37.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.995 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.436 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 8.6 t -116.34 115.02 40.39 Favored Pre-proline 0 N--CA 1.435 -1.178 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.117 175.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.563 ' O ' ' HB3' ' A' ' 49' ' ' SER . 34.2 Cg_endo -69.0 157.38 62.09 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.601 2.201 . . . . 0.0 111.452 174.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.563 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 35.9 t 88.51 -57.33 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.027 0.931 . . . . 0.0 110.586 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.7 p -90.43 -28.29 18.72 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.003 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.8 t 68.87 54.76 0.46 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.898 177.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 53' ' ' MET . 1.9 tt -114.76 137.2 52.21 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.469 ' N ' HD23 ' A' ' 52' ' ' LEU . 35.6 mtm -132.61 138.23 47.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.021 -178.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -142.49 156.37 18.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.778 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 39.9 m-20 -80.21 159.95 25.78 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.59 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 11.2 p -136.32 138.07 47.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.993 0.425 . . . . 0.0 111.052 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.691 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 61.8 t -72.12 141.57 16.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -150.03 155.94 40.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.854 0.359 . . . . 0.0 110.908 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -134.88 155.5 50.57 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -63.73 -34.67 78.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.178 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -73.93 -40.93 62.76 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.035 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -59.4 -46.39 88.84 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.16 0.505 . . . . 0.0 110.269 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 72.9 mt -69.51 -44.55 70.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.412 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.78 -46.69 88.4 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.66 0.267 . . . . 0.0 111.259 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.574 ' O ' ' HG3' ' A' ' 69' ' ' GLU . 23.8 tt0 -64.95 -49.55 69.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.861 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.477 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 80.0 t80 -62.22 -34.81 77.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.151 -178.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.533 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 2.0 t80 -54.18 -44.94 71.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.679 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -76.96 -33.84 57.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.105 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.574 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 48.2 mt-10 -61.17 -49.74 76.01 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.974 0.416 . . . . 0.0 110.859 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.23 -25.95 63.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.158 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.56 33.31 10.33 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.657 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 73' ' ' HIS . 0.6 OUTLIER -72.82 -175.7 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.768 0.318 . . . . 0.0 110.455 177.689 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.567 ' H ' HG22 ' A' ' 72' ' ' ILE . 18.6 m170 -67.32 162.99 50.64 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.071 -173.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.49 115.69 2.09 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.774 2.316 . . . . 0.0 112.771 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.9 158.79 31.1 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.795 2.33 . . . . 0.0 112.604 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -90.57 143.83 29.72 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.641 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -62.23 139.37 77.43 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.374 2.05 . . . . 0.0 112.438 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 40.7 pt -112.65 152.81 14.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.092 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -110.05 95.7 5.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.978 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -129.01 -2.86 5.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.637 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -158.25 -46.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.507 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.18 179.626 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.46 0.069 0 CA-C-O 120.765 0.317 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.6 m -107.18 160.46 15.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.976 0.417 . . . . 0.0 111.184 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.7 p -82.69 127.05 33.04 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.211 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -102.9 -26.64 13.04 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.74 154.06 24.43 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.956 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . 42.3 tt0 -146.3 122.89 11.12 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.613 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 mp -122.61 156.0 27.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.574 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 47.0 mt-10 -73.21 151.93 41.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.266 0.555 . . . . 0.0 111.19 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.442 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 20.4 tt -59.64 -28.59 40.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.59 -178.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -58.8 -38.53 78.78 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.26 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -73.18 -36.56 66.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.98 -174.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 89.5 mmm -58.37 149.92 23.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.188 176.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.4 m -100.9 108.02 19.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.959 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.419 ' HD2' ' HD3' ' A' ' 16' ' ' PRO . 44.6 p90 -74.08 136.03 43.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.011 0.434 . . . . 0.0 111.116 -176.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.426 ' HA ' ' OE1' ' A' ' 15' ' ' GLU . 6.4 tp10 -115.21 86.7 14.64 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.623 176.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.419 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 20.7 Cg_endo -61.31 -28.2 84.2 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.01 2.473 . . . . 0.0 112.455 -174.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -69.53 -20.28 63.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.117 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -111.72 -1.06 15.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.702 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 57.64 43.07 22.95 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.292 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -154.16 165.89 34.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.846 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.49 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 88.0 m-85 -103.87 139.59 38.85 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.609 ' HB ' ' HD3' ' A' ' 30' ' ' ARG . 77.5 p -130.59 169.86 15.04 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 121.141 -0.223 . . . . 0.0 110.929 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -152.77 127.23 4.57 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.36 126.31 21.79 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 123.144 2.563 . . . . 0.0 112.655 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.591 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 9.5 t -135.51 144.3 48.71 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.027 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -86.06 117.92 1.66 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.772 1.648 . . . . 0.0 111.949 173.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.437 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 30.3 p 172.48 -49.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.57 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.437 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 163.19 -24.48 0.19 Allowed Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.398 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.419 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 1.3 t0 -134.61 176.41 8.66 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.351 -0.241 . . . . 0.0 110.351 -177.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.609 ' HD3' ' HB ' ' A' ' 22' ' ' THR . 15.4 ptp180 -109.18 150.77 27.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.942 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.631 ' CD1' ' HB2' ' A' ' 47' ' ' CYS . 97.2 m-85 -55.39 140.46 39.77 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -137.16 134.14 36.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.181 0.515 . . . . 0.0 110.666 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.49 ' CG2' ' HB2' ' A' ' 21' ' ' PHE . 12.4 tt -131.16 130.39 63.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.679 177.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.492 ' O ' ' HG3' ' A' ' 38' ' ' MET . 24.4 m-85 -87.67 147.57 25.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.243 -174.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.481 ' HG ' ' CD1' ' A' ' 72' ' ' ILE . 0.6 OUTLIER -66.7 -35.36 79.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.956 -176.16 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.1 -44.78 79.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.803 178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.401 ' OD1' ' HB2' ' A' ' 34' ' ' TYR . 3.4 m-20 -64.08 -43.04 96.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.628 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.492 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 55.3 mtp -63.57 -37.59 87.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.488 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -65.32 -35.45 81.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.272 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -70.92 -15.94 62.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.655 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.31 -3.63 59.91 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -81.84 81.64 7.78 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.31 0.576 . . . . 0.0 109.522 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.72 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.64 98.39 11.61 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.358 1.075 . . . . 0.0 110.439 -179.563 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 2.0 p -167.09 129.46 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.802 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 53' ' ' MET . . . -99.46 130.21 45.71 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -107.05 134.36 48.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.147 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.631 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 35.0 t -105.31 123.77 38.57 Favored Pre-proline 0 N--CA 1.433 -1.303 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.093 176.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.626 ' O ' ' HB3' ' A' ' 49' ' ' SER . 33.3 Cg_endo -65.89 156.57 63.6 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.499 2.133 . . . . 0.0 111.044 172.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.626 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 27.4 t 86.21 -61.37 0.05 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.349 0.659 . . . . 0.0 110.963 178.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.4 p -90.99 -23.43 20.4 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.188 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.5 t 68.2 41.57 1.9 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.117 175.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.556 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 54.3 tp -98.79 142.35 30.43 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.112 0.482 . . . . 0.0 109.943 -178.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.476 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 43.5 mtm -132.5 138.01 47.39 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.798 -178.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -141.3 150.38 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 177.305 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 7.3 m-20 -68.85 155.58 39.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.815 0.34 . . . . 0.0 110.181 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 90.7 t -135.29 124.51 41.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.83 176.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.574 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 41.5 t -75.64 104.84 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -108.67 164.78 12.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.909 -175.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.562 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 13.8 t70 -130.13 146.9 51.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.79 175.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -64.07 -32.56 74.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.975 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -73.57 -40.5 63.86 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.663 0.268 . . . . 0.0 110.606 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.73 -41.27 90.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.872 0.367 . . . . 0.0 110.322 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 67.3 mt -63.85 -48.94 74.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.79 178.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.15 -41.95 93.87 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.879 -177.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -63.06 -53.79 48.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.347 0.594 . . . . 0.0 110.466 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.414 ' CE2' HD11 ' A' ' 72' ' ' ILE . 78.9 t80 -63.81 -36.19 83.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.389 -178.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.466 ' HA ' HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -53.14 -44.71 67.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.119 177.889 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -69.55 -36.18 76.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.625 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -75.96 -34.34 59.82 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.97 -20.27 24.67 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.7 57.08 5.12 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.552 HG22 ' H ' ' A' ' 73' ' ' HIS . 6.6 mt -97.81 172.92 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.625 -0.287 . . . . 0.0 110.712 -173.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.552 ' H ' HG22 ' A' ' 72' ' ' ILE . 79.5 t60 -53.0 125.89 41.73 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.476 173.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.47 114.14 2.4 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.784 2.323 . . . . 0.0 112.774 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.03 163.43 3.86 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.314 2.676 . . . . 0.0 111.316 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.77 118.24 67.6 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.99 147.63 55.38 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.887 2.392 . . . . 0.0 113.192 -173.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.0 pt -94.7 -177.63 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.206 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.11 89.14 3.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.885 0.374 . . . . 0.0 110.755 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.46 82.86 8.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.112 0.482 . . . . 0.0 110.143 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.26 -16.03 20.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.918 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.392 -0.813 . . . . 0.0 110.002 -179.412 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 C--O 1.234 0.258 0 CA-C-O 121.52 0.676 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.0 m -131.37 171.26 13.57 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.272 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.3 p -88.77 108.56 19.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.014 0.435 . . . . 0.0 110.32 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -98.33 -0.47 43.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.588 -174.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -134.04 162.95 30.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.53 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 40.1 tt0 -159.86 120.28 3.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.86 -177.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 8' ' ' GLU . 1.8 mp -120.65 161.69 20.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -175.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.402 ' N ' HG22 ' A' ' 7' ' ' ILE . 40.9 mt-10 -74.06 146.81 43.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.371 177.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.0 tt -59.41 -29.69 42.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.422 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -68.84 -28.26 66.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.923 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -79.4 -31.21 42.73 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.99 0.424 . . . . 0.0 110.3 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 82.3 mmm -63.58 128.07 34.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.986 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 22' ' ' THR . 86.2 m -71.83 119.43 15.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.198 0.523 . . . . 0.0 110.899 -177.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.672 ' HB2' ' HE1' ' A' ' 66' ' ' TYR . 36.2 p90 -74.58 138.81 43.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.035 -177.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -129.23 87.71 53.05 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.914 177.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.431 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 18.7 Cg_endo -59.84 -33.02 96.21 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.274 2.649 . . . . 0.0 112.897 -175.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.63 -28.71 70.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.891 -176.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -113.03 4.95 16.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.707 0.289 . . . . 0.0 111.112 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.418 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 2.1 mp0 59.14 32.0 21.73 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.395 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -144.94 159.01 43.6 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.165 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -93.89 141.81 28.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.726 175.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 20.6 p -137.7 141.57 41.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.642 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.456 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 17.6 t80 -125.52 117.82 24.77 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -178.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -48.44 118.53 3.36 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.47 2.78 . . . . 0.0 113.286 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 19.9 t -130.39 135.66 27.76 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.439 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 5.8 Cg_endo -84.74 118.21 2.09 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.869 1.712 . . . . 0.0 111.442 175.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.409 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 29.9 p 174.62 -45.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -177.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.409 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 159.65 -27.1 0.35 Allowed Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.783 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -138.23 176.0 9.08 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.476 ' HG3' ' HB ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -120.06 156.49 30.86 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.155 -177.078 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.64 ' O ' ' HA ' ' A' ' 22' ' ' THR . 97.3 m-85 -56.4 123.03 13.31 Favored 'General case' 0 CA--C 1.518 -0.258 0 O-C-N 123.384 0.428 . . . . 0.0 110.165 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.579 ' HG2' HG22 ' A' ' 22' ' ' THR . 98.3 mt-30 -120.8 137.63 54.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.823 0.344 . . . . 0.0 110.756 -178.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.5 ' HB ' ' HA ' ' A' ' 45' ' ' ALA . 10.1 tt -145.93 125.22 5.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.419 175.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -87.31 149.49 24.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.252 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.625 ' HA ' ' HG3' ' A' ' 38' ' ' MET . 7.7 tp -71.3 -24.65 62.18 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.12 0.485 . . . . 0.0 110.65 -176.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -54.6 -40.15 68.57 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.429 173.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -68.74 -44.56 73.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.202 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.625 ' HG3' ' HA ' ' A' ' 35' ' ' LEU . 15.2 mtp -62.72 -46.48 87.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.602 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.731 ' HZ ' ' HG2' ' A' ' 76' ' ' GLU . 82.3 t80 -65.29 -25.19 67.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.095 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.92 -21.86 65.1 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.226 0.536 . . . . 0.0 110.523 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.75 -2.34 34.03 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.012 -177.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.459 ' HG3' HG12 ' A' ' 44' ' ' VAL . 10.2 tp10 -100.19 130.28 46.3 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 20.3 pttp -122.78 101.25 7.34 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.448 0.642 . . . . 0.0 111.068 -176.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 2.6 p -167.3 129.33 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.258 -177.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.5 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . . . -100.74 141.7 33.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.472 175.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.9 p -122.0 134.37 65.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.906 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.451 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 10.9 t -104.33 128.25 27.42 Favored Pre-proline 0 N--CA 1.438 -1.051 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 174.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.82 156.56 20.85 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.734 2.29 . . . . 0.0 111.553 176.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.0 t 85.95 -55.39 0.07 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.699 0.8 . . . . 0.0 110.681 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 15.9 p -87.32 -32.22 19.77 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 47' ' ' CYS . 16.6 m 68.96 76.26 0.24 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.233 174.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.485 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 57.6 tp -133.56 143.75 48.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.627 175.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.446 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 36.2 mtm -132.42 138.26 47.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.578 -177.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -143.31 152.82 16.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.942 178.955 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.532 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 2.2 m-20 -70.87 153.3 42.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.648 0.261 . . . . 0.0 110.557 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.526 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 99.9 t -135.46 114.74 16.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.501 176.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.54 117.8 15.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.069 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 43' ' ' LYS . 51.5 p90 -111.7 164.86 12.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.819 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.609 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 15.0 t70 -131.74 159.05 39.56 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.355 177.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.75 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 9.2 mptt -58.74 -44.1 90.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.473 178.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -75.53 -37.27 60.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.987 -176.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -62.1 -39.74 93.49 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.671 177.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 80.7 mt -68.83 -44.23 73.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.468 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.36 -51.27 70.21 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.779 -176.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -70.89 -33.39 70.53 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.362 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.672 ' HE1' ' HB2' ' A' ' 14' ' ' PHE . 56.4 t80 -67.16 -35.71 80.27 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.208 176.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.458 ' HA ' HD12 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -52.52 -46.1 66.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.623 174.269 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -71.51 -43.85 65.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.014 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -72.82 -34.11 66.64 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -83.05 -17.4 43.38 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.147 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.29 54.52 4.69 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.524 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.591 HG22 ' H ' ' A' ' 73' ' ' HIS . 3.7 mt -104.81 177.94 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.591 ' H ' HG22 ' A' ' 72' ' ' ILE . 13.3 m-70 -92.69 146.53 32.42 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 176.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.481 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 19.2 Cg_endo -57.33 126.23 21.38 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.659 2.906 . . . . 0.0 114.479 -171.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 74' ' ' PRO . 6.0 Cg_exo -78.94 167.45 22.07 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.997 3.132 . . . . 0.0 110.428 169.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.731 ' HG2' ' HZ ' ' A' ' 39' ' ' PHE . 13.8 pt-20 -71.82 143.48 86.92 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.531 ' HG2' ' HB2' ' A' ' 82' ' ' ALA . 77.4 Cg_exo -48.81 137.45 27.37 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.05 2.5 . . . . 0.0 113.773 -170.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 pp -82.59 107.5 14.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.398 -175.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 56.66 11.99 1.01 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.344 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.94 152.36 24.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.796 -178.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.27 133.79 48.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.531 ' HB2' ' HG2' ' A' ' 77' ' ' PRO . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.121 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 121.2 0.524 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 p -97.55 151.3 20.18 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.118 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 53' ' ' MET . 12.3 p -74.09 112.57 10.35 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.944 175.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -95.27 -1.61 51.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.643 -171.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -143.19 171.92 13.43 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 44.3 tt0 -162.19 108.54 1.28 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -177.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.46 ' CD1' HG13 ' A' ' 54' ' ' ILE . 2.2 mp -119.67 151.26 22.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.385 -172.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -63.17 144.62 56.76 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 175.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.3 tt -60.54 -33.28 53.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.206 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.69 -27.82 62.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.209 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.453 ' HB3' HG22 ' A' ' 7' ' ' ILE . 17.8 t70 -73.57 -35.89 65.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.581 -176.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.465 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 81.4 mtp -69.2 153.76 43.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.479 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.1 m -82.12 113.22 19.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.82 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.498 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . 33.4 p90 -77.5 138.73 39.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.946 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -113.5 88.98 14.17 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.47 -29.51 88.82 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.215 2.61 . . . . 0.0 113.901 -169.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.94 -32.52 73.02 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.883 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.473 ' HB2' ' HG2' ' A' ' 20' ' ' MET . 46.6 m-80 -105.02 1.38 28.55 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.466 -173.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 57.28 39.05 28.85 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.032 0.444 . . . . 0.0 110.383 -178.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.473 ' HG2' ' HB2' ' A' ' 18' ' ' ASN . 27.1 ptt? -137.71 170.66 15.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.934 0.397 . . . . 0.0 111.004 -175.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.522 ' HE1' HD23 ' A' ' 35' ' ' LEU . 52.8 m-85 -119.47 144.67 46.86 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.867 176.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 35.6 p -133.03 158.37 42.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.376 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.465 ' CD1' ' HA ' ' A' ' 12' ' ' MET . 4.5 t80 -141.31 129.52 12.21 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -57.7 119.43 6.68 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.985 2.457 . . . . 0.0 113.361 -175.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.465 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 17.3 t -133.21 131.8 21.86 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.304 176.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 1.3 Cg_endo -85.31 117.83 1.87 Allowed 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.949 1.766 . . . . 0.0 111.487 173.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 28.4 p -179.15 -47.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.648 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.45 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 168.19 -25.4 0.12 Allowed Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.227 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.54 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 2.5 t70 -143.29 176.35 9.21 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -117.48 154.33 31.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.326 0.108 . . . . 0.0 110.769 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 22' ' ' THR . 94.3 m-85 -48.4 131.32 16.93 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.528 0.517 . . . . 0.0 111.342 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -127.15 126.87 43.64 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.977 -173.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.462 ' HB ' ' HA ' ' A' ' 45' ' ' ALA . 11.5 tt -148.84 136.4 13.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.321 176.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.448 ' O ' ' HG3' ' A' ' 38' ' ' MET . 91.3 m-85 -98.61 147.06 25.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.954 0.406 . . . . 0.0 111.36 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.522 HD23 ' HE1' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -65.62 -33.91 77.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.297 -178.244 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.79 -42.31 71.63 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.962 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -68.96 -40.53 78.85 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.97 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.448 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 75.2 mtp -63.8 -31.39 72.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.342 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -72.94 -21.19 60.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.624 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -79.1 -6.78 57.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.221 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.08 -18.2 34.03 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.089 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 38' ' ' MET . 33.0 tt0 -94.62 135.09 36.49 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.688 ' HD2' ' HE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -133.22 101.04 5.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.608 0.718 . . . . 0.0 110.983 -177.365 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 p -165.65 128.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.73 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.462 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . . . -100.07 135.86 40.85 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.004 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p -109.74 134.2 52.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.117 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.544 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 24.6 t -101.17 118.47 60.18 Favored Pre-proline 0 N--CA 1.433 -1.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.896 176.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.571 ' O ' ' HB3' ' A' ' 49' ' ' SER . 24.6 Cg_endo -65.38 156.54 62.79 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.397 2.065 . . . . 0.0 111.034 173.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.571 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 35.6 t 87.13 -56.91 0.04 OUTLIER 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.621 0.768 . . . . 0.0 111.035 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.0 p -92.96 -26.97 17.33 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.132 177.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.7 t 70.27 44.07 0.78 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.927 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 53' ' ' MET . 2.1 tt -101.33 136.22 41.54 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' A' ' 3' ' ' THR . 36.9 mtm -125.07 138.56 54.19 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 -177.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.46 HG13 ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -140.45 155.39 23.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.865 178.934 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.557 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 15.1 m-20 -80.92 159.15 25.04 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.2 t -130.94 126.28 59.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.71 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.7 t -87.49 101.74 11.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.066 0.46 . . . . 0.0 110.642 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.688 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 47.5 p90 -104.48 164.72 11.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.418 -178.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.506 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 20.3 t70 -128.47 159.5 35.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.944 0.402 . . . . 0.0 110.72 175.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.815 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -59.95 -47.55 85.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.416 177.208 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.13 -36.9 80.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.501 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -69.87 -40.66 75.58 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.618 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 42.8 mt -61.57 -44.81 96.34 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.73 177.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.17 -34.4 76.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.932 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -64.84 -54.07 36.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.701 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.498 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 77.0 t80 -65.0 -34.64 78.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.448 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.64 ' HD1' ' HB ' ' A' ' 72' ' ' ILE . 10.4 t80 -51.46 -47.14 63.21 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.165 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.81 -45.15 62.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.149 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.54 -43.89 88.53 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.12 -25.69 36.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.744 0.307 . . . . 0.0 111.407 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.95 59.06 2.51 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.64 ' HB ' ' HD1' ' A' ' 67' ' ' TYR . 18.4 mt -87.6 162.36 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.503 -0.349 . . . . 0.0 110.137 -176.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.4 ' N ' HG22 ' A' ' 72' ' ' ILE . 21.6 p-80 -61.2 146.25 88.79 Favored Pre-proline 0 C--O 1.232 0.164 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 9.4 Cg_endo -53.19 115.46 2.3 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.993 2.462 . . . . 0.0 111.8 176.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.597 ' HD3' ' CE1' ' A' ' 67' ' ' TYR . 86.1 Cg_endo -92.65 164.54 2.8 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.507 2.804 . . . . 0.0 112.595 -175.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 1.3 mp0 -74.55 138.26 74.25 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 76' ' ' GLU . 52.6 Cg_exo -53.34 144.3 50.12 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.27 2.647 . . . . 0.0 114.188 -172.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.664 HD12 ' HB3' ' A' ' 60' ' ' LYS . 45.3 pt -122.54 152.16 26.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.295 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.94 85.8 3.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.044 0.449 . . . . 0.0 110.341 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.97 -14.23 37.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.008 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -128.55 105.6 8.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.628 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.677 -0.678 . . . . 0.0 110.193 -179.651 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.664 ' HB ' ' HB2' ' A' ' 55' ' ' ASP . 5.1 p . . . . . 0 N--CA 1.45 -0.47 0 CA-C-O 121.251 0.548 . . . . 0.0 111.615 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -103.06 -16.83 15.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.478 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -102.1 138.35 39.16 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -137.72 114.94 10.95 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -175.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.681 HD13 HD13 ' A' ' 54' ' ' ILE . 4.3 mp -111.36 138.75 38.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.889 0.376 . . . . 0.0 110.235 -176.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.562 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 31.6 mt-10 -66.69 141.6 57.71 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.156 175.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.1 tt -57.07 -28.33 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.995 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -68.14 -28.76 67.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.355 -0.384 . . . . 0.0 112.014 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -82.2 -38.77 24.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.91 0.386 . . . . 0.0 109.995 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 81.1 mmm -53.33 127.07 23.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.496 170.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.3 m -79.1 123.24 27.16 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.666 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 35.7 p90 -94.65 134.47 37.2 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.636 -176.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -107.24 94.26 10.93 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.559 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.9 -27.99 86.16 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.113 2.542 . . . . 0.0 112.763 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -73.74 -27.52 61.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.969 0.414 . . . . 0.0 110.329 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -96.91 -10.08 27.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.895 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 62.66 36.66 13.36 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.833 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -151.78 169.23 22.74 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.456 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.666 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 30.0 m-85 -110.05 140.68 43.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.267 175.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 79.7 p -127.96 163.54 24.28 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.037 0.446 . . . . 0.0 110.759 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -134.8 126.7 18.06 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.31 115.3 1.98 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 123.18 2.587 . . . . 0.0 113.254 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.498 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 41.9 t -128.67 137.37 30.79 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.866 177.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 9.0 Cg_endo -90.3 120.14 0.8 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.487 2.125 . . . . 0.0 111.369 172.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 28.7 p 175.54 -43.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.41 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 160.15 -23.38 0.27 Allowed Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.51 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.424 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 2.8 t0 -142.49 175.71 9.58 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.543 HH11 ' HG3' ' A' ' 30' ' ' ARG . 9.3 ptt85 -113.26 152.96 29.16 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 122.799 0.439 . . . . 0.0 110.706 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 22' ' ' THR . 86.7 m-85 -55.4 136.26 49.6 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.334 0.397 . . . . 0.0 110.227 176.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -128.83 124.1 34.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.093 0.473 . . . . 0.0 111.524 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' A' ' 45' ' ' ALA . 12.0 tt -127.46 127.1 68.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.661 174.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.525 ' O ' ' HG3' ' A' ' 38' ' ' MET . 36.7 m-85 -93.96 131.07 39.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.001 -172.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -59.27 -31.63 69.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.187 -178.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -54.28 -47.2 72.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.12 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -83.37 -24.53 31.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.271 -176.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.59 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 93.9 mtp -65.1 -38.76 91.76 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.66 174.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -65.61 -29.43 70.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.225 175.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -71.15 -12.32 61.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.214 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.44 -6.86 36.45 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.623 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 38' ' ' MET . 9.2 tp10 -94.86 138.39 32.69 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.635 ' HD2' ' HE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -138.71 101.51 4.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 122.103 0.954 . . . . 0.0 111.553 -179.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.3 p -165.23 130.87 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.735 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.564 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -100.51 131.07 46.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.717 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.76 139.44 34.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.752 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 51' ' ' SER . 18.5 t -108.27 134.45 20.19 Favored Pre-proline 0 N--CA 1.436 -1.129 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.006 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.521 ' O ' ' HB2' ' A' ' 49' ' ' SER . 47.1 Cg_endo -83.0 157.18 15.34 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.16 2.573 . . . . 0.0 111.848 175.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.521 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 75.4 m 84.73 -55.8 0.1 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.889 0.876 . . . . 0.0 110.772 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.2 p -87.67 -33.06 18.92 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 174.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 47' ' ' CYS . 59.3 m 67.42 64.07 0.42 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.613 177.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.465 ' HB3' ' HE1' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -114.54 154.62 27.95 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.277 176.068 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 41.1 mtm -132.52 137.09 47.03 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.446 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.681 HD13 HD13 ' A' ' 7' ' ' ILE . 2.8 pp -143.68 148.16 19.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.471 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.664 ' HB2' ' HB ' ' A' ' 3' ' ' THR . 4.7 t70 -85.15 152.95 22.99 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -175.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.2 t -134.12 117.79 26.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.54 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.562 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 26.9 t -71.35 108.14 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.605 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.635 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 25.8 p90 -109.77 164.86 12.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.618 0.247 . . . . 0.0 110.407 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.629 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 5.7 t70 -134.09 160.31 38.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.111 0.482 . . . . 0.0 110.647 175.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -62.54 -44.58 96.01 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.755 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -69.39 -35.58 75.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.801 -176.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -67.91 -44.04 77.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.174 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 81.6 mt -59.34 -49.23 78.63 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.183 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.57 -41.63 95.01 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.236 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -66.67 -45.92 77.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.295 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.518 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 84.1 t80 -67.57 -35.7 79.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.082 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.8 -41.31 67.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 110.442 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -70.14 -38.77 75.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.088 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -70.15 -45.89 65.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.3 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.9 -15.48 63.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.197 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.783 0 C-N-CA 120.823 -0.704 . . . . 0.0 111.593 178.527 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.448 -0.57 0 CA-C-O 121.023 0.44 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -83.53 1.42 42.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.157 -177.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -146.0 163.98 33.51 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 34.6 tt0 -156.96 108.81 2.42 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -176.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 mp -116.16 145.45 21.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.281 -173.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.587 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 44.4 mt-10 -63.33 138.26 58.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 173.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.401 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 14.1 tt -51.51 -29.38 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.715 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -60.19 -34.06 73.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.218 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -81.33 -28.77 34.4 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.52 -172.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.578 ' HA ' ' HD1' ' A' ' 23' ' ' TYR . 84.2 mtp -66.3 156.41 34.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.139 0.495 . . . . 0.0 110.967 176.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.7 m -93.39 110.36 21.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.35 0.595 . . . . 0.0 110.207 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.553 ' HD2' ' HD3' ' A' ' 16' ' ' PRO . 38.8 p90 -74.86 140.08 43.62 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.894 -177.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -124.14 89.06 52.22 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 121.229 0.537 . . . . 0.0 109.943 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.553 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 26.4 Cg_endo -62.23 -26.26 77.4 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.369 2.713 . . . . 0.0 112.747 -173.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -69.34 -21.34 63.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.504 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -116.24 7.94 14.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.839 0.352 . . . . 0.0 110.698 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 57.39 43.1 23.76 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.751 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -154.0 171.72 18.6 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.451 -0.499 . . . . 0.0 111.403 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.534 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 57.6 m-85 -112.86 141.93 46.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.412 176.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 17.2 p -133.63 135.4 44.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.993 0.425 . . . . 0.0 111.107 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.588 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 7.6 t80 -106.36 117.47 57.11 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -56.38 113.37 1.42 Allowed 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.028 2.486 . . . . 0.0 113.717 -173.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 12.2 t -126.86 132.14 24.19 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.65 175.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 2.1 Cg_endo -86.08 118.16 1.68 Allowed 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 121.802 1.668 . . . . 0.0 111.582 174.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 29.3 p -177.09 -46.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.414 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 169.29 -27.46 0.13 Allowed Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.367 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.468 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 3.5 t70 -142.02 175.09 10.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -123.26 147.82 46.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.639 0.2 . . . . 0.0 110.619 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.588 ' HB2' ' HB3' ' A' ' 23' ' ' TYR . 96.7 m-85 -46.51 111.35 0.37 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.597 0.561 . . . . 0.0 111.221 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -111.37 135.39 51.99 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.089 0.471 . . . . 0.0 111.073 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' A' ' 45' ' ' ALA . 16.9 tt -132.62 136.7 55.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.754 177.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.538 ' O ' ' HG3' ' A' ' 38' ' ' MET . 30.0 m-85 -95.02 126.37 40.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.369 -174.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 35' ' ' LEU . 0.5 OUTLIER -55.3 -34.73 64.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.123 0.487 . . . . 0.0 110.625 -178.12 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -57.3 -48.74 78.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.414 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -70.78 -32.16 69.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.909 -178.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.538 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 81.2 mtp -61.18 -43.67 98.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.307 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -66.64 -31.15 71.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.192 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -72.37 -14.23 61.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.427 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.74 0.78 36.74 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.632 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -99.54 93.89 6.11 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -106.19 101.06 10.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 122.001 0.905 . . . . 0.0 111.265 -176.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 p -166.55 131.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.839 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.462 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -100.39 138.93 36.79 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.323 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.07 139.22 43.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.17 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.581 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 7.0 t -110.6 116.02 53.02 Favored Pre-proline 0 C--N 1.313 -0.989 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.133 176.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.51 ' O ' ' HB3' ' A' ' 49' ' ' SER . 35.1 Cg_endo -71.59 157.14 56.65 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.373 2.049 . . . . 0.0 111.192 172.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.51 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 46.2 t 89.93 -59.36 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.045 0.938 . . . . 0.0 110.322 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.9 p -89.46 -29.19 19.18 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.677 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 t 69.01 74.53 0.25 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.621 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.448 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 53.9 tp -138.68 152.02 47.68 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.6 mtm -133.44 137.94 45.98 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.587 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.479 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -137.56 153.5 28.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.155 178.257 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 3.8 t70 -80.05 151.81 29.72 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.23 115.59 26.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.976 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.587 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 42.5 t -70.12 118.07 14.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.509 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -122.78 159.96 26.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.571 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.494 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.8 t70 -131.35 167.44 19.25 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.405 ' H ' ' HG3' ' A' ' 60' ' ' LYS . 23.2 mtmm -63.05 -45.32 92.81 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.342 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -68.69 -40.31 80.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.038 -1.437 . . . . 0.0 111.14 -175.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.47 -42.11 99.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.761 0.315 . . . . 0.0 110.994 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 75.9 mt -63.83 -46.28 85.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.241 177.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.558 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . . . -57.38 -47.21 82.27 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.38 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.18 -46.38 79.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.06 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -67.83 -36.05 79.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.641 -176.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.558 ' HD2' ' HA ' ' A' ' 64' ' ' ALA . 26.3 m-85 -53.49 -48.6 68.78 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.007 0.432 . . . . 0.0 110.378 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -67.52 -43.02 81.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.402 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -74.65 -29.71 61.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -174.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.88 -21.41 26.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.617 0.246 . . . . 0.0 111.103 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.893 -179.325 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.448 -0.547 0 CA-C-O 121.348 0.594 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -80.13 -35.09 37.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.241 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -114.85 159.2 20.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.362 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.532 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 34.9 tt0 -143.11 110.73 5.85 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.39 139.45 43.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.251 -170.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.583 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 39.0 mt-10 -58.2 135.52 57.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.062 0.458 . . . . 0.0 110.34 173.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.422 ' CG2' ' HA ' ' A' ' 58' ' ' PHE . 15.5 tt -54.54 -29.45 20.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.771 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.9 -27.94 68.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.967 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -83.93 -39.91 19.19 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.464 -175.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 83.0 mtp -60.84 142.78 55.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.708 0.29 . . . . 0.0 111.021 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.0 m -79.69 124.68 28.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.973 -176.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.484 ' HB2' ' HE1' ' A' ' 66' ' ' TYR . 39.2 p90 -84.27 141.65 30.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.099 0.476 . . . . 0.0 111.783 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -125.7 92.05 47.26 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 173.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.62 -26.38 53.88 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 123.094 2.529 . . . . 0.0 113.253 -172.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -69.57 -28.93 66.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.007 0.432 . . . . 0.0 110.918 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -107.41 4.54 26.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.838 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 58.56 37.93 25.4 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.993 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 26.0 ptt? -143.12 171.46 14.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.292 0.568 . . . . 0.0 111.841 -174.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.479 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 41.8 m-85 -116.0 148.18 40.41 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.392 173.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 41.5 p -136.27 167.24 21.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.894 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.462 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 84.3 t80 -144.08 118.07 5.9 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -56.97 109.83 0.51 Allowed 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.201 2.601 . . . . 0.0 113.19 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.1 t -127.22 131.3 23.78 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.712 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 5.2 Cg_exo -80.2 119.42 3.85 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.951 1.768 . . . . 0.0 111.472 176.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.448 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 30.6 p -179.4 -52.72 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.448 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 174.44 -28.57 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.215 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.588 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 1.2 t70 -142.8 175.93 9.44 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -115.71 154.87 28.78 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.578 ' O ' ' HA ' ' A' ' 22' ' ' THR . 80.4 m-85 -50.29 134.75 22.61 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.519 0.512 . . . . 0.0 110.61 178.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -131.77 133.29 44.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.168 0.509 . . . . 0.0 111.066 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 20' ' ' MET . 10.9 tt -151.28 126.11 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.009 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -87.29 138.16 31.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.79 0.329 . . . . 0.0 110.895 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.6 ' HG ' ' HD2' ' A' ' 66' ' ' TYR . 1.2 tm? -64.19 -31.73 73.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.018 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -61.92 -29.92 70.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.792 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.17 -32.63 29.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.419 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.553 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 84.6 mtp -67.6 -34.12 76.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.145 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -64.64 -24.44 67.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.398 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -76.93 -12.21 59.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.025 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.91 -11.49 41.26 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.402 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.553 ' O ' ' HA ' ' A' ' 38' ' ' MET . 9.3 tp10 -89.41 133.77 34.38 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -142.08 100.13 3.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.115 0.96 . . . . 0.0 111.503 -177.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.4 p -167.27 127.7 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.424 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.58 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -100.73 141.55 33.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.106 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.6 137.42 51.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.687 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.41 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 18.0 t -99.68 111.88 62.53 Favored Pre-proline 0 N--CA 1.431 -1.408 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.588 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 14.7 Cg_endo -62.6 156.6 51.57 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.935 1.757 . . . . 0.0 110.794 174.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 37.4 m 85.5 -55.75 0.08 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.197 0.999 . . . . 0.0 111.192 -176.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 52' ' ' LEU . 16.6 p -98.13 -17.09 19.24 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.836 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.8 t 70.23 29.77 3.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.423 0.689 . . . . 0.0 111.975 172.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.433 HD13 ' HZ ' ' A' ' 31' ' ' PHE . 1.6 tt -86.56 130.57 34.44 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -174.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.4 mtm -115.35 137.39 52.09 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.85 -176.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.58 HD11 ' HB3' ' A' ' 45' ' ' ALA . 2.8 pp -141.88 144.21 25.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.532 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 4.9 t0 -84.27 156.06 22.15 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.73 125.32 55.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.045 0.45 . . . . 0.0 112.068 -174.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.583 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 21.8 t -88.86 100.03 10.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.422 ' HA ' ' CG2' ' A' ' 9' ' ' ILE . 50.6 p90 -94.52 160.3 14.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.843 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.579 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 27.3 t70 -116.14 151.65 35.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.857 0.36 . . . . 0.0 110.515 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.455 ' HE2' ' HB2' ' A' ' 60' ' ' LYS . 22.2 mtmm -58.56 -46.36 87.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.14 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -81.09 -32.19 34.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.346 -174.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.411 ' CB ' ' HB3' ' A' ' 59' ' ' ASP . 15.9 t70 -64.44 -43.66 93.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.324 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 54.4 mt -61.03 -47.38 86.67 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.82 0.343 . . . . 0.0 110.391 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.16 -43.01 77.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.185 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -62.99 -44.87 94.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.688 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.6 ' HD2' ' HG ' ' A' ' 35' ' ' LEU . 84.1 t80 -70.54 -35.3 73.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.07 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.5 -42.95 79.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.446 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -74.98 -30.08 61.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.09 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -63.54 -57.83 8.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.264 0.555 . . . . 0.0 110.793 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.62 -25.48 60.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.656 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.516 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.612 -178.88 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.448 -0.558 0 CA-C-O 121.237 0.541 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -94.89 -12.35 27.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.822 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -125.94 155.16 41.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.776 174.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.558 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 33.9 tt0 -151.44 114.43 4.73 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -176.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -127.55 161.8 34.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.591 -173.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -78.57 148.68 33.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.86 0.362 . . . . 0.0 110.388 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.6 tt -57.02 -28.95 30.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.5 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -63.55 -28.19 69.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.993 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -77.49 -31.21 53.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.947 0.403 . . . . 0.0 111.052 -175.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.593 ' HA ' ' HD1' ' A' ' 23' ' ' TYR . 84.4 mtp -69.5 170.52 10.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.951 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.3 m -106.76 121.25 44.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.707 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.533 ' HB2' ' HE1' ' A' ' 66' ' ' TYR . 44.0 p90 -74.56 142.58 44.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.624 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.421 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 17.8 tt0 -139.95 93.7 9.27 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 121.356 0.598 . . . . 0.0 110.649 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 25.1 Cg_endo -66.22 -19.05 56.68 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.69 2.26 . . . . 0.0 112.279 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.83 -35.1 77.27 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.206 0.526 . . . . 0.0 110.603 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -111.61 5.95 19.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.874 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.554 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 2.1 mp0 57.91 31.58 20.77 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.809 178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 27.4 ptt? -152.33 162.95 40.43 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.462 -174.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -91.39 138.3 31.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.635 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 21.9 p -129.29 143.58 50.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.709 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.609 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 9.8 t80 -112.94 117.15 46.62 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.48 115.97 2.55 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.235 2.623 . . . . 0.0 113.622 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 13.6 t -135.94 125.65 16.21 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.07 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 2.2 Cg_endo -82.96 119.21 2.82 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 121.897 1.732 . . . . 0.0 111.48 174.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.3 p -176.71 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 164.18 -29.15 0.23 Allowed Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 113.968 -1.469 . . . . 0.0 110.237 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.534 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 3.3 t70 -143.2 174.69 10.49 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -119.93 146.23 45.99 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.609 ' HB2' ' HB3' ' A' ' 23' ' ' TYR . 88.5 m-85 -44.33 118.39 1.51 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.679 0.612 . . . . 0.0 111.361 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -114.24 136.94 52.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.019 0.437 . . . . 0.0 110.337 -177.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 20' ' ' MET . 18.4 tt -134.83 129.67 51.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.586 ' O ' ' HG3' ' A' ' 38' ' ' MET . 48.2 m-85 -84.23 126.78 33.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.836 -174.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -33.39 74.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.894 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -58.25 -34.57 70.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.257 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -87.08 -31.16 20.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.586 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 82.9 mtp -64.86 -41.52 95.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.73 0.3 . . . . 0.0 110.983 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -63.04 -25.4 68.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.577 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -77.3 -10.64 59.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.801 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.26 -5.61 38.76 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.689 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 38' ' ' MET . 7.4 tp10 -89.4 130.97 35.68 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.584 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -137.68 100.27 4.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.25 1.024 . . . . 0.0 111.784 -175.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.0 p -166.82 128.98 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.807 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.451 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -100.27 139.76 35.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.032 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.54 135.81 57.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.176 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.559 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 8.1 t -104.23 116.78 60.8 Favored Pre-proline 0 N--CA 1.435 -1.208 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.846 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.534 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 49.9 Cg_endo -70.41 156.74 60.99 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.582 2.188 . . . . 0.0 110.98 173.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 33.3 m 86.97 -56.72 0.05 OUTLIER 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.161 0.984 . . . . 0.0 111.398 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.7 p -91.12 -27.29 18.66 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.87 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.6 t 69.05 72.78 0.26 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.183 174.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.533 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 51.7 tp -134.57 148.49 50.47 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 174.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.439 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 35.2 mtm -131.06 137.75 49.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.426 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.46 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -138.98 152.46 24.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.254 178.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.558 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 8.2 t70 -80.87 145.63 31.25 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 83.9 t -134.12 115.34 20.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.223 0.535 . . . . 0.0 111.715 -177.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.8 t -74.17 107.35 4.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.93 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -96.18 165.24 12.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.455 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.547 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 14.7 t70 -115.14 146.16 41.64 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.968 173.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.02 -40.06 96.6 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -76.76 -40.87 46.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.302 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.408 ' HB2' ' HB3' ' A' ' 59' ' ' ASP . 8.7 m-20 -66.59 -32.03 73.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.192 -177.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 48.0 mt -66.96 -53.34 32.61 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.751 176.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 67' ' ' TYR . . . -58.94 -46.05 88.93 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.03 0.443 . . . . 0.0 111.163 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.22 -41.4 88.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.27 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.533 ' HE1' ' HB2' ' A' ' 14' ' ' PHE . 57.5 t80 -65.75 -35.37 80.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.203 -178.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' A' ' 64' ' ' ALA . 12.7 m-85 -52.29 -47.91 65.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.958 0.409 . . . . 0.0 110.342 174.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -74.28 -26.7 60.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.362 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -75.41 -44.0 46.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 0.0 111.303 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.554 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -80.2 -12.85 59.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.411 -176.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.792 178.128 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 120.862 0.363 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -100.09 5.95 44.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.758 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -162.2 172.5 15.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.55 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 36.0 tt0 -154.13 111.7 3.47 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 3.5 mp -116.91 151.04 18.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.029 -177.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.576 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 57.7 mt-10 -78.34 149.97 33.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.886 0.374 . . . . 0.0 110.567 176.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.7 tt -59.01 -28.82 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.886 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -68.82 -29.98 68.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.381 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.444 ' HB3' HG22 ' A' ' 7' ' ' ILE . 31.9 t70 -84.74 -36.16 21.98 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.322 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.55 ' SD ' ' HB2' ' A' ' 23' ' ' TYR . 4.1 tpt -49.25 141.69 8.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.058 170.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 m -87.48 108.99 19.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.982 0.42 . . . . 0.0 110.069 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.513 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 40.0 p90 -74.17 137.7 43.3 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.976 0.417 . . . . 0.0 110.78 -177.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -115.34 93.9 37.6 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.649 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 70' ' ' ALA . 49.2 Cg_endo -68.86 -22.39 36.54 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.739 2.293 . . . . 0.0 112.449 -174.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -77.09 -18.83 57.71 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.075 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.53 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 4.3 t-20 -116.26 -6.7 11.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.516 0.198 . . . . 0.0 111.247 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.512 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 1.8 mp0 64.35 42.35 5.3 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.08 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.543 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 26.2 ptt? -151.46 174.07 13.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.46 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.513 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 36.0 m-85 -109.86 149.12 30.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.955 0.407 . . . . 0.0 110.674 176.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 36.8 p -137.62 159.93 40.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.283 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.55 ' HB2' ' SD ' ' A' ' 12' ' ' MET . 6.1 t80 -141.28 131.39 13.02 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.34 127.06 21.72 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.692 2.261 . . . . 0.0 113.327 -176.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.511 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 20.0 t -140.74 141.37 24.54 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.214 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 12.0 Cg_endo -91.3 117.99 0.52 Allowed 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 122.171 1.914 . . . . 0.0 112.079 174.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.9 p 177.83 -44.38 0.01 OUTLIER 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.208 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.22 -19.86 0.48 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.168 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -140.12 173.63 11.32 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.432 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -122.27 151.63 40.89 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.622 -0.14 . . . . 0.0 110.622 177.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.601 ' O ' ' HA ' ' A' ' 22' ' ' THR . 93.9 m-85 -47.88 126.94 11.27 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 123.802 0.688 . . . . 0.0 110.642 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -127.86 138.64 52.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.857 0.361 . . . . 0.0 110.939 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.543 ' O ' ' HB2' ' A' ' 20' ' ' MET . 12.1 tt -148.88 132.87 8.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.712 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -87.54 142.57 27.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.55 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.43 HD11 HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -67.86 -30.76 70.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.083 0.468 . . . . 0.0 110.741 -177.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -61.26 -31.24 71.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.839 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 6.7 m-20 -80.74 -34.02 34.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.569 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 79.0 mtp -63.99 -35.42 80.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.976 0.417 . . . . 0.0 110.07 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -68.27 -20.77 64.81 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.638 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 44.5 mm-40 -76.59 -13.42 60.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.361 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.49 -3.87 61.6 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.433 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -90.47 105.09 17.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.743 ' HD2' ' HE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -115.4 100.0 7.78 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.995 0.902 . . . . 0.0 110.552 -177.082 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 1.8 p -167.03 129.5 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.727 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.497 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -100.01 139.0 36.31 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.84 HG22 ' HG2' ' A' ' 53' ' ' MET . 38.4 t -115.67 119.0 60.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.194 -176.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.57 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 6.8 t -90.19 120.88 69.14 Favored Pre-proline 0 C--N 1.317 -0.824 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' A' ' 49' ' ' SER . 58.2 Cg_endo -73.45 154.95 50.76 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.355 2.037 . . . . 0.0 112.578 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 51.4 m 78.09 -54.4 0.5 Allowed 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.963 0.905 . . . . 0.0 111.637 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 12.1 p -82.2 -25.83 33.88 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.4 t 70.49 42.91 0.84 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.04 169.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.499 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 26.7 tp -103.96 128.61 51.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.359 0.599 . . . . 0.0 110.076 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.84 ' HG2' HG22 ' A' ' 46' ' ' VAL . 35.6 mtm -117.07 136.98 52.58 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.918 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.497 HD11 ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -138.68 152.98 25.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.747 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.55 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 4.7 t70 -82.42 151.4 26.6 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.533 HG13 ' HB2' ' A' ' 43' ' ' LYS . 6.3 p -129.7 112.99 25.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.559 0.695 . . . . 0.0 111.378 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.576 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 53.0 t -68.38 118.62 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.709 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.743 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 20.7 p90 -133.37 164.58 26.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.466 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.569 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 11.6 t70 -137.23 159.95 40.44 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.502 ' HD3' ' H ' ' A' ' 60' ' ' LYS . 3.0 mppt? -62.15 -37.64 85.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.028 0.442 . . . . 0.0 109.851 176.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -64.16 -45.16 89.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.523 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.97 -45.54 88.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.667 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 40.8 mt -55.02 -53.68 52.76 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.108 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.13 -43.18 73.88 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.217 0.323 . . . . 0.0 111.368 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -66.2 -49.89 65.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.022 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -67.73 -32.31 72.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.651 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.432 ' HD1' ' O ' ' A' ' 63' ' ' LEU . 2.2 m-85 -50.87 -44.28 59.62 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 172.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -63.21 -49.57 73.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.667 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -68.86 -32.51 72.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.287 -175.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.512 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -81.69 -10.63 59.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.776 0.322 . . . . 0.0 111.105 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.62 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.814 177.106 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.448 -0.57 0 CA-C-O 121.083 0.468 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -86.08 -23.24 26.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.972 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.637 ' HB2' HG22 ' A' ' 54' ' ' ILE . 1.6 m-20 -119.46 145.38 46.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.646 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.408 ' HG3' ' CB ' ' A' ' 55' ' ' ASP . 36.5 tt0 -140.36 108.28 5.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.726 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.5 mp -110.95 160.84 9.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -176.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.446 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 5.2 mp0 -79.38 148.99 31.79 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.3 tt -58.15 -29.95 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.129 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -68.07 -27.76 66.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.045 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.28 -39.44 54.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.782 0.325 . . . . 0.0 110.893 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 81.1 mtp -64.2 157.19 26.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.13 0.49 . . . . 0.0 111.154 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.6 m -90.44 109.22 20.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.482 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.602 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 42.1 p90 -78.96 134.63 36.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.192 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 9.5 tp10 -117.76 97.65 50.95 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.197 177.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 21.9 Cg_endo -61.25 -29.72 86.89 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.981 2.454 . . . . 0.0 111.953 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.62 -23.54 63.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.375 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.81 -11.63 15.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.119 0.485 . . . . 0.0 109.977 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.55 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 1.9 mp0 69.84 35.11 2.41 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.696 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.549 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 25.0 ptt? -157.99 174.71 14.83 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.593 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.602 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 42.8 m-85 -105.33 140.49 38.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.382 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 42.6 p -132.08 163.01 29.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.904 177.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.614 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 45.6 t80 -136.66 118.57 11.48 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.13 118.51 5.25 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 123.23 2.62 . . . . 0.0 112.794 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.0 t -137.55 140.58 30.64 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.57 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -90.94 118.9 0.61 Allowed 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 121.828 1.685 . . . . 0.0 111.973 174.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.2 p 179.52 -41.27 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 160.17 -26.3 0.31 Allowed Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.398 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.562 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 3.5 t0 -142.94 175.23 10.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.21 153.34 25.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.338 0.113 . . . . 0.0 111.137 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.614 ' HB2' ' HB3' ' A' ' 23' ' ' TYR . 81.2 m-85 -52.45 136.12 32.31 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.063 175.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 2.2 pt20 -133.3 136.68 45.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.876 0.37 . . . . 0.0 110.884 -176.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.549 ' O ' ' HB2' ' A' ' 20' ' ' MET . 15.2 tt -151.55 142.5 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.477 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.546 ' O ' ' HG3' ' A' ' 38' ' ' MET . 95.0 m-85 -99.31 147.74 24.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.914 0.388 . . . . 0.0 111.129 -177.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.47 -41.55 93.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.312 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -65.04 -31.99 73.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.186 0.517 . . . . 0.0 110.849 -175.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.01 -44.07 73.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.093 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.546 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 78.5 mtp -62.18 -42.61 99.44 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.684 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -65.93 -16.55 63.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.254 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -81.99 -12.48 58.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.41 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.2 -4.43 35.5 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.749 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -105.77 111.0 23.49 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.549 ' HD3' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -118.75 102.87 9.15 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.842 0.829 . . . . 0.0 110.732 -172.622 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 1.6 p -162.42 126.22 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.665 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.552 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -99.85 137.2 38.64 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.389 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.764 HG22 ' HG2' ' A' ' 53' ' ' MET . 47.7 t -114.62 123.01 69.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.764 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.532 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 12.0 t -90.73 122.3 67.11 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.562 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 43.2 Cg_endo -74.59 156.31 44.87 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.225 1.95 . . . . 0.0 111.29 175.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 35.5 t 89.28 -58.39 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.857 0.863 . . . . 0.0 110.107 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.4 p -89.3 -26.15 21.28 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 175.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.9 m 67.36 47.99 1.21 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.227 174.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 53' ' ' MET . 1.7 tt -102.71 135.23 44.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.764 ' HG2' HG22 ' A' ' 46' ' ' VAL . 32.3 mtm -117.11 137.14 52.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.466 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.637 HG22 ' HB2' ' A' ' 5' ' ' ASP . 2.8 pp -142.54 146.1 22.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.222 -176.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.408 ' CB ' ' HG3' ' A' ' 6' ' ' GLU . 6.4 m-20 -79.17 151.28 31.37 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.89 109.69 15.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.302 0.572 . . . . 0.0 110.941 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.446 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 46.9 t -65.95 112.37 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.423 -177.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -108.09 160.09 16.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.017 0.437 . . . . 0.0 111.651 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.734 ' HB3' ' HB2' ' A' ' 62' ' ' ASP . 20.3 t70 -117.01 146.15 43.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.093 173.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.418 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 12.3 mptt -62.4 -37.66 86.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.881 0.372 . . . . 0.0 110.563 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.39 -26.58 28.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.176 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.734 ' HB2' ' HB3' ' A' ' 59' ' ' ASP . 4.2 m-20 -65.58 -48.39 72.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.071 173.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 83.5 mt -55.08 -49.35 71.91 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.741 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.09 -37.01 83.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.0 0.429 . . . . 0.0 111.534 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -69.16 -52.83 24.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.677 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -64.13 -34.91 79.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.743 0.306 . . . . 0.0 110.934 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -53.83 -46.73 71.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.056 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.28 -41.89 76.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.584 -178.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -59.39 -44.92 92.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.232 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.55 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -81.73 -27.31 33.95 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.521 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.827 -179.824 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 55' ' ' ASP . 17.4 p . . . . . 0 N--CA 1.45 -0.471 0 CA-C-O 121.642 0.734 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -110.23 -13.24 14.37 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.509 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.512 ' HB2' HG22 ' A' ' 54' ' ' ILE . 9.5 m-20 -97.42 127.02 43.04 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 176.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -124.46 108.58 12.29 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.717 -173.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.468 HG22 ' HB3' ' A' ' 11' ' ' ASP . 2.7 mp -111.84 150.27 14.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.126 -175.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -71.4 145.32 49.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.985 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.439 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 20.7 tt -62.36 -27.57 42.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 172.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -56.79 -29.42 62.68 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.573 173.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.468 ' HB3' HG22 ' A' ' 7' ' ' ILE . 27.8 t70 -94.96 -41.13 9.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.794 -0.184 . . . . 0.0 111.224 -175.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.477 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 68.7 mtp -60.78 145.63 49.01 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.17 0.509 . . . . 0.0 110.867 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 m -89.92 124.03 34.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.053 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.434 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . 38.5 p90 -74.27 135.74 42.65 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.291 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -118.3 88.4 32.86 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.131 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.79 -15.91 45.04 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.117 2.544 . . . . 0.0 112.632 -174.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -68.98 -29.7 67.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.866 0.365 . . . . 0.0 111.217 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.583 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 2.0 t-20 -118.47 6.27 11.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.872 0.367 . . . . 0.0 110.571 -177.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 59.43 43.53 16.25 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.007 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.583 ' HG2' ' HB3' ' A' ' 18' ' ' ASN . 22.9 ptt? -145.58 174.45 11.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.975 0.416 . . . . 0.0 110.925 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.439 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 92.0 m-85 -108.14 142.6 38.12 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 73.0 p -137.37 167.07 22.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.716 0.293 . . . . 0.0 111.192 -175.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.477 ' CD1' ' HA ' ' A' ' 12' ' ' MET . 5.6 t80 -146.68 124.04 5.94 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.9 111.71 0.77 Allowed 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.129 2.552 . . . . 0.0 112.993 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.405 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 27.6 t -118.64 137.96 25.39 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.756 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -88.83 116.95 0.85 Allowed 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 121.349 1.366 . . . . 0.0 111.558 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.5 p 175.15 -41.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.497 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 153.66 -15.6 0.63 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.882 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -142.45 176.15 9.23 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.412 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 18.8 ptp180 -113.62 153.62 28.56 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 22' ' ' THR . 91.5 m-85 -55.74 134.28 51.39 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 174.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 30' ' ' ARG . 24.3 mt-30 -129.8 132.18 46.43 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.946 0.403 . . . . 0.0 111.431 -176.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 20' ' ' MET . 14.6 tt -141.58 128.14 19.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.731 171.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.431 ' O ' ' HG3' ' A' ' 38' ' ' MET . 69.6 m-85 -91.13 154.56 19.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.904 0.383 . . . . 0.0 110.698 -176.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.76 -34.82 75.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.658 -177.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.53 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 27.4 t70 -59.67 -45.54 91.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.025 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.406 ' OD2' ' HB2' ' A' ' 34' ' ' TYR . 21.0 m-20 -64.76 -33.74 76.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 110.61 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 59.5 mtp -74.66 -36.12 62.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.987 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -65.08 -29.61 70.51 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.55 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 36' ' ' ASP . 24.6 mm-40 -58.98 -22.94 61.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.617 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.3 8.2 38.84 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.57 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -115.36 157.65 23.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.666 ' HD3' ' N ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -145.47 100.73 3.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.7 0.762 . . . . 0.0 111.566 -174.091 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 1.4 p -166.71 131.41 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.503 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.537 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -100.57 132.36 45.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.699 HG22 ' HG2' ' A' ' 53' ' ' MET . 47.2 t -115.13 133.89 59.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.454 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 14.2 t -104.38 130.96 22.37 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.411 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.542 ' O ' ' HB2' ' A' ' 49' ' ' SER . 58.4 Cg_endo -79.44 156.45 25.22 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.866 2.377 . . . . 0.0 112.021 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.542 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 41.6 m 83.22 -53.89 0.16 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.196 0.998 . . . . 0.0 111.609 -177.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 18.0 p -90.65 -24.88 20.36 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.631 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.1 t 64.77 49.8 2.16 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.33 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.2 mt -117.32 154.78 30.67 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.366 0.603 . . . . 0.0 111.308 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.699 ' HG2' HG22 ' A' ' 46' ' ' VAL . 25.2 mtm -135.01 138.47 43.99 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.609 -168.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.537 HD11 ' HB3' ' A' ' 45' ' ' ALA . 2.7 pp -140.37 152.49 21.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.319 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.438 ' HB2' ' HB ' ' A' ' 3' ' ' THR . 4.9 t70 -91.81 147.84 22.68 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -173.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 5.1 p -133.9 123.5 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.4 t -79.8 114.76 21.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 122.137 -0.352 . . . . 0.0 110.661 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.566 ' CE1' ' HB3' ' A' ' 43' ' ' LYS . 44.1 p90 -121.63 165.09 16.24 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.707 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.417 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 14.0 t70 -121.26 161.16 22.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.206 0.527 . . . . 0.0 110.086 174.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -61.66 -40.12 93.82 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.46 175.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -78.23 -35.25 48.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.771 -174.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -70.91 -32.1 68.93 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.341 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 61.7 mt -63.51 -48.71 76.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.76 0.314 . . . . 0.0 110.303 172.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.99 -38.92 93.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.326 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -66.49 -48.86 68.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.34 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.434 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 85.4 t80 -62.6 -36.49 82.9 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.945 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -51.99 -42.14 62.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.684 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.41 -37.75 60.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.611 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -60.4 -54.36 46.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.057 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.88 -22.92 45.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.939 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -177.937 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.8 p . . . . . 0 N--CA 1.447 -0.601 0 CA-C-O 121.001 0.429 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -90.11 -11.38 41.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.608 -175.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.448 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 7.3 m-20 -141.99 169.7 17.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.276 176.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 35.5 tt0 -155.86 118.99 4.28 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -134.96 153.89 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.788 -175.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.531 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 45.4 mt-10 -72.81 152.08 41.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.036 0.446 . . . . 0.0 110.813 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.439 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 18.6 tt -55.49 -29.03 23.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.479 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.02 -35.1 80.1 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.402 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -78.08 -27.73 48.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.947 0.403 . . . . 0.0 111.12 -172.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 90.4 mtp -75.84 161.18 29.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.283 0.563 . . . . 0.0 111.317 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.8 m -95.12 115.76 27.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.956 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.454 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 44.5 p90 -81.33 138.88 35.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.091 0.472 . . . . 0.0 111.254 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -118.98 91.46 43.31 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.61 -28.36 52.78 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.188 2.592 . . . . 0.0 113.182 -172.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -70.98 -21.56 62.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.8 -175.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -112.97 3.58 16.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.62 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 55.09 44.53 27.84 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.904 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -146.66 165.7 28.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.94 0.4 . . . . 0.0 110.913 -176.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.543 ' HE1' HD23 ' A' ' 35' ' ' LEU . 68.4 m-85 -112.36 145.33 40.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.716 175.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 36.7 p -133.12 157.87 44.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.75 0.309 . . . . 0.0 110.987 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.496 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 9.6 t80 -140.34 125.17 11.07 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -51.21 127.89 23.47 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.376 2.718 . . . . 0.0 113.743 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 20.4 t -145.46 135.02 11.48 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.915 177.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 2.5 Cg_endo -87.24 118.09 1.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.026 1.817 . . . . 0.0 111.679 174.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 31.0 p -178.55 -54.05 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.404 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.468 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 169.44 -25.15 0.1 Allowed Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.99 -177.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -136.68 174.43 10.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.5 147.79 43.28 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 122.437 -0.164 . . . . 0.0 110.563 176.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' A' ' 22' ' ' THR . 92.1 m-85 -45.94 128.86 9.38 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.448 0.467 . . . . 0.0 110.445 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -131.51 138.18 48.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.231 0.539 . . . . 0.0 110.884 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.0 tt -143.17 129.63 17.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.802 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -86.27 143.99 27.64 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.143 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.543 HD23 ' HE1' ' A' ' 21' ' ' PHE . 1.6 tm? -62.46 -36.38 82.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.142 -173.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -65.26 -34.18 77.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.933 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.97 -44.08 97.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.106 0.479 . . . . 0.0 110.408 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 70.3 mtp -62.74 -41.69 99.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.116 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -65.72 -31.41 72.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.902 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -76.01 -3.88 38.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.734 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.48 -17.97 45.65 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.972 174.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -91.23 95.57 10.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.155 0.502 . . . . 0.0 110.696 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -100.68 100.93 11.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.579 0.704 . . . . 0.0 110.966 -177.115 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.9 p -165.51 126.96 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.68 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.454 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -99.99 143.6 30.01 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.018 0.437 . . . . 0.0 110.36 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.43 140.05 44.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.38 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.539 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 11.1 t -109.37 118.04 51.7 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -70.61 156.51 60.98 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.439 2.093 . . . . 0.0 112.135 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.1 t 85.78 -53.53 0.08 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.852 0.861 . . . . 0.0 110.659 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 17.5 p -89.14 -28.39 20.08 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.4 m 66.92 54.69 0.76 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.387 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 53' ' ' MET . 1.7 tt -110.9 136.5 49.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.443 ' N ' HD23 ' A' ' 52' ' ' LEU . 31.9 mtm -123.84 137.99 54.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.742 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.454 HD11 ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -140.22 153.8 22.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 43.1 m-20 -82.01 159.79 23.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.838 0.351 . . . . 0.0 110.506 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.56 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 49.0 t -130.97 144.19 38.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.09 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.531 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 44.0 t -106.56 108.85 26.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.632 0.253 . . . . 0.0 110.592 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.513 ' HE2' ' HD2' ' A' ' 43' ' ' LYS . 45.2 p90 -112.98 165.24 12.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.041 -177.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.464 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 2.7 t70 -127.4 170.63 12.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.233 0.539 . . . . 0.0 110.234 175.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -63.62 -46.25 86.61 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.999 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -72.88 -37.44 67.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.917 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -63.8 -31.48 72.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.773 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 58.9 mt -75.03 -45.31 42.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.605 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.93 -49.63 76.93 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.583 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.61 -40.27 96.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.174 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.421 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 91.2 t80 -69.22 -38.05 78.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.737 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.15 -45.18 83.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.861 0.362 . . . . 0.0 110.794 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -76.45 -25.72 54.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.586 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -79.26 -40.53 30.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.747 0.308 . . . . 0.0 111.64 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.54 -26.4 30.15 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.419 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.446 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 -176.038 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.451 -0.424 0 CA-C-O 121.364 0.602 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -83.18 -20.76 34.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.107 -173.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -132.66 162.81 30.41 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.172 0.51 . . . . 0.0 111.034 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 37.2 tt0 -146.93 108.52 4.32 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.657 171.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.96 155.74 18.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.056 -175.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.553 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 32.3 mp0 -65.32 144.42 57.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.391 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.0 tt -57.54 -29.35 33.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.445 0.64 . . . . 0.0 110.139 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -64.41 -28.8 69.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.927 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -82.1 -31.31 30.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.772 -175.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 84.2 mtp -68.65 160.84 29.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.027 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.1 m -85.17 110.89 19.33 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.076 0.465 . . . . 0.0 110.362 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.531 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 35.0 p90 -74.86 139.0 42.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.542 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -126.58 85.4 60.51 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.085 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.476 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 24.5 Cg_endo -62.86 -29.84 76.79 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.609 2.206 . . . . 0.0 111.579 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -63.81 -23.94 67.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.149 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -118.5 5.52 11.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.324 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.461 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 2.0 mp0 57.9 30.95 19.88 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.762 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 27.5 ptt? -144.36 170.89 15.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.061 0.458 . . . . 0.0 111.234 -175.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.531 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 31.0 m-85 -119.35 140.19 50.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.766 177.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 38.5 p -130.72 148.29 52.48 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.81 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.535 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 2.4 t80 -119.41 122.54 29.3 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.62 116.72 3.71 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.755 2.303 . . . . 0.0 113.383 -175.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 10.7 t -132.98 136.37 27.51 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.19 177.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 9.8 Cg_endo -90.29 118.24 0.68 Allowed 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 121.912 1.741 . . . . 0.0 111.642 174.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.409 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 32.0 p -176.56 -47.07 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.409 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 168.73 -26.89 0.13 Allowed Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.96 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.52 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 3.1 t0 -142.8 176.22 9.23 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.483 ' H ' ' HD2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -114.0 156.4 24.15 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -177.141 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 22' ' ' THR . 91.1 m-85 -58.39 117.72 4.78 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 172.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 30' ' ' ARG . 49.1 mt-30 -116.9 135.92 53.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.671 0.272 . . . . 0.0 111.105 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.421 HD13 HG11 ' A' ' 56' ' ' VAL . 13.8 tt -148.63 135.04 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.789 174.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -94.24 149.79 20.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.646 0.26 . . . . 0.0 110.62 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -32.11 70.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.488 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -60.51 -41.4 94.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.886 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 64.0 m-20 -66.11 -36.5 83.33 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.246 0.546 . . . . 0.0 110.115 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.532 ' HE2' ' HB3' ' A' ' 58' ' ' PHE . 57.7 mtp -69.19 -38.92 78.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.368 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -62.84 -30.2 71.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.22 0.533 . . . . 0.0 110.426 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 5.5 mm-40 -64.8 -22.16 66.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.319 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.72 -1.18 55.44 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -174.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -93.18 98.38 11.25 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.654 ' HB3' ' HE2' ' A' ' 58' ' ' PHE . 20.2 pttp -103.44 98.97 8.78 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.627 0.727 . . . . 0.0 111.421 -176.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 2.5 p -169.01 127.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.746 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.35 137.39 39.76 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 176.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.794 HG22 ' HG2' ' A' ' 53' ' ' MET . 40.8 t -111.84 132.4 60.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.022 -178.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.518 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 7.8 t -102.55 112.54 65.69 Favored Pre-proline 0 N--CA 1.448 -0.528 0 CA-C-O 120.991 0.424 . . . . 0.0 110.073 176.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.546 ' O ' ' HB3' ' A' ' 49' ' ' SER . 24.6 Cg_endo -67.81 157.38 62.02 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.27 1.98 . . . . 0.0 110.953 170.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.546 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 41.2 t 90.9 -58.43 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.053 0.941 . . . . 0.0 110.89 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 27.5 p -92.26 -28.25 17.11 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.948 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.8 t 69.65 73.25 0.24 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.399 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.543 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 46.6 tp -134.53 154.41 51.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.354 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.794 ' HG2' HG22 ' A' ' 46' ' ' VAL . 39.4 mtm -139.45 138.37 36.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.294 -177.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -140.17 152.38 21.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.86 177.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 2.1 m-20 -74.48 156.38 36.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.642 0.258 . . . . 0.0 110.32 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 5.0 p -131.15 124.75 56.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.278 0.561 . . . . 0.0 111.165 176.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.553 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 78.4 t -82.58 111.58 19.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.954 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.654 ' HE2' ' HB3' ' A' ' 43' ' ' LYS . 50.2 p90 -112.97 163.03 15.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.19 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.57 ' OD1' ' HG2' ' A' ' 61' ' ' GLU . 5.6 t70 -118.24 157.24 27.38 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.499 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -63.7 -40.49 96.93 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.223 179.087 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.57 ' HG2' ' OD1' ' A' ' 59' ' ' ASP . 10.3 pt-20 -73.34 -37.91 65.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.12 -177.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -63.05 -45.56 91.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.75 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 54.8 mt -56.75 -49.72 74.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.809 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.21 -42.78 86.97 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.974 0.416 . . . . 0.0 111.59 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.9 -46.01 79.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.355 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -66.02 -34.54 78.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.259 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -51.83 -53.1 44.02 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.693 0.283 . . . . 0.0 110.826 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.6 -36.55 81.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.68 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.52 -54.49 19.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.145 0.498 . . . . 0.0 111.436 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.461 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -65.91 -18.38 65.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.895 -176.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.616 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.97 179.239 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -113.22 6.38 17.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.86 0.362 . . . . 0.0 111.079 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -150.5 172.14 15.94 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.501 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 35.3 tt0 -158.9 117.14 2.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.818 0.342 . . . . 0.0 110.326 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.9 OUTLIER -125.99 163.05 28.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.457 ' HG2' ' HB ' ' A' ' 57' ' ' VAL . 46.0 mt-10 -87.88 152.97 21.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.024 0.44 . . . . 0.0 111.145 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.6 tt -60.15 -29.57 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.05 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -69.38 -28.86 66.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.733 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.23 -35.55 35.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.106 0.479 . . . . 0.0 109.769 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 78.5 mmm -57.01 152.28 13.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.41 171.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.6 m -96.85 124.55 40.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.833 0.349 . . . . 0.0 110.816 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -80.9 130.38 35.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.096 0.474 . . . . 0.0 110.507 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -115.43 90.07 24.0 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 30.9 Cg_endo -63.88 -21.57 68.97 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.959 2.439 . . . . 0.0 112.013 -176.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -59.86 -42.61 94.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.75 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.453 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 0.4 OUTLIER -110.79 5.62 20.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.9 -175.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.548 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 1.9 mp0 59.11 41.22 20.91 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.206 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.453 ' HG2' ' HB3' ' A' ' 18' ' ' ASN . 27.2 ptt? -147.3 173.74 12.3 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.91 -177.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -109.11 138.56 45.27 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.916 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.535 ' HB ' ' HD3' ' A' ' 30' ' ' ARG . 21.1 p -137.14 162.57 33.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.693 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.438 ' O ' ' HB2' ' A' ' 30' ' ' ARG . 52.3 t80 -144.14 128.16 9.1 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.82 107.96 0.31 Allowed 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.292 2.662 . . . . 0.0 113.774 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.46 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 20.8 t -113.0 140.83 24.61 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.002 174.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 21.0 Cg_endo -91.95 117.5 0.44 Allowed 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.989 1.793 . . . . 0.0 111.837 174.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.436 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 31.6 p 178.36 -46.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.919 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.436 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 164.23 -24.27 0.18 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.917 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.504 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -141.97 175.42 9.75 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.535 ' HD3' ' HB ' ' A' ' 22' ' ' THR . 7.6 ptp180 -118.33 157.6 26.78 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.326 -178.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.534 ' O ' ' HA ' ' A' ' 22' ' ' THR . 91.5 m-85 -50.04 129.6 20.96 Favored 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 123.831 0.707 . . . . 0.0 110.156 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -130.64 127.48 39.02 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.098 -171.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.479 ' HB ' ' HA ' ' A' ' 45' ' ' ALA . 13.3 tt -146.89 135.92 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.528 175.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.416 ' O ' ' HG3' ' A' ' 38' ' ' MET . 27.0 m-85 -97.48 144.16 27.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.481 -177.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.565 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 3.6 mm? -62.81 -27.83 69.58 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.941 0.4 . . . . 0.0 110.658 176.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -55.43 -43.55 75.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.724 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.4 -31.98 54.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.496 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.603 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 78.2 mtp -70.3 -32.4 70.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.116 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -68.82 -27.26 65.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.845 177.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -72.85 -7.0 48.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.855 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.0 -0.83 47.83 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.994 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.603 ' O ' ' HA ' ' A' ' 38' ' ' MET . 9.9 tp10 -105.7 155.06 19.62 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.664 ' HD3' ' N ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -147.62 100.99 3.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.769 0.795 . . . . 0.0 110.942 -176.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 p -167.2 131.08 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.98 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.479 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . . . -100.73 135.39 42.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.31 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 p -112.91 136.74 48.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.268 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.409 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 18.7 t -105.07 124.75 35.57 Favored Pre-proline 0 N--CA 1.436 -1.162 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.444 175.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.504 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 58.3 Cg_endo -75.7 156.42 39.93 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.805 2.337 . . . . 0.0 111.094 173.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 33.0 t 89.58 -57.37 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.764 0.826 . . . . 0.0 110.629 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.413 ' HB3' ' CB ' ' A' ' 27' ' ' CYS . 21.5 p -91.25 -30.91 16.36 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.306 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t 70.38 73.23 0.21 Allowed 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.276 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.3 tp -130.35 144.53 51.44 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.458 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.406 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 46.3 mtm -135.18 137.86 43.1 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.131 0.491 . . . . 0.0 110.984 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.469 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -138.61 154.86 27.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.663 179.43 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.501 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 2.1 t70 -83.4 151.31 25.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 43' ' ' LYS . 6.1 p -130.04 116.47 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.521 0.677 . . . . 0.0 111.909 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.457 ' HB ' ' HG2' ' A' ' 8' ' ' GLU . 48.4 t -72.76 111.55 7.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.446 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.486 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 28.4 p90 -115.33 164.7 13.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.032 -175.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.52 ' OD1' ' HG2' ' A' ' 61' ' ' GLU . 8.8 t70 -126.05 157.61 37.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 171.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.67 -37.76 88.67 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.629 178.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.52 ' HG2' ' OD1' ' A' ' 59' ' ' ASP . 12.9 pt-20 -73.13 -37.87 66.48 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.355 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.506 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 4.0 m-20 -59.06 -53.13 61.89 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.488 175.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.422 HD22 HD12 ' A' ' 35' ' ' LEU . 28.4 mt -55.42 -50.7 69.1 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.881 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.48 -48.23 81.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.681 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -68.46 -43.56 76.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.867 0.365 . . . . 0.0 110.876 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.506 ' HD1' ' O ' ' A' ' 62' ' ' ASP . 48.1 m-85 -68.13 -32.48 72.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.299 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.565 ' CE1' ' HB3' ' A' ' 35' ' ' LEU . 1.2 m-85 -51.63 -48.13 63.42 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.261 0.553 . . . . 0.0 109.956 170.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.44 -30.87 64.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.776 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 66' ' ' TYR . 67.8 mm-40 -66.73 -45.25 79.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.118 176.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.548 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -75.34 -20.47 59.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.509 -176.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.77 -179.946 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.634 ' HB ' ' OD1' ' A' ' 55' ' ' ASP . 5.7 p . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 120.973 0.416 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -114.08 -21.37 10.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.339 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -121.02 152.64 38.36 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.025 -173.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -144.67 117.65 8.83 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 123.12 0.262 . . . . 0.0 110.492 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.4 ' CD1' HG13 ' A' ' 54' ' ' ILE . 0.6 OUTLIER -118.17 162.58 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.564 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 41.6 mt-10 -69.29 148.85 49.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.956 0.408 . . . . 0.0 111.254 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.3 tt -62.36 -33.18 57.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.049 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.68 -27.25 61.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.753 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -72.53 -30.33 64.37 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.613 ' HA ' ' HD1' ' A' ' 23' ' ' TYR . 84.5 mtp -69.74 151.06 46.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.06 172.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.1 m -76.86 131.52 38.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.121 0.486 . . . . 0.0 111.578 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -74.92 127.17 32.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.329 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -125.24 85.26 58.48 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.002 0.43 . . . . 0.0 110.304 173.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.68 -34.17 42.15 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.759 2.306 . . . . 0.0 111.949 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.33 -34.11 76.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.478 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.476 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 3.5 t-20 -102.62 -1.6 29.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.875 0.369 . . . . 0.0 111.024 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.404 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 1.5 mp0 62.01 35.96 15.75 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.856 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.551 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 26.2 ptt? -154.0 167.58 29.28 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.544 -177.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -100.36 146.28 27.16 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.477 177.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 23.4 p -138.51 136.82 36.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.86 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.613 ' HD1' ' HA ' ' A' ' 12' ' ' MET . 8.6 t80 -115.38 121.31 34.94 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -50.68 118.73 4.38 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.672 2.915 . . . . 0.0 113.778 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.515 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 16.5 t -135.47 139.98 32.85 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.339 176.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -91.8 120.32 0.56 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.644 2.229 . . . . 0.0 111.947 172.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.6 p 177.61 -39.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.775 0.798 . . . . 0.0 108.958 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 158.14 -26.95 0.44 Allowed Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.627 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.452 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 3.7 t0 -142.04 176.34 9.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.464 ' HE ' ' HB ' ' A' ' 22' ' ' THR . 12.7 ptm180 -117.63 153.7 32.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.582 ' O ' ' HA ' ' A' ' 22' ' ' THR . 99.4 m-85 -51.57 128.24 22.56 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.58 0.55 . . . . 0.0 110.003 177.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -133.55 142.66 48.28 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.065 0.459 . . . . 0.0 110.686 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.551 ' O ' ' HB2' ' A' ' 20' ' ' MET . 14.6 tt -144.44 132.46 17.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.557 -178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -82.38 128.85 34.64 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.496 -177.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.494 HD12 ' CE1' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -62.59 -34.65 77.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -176.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -65.16 -25.92 67.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.246 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.87 -32.49 27.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.308 0.575 . . . . 0.0 109.76 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 83.6 mtp -67.46 -35.56 79.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.944 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -67.1 -23.6 65.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.154 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -77.69 -9.13 58.82 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.035 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.75 -18.63 34.42 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.058 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.45 121.43 27.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.874 0.369 . . . . 0.0 110.668 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.515 ' HD3' ' CE2' ' A' ' 58' ' ' PHE . 19.7 pttp -120.22 100.56 7.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.675 0.75 . . . . 0.0 112.131 -174.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 p -166.78 126.41 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.573 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.45 142.16 32.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.125 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.94 138.67 51.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.966 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.546 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 23.0 t -107.0 121.69 44.0 Favored Pre-proline 0 N--CA 1.436 -1.15 0 C-N-CA 120.521 -0.471 . . . . 0.0 109.787 176.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 34.0 Cg_endo -68.69 157.1 63.23 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.434 2.089 . . . . 0.0 111.285 174.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 29.5 m 86.51 -60.42 0.05 OUTLIER 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.136 0.975 . . . . 0.0 110.952 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 20.3 p -89.02 -26.88 21.21 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.3 t 69.39 46.45 0.76 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.146 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.548 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 1.7 tt -99.59 129.11 45.72 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 30.4 mtm -120.52 136.79 54.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.102 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.4 HG13 ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -147.01 162.21 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.634 ' OD1' ' HB ' ' A' ' 3' ' ' THR . 5.0 m-20 -80.29 162.34 24.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.695 0.283 . . . . 0.0 110.382 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.419 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 8.9 p -132.81 137.03 54.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.671 175.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.564 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 44.4 t -88.89 112.91 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.556 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.515 ' CE2' ' HD3' ' A' ' 43' ' ' LYS . 39.7 p90 -117.36 165.25 13.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.734 0.302 . . . . 0.0 110.824 -177.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -134.94 151.45 50.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.034 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -56.5 -40.92 75.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.713 175.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.18 -46.91 72.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.268 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.95 -44.73 96.15 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.541 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.42 HD22 HD11 ' A' ' 35' ' ' LEU . 36.4 mt -64.55 -48.21 75.89 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.083 -0.247 . . . . 0.0 111.185 -178.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.66 -41.84 95.83 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.058 0.456 . . . . 0.0 111.01 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -68.48 -42.5 78.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.303 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -66.7 -37.2 84.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.06 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.494 ' CE1' HD12 ' A' ' 35' ' ' LEU . 2.6 m-85 -52.71 -43.45 65.67 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.335 0.588 . . . . 0.0 110.147 174.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -66.66 -52.4 45.31 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.467 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -69.49 -31.63 70.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.782 -175.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.404 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -73.69 -18.29 61.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.748 0.309 . . . . 0.0 111.089 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.711 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.608 178.788 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.0 p . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 120.516 0.198 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -85.23 6.49 25.78 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -166.99 169.64 12.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.632 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -144.34 113.96 7.15 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.451 HG22 ' HB3' ' A' ' 11' ' ' ASP . 4.1 mt -120.9 142.07 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -169.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -62.52 140.07 58.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.458 171.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.8 tt -55.42 -33.93 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.518 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -73.36 -28.34 61.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.59 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.451 ' HB3' HG22 ' A' ' 7' ' ' ILE . 12.3 t70 -72.01 -29.41 64.17 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 83.0 mmm -69.1 145.02 53.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.373 176.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 50.9 m -90.35 115.76 27.79 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.102 0.477 . . . . 0.0 110.412 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.693 ' HB2' ' HE1' ' A' ' 66' ' ' TYR . 39.2 p90 -74.35 139.13 43.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.554 -176.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -115.38 85.02 12.5 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.223 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 21.3 Cg_endo -60.33 -28.92 87.76 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.163 2.575 . . . . 0.0 113.799 -170.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.35 -29.45 68.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.875 0.369 . . . . 0.0 110.988 -177.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -108.45 -0.4 20.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.955 -175.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 60.02 40.4 18.77 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.096 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -141.74 170.3 15.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.985 0.421 . . . . 0.0 110.757 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -109.7 144.78 37.59 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.547 174.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 35.5 p -134.66 158.35 44.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.079 -178.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.435 ' HB3' ' CD2' ' A' ' 31' ' ' PHE . 4.4 t80 -137.81 132.81 17.44 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.7 121.81 10.28 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.716 2.277 . . . . 0.0 113.222 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.53 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 28.4 t -132.5 144.66 53.95 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.377 177.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 41.3 Cg_endo -94.28 118.52 0.29 Allowed 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 122.184 1.923 . . . . 0.0 111.778 173.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.4 p 174.93 -40.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.767 0.794 . . . . 0.0 109.158 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 148.26 -12.53 1.22 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.257 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.58 176.15 9.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.577 0.227 . . . . 0.0 110.461 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.483 ' HD3' ' HB ' ' A' ' 22' ' ' THR . 16.0 ptp180 -121.05 150.35 41.31 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.073 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.645 ' O ' ' HA ' ' A' ' 22' ' ' THR . 98.9 m-85 -51.21 125.46 14.09 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.283 0.364 . . . . 0.0 110.319 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 3.0 pt20 -120.6 133.68 55.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.179 0.514 . . . . 0.0 111.025 -176.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.5 tt -146.54 126.49 5.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.606 175.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -91.44 147.12 23.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.557 -175.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.42 ' HA ' HD22 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -61.32 -30.63 70.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.345 -177.375 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -55.46 -50.64 69.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.082 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -65.94 -38.4 88.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.45 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 84.0 mtp -63.51 -41.74 98.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.467 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.25 -29.57 69.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.677 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -68.63 -16.73 63.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.215 177.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.73 -9.5 52.06 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.945 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -90.92 92.78 8.92 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.619 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -105.46 100.77 10.34 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.255 1.026 . . . . 0.0 111.73 -174.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 p -166.12 130.43 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.036 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.516 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -99.96 141.95 32.09 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.412 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 7.4 p -120.17 138.02 52.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.905 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.569 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 12.9 t -102.22 121.48 50.13 Favored Pre-proline 0 N--CA 1.432 -1.356 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 49' ' ' SER . 45.6 Cg_endo -70.42 155.97 62.62 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.688 2.259 . . . . 0.0 111.846 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 67.5 m 79.78 -51.29 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.519 0.728 . . . . 0.0 111.785 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 13.8 p -91.92 -23.66 19.53 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.053 177.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.4 t 67.59 45.27 1.54 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.231 171.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.537 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 50.5 tp -102.68 137.03 41.44 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.893 -0.504 . . . . 0.0 109.815 176.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 37.1 mtm -123.93 138.21 54.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.949 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.516 HD11 ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -141.64 152.23 19.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.118 179.029 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -78.38 146.14 34.8 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.794 -178.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.619 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 96.8 t -131.42 113.06 22.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.053 0.454 . . . . 0.0 110.704 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.6 t -84.87 124.87 40.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 -175.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.419 ' CD1' HD11 ' A' ' 63' ' ' LEU . 52.8 p90 -118.15 164.9 14.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.906 0.384 . . . . 0.0 111.382 -175.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.441 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -127.69 152.4 47.76 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.834 173.339 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -62.97 -39.4 94.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.468 -176.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -64.64 -43.18 94.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.097 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -68.32 -35.53 77.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.06 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 51.0 mt -60.89 -53.94 51.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.537 177.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.451 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . . . -57.81 -41.75 82.81 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.121 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.92 -47.69 83.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.408 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.693 ' HE1' ' HB2' ' A' ' 14' ' ' PHE . 76.0 t80 -61.98 -35.81 79.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.132 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.451 ' HD2' ' HA ' ' A' ' 64' ' ' ALA . 24.5 m-85 -54.2 -44.26 71.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.032 0.444 . . . . 0.0 110.82 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -76.61 -43.18 39.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.692 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -58.49 -48.08 81.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.825 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.0 -25.52 43.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.252 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.544 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.256 -178.261 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.452 -0.364 0 CA-C-O 121.289 0.566 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -72.46 -36.87 68.59 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.822 -173.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -110.73 162.56 14.64 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.842 0.353 . . . . 0.0 110.891 -171.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -156.67 108.05 2.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.18 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.43 162.41 17.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.0 -175.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.523 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 42.8 mt-10 -71.45 151.58 43.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.262 0.553 . . . . 0.0 110.93 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.5 tt -60.61 -31.18 48.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.509 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.24 -28.05 65.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.313 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -78.71 -29.98 45.72 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.886 0.374 . . . . 0.0 110.584 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 82.4 mmm -58.98 130.44 47.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.387 175.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.3 m -72.92 107.31 5.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.199 0.524 . . . . 0.0 110.48 -176.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.549 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . 43.7 p90 -84.37 133.98 34.5 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.573 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.523 ' HA ' ' OE1' ' A' ' 15' ' ' GLU . 4.9 tp10 -112.04 98.24 41.56 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.747 176.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.02 -22.14 73.7 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.884 2.389 . . . . 0.0 111.692 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -70.16 -25.75 63.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.815 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -114.22 -0.26 13.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.033 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 57.63 42.68 23.6 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.528 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -160.15 172.72 16.93 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.615 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 14' ' ' PHE . 95.8 m-85 -103.45 137.09 42.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.001 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 30.2 p -136.7 166.63 23.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.438 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.441 ' CB ' ' HB2' ' A' ' 31' ' ' PHE . 0.4 OUTLIER -138.95 121.58 10.53 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -54.94 122.29 11.41 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.085 2.523 . . . . 0.0 113.414 -177.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 16.3 t -146.32 127.53 7.36 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.267 176.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -85.65 119.28 1.92 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.351 2.034 . . . . 0.0 111.683 174.175 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.8 p -175.63 -43.71 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.1 -30.52 0.17 Allowed Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.342 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.5 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 2.4 t70 -143.2 176.06 9.41 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.94 153.11 25.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.531 ' HZ ' HD23 ' A' ' 52' ' ' LEU . 79.0 m-85 -52.89 124.97 15.51 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -134.31 145.91 49.5 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.09 0.471 . . . . 0.0 111.383 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.3 tt -142.61 135.34 26.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.029 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -91.53 138.8 31.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.785 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.541 ' HA ' ' HG3' ' A' ' 38' ' ' MET . 1.1 mt -68.56 -25.14 64.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.162 -177.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -54.02 -45.48 71.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.542 172.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.66 -44.49 73.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.509 176.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.541 ' HG3' ' HA ' ' A' ' 35' ' ' LEU . 28.3 mtp -60.15 -46.01 91.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -69.24 -22.62 63.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.62 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -76.11 -20.72 57.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.165 0.507 . . . . 0.0 110.11 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.84 -3.3 31.97 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.257 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -83.62 117.32 23.09 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 175.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.52 ' HD3' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -126.83 98.52 5.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.072 0.939 . . . . 0.0 111.832 -174.295 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 p -168.54 132.07 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.904 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.25 138.12 38.7 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.0 p -120.23 137.79 52.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.541 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.499 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 10.0 t -104.1 123.88 39.35 Favored Pre-proline 0 N--CA 1.434 -1.24 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 174.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.5 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 35.5 Cg_endo -80.27 157.22 22.82 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.416 2.077 . . . . 0.0 111.451 175.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 23.0 t 88.85 -55.88 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.224 1.01 . . . . 0.0 110.585 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.9 p -89.01 -32.02 17.81 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 47' ' ' CYS . 20.2 m 68.49 74.02 0.28 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.652 176.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.531 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 42.2 tp -132.21 150.28 52.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.0 mtm -135.14 141.12 45.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.076 -175.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.38 148.52 21.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.66 175.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.21 156.66 37.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.837 0.351 . . . . 0.0 110.773 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.407 HG13 ' HB2' ' A' ' 43' ' ' LYS . 7.5 p -132.46 127.99 57.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.151 0.5 . . . . 0.0 111.098 176.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 46.8 t -83.45 105.68 13.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.152 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -113.09 164.65 13.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.572 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.605 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 5.2 t0 -134.12 158.67 43.04 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 173.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.652 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 9.0 mptt -64.24 -38.41 90.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.164 0.507 . . . . 0.0 110.17 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -73.53 -36.93 65.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.083 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.73 -38.44 90.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.794 0.33 . . . . 0.0 110.594 176.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 87.6 mt -63.84 -53.46 50.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.558 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.21 -42.92 66.81 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.673 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -59.07 -49.13 79.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.623 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.549 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 70.5 t80 -65.85 -35.96 82.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.28 -177.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -53.66 -44.64 69.83 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.614 0.245 . . . . 0.0 110.787 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -72.32 -39.92 67.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.699 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -63.75 -36.92 85.48 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.152 -0.477 . . . . 0.0 112.279 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.47 -17.64 33.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.648 0.261 . . . . 0.0 111.417 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.794 -178.772 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.45 -0.44 0 CA-C-O 121.16 0.505 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -74.38 -26.77 60.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.369 -171.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -128.98 165.64 20.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.06 0.457 . . . . 0.0 111.635 -174.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.569 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 43.9 tt0 -148.45 116.76 6.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.235 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.489 ' CD1' HG13 ' A' ' 54' ' ' ILE . 4.5 mp -113.43 149.7 15.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -173.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.543 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 43.0 mt-10 -67.8 144.17 55.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.8 0.333 . . . . 0.0 110.25 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.403 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 19.3 tt -57.56 -28.57 31.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.161 177.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -71.69 -35.17 70.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.13 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.474 ' HB3' ' CG2' ' A' ' 7' ' ' ILE . 11.5 t70 -76.84 -40.57 47.37 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 83.7 mmm -49.22 137.18 14.25 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.913 169.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.5 m -79.59 106.87 11.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.403 0.621 . . . . 0.0 110.353 -176.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -75.52 128.2 34.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.558 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 37.4 tp10 -118.03 88.07 30.46 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.822 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 31.7 Cg_endo -63.55 -26.04 69.78 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.71 2.274 . . . . 0.0 111.536 -178.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.12 -29.6 70.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.765 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -110.28 5.21 21.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.528 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.54 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 2.3 mp0 58.86 38.33 24.58 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.948 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -160.4 174.68 13.76 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.051 0.453 . . . . 0.0 111.411 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.403 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 72.0 m-85 -108.35 140.62 41.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.617 177.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.555 ' HB ' ' HD3' ' A' ' 30' ' ' ARG . 40.6 p -136.24 169.22 17.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.467 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.414 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 5.4 t80 -140.99 120.45 8.4 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.05 116.28 2.82 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 123.307 2.672 . . . . 0.0 112.975 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 28.4 t -130.29 138.99 34.29 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.422 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 46.3 Cg_endo -91.7 117.87 0.48 Allowed 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 122.049 1.832 . . . . 0.0 111.734 174.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.4 p 178.83 -43.65 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.753 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.89 -25.33 0.24 Allowed Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.994 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.54 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 2.3 t0 -142.76 175.72 9.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.555 ' HD3' ' HB ' ' A' ' 22' ' ' THR . 12.4 ptp180 -114.57 155.54 26.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.587 0.232 . . . . 0.0 111.11 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.636 ' HZ ' HD23 ' A' ' 52' ' ' LEU . 91.0 m-85 -54.57 127.72 29.11 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.16 175.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -124.5 137.9 54.38 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.099 0.476 . . . . 0.0 110.505 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.4 tt -140.66 140.29 33.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.658 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.488 ' O ' ' HG3' ' A' ' 38' ' ' MET . 17.1 m-85 -103.17 136.15 43.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.921 -172.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -56.5 -35.54 68.12 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.103 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.484 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 11.9 t70 -54.34 -51.72 63.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.088 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.97 -29.6 58.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.556 -174.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.488 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 90.4 mtp -65.76 -39.58 91.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.051 176.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -69.71 -23.49 63.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.385 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 36' ' ' ASP . 17.3 mm-40 -73.45 -16.08 61.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.588 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.8 -10.76 38.11 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.883 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -94.04 109.0 20.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.187 0.518 . . . . 0.0 110.331 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.679 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -108.0 102.47 11.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.799 0.809 . . . . 0.0 111.722 -176.11 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 p -164.43 129.3 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.263 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 53' ' ' MET . . . -101.27 143.52 31.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.134 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.09 139.4 47.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.974 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.534 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 17.4 t -107.73 124.02 36.14 Favored Pre-proline 0 N--CA 1.439 -0.982 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.31 175.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.563 ' O ' ' HB3' ' A' ' 49' ' ' SER . 58.5 Cg_endo -74.86 156.84 43.63 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.758 2.306 . . . . 0.0 111.023 173.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.563 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 40.1 t 88.66 -57.46 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.752 0.821 . . . . 0.0 110.906 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.0 p -91.63 -29.14 17.06 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.514 -0.475 . . . . 0.0 109.724 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 47' ' ' CYS . 33.7 t 66.92 70.13 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.517 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.636 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 53.7 tp -125.51 151.32 46.48 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.401 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 32.7 mtm -134.26 138.23 44.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.383 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.489 HG13 ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -142.72 154.43 17.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 177.579 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.569 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 2.4 m-20 -77.09 158.29 30.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.762 0.315 . . . . 0.0 110.403 177.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 86.0 t -132.79 125.3 52.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.847 0.356 . . . . 0.0 111.123 178.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.543 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 89.2 t -77.75 126.42 38.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.084 177.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -142.71 165.11 28.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.713 0.292 . . . . 0.0 111.154 -175.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.564 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 9.6 t70 -132.2 151.83 51.61 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 171.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -63.61 -33.2 75.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.046 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -65.61 -49.51 68.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.12 176.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -60.47 -39.56 88.06 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.086 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 40.9 mt -58.17 -57.15 14.12 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.766 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.5 -40.81 75.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.268 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -66.19 -37.54 85.85 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.434 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -77.81 -33.86 52.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -51.09 -44.84 61.32 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.893 0.377 . . . . 0.0 110.611 172.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -63.03 -45.64 91.34 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.661 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.79 -40.49 88.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.828 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.54 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -78.93 -12.56 60.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.529 -177.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.596 177.321 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.8 p . . . . . 0 N--CA 1.449 -0.496 0 CA-C-O 120.843 0.354 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -96.12 -24.62 16.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.72 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.418 ' HB3' ' CG2' ' A' ' 54' ' ' ILE . 47.1 t0 -120.62 167.04 12.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 33.2 tt0 -156.72 110.86 2.72 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.584 ' CD1' HG13 ' A' ' 54' ' ' ILE . 4.2 mp -109.9 147.79 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.003 0.43 . . . . 0.0 111.469 -173.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -65.33 147.01 54.18 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.129 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.676 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 21.0 tt -65.17 -28.46 44.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.371 0.605 . . . . 0.0 110.011 177.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -62.97 -39.13 93.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.618 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.49 ' HB3' ' CG2' ' A' ' 7' ' ' ILE . 19.2 t70 -80.63 -36.03 33.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.515 -175.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 79.9 mmm -54.03 144.81 18.28 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.86 170.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.7 m -91.73 127.34 37.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.688 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.679 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . 47.3 p90 -81.76 138.0 35.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.998 0.427 . . . . 0.0 110.669 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -124.39 84.25 56.67 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.605 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.2 -22.0 54.44 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.03 2.487 . . . . 0.0 112.973 -172.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -68.29 -33.3 74.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.973 0.416 . . . . 0.0 110.586 -178.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -105.61 -5.16 20.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.965 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 64.5 36.3 8.81 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.296 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -145.15 167.98 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.597 -177.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.445 ' HB2' HG23 ' A' ' 33' ' ' ILE . 71.2 m-85 -96.89 146.76 24.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.871 0.367 . . . . 0.0 110.336 177.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 22.3 p -136.82 164.46 28.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.503 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.436 ' HB3' ' CD2' ' A' ' 31' ' ' PHE . 10.1 t80 -147.59 127.02 6.45 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.91 120.42 7.87 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.414 2.742 . . . . 0.0 113.655 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.551 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 11.6 t -136.28 135.98 21.83 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.305 174.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -84.39 118.4 2.23 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 121.901 1.734 . . . . 0.0 111.572 175.19 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 32.0 p 177.14 -46.17 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 164.08 -27.11 0.21 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.326 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.565 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 2.5 t0 -139.63 175.22 9.75 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -113.58 153.17 29.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.496 -177.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.636 ' CD1' ' HB2' ' A' ' 47' ' ' CYS . 97.2 m-85 -50.19 130.66 23.06 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.194 0.309 . . . . 0.0 110.752 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 4.2 pt20 -117.85 134.67 54.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.918 0.389 . . . . 0.0 110.638 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.445 HG23 ' HB2' ' A' ' 21' ' ' PHE . 12.9 tt -147.56 133.87 12.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.288 176.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.422 ' HB2' ' OD2' ' A' ' 37' ' ' ASP . 90.5 m-85 -96.13 147.4 23.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.857 -177.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 35' ' ' LEU . 4.1 mm? -61.0 -33.92 74.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.062 178.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -56.7 -43.38 80.49 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.155 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.422 ' OD2' ' HB2' ' A' ' 34' ' ' TYR . 25.0 m-20 -67.77 -44.39 77.56 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.111 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.414 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 76.1 mtp -61.84 -44.28 97.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.643 -177.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -69.53 -29.23 66.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.68 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -72.94 -18.13 61.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.056 0.455 . . . . 0.0 110.589 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.11 1.41 33.72 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.61 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -108.16 100.61 9.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.153 0.501 . . . . 0.0 109.714 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.549 ' HD3' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -108.63 101.32 10.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.841 0.829 . . . . 0.0 111.03 -171.409 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.8 p -163.43 131.38 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.003 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.1 134.78 42.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.059 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.799 HG22 ' HG2' ' A' ' 53' ' ' MET . 46.7 t -114.74 122.99 69.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.636 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 26.1 t -83.49 124.86 75.14 Favored Pre-proline 0 C--N 1.318 -0.779 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.008 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.565 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 58.8 Cg_endo -73.2 156.64 51.09 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.832 2.355 . . . . 0.0 110.746 173.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.529 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 42.8 t 86.79 -60.38 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.447 0.699 . . . . 0.0 110.876 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 15.7 p -92.56 -24.76 18.62 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.207 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 t 64.48 79.61 0.25 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.535 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.411 HD23 ' N ' ' A' ' 53' ' ' MET . 3.4 tt -131.09 131.01 43.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.799 ' HG2' HG22 ' A' ' 46' ' ' VAL . 27.7 mtm -118.94 136.62 53.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.683 0.277 . . . . 0.0 111.265 -175.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.584 HG13 ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -145.52 155.43 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.66 177.143 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.553 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -76.79 152.24 35.65 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.583 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.7 t -132.7 120.05 40.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.964 0.411 . . . . 0.0 110.291 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.676 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 21.1 t -75.71 149.54 6.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.5 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 55.1 p90 -146.84 164.64 32.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.364 0.126 . . . . 0.0 110.694 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.59 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 14.4 t70 -125.98 156.76 39.32 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.861 0.362 . . . . 0.0 110.625 174.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.889 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 0.8 OUTLIER -60.63 -46.55 89.85 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.08 178.722 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -72.89 -40.67 65.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.726 -177.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -63.77 -39.6 94.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.3 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 66.8 mt -64.21 -52.42 58.91 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.498 176.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.14 -45.12 71.89 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.273 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.48 -44.73 95.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.354 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.679 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 54.6 t80 -66.36 -40.83 90.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.586 -176.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -51.31 -48.43 62.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.923 0.392 . . . . 0.0 110.679 175.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -71.15 -35.68 71.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.833 -177.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -70.14 -45.22 67.26 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.75 -12.68 59.42 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -174.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.618 0 C-N-CA 120.424 -0.894 . . . . 0.0 111.387 -179.523 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 N--CA 1.448 -0.551 0 CA-C-O 120.99 0.424 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -88.14 -14.2 39.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.157 -172.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -142.7 174.76 10.36 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.294 -177.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.554 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 33.5 tt0 -155.67 116.59 3.86 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.466 0.479 . . . . 0.0 109.747 -176.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.434 ' CD1' HG13 ' A' ' 54' ' ' ILE . 1.6 mp -129.33 146.44 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.79 -177.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.552 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 46.4 mt-10 -69.82 145.75 51.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.951 0.405 . . . . 0.0 110.463 174.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.2 tt -55.26 -28.89 22.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.474 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -63.1 -33.61 75.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.721 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -86.16 -31.62 21.71 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.164 -174.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.533 ' HA ' ' HD1' ' A' ' 23' ' ' TYR . 80.2 mtp -65.16 145.33 56.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 110.974 177.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.6 m -72.84 120.32 18.3 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.484 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -79.83 133.98 36.31 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.209 177.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -122.54 89.93 49.61 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.125 0.488 . . . . 0.0 110.061 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.77 -14.89 43.02 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.898 2.398 . . . . 0.0 111.917 -177.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -66.46 -40.3 89.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.488 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.557 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 2.8 t-20 -110.73 0.79 17.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.247 -177.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.738 ' N ' HE21 ' A' ' 19' ' ' GLN . 0.0 OUTLIER 59.83 42.32 16.73 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.834 -179.753 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.557 ' HG2' ' HB3' ' A' ' 18' ' ' ASN . 26.9 ptt? -146.96 174.3 11.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.076 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -114.46 142.27 46.6 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 38.6 p -133.2 145.99 51.09 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.533 ' HD1' ' HA ' ' A' ' 12' ' ' MET . 9.6 t80 -119.61 131.15 24.5 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.55 122.79 12.25 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 123.016 2.477 . . . . 0.0 113.096 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.561 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 22.4 t -139.45 138.76 20.92 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.926 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -91.87 117.99 0.47 Allowed 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.19 1.927 . . . . 0.0 111.859 174.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.464 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 30.7 p -178.54 -52.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.745 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.464 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 172.43 -27.89 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.883 -178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.571 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 2.5 t70 -142.41 176.52 8.94 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.439 ' HE ' ' CB ' ' A' ' 22' ' ' THR . 10.6 ptm180 -114.7 147.51 39.56 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.641 ' CE1' ' HB3' ' A' ' 52' ' ' LEU . 97.7 m-85 -46.97 121.27 3.54 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.517 0.511 . . . . 0.0 110.18 178.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -120.49 131.52 54.77 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.897 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 20' ' ' MET . 14.7 tt -132.54 132.5 60.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.936 176.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.445 ' O ' ' HG3' ' A' ' 38' ' ' MET . 30.5 m-85 -90.27 134.83 34.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.756 -173.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 35' ' ' LEU . 0.5 OUTLIER -61.46 -30.54 70.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.012 -178.315 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -54.04 -44.82 71.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.943 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . 16.3 m-20 -77.26 -37.67 52.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.768 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.445 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 79.1 mtp -59.88 -42.43 93.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.544 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -60.49 -37.73 82.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.7 176.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.83 -22.22 64.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.768 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.51 7.06 32.66 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.653 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.535 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 8.0 tp10 -93.17 107.01 18.9 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.813 ' HD2' ' HE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -120.48 98.97 6.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.015 0.912 . . . . 0.0 111.68 -174.737 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 p -167.23 130.14 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.261 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.489 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -100.82 136.04 41.32 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.864 0.364 . . . . 0.0 110.406 -178.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.765 HG22 ' HG2' ' A' ' 53' ' ' MET . 44.7 t -114.07 129.84 69.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.535 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.572 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 13.0 t -99.25 119.46 60.46 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.778 178.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.571 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 34.4 Cg_endo -69.23 155.93 66.22 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.136 1.89 . . . . 0.0 111.162 175.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.51 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 44.5 t 85.36 -56.19 0.09 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.692 0.797 . . . . 0.0 111.366 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 52' ' ' LEU . 16.3 p -93.65 -18.56 22.03 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.4 t 67.23 43.06 2.13 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.839 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.641 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -94.21 148.55 22.08 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.676 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.765 ' HG2' HG22 ' A' ' 46' ' ' VAL . 48.9 mtm -140.36 135.73 32.45 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.032 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.489 HD11 ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -144.75 152.65 14.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.957 179.43 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 0.4 OUTLIER -76.04 152.95 36.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.879 178.703 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.78 143.37 39.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.552 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 56.5 t -103.07 107.99 23.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.813 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 24.3 p90 -113.57 164.53 13.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.099 -177.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -136.46 158.26 44.86 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.482 ' N ' ' HD2' ' A' ' 60' ' ' LYS . 12.4 mptt -64.02 -33.97 76.96 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.764 176.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -60.13 -54.08 50.19 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.232 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -61.46 -43.9 98.06 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.511 -176.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 35.2 mt -59.86 -49.62 77.0 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.285 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.45 80.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.775 0.321 . . . . 0.0 111.381 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -65.72 -53.73 36.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.452 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -68.91 -33.76 74.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.462 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.94 -46.23 64.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.916 175.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -67.25 -45.78 75.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.938 0.399 . . . . 0.0 110.983 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -61.51 -49.58 76.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.882 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.84 -20.34 53.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.113 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -177.995 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.0 p . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 121.054 0.454 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -92.0 -28.18 17.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.439 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -135.81 171.69 14.09 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.067 -171.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 39.7 tt0 -150.58 109.84 3.96 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.02 158.11 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 -175.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.519 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 57.3 mm-40 -61.63 150.59 35.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.138 0.494 . . . . 0.0 111.21 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.691 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 20.6 tt -62.4 -28.7 45.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.227 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -63.2 -29.96 71.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.397 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -79.16 -34.63 43.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.259 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.679 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 90.6 mmm -62.11 118.13 6.93 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 173.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.3 m -71.59 107.86 4.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.406 0.622 . . . . 0.0 110.442 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.597 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 39.0 p90 -74.54 137.6 42.53 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.183 -177.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -114.75 101.93 54.61 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.14 175.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.66 -9.15 23.39 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.072 2.515 . . . . 0.0 112.432 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -93.05 -38.53 11.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.121 0.486 . . . . 0.0 109.877 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.44 HD22 ' HA ' ' A' ' 18' ' ' ASN . 1.3 t-20 -89.39 -5.85 57.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.464 -175.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 73.46 18.2 3.67 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.608 171.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.583 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 27.3 ptt? -161.75 175.71 11.69 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.081 -173.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.679 ' HB3' ' HB3' ' A' ' 12' ' ' MET . 87.3 m-85 -95.76 131.08 42.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.133 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 23.8 p -129.04 137.8 51.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.795 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 36.0 t80 -109.64 122.6 38.81 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.21 121.31 9.18 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.229 2.62 . . . . 0.0 113.193 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.7 t -138.29 141.11 30.61 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.3 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -94.69 118.18 0.25 Allowed 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 122.157 1.905 . . . . 0.0 112.004 173.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.1 p -179.75 -44.95 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.391 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.71 -24.64 0.23 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.143 -177.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.461 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 4.3 t70 -141.91 177.01 8.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.94 151.04 32.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.933 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.795 ' HB2' ' HB3' ' A' ' 23' ' ' TYR . 75.6 m-85 -54.8 114.67 1.8 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 175.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.41 137.06 52.74 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.992 0.425 . . . . 0.0 110.98 -174.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.583 ' O ' ' HB2' ' A' ' 20' ' ' MET . 14.5 tt -139.64 129.13 29.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.827 173.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.439 ' O ' ' HG3' ' A' ' 38' ' ' MET . 14.1 m-85 -79.59 135.86 36.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.162 -173.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.471 HD12 ' CD2' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -66.88 -36.66 82.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.007 0.432 . . . . 0.0 110.049 -176.751 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 17.3 t70 -61.13 -35.44 77.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.454 176.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -69.54 -42.8 74.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.215 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.616 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 75.5 mtp -65.4 -37.72 87.83 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.5 178.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -69.53 -23.48 63.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.471 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 36' ' ' ASP . 70.4 mm-40 -75.05 -12.51 60.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 176.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.15 -5.42 33.97 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.529 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.616 ' O ' ' HA ' ' A' ' 38' ' ' MET . 0.7 OUTLIER -85.34 146.89 26.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 177.605 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 32.2 pttt -144.89 97.59 3.04 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.586 0.708 . . . . 0.0 111.2 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 p -167.74 126.67 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.036 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 53' ' ' MET . . . -100.54 131.15 46.6 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.966 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.9 p -111.91 139.29 37.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.995 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.436 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 8.6 t -116.34 115.02 40.39 Favored Pre-proline 0 N--CA 1.435 -1.178 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.117 175.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.563 ' O ' ' HB3' ' A' ' 49' ' ' SER . 34.2 Cg_endo -69.0 157.38 62.09 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.601 2.201 . . . . 0.0 111.452 174.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.563 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 35.9 t 88.51 -57.33 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.027 0.931 . . . . 0.0 110.586 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.7 p -90.43 -28.29 18.72 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.003 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.8 t 68.87 54.76 0.46 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.898 177.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 53' ' ' MET . 1.9 tt -114.76 137.2 52.21 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.469 ' N ' HD23 ' A' ' 52' ' ' LEU . 35.6 mtm -132.61 138.23 47.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.021 -178.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -142.49 156.37 18.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 39.9 m-20 -80.21 159.95 25.78 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.59 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 11.2 p -136.32 138.07 47.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.993 0.425 . . . . 0.0 111.052 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.691 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 61.8 t -72.12 141.57 16.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -150.03 155.94 40.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.854 0.359 . . . . 0.0 110.908 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -134.88 155.5 50.57 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -63.73 -34.67 78.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.178 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -73.93 -40.93 62.76 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.035 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -59.4 -46.39 88.84 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.16 0.505 . . . . 0.0 110.269 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 72.9 mt -69.51 -44.55 70.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.412 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.78 -46.69 88.4 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.66 0.267 . . . . 0.0 111.259 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.574 ' O ' ' HG3' ' A' ' 69' ' ' GLU . 23.8 tt0 -64.95 -49.55 69.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.861 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.477 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 80.0 t80 -62.22 -34.81 77.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.151 -178.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.471 ' CD2' HD12 ' A' ' 35' ' ' LEU . 2.0 t80 -54.18 -44.94 71.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.679 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -76.96 -33.84 57.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.105 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.574 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 48.2 mt-10 -61.17 -49.74 76.01 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.974 0.416 . . . . 0.0 110.859 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.23 -25.95 63.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.158 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.57 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.657 177.502 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.448 -0.565 0 CA-C-O 120.841 0.353 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -102.9 -26.64 13.04 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.74 154.06 24.43 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.956 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . 42.3 tt0 -146.3 122.89 11.12 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.613 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 mp -122.61 156.0 27.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.574 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 47.0 mt-10 -73.21 151.93 41.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.266 0.555 . . . . 0.0 111.19 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.442 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 20.4 tt -59.64 -28.59 40.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.59 -178.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -58.8 -38.53 78.78 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.26 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -73.18 -36.56 66.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.98 -174.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 89.5 mmm -58.37 149.92 23.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.188 176.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.4 m -100.9 108.02 19.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.959 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.419 ' HD2' ' HD3' ' A' ' 16' ' ' PRO . 44.6 p90 -74.08 136.03 43.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.011 0.434 . . . . 0.0 111.116 -176.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.426 ' HA ' ' OE1' ' A' ' 15' ' ' GLU . 6.4 tp10 -115.21 86.7 14.64 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.623 176.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.419 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 20.7 Cg_endo -61.31 -28.2 84.2 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.01 2.473 . . . . 0.0 112.455 -174.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -69.53 -20.28 63.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.117 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -111.72 -1.06 15.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.702 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 57.64 43.07 22.95 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.292 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -154.16 165.89 34.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.846 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.49 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 88.0 m-85 -103.87 139.59 38.85 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.609 ' HB ' ' HD3' ' A' ' 30' ' ' ARG . 77.5 p -130.59 169.86 15.04 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 121.141 -0.223 . . . . 0.0 110.929 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -152.77 127.23 4.57 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.36 126.31 21.79 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 123.144 2.563 . . . . 0.0 112.655 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.591 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 9.5 t -135.51 144.3 48.71 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.027 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -86.06 117.92 1.66 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.772 1.648 . . . . 0.0 111.949 173.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.437 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 30.3 p 172.48 -49.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.57 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.437 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 163.19 -24.48 0.19 Allowed Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.398 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.419 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 1.3 t0 -134.61 176.41 8.66 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.351 -0.241 . . . . 0.0 110.351 -177.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.609 ' HD3' ' HB ' ' A' ' 22' ' ' THR . 15.4 ptp180 -109.18 150.77 27.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.942 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.631 ' CD1' ' HB2' ' A' ' 47' ' ' CYS . 97.2 m-85 -55.39 140.46 39.77 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -137.16 134.14 36.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.181 0.515 . . . . 0.0 110.666 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.49 ' CG2' ' HB2' ' A' ' 21' ' ' PHE . 12.4 tt -131.16 130.39 63.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.679 177.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.492 ' O ' ' HG3' ' A' ' 38' ' ' MET . 24.4 m-85 -87.67 147.57 25.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.243 -174.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.429 ' HA ' HD22 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -66.7 -35.36 79.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.956 -176.16 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.1 -44.78 79.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.803 178.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.401 ' OD1' ' HB2' ' A' ' 34' ' ' TYR . 3.4 m-20 -64.08 -43.04 96.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.628 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.492 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 55.3 mtp -63.57 -37.59 87.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.488 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -65.32 -35.45 81.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.272 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -70.92 -15.94 62.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.655 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.31 -3.63 59.91 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -81.84 81.64 7.78 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.31 0.576 . . . . 0.0 109.522 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.72 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.64 98.39 11.61 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.358 1.075 . . . . 0.0 110.439 -179.563 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 2.0 p -167.09 129.46 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.802 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 53' ' ' MET . . . -99.46 130.21 45.71 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -107.05 134.36 48.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.147 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.631 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 35.0 t -105.31 123.77 38.57 Favored Pre-proline 0 N--CA 1.433 -1.303 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.093 176.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.626 ' O ' ' HB3' ' A' ' 49' ' ' SER . 33.3 Cg_endo -65.89 156.57 63.6 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.499 2.133 . . . . 0.0 111.044 172.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.626 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 27.4 t 86.21 -61.37 0.05 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.349 0.659 . . . . 0.0 110.963 178.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.4 p -90.99 -23.43 20.4 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.188 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.5 t 68.2 41.57 1.9 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.117 175.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.556 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 54.3 tp -98.79 142.35 30.43 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.112 0.482 . . . . 0.0 109.943 -178.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.476 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 43.5 mtm -132.5 138.01 47.39 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.798 -178.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -141.3 150.38 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 177.305 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 7.3 m-20 -68.85 155.58 39.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.815 0.34 . . . . 0.0 110.181 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 90.7 t -135.29 124.51 41.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.83 176.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.574 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 41.5 t -75.64 104.84 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -108.67 164.78 12.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.909 -175.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.562 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 13.8 t70 -130.13 146.9 51.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.79 175.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -64.07 -32.56 74.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.975 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -73.57 -40.5 63.86 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.663 0.268 . . . . 0.0 110.606 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.73 -41.27 90.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.872 0.367 . . . . 0.0 110.322 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 67.3 mt -63.85 -48.94 74.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.79 178.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.15 -41.95 93.87 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.879 -177.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -63.06 -53.79 48.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.347 0.594 . . . . 0.0 110.466 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.411 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 78.9 t80 -63.81 -36.19 83.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.389 -178.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.14 -44.71 67.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.119 177.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -69.55 -36.18 76.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.625 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -75.96 -34.34 59.82 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.97 -20.27 24.67 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -177.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -178.179 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.3 p . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 121.014 0.435 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -98.33 -0.47 43.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.588 -174.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -134.04 162.95 30.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.53 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 40.1 tt0 -159.86 120.28 3.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.86 -177.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 8' ' ' GLU . 1.8 mp -120.65 161.69 20.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -175.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.402 ' N ' HG22 ' A' ' 7' ' ' ILE . 40.9 mt-10 -74.06 146.81 43.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.371 177.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.0 tt -59.41 -29.69 42.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.422 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -68.84 -28.26 66.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.923 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -79.4 -31.21 42.73 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.99 0.424 . . . . 0.0 110.3 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 82.3 mmm -63.58 128.07 34.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.986 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 22' ' ' THR . 86.2 m -71.83 119.43 15.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.198 0.523 . . . . 0.0 110.899 -177.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.672 ' HB2' ' HE1' ' A' ' 66' ' ' TYR . 36.2 p90 -74.58 138.81 43.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.035 -177.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -129.23 87.71 53.05 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.914 177.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.431 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 18.7 Cg_endo -59.84 -33.02 96.21 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.274 2.649 . . . . 0.0 112.897 -175.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.63 -28.71 70.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.891 -176.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -113.03 4.95 16.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.707 0.289 . . . . 0.0 111.112 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.418 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 2.1 mp0 59.14 32.0 21.73 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.395 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -144.94 159.01 43.6 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.165 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -93.89 141.81 28.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.726 175.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 20.6 p -137.7 141.57 41.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.642 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.456 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 17.6 t80 -125.52 117.82 24.77 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -178.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -48.44 118.53 3.36 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.47 2.78 . . . . 0.0 113.286 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 19.9 t -130.39 135.66 27.76 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.439 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 5.8 Cg_endo -84.74 118.21 2.09 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.869 1.712 . . . . 0.0 111.442 175.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.409 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 29.9 p 174.62 -45.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -177.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.409 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 159.65 -27.1 0.35 Allowed Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.783 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -138.23 176.0 9.08 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.476 ' HG3' ' HB ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -120.06 156.49 30.86 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.155 -177.078 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.64 ' O ' ' HA ' ' A' ' 22' ' ' THR . 97.3 m-85 -56.4 123.03 13.31 Favored 'General case' 0 CA--C 1.518 -0.258 0 O-C-N 123.384 0.428 . . . . 0.0 110.165 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.579 ' HG2' HG22 ' A' ' 22' ' ' THR . 24.2 mt-30 -120.8 137.63 54.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.823 0.344 . . . . 0.0 110.756 -178.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.5 ' HB ' ' HA ' ' A' ' 45' ' ' ALA . 10.1 tt -145.93 125.22 5.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.419 175.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -87.31 149.49 24.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.252 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.625 ' HA ' ' HG3' ' A' ' 38' ' ' MET . 7.7 tp -71.3 -24.65 62.18 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.12 0.485 . . . . 0.0 110.65 -176.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -54.6 -40.15 68.57 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.429 173.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -68.74 -44.56 73.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.202 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.625 ' HG3' ' HA ' ' A' ' 35' ' ' LEU . 15.2 mtp -62.72 -46.48 87.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.602 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -65.29 -25.19 67.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.095 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.92 -21.86 65.1 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.226 0.536 . . . . 0.0 110.523 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.75 -2.34 34.03 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.012 -177.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.459 ' HG3' HG12 ' A' ' 44' ' ' VAL . 10.2 tp10 -100.19 130.28 46.3 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 20.3 pttp -122.78 101.25 7.34 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.448 0.642 . . . . 0.0 111.068 -176.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 2.6 p -167.3 129.33 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.258 -177.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.5 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . . . -100.74 141.7 33.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.472 175.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.9 p -122.0 134.37 65.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.906 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.451 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 10.9 t -104.33 128.25 27.42 Favored Pre-proline 0 N--CA 1.438 -1.051 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 174.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.82 156.56 20.85 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.734 2.29 . . . . 0.0 111.553 176.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.0 t 85.95 -55.39 0.07 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.699 0.8 . . . . 0.0 110.681 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 15.9 p -87.32 -32.22 19.77 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 47' ' ' CYS . 16.6 m 68.96 76.26 0.24 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.233 174.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.485 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 57.6 tp -133.56 143.75 48.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.627 175.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.446 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 36.2 mtm -132.42 138.26 47.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.578 -177.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -143.31 152.82 16.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.942 178.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.532 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 2.2 m-20 -70.87 153.3 42.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.648 0.261 . . . . 0.0 110.557 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.526 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 99.9 t -135.46 114.74 16.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.501 176.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.54 117.8 15.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.069 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 43' ' ' LYS . 51.5 p90 -111.7 164.86 12.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.819 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.609 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 15.0 t70 -131.74 159.05 39.56 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.355 177.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.75 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 9.2 mptt -58.74 -44.1 90.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.473 178.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -75.53 -37.27 60.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.987 -176.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -62.1 -39.74 93.49 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.671 177.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 80.7 mt -68.83 -44.23 73.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.468 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.36 -51.27 70.21 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.779 -176.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -70.89 -33.39 70.53 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.362 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.672 ' HE1' ' HB2' ' A' ' 14' ' ' PHE . 56.4 t80 -67.16 -35.71 80.27 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.208 176.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.52 -46.1 66.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.623 174.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -71.51 -43.85 65.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.014 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -72.82 -34.11 66.64 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -83.05 -17.4 43.38 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.147 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.462 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.524 178.892 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 53' ' ' MET . 12.3 p . . . . . 0 N--CA 1.446 -0.648 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -95.27 -1.61 51.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.643 -171.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -143.19 171.92 13.43 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 44.3 tt0 -162.19 108.54 1.28 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -177.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.46 ' CD1' HG13 ' A' ' 54' ' ' ILE . 2.2 mp -119.67 151.26 22.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.385 -172.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -63.17 144.62 56.76 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 175.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.3 tt -60.54 -33.28 53.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.206 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.69 -27.82 62.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.209 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.453 ' HB3' HG22 ' A' ' 7' ' ' ILE . 17.8 t70 -73.57 -35.89 65.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.581 -176.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.465 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 81.4 mtp -69.2 153.76 43.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.479 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.1 m -82.12 113.22 19.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.82 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.498 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . 33.4 p90 -77.5 138.73 39.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.946 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -113.5 88.98 14.17 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.47 -29.51 88.82 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.215 2.61 . . . . 0.0 113.901 -169.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.94 -32.52 73.02 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.883 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.473 ' HB2' ' HG2' ' A' ' 20' ' ' MET . 46.6 m-80 -105.02 1.38 28.55 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.466 -173.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 57.28 39.05 28.85 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.032 0.444 . . . . 0.0 110.383 -178.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.473 ' HG2' ' HB2' ' A' ' 18' ' ' ASN . 27.1 ptt? -137.71 170.66 15.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.934 0.397 . . . . 0.0 111.004 -175.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.522 ' HE1' HD23 ' A' ' 35' ' ' LEU . 52.8 m-85 -119.47 144.67 46.86 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.867 176.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 35.6 p -133.03 158.37 42.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.376 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.465 ' CD1' ' HA ' ' A' ' 12' ' ' MET . 4.5 t80 -141.31 129.52 12.21 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -57.7 119.43 6.68 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.985 2.457 . . . . 0.0 113.361 -175.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.465 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 17.3 t -133.21 131.8 21.86 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.304 176.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 1.3 Cg_endo -85.31 117.83 1.87 Allowed 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.949 1.766 . . . . 0.0 111.487 173.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 28.4 p -179.15 -47.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.648 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.45 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 168.19 -25.4 0.12 Allowed Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.227 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.54 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 2.5 t70 -143.29 176.35 9.21 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -117.48 154.33 31.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.326 0.108 . . . . 0.0 110.769 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 22' ' ' THR . 94.3 m-85 -48.4 131.32 16.93 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.528 0.517 . . . . 0.0 111.342 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -127.15 126.87 43.64 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.977 -173.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.462 ' HB ' ' HA ' ' A' ' 45' ' ' ALA . 11.5 tt -148.84 136.4 13.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.321 176.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.448 ' O ' ' HG3' ' A' ' 38' ' ' MET . 91.3 m-85 -98.61 147.06 25.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.954 0.406 . . . . 0.0 111.36 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.522 HD23 ' HE1' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -65.62 -33.91 77.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.297 -178.244 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.79 -42.31 71.63 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.962 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -68.96 -40.53 78.85 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.97 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.448 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 75.2 mtp -63.8 -31.39 72.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.342 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -72.94 -21.19 60.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.624 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -79.1 -6.78 57.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.221 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.08 -18.2 34.03 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.089 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 38' ' ' MET . 33.0 tt0 -94.62 135.09 36.49 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.688 ' HD2' ' HE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -133.22 101.04 5.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.608 0.718 . . . . 0.0 110.983 -177.365 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 p -165.65 128.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.73 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.462 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . . . -100.07 135.86 40.85 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.004 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p -109.74 134.2 52.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.117 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.544 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 24.6 t -101.17 118.47 60.18 Favored Pre-proline 0 N--CA 1.433 -1.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.896 176.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.571 ' O ' ' HB3' ' A' ' 49' ' ' SER . 24.6 Cg_endo -65.38 156.54 62.79 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.397 2.065 . . . . 0.0 111.034 173.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.571 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 35.6 t 87.13 -56.91 0.04 OUTLIER 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.621 0.768 . . . . 0.0 111.035 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.0 p -92.96 -26.97 17.33 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.132 177.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.7 t 70.27 44.07 0.78 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.927 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 53' ' ' MET . 2.1 tt -101.33 136.22 41.54 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' A' ' 3' ' ' THR . 36.9 mtm -125.07 138.56 54.19 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 -177.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.46 HG13 ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -140.45 155.39 23.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.865 178.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.557 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 15.1 m-20 -80.92 159.15 25.04 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.2 t -130.94 126.28 59.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.71 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.7 t -87.49 101.74 11.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.066 0.46 . . . . 0.0 110.642 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.688 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 47.5 p90 -104.48 164.72 11.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.418 -178.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.506 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 20.3 t70 -128.47 159.5 35.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.944 0.402 . . . . 0.0 110.72 175.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.815 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -59.95 -47.55 85.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.416 177.208 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.13 -36.9 80.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.501 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -69.87 -40.66 75.58 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.618 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 42.8 mt -61.57 -44.81 96.34 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.73 177.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.17 -34.4 76.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.932 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -64.84 -54.07 36.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.701 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.498 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 77.0 t80 -65.0 -34.64 78.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.448 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -51.46 -47.14 63.21 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.165 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.81 -45.15 62.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.149 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.54 -43.89 88.53 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.12 -25.69 36.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.744 0.307 . . . . 0.0 111.407 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.673 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -176.656 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.475 0.655 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m -152.31 179.17 8.78 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.178 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.664 ' HB ' ' HB2' ' A' ' 55' ' ' ASP . 5.1 p -82.12 100.78 10.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 0.0 111.615 -178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -103.06 -16.83 15.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.478 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -102.1 138.35 39.16 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -137.72 114.94 10.95 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -175.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.681 HD13 HD13 ' A' ' 54' ' ' ILE . 4.3 mp -111.36 138.75 38.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.889 0.376 . . . . 0.0 110.235 -176.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.562 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 31.6 mt-10 -66.69 141.6 57.71 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.156 175.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.1 tt -57.07 -28.33 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.995 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -68.14 -28.76 67.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.355 -0.384 . . . . 0.0 112.014 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -82.2 -38.77 24.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.91 0.386 . . . . 0.0 109.995 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 81.1 mmm -53.33 127.07 23.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.496 170.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.3 m -79.1 123.24 27.16 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.666 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 35.7 p90 -94.65 134.47 37.2 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.636 -176.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -107.24 94.26 10.93 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.559 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.9 -27.99 86.16 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.113 2.542 . . . . 0.0 112.763 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -73.74 -27.52 61.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.969 0.414 . . . . 0.0 110.329 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -96.91 -10.08 27.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.895 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 62.66 36.66 13.36 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.833 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -151.78 169.23 22.74 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.456 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.666 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 30.0 m-85 -110.05 140.68 43.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.267 175.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 79.7 p -127.96 163.54 24.28 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.037 0.446 . . . . 0.0 110.759 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -134.8 126.7 18.06 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.31 115.3 1.98 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 123.18 2.587 . . . . 0.0 113.254 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.498 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 41.9 t -128.67 137.37 30.79 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.866 177.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 9.0 Cg_endo -90.3 120.14 0.8 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.487 2.125 . . . . 0.0 111.369 172.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 28.7 p 175.54 -43.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -178.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.41 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 160.15 -23.38 0.27 Allowed Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.51 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.424 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 2.8 t0 -142.49 175.71 9.58 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.543 HH11 ' HG3' ' A' ' 30' ' ' ARG . 9.3 ptt85 -113.26 152.96 29.16 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 122.799 0.439 . . . . 0.0 110.706 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 22' ' ' THR . 86.7 m-85 -55.4 136.26 49.6 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.334 0.397 . . . . 0.0 110.227 176.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -128.83 124.1 34.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.093 0.473 . . . . 0.0 111.524 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' A' ' 45' ' ' ALA . 12.0 tt -127.46 127.1 68.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.661 174.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.525 ' O ' ' HG3' ' A' ' 38' ' ' MET . 36.7 m-85 -93.96 131.07 39.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.001 -172.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -59.27 -31.63 69.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.187 -178.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -54.28 -47.2 72.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.12 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -83.37 -24.53 31.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.271 -176.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.59 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 93.9 mtp -65.1 -38.76 91.76 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.66 174.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -65.61 -29.43 70.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.225 175.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -71.15 -12.32 61.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.214 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.44 -6.86 36.45 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.623 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 38' ' ' MET . 9.2 tp10 -94.86 138.39 32.69 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.635 ' HD2' ' HE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -138.71 101.51 4.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 122.103 0.954 . . . . 0.0 111.553 -179.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.3 p -165.23 130.87 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.735 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.564 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -100.51 131.07 46.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.717 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.76 139.44 34.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.752 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 51' ' ' SER . 18.5 t -108.27 134.45 20.19 Favored Pre-proline 0 N--CA 1.436 -1.129 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.006 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.521 ' O ' ' HB2' ' A' ' 49' ' ' SER . 47.1 Cg_endo -83.0 157.18 15.34 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.16 2.573 . . . . 0.0 111.848 175.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.521 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 75.4 m 84.73 -55.8 0.1 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.889 0.876 . . . . 0.0 110.772 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.2 p -87.67 -33.06 18.92 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 174.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 47' ' ' CYS . 59.3 m 67.42 64.07 0.42 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.613 177.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.465 ' HB3' ' HE1' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -114.54 154.62 27.95 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.277 176.068 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 41.1 mtm -132.52 137.09 47.03 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.446 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.681 HD13 HD13 ' A' ' 7' ' ' ILE . 2.8 pp -143.68 148.16 19.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.471 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.664 ' HB2' ' HB ' ' A' ' 3' ' ' THR . 4.7 t70 -85.15 152.95 22.99 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -175.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.2 t -134.12 117.79 26.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.54 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.562 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 26.9 t -71.35 108.14 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.605 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.635 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 25.8 p90 -109.77 164.86 12.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.618 0.247 . . . . 0.0 110.407 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.629 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 5.7 t70 -134.09 160.31 38.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.111 0.482 . . . . 0.0 110.647 175.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.565 ' HB3' HG21 ' A' ' 78' ' ' ILE . 21.0 mtmm -62.54 -44.58 96.01 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.755 177.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -69.39 -35.58 75.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.801 -176.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -67.91 -44.04 77.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.174 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 81.6 mt -59.34 -49.23 78.63 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.183 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.57 -41.63 95.01 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.236 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -66.67 -45.92 77.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.295 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.518 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 84.1 t80 -67.57 -35.7 79.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.082 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.543 ' CE2' ' HB ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -53.8 -41.31 67.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 110.442 178.469 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -70.14 -38.77 75.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.088 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -70.15 -45.89 65.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.3 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.9 -15.48 63.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.197 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.58 52.97 10.69 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.823 -0.704 . . . . 0.0 111.593 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.543 ' HB ' ' CE2' ' A' ' 67' ' ' TYR . 0.4 OUTLIER -106.42 162.95 5.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -62.4 131.02 93.71 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.754 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -42.17 120.41 1.56 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 124.103 3.202 . . . . 0.0 114.072 -175.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -81.68 165.49 17.96 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.628 2.885 . . . . 0.0 111.614 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -72.79 133.02 82.59 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.62 146.89 94.04 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 123.096 2.53 . . . . 0.0 112.934 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.565 HG21 ' HB3' ' A' ' 60' ' ' LYS . 32.1 pt -85.15 169.45 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.23 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.82 52.93 1.55 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.922 0.392 . . . . 0.0 111.33 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.62 94.07 2.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.041 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.76 105.9 4.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.718 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.86 176.535 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.5 mtp . . . . . 0 C--O 1.234 0.271 0 CA-C-O 121.275 0.559 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 p -154.99 166.1 34.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.0 -173.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.4 p -73.75 102.35 3.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.27 177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -83.53 1.42 42.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.157 -177.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -146.0 163.98 33.51 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 34.6 tt0 -156.96 108.81 2.42 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -176.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 mp -116.16 145.45 21.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.281 -173.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.587 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 44.4 mt-10 -63.33 138.26 58.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 173.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.401 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 14.1 tt -51.51 -29.38 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.715 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -60.19 -34.06 73.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.218 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -81.33 -28.77 34.4 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.52 -172.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.578 ' HA ' ' HD1' ' A' ' 23' ' ' TYR . 84.2 mtp -66.3 156.41 34.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.139 0.495 . . . . 0.0 110.967 176.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.7 m -93.39 110.36 21.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.35 0.595 . . . . 0.0 110.207 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.553 ' HD2' ' HD3' ' A' ' 16' ' ' PRO . 38.8 p90 -74.86 140.08 43.62 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.894 -177.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -124.14 89.06 52.22 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 121.229 0.537 . . . . 0.0 109.943 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.553 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 26.4 Cg_endo -62.23 -26.26 77.4 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.369 2.713 . . . . 0.0 112.747 -173.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -69.34 -21.34 63.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.504 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -116.24 7.94 14.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.839 0.352 . . . . 0.0 110.698 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 57.39 43.1 23.76 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.751 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -154.0 171.72 18.6 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.451 -0.499 . . . . 0.0 111.403 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.534 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 57.6 m-85 -112.86 141.93 46.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.412 176.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 17.2 p -133.63 135.4 44.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.993 0.425 . . . . 0.0 111.107 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.588 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 7.6 t80 -106.36 117.47 57.11 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -56.38 113.37 1.42 Allowed 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.028 2.486 . . . . 0.0 113.717 -173.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 12.2 t -126.86 132.14 24.19 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.65 175.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 2.1 Cg_endo -86.08 118.16 1.68 Allowed 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 121.802 1.668 . . . . 0.0 111.582 174.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 29.3 p -177.09 -46.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.414 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 169.29 -27.46 0.13 Allowed Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.367 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.468 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 3.5 t70 -142.02 175.09 10.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -123.26 147.82 46.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.639 0.2 . . . . 0.0 110.619 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.588 ' HB2' ' HB3' ' A' ' 23' ' ' TYR . 96.7 m-85 -46.51 111.35 0.37 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.597 0.561 . . . . 0.0 111.221 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -111.37 135.39 51.99 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.089 0.471 . . . . 0.0 111.073 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' A' ' 45' ' ' ALA . 16.9 tt -132.62 136.7 55.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.754 177.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.538 ' O ' ' HG3' ' A' ' 38' ' ' MET . 30.0 m-85 -95.02 126.37 40.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.369 -174.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 35' ' ' LEU . 0.5 OUTLIER -55.3 -34.73 64.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.123 0.487 . . . . 0.0 110.625 -178.12 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -57.3 -48.74 78.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.414 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -70.78 -32.16 69.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.909 -178.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.538 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 81.2 mtp -61.18 -43.67 98.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.307 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -66.64 -31.15 71.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.192 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -72.37 -14.23 61.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.427 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.74 0.78 36.74 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.632 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -99.54 93.89 6.11 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -106.19 101.06 10.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 122.001 0.905 . . . . 0.0 111.265 -176.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 p -166.55 131.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.839 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.462 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -100.39 138.93 36.79 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.323 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.07 139.22 43.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.17 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.581 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 7.0 t -110.6 116.02 53.02 Favored Pre-proline 0 C--N 1.313 -0.989 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.133 176.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.51 ' O ' ' HB3' ' A' ' 49' ' ' SER . 35.1 Cg_endo -71.59 157.14 56.65 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.373 2.049 . . . . 0.0 111.192 172.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.51 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 46.2 t 89.93 -59.36 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.045 0.938 . . . . 0.0 110.322 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.9 p -89.46 -29.19 19.18 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.677 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 t 69.01 74.53 0.25 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.621 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.448 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 53.9 tp -138.68 152.02 47.68 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.6 mtm -133.44 137.94 45.98 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.587 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.479 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -137.56 153.5 28.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.155 178.257 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 3.8 t70 -80.05 151.81 29.72 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.23 115.59 26.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.976 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.587 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 42.5 t -70.12 118.07 14.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.509 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -122.78 159.96 26.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.571 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.494 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.8 t70 -131.35 167.44 19.25 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.405 ' H ' ' HG3' ' A' ' 60' ' ' LYS . 23.2 mtmm -63.05 -45.32 92.81 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.342 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -68.69 -40.31 80.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.038 -1.437 . . . . 0.0 111.14 -175.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.47 -42.11 99.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.761 0.315 . . . . 0.0 110.994 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 75.9 mt -63.83 -46.28 85.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.241 177.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.558 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . . . -57.38 -47.21 82.27 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.38 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.18 -46.38 79.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.06 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -67.83 -36.05 79.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.641 -176.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.684 ' HD1' ' HB ' ' A' ' 72' ' ' ILE . 26.3 m-85 -53.49 -48.6 68.78 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.007 0.432 . . . . 0.0 110.378 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -67.52 -43.02 81.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.402 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -74.65 -29.71 61.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -174.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.88 -21.41 26.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.617 0.246 . . . . 0.0 111.103 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.83 38.45 6.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.893 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.684 ' HB ' ' HD1' ' A' ' 67' ' ' TYR . 2.0 mt -99.9 -179.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.651 ' H ' HG22 ' A' ' 72' ' ' ILE . 36.3 m80 -63.45 141.41 97.85 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -57.6 132.69 51.88 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.361 2.041 . . . . 0.0 111.065 173.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.49 164.53 20.39 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.297 2.665 . . . . 0.0 113.115 -175.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.16 139.9 79.63 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -50.8 133.94 40.37 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.329 2.686 . . . . 0.0 113.185 -174.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.3 pt -142.43 171.58 10.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.121 -175.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.75 78.9 9.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.952 0.406 . . . . 0.0 110.2 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -134.12 61.79 1.67 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.233 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.84 168.82 21.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.717 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.785 -0.626 . . . . 0.0 110.358 -179.336 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.837 0.351 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.2 m 63.24 -165.33 0.24 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.835 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.2 p -90.08 101.53 14.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.348 0.594 . . . . 0.0 110.812 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -80.13 -35.09 37.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.241 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -114.85 159.2 20.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.362 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.532 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 34.9 tt0 -143.11 110.73 5.85 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.39 139.45 43.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.251 -170.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.583 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 39.0 mt-10 -58.2 135.52 57.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.062 0.458 . . . . 0.0 110.34 173.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.422 ' CG2' ' HA ' ' A' ' 58' ' ' PHE . 15.5 tt -54.54 -29.45 20.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.771 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.9 -27.94 68.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.967 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -83.93 -39.91 19.19 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.464 -175.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 83.0 mtp -60.84 142.78 55.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.708 0.29 . . . . 0.0 111.021 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.0 m -79.69 124.68 28.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.973 -176.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.484 ' HB2' ' HE1' ' A' ' 66' ' ' TYR . 39.2 p90 -84.27 141.65 30.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.099 0.476 . . . . 0.0 111.783 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -125.7 92.05 47.26 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 173.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.62 -26.38 53.88 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 123.094 2.529 . . . . 0.0 113.253 -172.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -69.57 -28.93 66.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.007 0.432 . . . . 0.0 110.918 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -107.41 4.54 26.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.838 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 58.56 37.93 25.4 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.993 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 26.0 ptt? -143.12 171.46 14.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.292 0.568 . . . . 0.0 111.841 -174.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.479 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 41.8 m-85 -116.0 148.18 40.41 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.392 173.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 41.5 p -136.27 167.24 21.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.894 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.462 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 84.3 t80 -144.08 118.07 5.9 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -56.97 109.83 0.51 Allowed 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.201 2.601 . . . . 0.0 113.19 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.1 t -127.22 131.3 23.78 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.712 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 5.2 Cg_exo -80.2 119.42 3.85 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.951 1.768 . . . . 0.0 111.472 176.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.448 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 30.6 p -179.4 -52.72 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.448 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 174.44 -28.57 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.215 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.588 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 1.2 t70 -142.8 175.93 9.44 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -115.71 154.87 28.78 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.578 ' O ' ' HA ' ' A' ' 22' ' ' THR . 80.4 m-85 -50.29 134.75 22.61 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.519 0.512 . . . . 0.0 110.61 178.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -131.77 133.29 44.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.168 0.509 . . . . 0.0 111.066 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 20' ' ' MET . 10.9 tt -151.28 126.11 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.009 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -87.29 138.16 31.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.79 0.329 . . . . 0.0 110.895 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.6 ' HG ' ' HD2' ' A' ' 66' ' ' TYR . 1.2 tm? -64.19 -31.73 73.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.018 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -61.92 -29.92 70.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.792 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.17 -32.63 29.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.419 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.553 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 84.6 mtp -67.6 -34.12 76.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.145 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -64.64 -24.44 67.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.398 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -76.93 -12.21 59.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.025 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.91 -11.49 41.26 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.402 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.553 ' O ' ' HA ' ' A' ' 38' ' ' MET . 9.3 tp10 -89.41 133.77 34.38 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -142.08 100.13 3.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.115 0.96 . . . . 0.0 111.503 -177.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.4 p -167.27 127.7 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.424 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.58 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -100.73 141.55 33.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.106 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.6 137.42 51.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.687 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.41 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 18.0 t -99.68 111.88 62.53 Favored Pre-proline 0 N--CA 1.431 -1.408 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.588 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 14.7 Cg_endo -62.6 156.6 51.57 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.935 1.757 . . . . 0.0 110.794 174.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 37.4 m 85.5 -55.75 0.08 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.197 0.999 . . . . 0.0 111.192 -176.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 52' ' ' LEU . 16.6 p -98.13 -17.09 19.24 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.836 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.8 t 70.23 29.77 3.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.423 0.689 . . . . 0.0 111.975 172.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.433 HD13 ' HZ ' ' A' ' 31' ' ' PHE . 1.6 tt -86.56 130.57 34.44 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -174.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.4 mtm -115.35 137.39 52.09 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.85 -176.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.58 HD11 ' HB3' ' A' ' 45' ' ' ALA . 2.8 pp -141.88 144.21 25.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.532 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 4.9 t0 -84.27 156.06 22.15 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.73 125.32 55.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.045 0.45 . . . . 0.0 112.068 -174.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.583 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 21.8 t -88.86 100.03 10.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.422 ' HA ' ' CG2' ' A' ' 9' ' ' ILE . 50.6 p90 -94.52 160.3 14.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.843 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.579 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 27.3 t70 -116.14 151.65 35.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.857 0.36 . . . . 0.0 110.515 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.455 ' HE2' ' HB2' ' A' ' 60' ' ' LYS . 22.2 mtmm -58.56 -46.36 87.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.14 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -81.09 -32.19 34.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.346 -174.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.411 ' CB ' ' HB3' ' A' ' 59' ' ' ASP . 15.9 t70 -64.44 -43.66 93.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.324 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 54.4 mt -61.03 -47.38 86.67 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.82 0.343 . . . . 0.0 110.391 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.16 -43.01 77.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.185 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -62.99 -44.87 94.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.688 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.6 ' HD2' ' HG ' ' A' ' 35' ' ' LEU . 84.1 t80 -70.54 -35.3 73.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.07 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.5 -42.95 79.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.446 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -74.98 -30.08 61.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.09 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -63.54 -57.83 8.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.264 0.555 . . . . 0.0 110.793 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.62 -25.48 60.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.656 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.61 49.88 4.69 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.612 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.779 HG22 ' H ' ' A' ' 73' ' ' HIS . 5.1 mt -83.69 -175.78 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.779 ' H ' HG22 ' A' ' 72' ' ' ILE . 49.7 m80 -76.11 130.2 78.55 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.553 0.216 . . . . 0.0 110.462 -177.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 36.2 Cg_endo -65.32 116.33 3.83 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.996 2.464 . . . . 0.0 113.149 -176.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 74' ' ' PRO . 15.8 Cg_endo -89.68 164.57 5.17 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.622 2.881 . . . . 0.0 111.638 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -75.1 155.52 86.32 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.4 140.01 73.87 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.619 2.212 . . . . 0.0 112.658 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.5 pt -91.13 153.72 3.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.352 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.95 80.37 9.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.498 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -149.61 29.78 0.76 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.292 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.79 -8.95 32.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.202 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.499 -0.762 . . . . 0.0 110.159 -179.162 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptp . . . . . 0 N--CA 1.463 0.21 0 CA-C-O 120.821 0.343 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.0 m -144.5 176.39 9.42 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.668 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.4 p -90.75 103.91 16.56 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.237 0.541 . . . . 0.0 110.677 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -94.89 -12.35 27.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.822 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -125.94 155.16 41.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.776 174.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.558 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 33.9 tt0 -151.44 114.43 4.73 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -176.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -127.55 161.8 34.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.591 -173.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -78.57 148.68 33.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.86 0.362 . . . . 0.0 110.388 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.6 tt -57.02 -28.95 30.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.5 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -63.55 -28.19 69.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.993 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -77.49 -31.21 53.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.947 0.403 . . . . 0.0 111.052 -175.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.593 ' HA ' ' HD1' ' A' ' 23' ' ' TYR . 84.4 mtp -69.5 170.52 10.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.951 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.3 m -106.76 121.25 44.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.707 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.533 ' HB2' ' HE1' ' A' ' 66' ' ' TYR . 44.0 p90 -74.56 142.58 44.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.624 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.421 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 17.8 tt0 -139.95 93.7 9.27 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 121.356 0.598 . . . . 0.0 110.649 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 25.1 Cg_endo -66.22 -19.05 56.68 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.69 2.26 . . . . 0.0 112.279 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.83 -35.1 77.27 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.206 0.526 . . . . 0.0 110.603 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -111.61 5.95 19.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.874 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.554 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 2.1 mp0 57.91 31.58 20.77 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.809 178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 27.4 ptt? -152.33 162.95 40.43 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.462 -174.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -91.39 138.3 31.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.635 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 21.9 p -129.29 143.58 50.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.709 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.609 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 9.8 t80 -112.94 117.15 46.62 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.48 115.97 2.55 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.235 2.623 . . . . 0.0 113.622 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 13.6 t -135.94 125.65 16.21 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.07 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 2.2 Cg_endo -82.96 119.21 2.82 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 121.897 1.732 . . . . 0.0 111.48 174.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.3 p -176.71 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 164.18 -29.15 0.23 Allowed Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 113.968 -1.469 . . . . 0.0 110.237 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.534 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 3.3 t70 -143.2 174.69 10.49 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -119.93 146.23 45.99 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.609 ' HB2' ' HB3' ' A' ' 23' ' ' TYR . 88.5 m-85 -44.33 118.39 1.51 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.679 0.612 . . . . 0.0 111.361 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -114.24 136.94 52.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.019 0.437 . . . . 0.0 110.337 -177.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 20' ' ' MET . 18.4 tt -134.83 129.67 51.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.586 ' O ' ' HG3' ' A' ' 38' ' ' MET . 48.2 m-85 -84.23 126.78 33.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.836 -174.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -33.39 74.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.894 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -58.25 -34.57 70.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.257 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -87.08 -31.16 20.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.586 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 82.9 mtp -64.86 -41.52 95.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.73 0.3 . . . . 0.0 110.983 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -63.04 -25.4 68.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.577 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -77.3 -10.64 59.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.801 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.26 -5.61 38.76 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.689 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 38' ' ' MET . 7.4 tp10 -89.4 130.97 35.68 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.584 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -137.68 100.27 4.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.25 1.024 . . . . 0.0 111.784 -175.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.0 p -166.82 128.98 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.807 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.451 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -100.27 139.76 35.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.032 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.54 135.81 57.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.176 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.559 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 8.1 t -104.23 116.78 60.8 Favored Pre-proline 0 N--CA 1.435 -1.208 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.846 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.534 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 49.9 Cg_endo -70.41 156.74 60.99 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.582 2.188 . . . . 0.0 110.98 173.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 33.3 m 86.97 -56.72 0.05 OUTLIER 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.161 0.984 . . . . 0.0 111.398 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.7 p -91.12 -27.29 18.66 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.87 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.6 t 69.05 72.78 0.26 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.183 174.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.533 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 51.7 tp -134.57 148.49 50.47 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 174.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.439 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 35.2 mtm -131.06 137.75 49.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.426 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.46 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -138.98 152.46 24.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.254 178.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.558 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 8.2 t70 -80.87 145.63 31.25 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 83.9 t -134.12 115.34 20.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.223 0.535 . . . . 0.0 111.715 -177.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.8 t -74.17 107.35 4.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.93 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -96.18 165.24 12.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.455 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.547 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 14.7 t70 -115.14 146.16 41.64 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.968 173.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.02 -40.06 96.6 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -76.76 -40.87 46.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.302 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.408 ' HB2' ' HB3' ' A' ' 59' ' ' ASP . 8.7 m-20 -66.59 -32.03 73.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.192 -177.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 48.0 mt -66.96 -53.34 32.61 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.751 176.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 67' ' ' TYR . . . -58.94 -46.05 88.93 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.03 0.443 . . . . 0.0 111.163 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.22 -41.4 88.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.27 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.533 ' HE1' ' HB2' ' A' ' 14' ' ' PHE . 57.5 t80 -65.75 -35.37 80.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.203 -178.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.458 ' HD1' ' HB ' ' A' ' 72' ' ' ILE . 12.7 m-85 -52.29 -47.91 65.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.958 0.409 . . . . 0.0 110.342 174.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -74.28 -26.7 60.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.362 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -75.41 -44.0 46.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 0.0 111.303 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.554 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -80.2 -12.85 59.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.411 -176.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.3 40.22 11.59 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.792 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.535 HG22 ' H ' ' A' ' 73' ' ' HIS . 1.5 mt -94.89 178.44 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.535 ' H ' HG22 ' A' ' 72' ' ' ILE . 51.3 m80 -71.09 137.53 84.63 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.05 120.91 6.7 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.391 2.727 . . . . 0.0 112.425 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.33 164.16 35.93 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.042 2.495 . . . . 0.0 111.862 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -73.65 134.4 78.98 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.12 139.54 52.39 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 123.058 2.505 . . . . 0.0 113.209 -175.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.0 pt -104.12 168.24 2.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.783 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.68 87.15 7.29 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.071 0.462 . . . . 0.0 110.769 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.8 101.42 11.02 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.671 176.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.05 -24.67 14.82 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.016 -176.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.148 -0.929 . . . . 0.0 110.395 -178.93 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.962 0.41 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.2 m -149.58 174.59 12.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.702 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.1 p -81.86 120.92 25.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.005 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -100.09 5.95 44.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.758 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -162.2 172.5 15.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.55 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 36.0 tt0 -154.13 111.7 3.47 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 3.5 mp -116.91 151.04 18.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.029 -177.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.576 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 57.7 mt-10 -78.34 149.97 33.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.886 0.374 . . . . 0.0 110.567 176.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.7 tt -59.01 -28.82 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.886 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -68.82 -29.98 68.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.381 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.444 ' HB3' HG22 ' A' ' 7' ' ' ILE . 31.9 t70 -84.74 -36.16 21.98 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.322 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.55 ' SD ' ' HB2' ' A' ' 23' ' ' TYR . 4.1 tpt -49.25 141.69 8.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.058 170.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 m -87.48 108.99 19.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.982 0.42 . . . . 0.0 110.069 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.513 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 40.0 p90 -74.17 137.7 43.3 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.976 0.417 . . . . 0.0 110.78 -177.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -115.34 93.9 37.6 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.649 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 70' ' ' ALA . 49.2 Cg_endo -68.86 -22.39 36.54 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.739 2.293 . . . . 0.0 112.449 -174.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -77.09 -18.83 57.71 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.075 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.53 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 4.3 t-20 -116.26 -6.7 11.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.516 0.198 . . . . 0.0 111.247 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.512 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 1.8 mp0 64.35 42.35 5.3 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.08 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.543 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 26.2 ptt? -151.46 174.07 13.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.46 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.513 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 36.0 m-85 -109.86 149.12 30.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.955 0.407 . . . . 0.0 110.674 176.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 36.8 p -137.62 159.93 40.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.283 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.55 ' HB2' ' SD ' ' A' ' 12' ' ' MET . 6.1 t80 -141.28 131.39 13.02 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.34 127.06 21.72 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.692 2.261 . . . . 0.0 113.327 -176.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.511 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 20.0 t -140.74 141.37 24.54 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.214 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 12.0 Cg_endo -91.3 117.99 0.52 Allowed 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 122.171 1.914 . . . . 0.0 112.079 174.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.9 p 177.83 -44.38 0.01 OUTLIER 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.208 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.22 -19.86 0.48 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.168 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -140.12 173.63 11.32 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.432 ' HD2' ' HB ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -122.27 151.63 40.89 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.622 -0.14 . . . . 0.0 110.622 177.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.601 ' O ' ' HA ' ' A' ' 22' ' ' THR . 93.9 m-85 -47.88 126.94 11.27 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 123.802 0.688 . . . . 0.0 110.642 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -127.86 138.64 52.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.857 0.361 . . . . 0.0 110.939 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.543 ' O ' ' HB2' ' A' ' 20' ' ' MET . 12.1 tt -148.88 132.87 8.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.712 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -87.54 142.57 27.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.55 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.43 HD11 HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -67.86 -30.76 70.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.083 0.468 . . . . 0.0 110.741 -177.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -61.26 -31.24 71.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.839 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 6.7 m-20 -80.74 -34.02 34.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.569 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 79.0 mtp -63.99 -35.42 80.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.976 0.417 . . . . 0.0 110.07 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -68.27 -20.77 64.81 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.638 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 44.5 mm-40 -76.59 -13.42 60.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.361 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.49 -3.87 61.6 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.433 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -90.47 105.09 17.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.743 ' HD2' ' HE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -115.4 100.0 7.78 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.995 0.902 . . . . 0.0 110.552 -177.082 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 1.8 p -167.03 129.5 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.727 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.497 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -100.01 139.0 36.31 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.84 HG22 ' HG2' ' A' ' 53' ' ' MET . 38.4 t -115.67 119.0 60.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.194 -176.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.57 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 6.8 t -90.19 120.88 69.14 Favored Pre-proline 0 C--N 1.317 -0.824 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' A' ' 49' ' ' SER . 58.2 Cg_endo -73.45 154.95 50.76 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.355 2.037 . . . . 0.0 112.578 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 51.4 m 78.09 -54.4 0.5 Allowed 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.963 0.905 . . . . 0.0 111.637 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 12.1 p -82.2 -25.83 33.88 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.4 t 70.49 42.91 0.84 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.04 169.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.499 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 26.7 tp -103.96 128.61 51.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.359 0.599 . . . . 0.0 110.076 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.84 ' HG2' HG22 ' A' ' 46' ' ' VAL . 35.6 mtm -117.07 136.98 52.58 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.918 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.497 HD11 ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -138.68 152.98 25.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.747 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.55 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 4.7 t70 -82.42 151.4 26.6 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.533 HG13 ' HB2' ' A' ' 43' ' ' LYS . 6.3 p -129.7 112.99 25.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.559 0.695 . . . . 0.0 111.378 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.576 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 53.0 t -68.38 118.62 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.709 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.743 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 20.7 p90 -133.37 164.58 26.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.466 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.569 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 11.6 t70 -137.23 159.95 40.44 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.502 ' HD3' ' H ' ' A' ' 60' ' ' LYS . 3.0 mppt? -62.15 -37.64 85.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.028 0.442 . . . . 0.0 109.851 176.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -64.16 -45.16 89.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.523 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.97 -45.54 88.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.667 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 40.8 mt -55.02 -53.68 52.76 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.108 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.13 -43.18 73.88 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.217 0.323 . . . . 0.0 111.368 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -66.2 -49.89 65.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.022 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -67.73 -32.31 72.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.651 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.46 ' CD2' ' HB ' ' A' ' 72' ' ' ILE . 2.2 m-85 -50.87 -44.28 59.62 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 172.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -63.21 -49.57 73.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.667 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -68.86 -32.51 72.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.287 -175.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.512 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -81.69 -10.63 59.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.776 0.322 . . . . 0.0 111.105 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.21 37.63 36.59 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.814 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.496 HG22 ' H ' ' A' ' 73' ' ' HIS . 2.2 mt -91.92 172.48 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.496 ' H ' HG22 ' A' ' 72' ' ' ILE . 16.3 t-80 -66.87 119.02 60.63 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.512 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 86.0 Cg_exo -47.84 124.72 10.3 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.292 2.661 . . . . 0.0 112.508 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' ' 74' ' ' PRO . 17.4 Cg_exo -66.38 149.87 84.65 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.87 2.38 . . . . 0.0 112.92 -176.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -75.56 165.68 51.53 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.844 173.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.02 138.33 43.54 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.045 1.83 . . . . 0.0 112.13 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.0 pt -119.25 177.52 2.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.169 -173.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.19 12.25 18.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.173 0.511 . . . . 0.0 110.987 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.47 109.01 19.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.107 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.89 10.48 38.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.611 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.303 0 O-C-N 124.52 1.137 . . . . 0.0 110.721 -178.069 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.55 0.691 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -144.27 161.21 39.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.155 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.9 p -90.66 112.36 24.06 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.083 0.468 . . . . 0.0 111.252 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -86.08 -23.24 26.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.972 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.637 ' HB2' HG22 ' A' ' 54' ' ' ILE . 1.6 m-20 -119.46 145.38 46.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.646 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.408 ' HG3' ' CB ' ' A' ' 55' ' ' ASP . 36.5 tt0 -140.36 108.28 5.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.726 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.5 mp -110.95 160.84 9.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -176.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.446 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 5.2 mp0 -79.38 148.99 31.79 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.3 tt -58.15 -29.95 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.129 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -68.07 -27.76 66.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.045 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.28 -39.44 54.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.782 0.325 . . . . 0.0 110.893 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 81.1 mtp -64.2 157.19 26.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.13 0.49 . . . . 0.0 111.154 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.6 m -90.44 109.22 20.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.482 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.602 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 42.1 p90 -78.96 134.63 36.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.192 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 9.5 tp10 -117.76 97.65 50.95 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.197 177.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 21.9 Cg_endo -61.25 -29.72 86.89 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.981 2.454 . . . . 0.0 111.953 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.62 -23.54 63.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.375 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.81 -11.63 15.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.119 0.485 . . . . 0.0 109.977 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.55 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 1.9 mp0 69.84 35.11 2.41 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.696 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.549 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 25.0 ptt? -157.99 174.71 14.83 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.593 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.602 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 42.8 m-85 -105.33 140.49 38.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.382 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 42.6 p -132.08 163.01 29.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.904 177.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.614 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 45.6 t80 -136.66 118.57 11.48 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.13 118.51 5.25 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 123.23 2.62 . . . . 0.0 112.794 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.0 t -137.55 140.58 30.64 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.57 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -90.94 118.9 0.61 Allowed 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 121.828 1.685 . . . . 0.0 111.973 174.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.2 p 179.52 -41.27 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 160.17 -26.3 0.31 Allowed Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.398 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.562 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 3.5 t0 -142.94 175.23 10.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.21 153.34 25.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.338 0.113 . . . . 0.0 111.137 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.614 ' HB2' ' HB3' ' A' ' 23' ' ' TYR . 81.2 m-85 -52.45 136.12 32.31 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.063 175.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 2.2 pt20 -133.3 136.68 45.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.876 0.37 . . . . 0.0 110.884 -176.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.549 ' O ' ' HB2' ' A' ' 20' ' ' MET . 15.2 tt -151.55 142.5 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.477 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.546 ' O ' ' HG3' ' A' ' 38' ' ' MET . 95.0 m-85 -99.31 147.74 24.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.914 0.388 . . . . 0.0 111.129 -177.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.47 -41.55 93.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.312 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -65.04 -31.99 73.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.186 0.517 . . . . 0.0 110.849 -175.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.01 -44.07 73.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.093 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.546 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 78.5 mtp -62.18 -42.61 99.44 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.684 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -65.93 -16.55 63.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.254 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -81.99 -12.48 58.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.41 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.2 -4.43 35.5 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.749 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -105.77 111.0 23.49 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.549 ' HD3' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -118.75 102.87 9.15 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.842 0.829 . . . . 0.0 110.732 -172.622 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 1.6 p -162.42 126.22 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.665 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.552 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -99.85 137.2 38.64 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.389 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.764 HG22 ' HG2' ' A' ' 53' ' ' MET . 47.7 t -114.62 123.01 69.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.764 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.532 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 12.0 t -90.73 122.3 67.11 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.562 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 43.2 Cg_endo -74.59 156.31 44.87 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.225 1.95 . . . . 0.0 111.29 175.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 35.5 t 89.28 -58.39 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.857 0.863 . . . . 0.0 110.107 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.4 p -89.3 -26.15 21.28 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 175.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.9 m 67.36 47.99 1.21 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.227 174.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 53' ' ' MET . 1.7 tt -102.71 135.23 44.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.764 ' HG2' HG22 ' A' ' 46' ' ' VAL . 32.3 mtm -117.11 137.14 52.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.466 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.637 HG22 ' HB2' ' A' ' 5' ' ' ASP . 2.8 pp -142.54 146.1 22.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.222 -176.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.408 ' CB ' ' HG3' ' A' ' 6' ' ' GLU . 6.4 m-20 -79.17 151.28 31.37 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.89 109.69 15.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.302 0.572 . . . . 0.0 110.941 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.446 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 46.9 t -65.95 112.37 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.423 -177.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -108.09 160.09 16.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.017 0.437 . . . . 0.0 111.651 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.734 ' HB3' ' HB2' ' A' ' 62' ' ' ASP . 20.3 t70 -117.01 146.15 43.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.093 173.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.418 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 12.3 mptt -62.4 -37.66 86.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.881 0.372 . . . . 0.0 110.563 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.39 -26.58 28.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.176 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.734 ' HB2' ' HB3' ' A' ' 59' ' ' ASP . 4.2 m-20 -65.58 -48.39 72.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.071 173.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 83.5 mt -55.08 -49.35 71.91 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.741 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.09 -37.01 83.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.0 0.429 . . . . 0.0 111.534 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -69.16 -52.83 24.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.677 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -64.13 -34.91 79.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.743 0.306 . . . . 0.0 110.934 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.424 ' CE1' ' HD3' ' A' ' 75' ' ' PRO . 0.5 OUTLIER -53.83 -46.73 71.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.056 174.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.28 -41.89 76.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.584 -178.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -59.39 -44.92 92.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.232 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.55 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -81.73 -27.31 33.95 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.27 58.17 3.22 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.827 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.419 ' HB ' ' HD1' ' A' ' 67' ' ' TYR . 5.2 mt -93.35 167.25 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.62 -0.29 . . . . 0.0 110.222 -176.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -56.22 131.98 75.25 Favored Pre-proline 0 N--CA 1.464 0.237 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 13.1 Cg_endo -56.4 117.11 3.71 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 123.352 2.701 . . . . 0.0 114.155 -176.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 74' ' ' PRO . 4.7 Cg_endo -87.4 168.88 7.29 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.625 3.55 . . . . 0.0 110.738 172.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 43.7 mt-10 -70.14 131.39 88.85 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 76' ' ' GLU . 38.0 Cg_exo -60.03 141.62 96.72 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.851 2.367 . . . . 0.0 113.004 -174.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.0 pt -90.54 150.08 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.756 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.5 90.8 3.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.104 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.54 -13.28 58.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.885 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.02 91.59 2.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.15 176.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.829 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.92 -179.534 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ttt . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 121.993 0.901 . . . . 0.0 109.823 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.1 m -146.94 179.78 7.35 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.399 -1.273 . . . . 0.0 107.818 175.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 55' ' ' ASP . 17.4 p -73.64 94.06 2.14 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.642 0.734 . . . . 0.0 110.987 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -110.23 -13.24 14.37 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.509 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.512 ' HB2' HG22 ' A' ' 54' ' ' ILE . 9.5 m-20 -97.42 127.02 43.04 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 176.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -124.46 108.58 12.29 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.717 -173.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.468 HG22 ' HB3' ' A' ' 11' ' ' ASP . 2.7 mp -111.84 150.27 14.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.126 -175.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -71.4 145.32 49.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.985 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.439 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 20.7 tt -62.36 -27.57 42.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 172.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -56.79 -29.42 62.68 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.573 173.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.468 ' HB3' HG22 ' A' ' 7' ' ' ILE . 27.8 t70 -94.96 -41.13 9.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.794 -0.184 . . . . 0.0 111.224 -175.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.477 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 68.7 mtp -60.78 145.63 49.01 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.17 0.509 . . . . 0.0 110.867 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 m -89.92 124.03 34.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.053 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.434 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . 38.5 p90 -74.27 135.74 42.65 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.291 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -118.3 88.4 32.86 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.131 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.79 -15.91 45.04 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.117 2.544 . . . . 0.0 112.632 -174.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -68.98 -29.7 67.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.866 0.365 . . . . 0.0 111.217 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.583 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 2.0 t-20 -118.47 6.27 11.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.872 0.367 . . . . 0.0 110.571 -177.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 59.43 43.53 16.25 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.007 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.583 ' HG2' ' HB3' ' A' ' 18' ' ' ASN . 22.9 ptt? -145.58 174.45 11.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.975 0.416 . . . . 0.0 110.925 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.439 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 92.0 m-85 -108.14 142.6 38.12 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 73.0 p -137.37 167.07 22.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.716 0.293 . . . . 0.0 111.192 -175.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.477 ' CD1' ' HA ' ' A' ' 12' ' ' MET . 5.6 t80 -146.68 124.04 5.94 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.9 111.71 0.77 Allowed 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.129 2.552 . . . . 0.0 112.993 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.405 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 27.6 t -118.64 137.96 25.39 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.756 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -88.83 116.95 0.85 Allowed 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 121.349 1.366 . . . . 0.0 111.558 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.5 p 175.15 -41.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.497 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 153.66 -15.6 0.63 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.882 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -142.45 176.15 9.23 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.412 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 18.8 ptp180 -113.62 153.62 28.56 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 22' ' ' THR . 91.5 m-85 -55.74 134.28 51.39 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 174.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 30' ' ' ARG . 24.3 mt-30 -129.8 132.18 46.43 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.946 0.403 . . . . 0.0 111.431 -176.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 20' ' ' MET . 14.6 tt -141.58 128.14 19.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.731 171.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.431 ' O ' ' HG3' ' A' ' 38' ' ' MET . 69.6 m-85 -91.13 154.56 19.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.904 0.383 . . . . 0.0 110.698 -176.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.76 -34.82 75.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.658 -177.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.53 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 27.4 t70 -59.67 -45.54 91.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.025 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.406 ' OD2' ' HB2' ' A' ' 34' ' ' TYR . 21.0 m-20 -64.76 -33.74 76.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 110.61 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 59.5 mtp -74.66 -36.12 62.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.987 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -65.08 -29.61 70.51 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.55 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 36' ' ' ASP . 24.6 mm-40 -58.98 -22.94 61.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.617 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.3 8.2 38.84 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.57 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -115.36 157.65 23.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.666 ' HD3' ' N ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -145.47 100.73 3.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.7 0.762 . . . . 0.0 111.566 -174.091 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 1.4 p -166.71 131.41 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.503 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.537 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -100.57 132.36 45.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.699 HG22 ' HG2' ' A' ' 53' ' ' MET . 47.2 t -115.13 133.89 59.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.454 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 14.2 t -104.38 130.96 22.37 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.411 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.542 ' O ' ' HB2' ' A' ' 49' ' ' SER . 58.4 Cg_endo -79.44 156.45 25.22 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.866 2.377 . . . . 0.0 112.021 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.542 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 41.6 m 83.22 -53.89 0.16 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.196 0.998 . . . . 0.0 111.609 -177.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 18.0 p -90.65 -24.88 20.36 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.631 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.1 t 64.77 49.8 2.16 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.33 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.2 mt -117.32 154.78 30.67 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.366 0.603 . . . . 0.0 111.308 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.699 ' HG2' HG22 ' A' ' 46' ' ' VAL . 25.2 mtm -135.01 138.47 43.99 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.609 -168.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.537 HD11 ' HB3' ' A' ' 45' ' ' ALA . 2.7 pp -140.37 152.49 21.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.319 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.438 ' HB2' ' HB ' ' A' ' 3' ' ' THR . 4.9 t70 -91.81 147.84 22.68 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -173.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 5.1 p -133.9 123.5 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.4 t -79.8 114.76 21.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 122.137 -0.352 . . . . 0.0 110.661 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.566 ' CE1' ' HB3' ' A' ' 43' ' ' LYS . 44.1 p90 -121.63 165.09 16.24 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.707 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.417 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 14.0 t70 -121.26 161.16 22.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.206 0.527 . . . . 0.0 110.086 174.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.569 ' HB3' HD12 ' A' ' 78' ' ' ILE . 3.4 mtmt -61.66 -40.12 93.82 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.46 175.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -78.23 -35.25 48.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.771 -174.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -70.91 -32.1 68.93 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.341 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 61.7 mt -63.51 -48.71 76.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.76 0.314 . . . . 0.0 110.303 172.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.99 -38.92 93.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.326 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -66.49 -48.86 68.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.34 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.434 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 85.4 t80 -62.6 -36.49 82.9 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.945 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.507 ' HA ' HD12 ' A' ' 72' ' ' ILE . 2.2 t80 -51.99 -42.14 62.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.684 175.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.41 -37.75 60.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.611 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -60.4 -54.36 46.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.057 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.88 -22.92 45.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.939 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.96 51.91 6.68 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.507 HD12 ' HA ' ' A' ' 67' ' ' TYR . 29.1 mt -78.58 156.78 4.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.533 -0.333 . . . . 0.0 111.203 -171.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -53.46 131.68 53.85 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.091 174.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -51.73 117.95 4.0 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.562 2.841 . . . . 0.0 113.576 -175.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -90.95 164.59 3.9 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.804 3.003 . . . . 0.0 110.91 172.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -73.03 132.46 82.65 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -46.47 142.55 9.41 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.383 2.722 . . . . 0.0 113.306 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.569 HD12 ' HB3' ' A' ' 60' ' ' LYS . 26.4 pt -109.19 168.39 3.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.995 -176.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.8 71.19 6.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.097 0.475 . . . . 0.0 110.688 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -132.14 110.26 10.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.943 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 63.73 21.75 12.81 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.195 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.186 -179.755 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.6 p -110.97 177.31 4.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.701 0.286 . . . . 0.0 110.257 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.8 p -86.18 122.42 30.16 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.001 0.429 . . . . 0.0 110.611 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -90.11 -11.38 41.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.608 -175.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.448 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 7.3 m-20 -141.99 169.7 17.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.276 176.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 35.5 tt0 -155.86 118.99 4.28 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -134.96 153.89 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.788 -175.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.531 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 45.4 mt-10 -72.81 152.08 41.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.036 0.446 . . . . 0.0 110.813 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.439 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 18.6 tt -55.49 -29.03 23.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.479 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.02 -35.1 80.1 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.402 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -78.08 -27.73 48.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.947 0.403 . . . . 0.0 111.12 -172.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 90.4 mtp -75.84 161.18 29.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.283 0.563 . . . . 0.0 111.317 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.8 m -95.12 115.76 27.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.956 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.454 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 44.5 p90 -81.33 138.88 35.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.091 0.472 . . . . 0.0 111.254 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -118.98 91.46 43.31 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.61 -28.36 52.78 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.188 2.592 . . . . 0.0 113.182 -172.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -70.98 -21.56 62.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.8 -175.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -112.97 3.58 16.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.62 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 55.09 44.53 27.84 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.904 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -146.66 165.7 28.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.94 0.4 . . . . 0.0 110.913 -176.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.543 ' HE1' HD23 ' A' ' 35' ' ' LEU . 68.4 m-85 -112.36 145.33 40.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.716 175.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 36.7 p -133.12 157.87 44.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.75 0.309 . . . . 0.0 110.987 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.496 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 9.6 t80 -140.34 125.17 11.07 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -51.21 127.89 23.47 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.376 2.718 . . . . 0.0 113.743 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 20.4 t -145.46 135.02 11.48 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.915 177.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 2.5 Cg_endo -87.24 118.09 1.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.026 1.817 . . . . 0.0 111.679 174.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 31.0 p -178.55 -54.05 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.404 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.468 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 169.44 -25.15 0.1 Allowed Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.99 -177.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -136.68 174.43 10.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.5 147.79 43.28 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 122.437 -0.164 . . . . 0.0 110.563 176.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' A' ' 22' ' ' THR . 92.1 m-85 -45.94 128.86 9.38 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.448 0.467 . . . . 0.0 110.445 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -131.51 138.18 48.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.231 0.539 . . . . 0.0 110.884 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.0 tt -143.17 129.63 17.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.802 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -86.27 143.99 27.64 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.143 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.543 HD23 ' HE1' ' A' ' 21' ' ' PHE . 1.6 tm? -62.46 -36.38 82.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.142 -173.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -65.26 -34.18 77.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.933 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.97 -44.08 97.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.106 0.479 . . . . 0.0 110.408 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 70.3 mtp -62.74 -41.69 99.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.116 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -65.72 -31.41 72.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.902 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -76.01 -3.88 38.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.734 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.48 -17.97 45.65 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.972 174.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -91.23 95.57 10.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.155 0.502 . . . . 0.0 110.696 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -100.68 100.93 11.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.579 0.704 . . . . 0.0 110.966 -177.115 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.9 p -165.51 126.96 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.68 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.454 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -99.99 143.6 30.01 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.018 0.437 . . . . 0.0 110.36 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.43 140.05 44.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.38 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.539 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 11.1 t -109.37 118.04 51.7 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -70.61 156.51 60.98 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.439 2.093 . . . . 0.0 112.135 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.1 t 85.78 -53.53 0.08 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.852 0.861 . . . . 0.0 110.659 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 17.5 p -89.14 -28.39 20.08 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.4 m 66.92 54.69 0.76 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.387 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 53' ' ' MET . 1.7 tt -110.9 136.5 49.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.443 ' N ' HD23 ' A' ' 52' ' ' LEU . 31.9 mtm -123.84 137.99 54.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.742 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.454 HD11 ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -140.22 153.8 22.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 43.1 m-20 -82.01 159.79 23.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.838 0.351 . . . . 0.0 110.506 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.56 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 49.0 t -130.97 144.19 38.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.09 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.531 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 44.0 t -106.56 108.85 26.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.632 0.253 . . . . 0.0 110.592 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.513 ' HE2' ' HD2' ' A' ' 43' ' ' LYS . 45.2 p90 -112.98 165.24 12.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.041 -177.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.464 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 2.7 t70 -127.4 170.63 12.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.233 0.539 . . . . 0.0 110.234 175.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -63.62 -46.25 86.61 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.999 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -72.88 -37.44 67.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.917 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -63.8 -31.48 72.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.773 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 58.9 mt -75.03 -45.31 42.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.605 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.93 -49.63 76.93 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.583 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.61 -40.27 96.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.174 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.421 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 91.2 t80 -69.22 -38.05 78.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.737 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.547 ' HA ' HD12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -57.15 -45.18 83.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.861 0.362 . . . . 0.0 110.794 178.204 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -76.45 -25.72 54.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.586 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -79.26 -40.53 30.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.747 0.308 . . . . 0.0 111.64 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.54 -26.4 30.15 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.419 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.1 53.97 4.63 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 -176.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 67' ' ' TYR . 51.8 mt -83.26 143.84 11.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.152 -0.524 . . . . 0.0 111.033 -173.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -52.48 122.58 26.26 Favored Pre-proline 0 C--O 1.234 0.259 0 O-C-N 123.522 0.514 . . . . 0.0 109.79 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -34.62 107.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 125.084 3.856 . . . . 0.0 114.589 -171.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -81.07 165.13 19.52 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.762 2.975 . . . . 0.0 110.78 172.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -73.16 149.17 89.3 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.93 138.11 84.64 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.511 2.141 . . . . 0.0 112.434 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.1 pt -101.93 171.23 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.86 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.78 83.58 6.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.081 0.467 . . . . 0.0 110.245 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -143.11 88.78 2.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.24 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.49 108.88 10.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.711 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.537 -0.744 . . . . 0.0 109.882 179.379 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.8 mtt . . . . . 0 CA--C 1.518 -0.283 0 CA-C-O 121.278 0.561 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -132.61 155.63 48.37 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.714 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.4 p -74.52 114.34 12.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.364 0.602 . . . . 0.0 110.405 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -83.18 -20.76 34.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.107 -173.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -132.66 162.81 30.41 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.172 0.51 . . . . 0.0 111.034 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 37.2 tt0 -146.93 108.52 4.32 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.657 171.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.96 155.74 18.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.056 -175.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.553 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 32.3 mp0 -65.32 144.42 57.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.391 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.0 tt -57.54 -29.35 33.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.445 0.64 . . . . 0.0 110.139 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -64.41 -28.8 69.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.927 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -82.1 -31.31 30.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.772 -175.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 84.2 mtp -68.65 160.84 29.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.027 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.1 m -85.17 110.89 19.33 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.076 0.465 . . . . 0.0 110.362 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.531 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 35.0 p90 -74.86 139.0 42.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.542 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -126.58 85.4 60.51 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.085 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.476 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 24.5 Cg_endo -62.86 -29.84 76.79 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.609 2.206 . . . . 0.0 111.579 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -63.81 -23.94 67.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.149 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -118.5 5.52 11.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.324 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.461 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 2.0 mp0 57.9 30.95 19.88 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.762 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 27.5 ptt? -144.36 170.89 15.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.061 0.458 . . . . 0.0 111.234 -175.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.531 ' CE2' ' HB3' ' A' ' 14' ' ' PHE . 31.0 m-85 -119.35 140.19 50.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.766 177.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 38.5 p -130.72 148.29 52.48 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.81 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.535 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 2.4 t80 -119.41 122.54 29.3 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.62 116.72 3.71 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.755 2.303 . . . . 0.0 113.383 -175.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 10.7 t -132.98 136.37 27.51 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.19 177.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 9.8 Cg_endo -90.29 118.24 0.68 Allowed 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 121.912 1.741 . . . . 0.0 111.642 174.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.409 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 32.0 p -176.56 -47.07 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.409 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 168.73 -26.89 0.13 Allowed Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.96 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.52 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 3.1 t0 -142.8 176.22 9.23 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.483 ' H ' ' HD2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -114.0 156.4 24.15 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -177.141 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 22' ' ' THR . 91.1 m-85 -58.39 117.72 4.78 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 172.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 30' ' ' ARG . 49.1 mt-30 -116.9 135.92 53.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.671 0.272 . . . . 0.0 111.105 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.421 HD13 HG11 ' A' ' 56' ' ' VAL . 13.8 tt -148.63 135.04 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.789 174.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -94.24 149.79 20.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.646 0.26 . . . . 0.0 110.62 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -32.11 70.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.488 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -60.51 -41.4 94.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.886 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 64.0 m-20 -66.11 -36.5 83.33 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.246 0.546 . . . . 0.0 110.115 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.532 ' HE2' ' HB3' ' A' ' 58' ' ' PHE . 57.7 mtp -69.19 -38.92 78.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.368 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -62.84 -30.2 71.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.22 0.533 . . . . 0.0 110.426 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 5.5 mm-40 -64.8 -22.16 66.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.319 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.72 -1.18 55.44 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -174.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -93.18 98.38 11.25 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.654 ' HB3' ' HE2' ' A' ' 58' ' ' PHE . 20.2 pttp -103.44 98.97 8.78 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.627 0.727 . . . . 0.0 111.421 -176.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 2.5 p -169.01 127.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.746 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.35 137.39 39.76 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 176.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.794 HG22 ' HG2' ' A' ' 53' ' ' MET . 40.8 t -111.84 132.4 60.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.022 -178.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.518 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 7.8 t -102.55 112.54 65.69 Favored Pre-proline 0 N--CA 1.448 -0.528 0 CA-C-O 120.991 0.424 . . . . 0.0 110.073 176.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.546 ' O ' ' HB3' ' A' ' 49' ' ' SER . 24.6 Cg_endo -67.81 157.38 62.02 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.27 1.98 . . . . 0.0 110.953 170.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.546 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 41.2 t 90.9 -58.43 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.053 0.941 . . . . 0.0 110.89 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 27.5 p -92.26 -28.25 17.11 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.948 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.8 t 69.65 73.25 0.24 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.399 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.543 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 46.6 tp -134.53 154.41 51.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.354 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.794 ' HG2' HG22 ' A' ' 46' ' ' VAL . 39.4 mtm -139.45 138.37 36.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.294 -177.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -140.17 152.38 21.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.86 177.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 2.1 m-20 -74.48 156.38 36.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.642 0.258 . . . . 0.0 110.32 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 5.0 p -131.15 124.75 56.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.278 0.561 . . . . 0.0 111.165 176.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.553 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 78.4 t -82.58 111.58 19.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.954 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.654 ' HE2' ' HB3' ' A' ' 43' ' ' LYS . 50.2 p90 -112.97 163.03 15.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.19 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.57 ' OD1' ' HG2' ' A' ' 61' ' ' GLU . 5.6 t70 -118.24 157.24 27.38 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.622 ' HB3' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -63.7 -40.49 96.93 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.223 179.087 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.57 ' HG2' ' OD1' ' A' ' 59' ' ' ASP . 10.3 pt-20 -73.34 -37.91 65.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.12 -177.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -63.05 -45.56 91.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.75 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 54.8 mt -56.75 -49.72 74.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.809 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.21 -42.78 86.97 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.974 0.416 . . . . 0.0 111.59 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.9 -46.01 79.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.355 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -66.02 -34.54 78.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.259 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.636 ' HD1' ' HB ' ' A' ' 72' ' ' ILE . 2.6 m-85 -51.83 -53.1 44.02 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.693 0.283 . . . . 0.0 110.826 174.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.6 -36.55 81.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.68 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.52 -54.49 19.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.145 0.498 . . . . 0.0 111.436 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.461 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -65.91 -18.38 65.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.895 -176.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.47 45.72 4.87 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.97 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.636 ' HB ' ' HD1' ' A' ' 67' ' ' TYR . 1.2 mt -106.29 142.67 18.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 67.7 m170 -64.72 147.2 98.13 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.705 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.477 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 4.0 Cg_endo -45.23 117.29 1.58 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.119 3.213 . . . . 0.0 113.815 -174.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.477 ' HD2' ' HA ' ' A' ' 74' ' ' PRO . 58.8 Cg_endo -71.25 164.75 34.69 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.396 2.731 . . . . 0.0 111.849 176.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -74.26 152.34 88.08 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.94 135.21 57.83 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.756 2.304 . . . . 0.0 112.892 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.622 HD12 ' HB3' ' A' ' 60' ' ' LYS . 38.3 pt -112.56 171.08 3.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.133 -175.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.581 ' O ' ' HG2' ' A' ' 60' ' ' LYS . . . -107.66 107.36 18.13 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 172.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.428 ' HA ' ' CB ' ' A' ' 60' ' ' LYS . . . -70.65 -174.67 0.93 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.754 -176.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.17 106.72 0.35 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.979 0.419 . . . . 0.0 110.65 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.303 -178.642 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 mtm . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.592 0.234 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -117.91 -174.2 2.59 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.1 p -89.43 118.76 29.32 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 175.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -113.22 6.38 17.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.86 0.362 . . . . 0.0 111.079 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -150.5 172.14 15.94 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.501 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 35.3 tt0 -158.9 117.14 2.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.818 0.342 . . . . 0.0 110.326 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.9 OUTLIER -125.99 163.05 28.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.457 ' HG2' ' HB ' ' A' ' 57' ' ' VAL . 46.0 mt-10 -87.88 152.97 21.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.024 0.44 . . . . 0.0 111.145 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.6 tt -60.15 -29.57 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.05 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -69.38 -28.86 66.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.733 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.23 -35.55 35.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.106 0.479 . . . . 0.0 109.769 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 78.5 mmm -57.01 152.28 13.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.41 171.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.6 m -96.85 124.55 40.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.833 0.349 . . . . 0.0 110.816 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -80.9 130.38 35.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.096 0.474 . . . . 0.0 110.507 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -115.43 90.07 24.0 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 30.9 Cg_endo -63.88 -21.57 68.97 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.959 2.439 . . . . 0.0 112.013 -176.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -59.86 -42.61 94.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.75 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.453 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 0.4 OUTLIER -110.79 5.62 20.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.9 -175.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.548 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 1.9 mp0 59.11 41.22 20.91 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.206 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.453 ' HG2' ' HB3' ' A' ' 18' ' ' ASN . 27.2 ptt? -147.3 173.74 12.3 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.91 -177.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -109.11 138.56 45.27 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.916 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.535 ' HB ' ' HD3' ' A' ' 30' ' ' ARG . 21.1 p -137.14 162.57 33.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.693 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.438 ' O ' ' HB2' ' A' ' 30' ' ' ARG . 52.3 t80 -144.14 128.16 9.1 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.82 107.96 0.31 Allowed 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.292 2.662 . . . . 0.0 113.774 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.46 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 20.8 t -113.0 140.83 24.61 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.002 174.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 21.0 Cg_endo -91.95 117.5 0.44 Allowed 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.989 1.793 . . . . 0.0 111.837 174.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.436 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 31.6 p 178.36 -46.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.919 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.436 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 164.23 -24.27 0.18 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.917 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.504 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -141.97 175.42 9.75 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.535 ' HD3' ' HB ' ' A' ' 22' ' ' THR . 7.6 ptp180 -118.33 157.6 26.78 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.326 -178.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.534 ' O ' ' HA ' ' A' ' 22' ' ' THR . 91.5 m-85 -50.04 129.6 20.96 Favored 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 123.831 0.707 . . . . 0.0 110.156 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -130.64 127.48 39.02 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.098 -171.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.479 ' HB ' ' HA ' ' A' ' 45' ' ' ALA . 13.3 tt -146.89 135.92 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.528 175.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.416 ' O ' ' HG3' ' A' ' 38' ' ' MET . 27.0 m-85 -97.48 144.16 27.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.481 -177.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.565 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 3.6 mm? -62.81 -27.83 69.58 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.941 0.4 . . . . 0.0 110.658 176.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -55.43 -43.55 75.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.724 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.4 -31.98 54.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.496 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.603 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 78.2 mtp -70.3 -32.4 70.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.116 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -68.82 -27.26 65.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.845 177.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -72.85 -7.0 48.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.855 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.0 -0.83 47.83 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.994 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.603 ' O ' ' HA ' ' A' ' 38' ' ' MET . 9.9 tp10 -105.7 155.06 19.62 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.664 ' HD3' ' N ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -147.62 100.99 3.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.769 0.795 . . . . 0.0 110.942 -176.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 p -167.2 131.08 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.98 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.479 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . . . -100.73 135.39 42.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.31 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 p -112.91 136.74 48.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.268 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.409 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 18.7 t -105.07 124.75 35.57 Favored Pre-proline 0 N--CA 1.436 -1.162 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.444 175.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.504 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 58.3 Cg_endo -75.7 156.42 39.93 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.805 2.337 . . . . 0.0 111.094 173.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 33.0 t 89.58 -57.37 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.764 0.826 . . . . 0.0 110.629 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.413 ' HB3' ' CB ' ' A' ' 27' ' ' CYS . 21.5 p -91.25 -30.91 16.36 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.306 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t 70.38 73.23 0.21 Allowed 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.276 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.3 tp -130.35 144.53 51.44 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.458 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.406 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 46.3 mtm -135.18 137.86 43.1 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.131 0.491 . . . . 0.0 110.984 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.469 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -138.61 154.86 27.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.663 179.43 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.501 ' HB3' ' HG3' ' A' ' 6' ' ' GLU . 2.1 t70 -83.4 151.31 25.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 43' ' ' LYS . 6.1 p -130.04 116.47 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.521 0.677 . . . . 0.0 111.909 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.457 ' HB ' ' HG2' ' A' ' 8' ' ' GLU . 48.4 t -72.76 111.55 7.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.446 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.486 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 28.4 p90 -115.33 164.7 13.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.032 -175.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.52 ' OD1' ' HG2' ' A' ' 61' ' ' GLU . 8.8 t70 -126.05 157.61 37.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 171.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.704 ' HB3' HD12 ' A' ' 78' ' ' ILE . 0.7 OUTLIER -64.67 -37.76 88.67 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.629 178.11 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.52 ' HG2' ' OD1' ' A' ' 59' ' ' ASP . 12.9 pt-20 -73.13 -37.87 66.48 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.355 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.506 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 4.0 m-20 -59.06 -53.13 61.89 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.488 175.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.422 HD22 HD12 ' A' ' 35' ' ' LEU . 28.4 mt -55.42 -50.7 69.1 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.881 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.48 -48.23 81.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.681 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -68.46 -43.56 76.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.867 0.365 . . . . 0.0 110.876 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.506 ' HD1' ' O ' ' A' ' 62' ' ' ASP . 48.1 m-85 -68.13 -32.48 72.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.299 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.565 ' CE1' ' HB3' ' A' ' 35' ' ' LEU . 1.2 m-85 -51.63 -48.13 63.42 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.261 0.553 . . . . 0.0 109.956 170.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.44 -30.87 64.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.776 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 66' ' ' TYR . 67.8 mm-40 -66.73 -45.25 79.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.118 176.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.548 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -75.34 -20.47 59.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.509 -176.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.73 43.4 6.09 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.77 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.541 HG22 ' H ' ' A' ' 73' ' ' HIS . 1.6 mt -97.72 175.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.541 ' H ' HG22 ' A' ' 72' ' ' ILE . 76.0 m-70 -66.16 135.58 95.08 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 73' ' ' HIS . 41.2 Cg_exo -56.27 119.57 6.85 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 123.047 2.498 . . . . 0.0 112.098 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.38 162.46 38.28 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.92 2.414 . . . . 0.0 113.14 -176.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.436 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 5.1 mp0 -74.79 164.19 63.1 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.261 176.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 15.6 Cg_endo -57.41 142.23 95.07 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.544 2.163 . . . . 0.0 112.42 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.704 HD12 ' HB3' ' A' ' 60' ' ' LYS . 17.6 pt -110.65 170.13 3.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.433 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.21 25.3 1.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.99 0.424 . . . . 0.0 110.934 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.35 114.41 9.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.448 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.99 -28.12 6.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.207 0.527 . . . . 0.0 110.203 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.447 179.503 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.464 0.252 0 CA-C-O 121.002 0.429 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.2 p -102.29 -158.04 0.65 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.563 -177.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.634 ' HB ' ' OD1' ' A' ' 55' ' ' ASP . 5.7 p -65.91 111.66 3.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.973 0.416 . . . . 0.0 111.271 177.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -114.08 -21.37 10.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.339 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -121.02 152.64 38.36 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.025 -173.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -144.67 117.65 8.83 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 123.12 0.262 . . . . 0.0 110.492 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.4 ' CD1' HG13 ' A' ' 54' ' ' ILE . 0.6 OUTLIER -118.17 162.58 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.564 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 41.6 mt-10 -69.29 148.85 49.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.956 0.408 . . . . 0.0 111.254 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.3 tt -62.36 -33.18 57.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.049 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.68 -27.25 61.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.753 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -72.53 -30.33 64.37 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.613 ' HA ' ' HD1' ' A' ' 23' ' ' TYR . 84.5 mtp -69.74 151.06 46.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.06 172.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.1 m -76.86 131.52 38.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.121 0.486 . . . . 0.0 111.578 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -74.92 127.17 32.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.329 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -125.24 85.26 58.48 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.002 0.43 . . . . 0.0 110.304 173.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.68 -34.17 42.15 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.759 2.306 . . . . 0.0 111.949 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.33 -34.11 76.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.478 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.476 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 3.5 t-20 -102.62 -1.6 29.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.875 0.369 . . . . 0.0 111.024 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.404 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 1.5 mp0 62.01 35.96 15.75 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.856 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.551 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 26.2 ptt? -154.0 167.58 29.28 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.544 -177.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -100.36 146.28 27.16 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.477 177.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 23.4 p -138.51 136.82 36.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.86 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.613 ' HD1' ' HA ' ' A' ' 12' ' ' MET . 8.6 t80 -115.38 121.31 34.94 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -50.68 118.73 4.38 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.672 2.915 . . . . 0.0 113.778 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.515 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 16.5 t -135.47 139.98 32.85 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.339 176.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -91.8 120.32 0.56 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.644 2.229 . . . . 0.0 111.947 172.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.6 p 177.61 -39.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.775 0.798 . . . . 0.0 108.958 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 158.14 -26.95 0.44 Allowed Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.627 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.452 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 3.7 t0 -142.04 176.34 9.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.464 ' HE ' ' HB ' ' A' ' 22' ' ' THR . 12.7 ptm180 -117.63 153.7 32.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.582 ' O ' ' HA ' ' A' ' 22' ' ' THR . 99.4 m-85 -51.57 128.24 22.56 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.58 0.55 . . . . 0.0 110.003 177.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -133.55 142.66 48.28 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.065 0.459 . . . . 0.0 110.686 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.551 ' O ' ' HB2' ' A' ' 20' ' ' MET . 14.6 tt -144.44 132.46 17.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.557 -178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -82.38 128.85 34.64 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.496 -177.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.494 HD12 ' CE1' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -62.59 -34.65 77.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -176.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -65.16 -25.92 67.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.246 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.87 -32.49 27.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.308 0.575 . . . . 0.0 109.76 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 83.6 mtp -67.46 -35.56 79.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.944 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -67.1 -23.6 65.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.154 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -77.69 -9.13 58.82 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.035 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.75 -18.63 34.42 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.058 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.45 121.43 27.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.874 0.369 . . . . 0.0 110.668 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.515 ' HD3' ' CE2' ' A' ' 58' ' ' PHE . 19.7 pttp -120.22 100.56 7.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.675 0.75 . . . . 0.0 112.131 -174.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 p -166.78 126.41 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.573 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.45 142.16 32.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.125 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.94 138.67 51.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.966 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.546 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 23.0 t -107.0 121.69 44.0 Favored Pre-proline 0 N--CA 1.436 -1.15 0 C-N-CA 120.521 -0.471 . . . . 0.0 109.787 176.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 34.0 Cg_endo -68.69 157.1 63.23 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.434 2.089 . . . . 0.0 111.285 174.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 29.5 m 86.51 -60.42 0.05 OUTLIER 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.136 0.975 . . . . 0.0 110.952 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 20.3 p -89.02 -26.88 21.21 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.3 t 69.39 46.45 0.76 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.146 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.548 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 1.7 tt -99.59 129.11 45.72 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 30.4 mtm -120.52 136.79 54.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.102 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.4 HG13 ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -147.01 162.21 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.634 ' OD1' ' HB ' ' A' ' 3' ' ' THR . 5.0 m-20 -80.29 162.34 24.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.695 0.283 . . . . 0.0 110.382 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.419 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 8.9 p -132.81 137.03 54.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.671 175.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.564 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 44.4 t -88.89 112.91 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.556 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.515 ' CE2' ' HD3' ' A' ' 43' ' ' LYS . 39.7 p90 -117.36 165.25 13.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.734 0.302 . . . . 0.0 110.824 -177.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -134.94 151.45 50.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.034 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.674 ' HB3' HD12 ' A' ' 78' ' ' ILE . 93.6 mttt -56.5 -40.92 75.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.713 175.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.18 -46.91 72.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.268 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.95 -44.73 96.15 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.541 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.42 HD22 HD11 ' A' ' 35' ' ' LEU . 36.4 mt -64.55 -48.21 75.89 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.083 -0.247 . . . . 0.0 111.185 -178.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.414 ' HA ' ' HG3' ' A' ' 75' ' ' PRO . . . -60.66 -41.84 95.83 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.058 0.456 . . . . 0.0 111.01 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -68.48 -42.5 78.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.303 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -66.7 -37.2 84.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.06 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.494 ' CE1' HD12 ' A' ' 35' ' ' LEU . 2.6 m-85 -52.71 -43.45 65.67 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.335 0.588 . . . . 0.0 110.147 174.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -66.66 -52.4 45.31 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.467 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -69.49 -31.63 70.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.782 -175.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.404 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -73.69 -18.29 61.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.748 0.309 . . . . 0.0 111.089 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.01 30.0 13.89 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.608 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.59 HG22 ' H ' ' A' ' 73' ' ' HIS . 1.4 mt -93.52 -176.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.59 ' H ' HG22 ' A' ' 72' ' ' ILE . 75.8 m-70 -88.85 135.62 31.79 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.03 128.02 13.29 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.986 2.458 . . . . 0.0 112.361 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.414 ' HG3' ' HA ' ' A' ' 64' ' ' ALA . 29.7 Cg_endo -64.25 156.26 60.62 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.414 2.076 . . . . 0.0 112.017 -177.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -73.55 151.77 89.48 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -47.68 131.3 19.8 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.138 2.559 . . . . 0.0 113.33 -173.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.674 HD12 ' HB3' ' A' ' 60' ' ' LYS . 33.5 pt -108.59 167.81 3.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.227 -177.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.47 81.08 8.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.917 0.389 . . . . 0.0 109.957 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -165.83 112.13 0.89 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.72 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.6 -37.34 5.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.944 0.402 . . . . 0.0 110.651 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.74 0 CA-C-O 118.392 -0.813 . . . . 0.0 109.937 -179.49 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptt? . . . . . 0 C--O 1.232 0.168 0 CA-C-O 121.182 0.515 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.0 p -90.39 165.8 13.64 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.121 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.0 p -73.15 122.07 21.28 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.905 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -85.23 6.49 25.78 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -166.99 169.64 12.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.632 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -144.34 113.96 7.15 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.451 HG22 ' HB3' ' A' ' 11' ' ' ASP . 4.1 mt -120.9 142.07 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -169.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -62.52 140.07 58.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.458 171.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.8 tt -55.42 -33.93 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.518 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -73.36 -28.34 61.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.59 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.451 ' HB3' HG22 ' A' ' 7' ' ' ILE . 12.3 t70 -72.01 -29.41 64.17 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 83.0 mmm -69.1 145.02 53.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.373 176.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 50.9 m -90.35 115.76 27.79 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.102 0.477 . . . . 0.0 110.412 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.693 ' HB2' ' HE1' ' A' ' 66' ' ' TYR . 39.2 p90 -74.35 139.13 43.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.554 -176.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -115.38 85.02 12.5 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.223 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 21.3 Cg_endo -60.33 -28.92 87.76 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.163 2.575 . . . . 0.0 113.799 -170.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.35 -29.45 68.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.875 0.369 . . . . 0.0 110.988 -177.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -108.45 -0.4 20.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.955 -175.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.44 ' CG ' HG12 ' A' ' 72' ' ' ILE . 1.8 mp0 60.02 40.4 18.77 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.096 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -141.74 170.3 15.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.985 0.421 . . . . 0.0 110.757 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -109.7 144.78 37.59 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.547 174.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 35.5 p -134.66 158.35 44.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.079 -178.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.435 ' HB3' ' CD2' ' A' ' 31' ' ' PHE . 4.4 t80 -137.81 132.81 17.44 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.7 121.81 10.28 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.716 2.277 . . . . 0.0 113.222 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.53 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 28.4 t -132.5 144.66 53.95 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.377 177.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 41.3 Cg_endo -94.28 118.52 0.29 Allowed 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 122.184 1.923 . . . . 0.0 111.778 173.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.4 p 174.93 -40.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.767 0.794 . . . . 0.0 109.158 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 148.26 -12.53 1.22 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.257 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.58 176.15 9.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.577 0.227 . . . . 0.0 110.461 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.483 ' HD3' ' HB ' ' A' ' 22' ' ' THR . 16.0 ptp180 -121.05 150.35 41.31 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.073 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.645 ' O ' ' HA ' ' A' ' 22' ' ' THR . 98.9 m-85 -51.21 125.46 14.09 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.283 0.364 . . . . 0.0 110.319 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 3.0 pt20 -120.6 133.68 55.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.179 0.514 . . . . 0.0 111.025 -176.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.5 tt -146.54 126.49 5.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.606 175.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -91.44 147.12 23.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.557 -175.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.42 ' HA ' HD22 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -61.32 -30.63 70.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.345 -177.375 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -55.46 -50.64 69.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.082 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -65.94 -38.4 88.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.45 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 84.0 mtp -63.51 -41.74 98.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.467 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.25 -29.57 69.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.677 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -68.63 -16.73 63.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.215 177.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.73 -9.5 52.06 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.945 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -90.92 92.78 8.92 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.619 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -105.46 100.77 10.34 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.255 1.026 . . . . 0.0 111.73 -174.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 p -166.12 130.43 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.036 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.516 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -99.96 141.95 32.09 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.412 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 7.4 p -120.17 138.02 52.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.905 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.569 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 12.9 t -102.22 121.48 50.13 Favored Pre-proline 0 N--CA 1.432 -1.356 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 49' ' ' SER . 45.6 Cg_endo -70.42 155.97 62.62 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.688 2.259 . . . . 0.0 111.846 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 67.5 m 79.78 -51.29 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.519 0.728 . . . . 0.0 111.785 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 13.8 p -91.92 -23.66 19.53 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.053 177.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.4 t 67.59 45.27 1.54 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.231 171.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.537 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 50.5 tp -102.68 137.03 41.44 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.893 -0.504 . . . . 0.0 109.815 176.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 37.1 mtm -123.93 138.21 54.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.949 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.516 HD11 ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -141.64 152.23 19.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.118 179.029 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -78.38 146.14 34.8 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.794 -178.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.619 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 96.8 t -131.42 113.06 22.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.053 0.454 . . . . 0.0 110.704 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.6 t -84.87 124.87 40.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 -175.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.419 ' CD1' HD11 ' A' ' 63' ' ' LEU . 52.8 p90 -118.15 164.9 14.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.906 0.384 . . . . 0.0 111.382 -175.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.441 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -127.69 152.4 47.76 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.834 173.339 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -62.97 -39.4 94.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.468 -176.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -64.64 -43.18 94.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.097 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -68.32 -35.53 77.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.06 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 51.0 mt -60.89 -53.94 51.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.537 177.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.451 ' HA ' ' HD2' ' A' ' 67' ' ' TYR . . . -57.81 -41.75 82.81 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.121 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.92 -47.69 83.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.408 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.693 ' HE1' ' HB2' ' A' ' 14' ' ' PHE . 76.0 t80 -61.98 -35.81 79.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.132 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.542 ' HD1' ' HB ' ' A' ' 72' ' ' ILE . 24.5 m-85 -54.2 -44.26 71.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.032 0.444 . . . . 0.0 110.82 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -76.61 -43.18 39.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.692 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -58.49 -48.08 81.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.825 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.0 -25.52 43.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.252 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.26 55.41 2.76 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.256 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.542 ' HB ' ' HD1' ' A' ' 67' ' ' TYR . 12.2 mt -94.33 153.49 3.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.273 -0.464 . . . . 0.0 109.991 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -56.61 139.21 76.1 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.096 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -35.17 108.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 124.576 3.518 . . . . 0.0 114.189 -177.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -80.89 164.74 20.13 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.42 2.747 . . . . 0.0 112.525 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -73.13 117.9 64.02 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -65.48 140.34 62.79 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.69 2.26 . . . . 0.0 113.177 -174.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.1 pt -95.52 172.69 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.791 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -127.43 102.26 6.8 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.51 110.6 6.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.821 -177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.7 -49.26 7.61 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.629 178.221 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mmt . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 120.763 0.316 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.7 m -139.57 136.21 34.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.939 0.4 . . . . 0.0 111.601 -177.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.6 93.83 7.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.289 0.566 . . . . 0.0 110.078 173.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -72.46 -36.87 68.59 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.822 -173.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -110.73 162.56 14.64 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.842 0.353 . . . . 0.0 110.891 -171.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -156.67 108.05 2.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.18 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.43 162.41 17.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.0 -175.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.523 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 42.8 mt-10 -71.45 151.58 43.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.262 0.553 . . . . 0.0 110.93 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.5 tt -60.61 -31.18 48.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.509 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.24 -28.05 65.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.313 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -78.71 -29.98 45.72 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.886 0.374 . . . . 0.0 110.584 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 82.4 mmm -58.98 130.44 47.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.387 175.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.3 m -72.92 107.31 5.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.199 0.524 . . . . 0.0 110.48 -176.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.549 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . 43.7 p90 -84.37 133.98 34.5 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.573 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.523 ' HA ' ' OE1' ' A' ' 15' ' ' GLU . 4.9 tp10 -112.04 98.24 41.56 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.747 176.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.02 -22.14 73.7 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.884 2.389 . . . . 0.0 111.692 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -70.16 -25.75 63.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.815 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -114.22 -0.26 13.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.033 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 57.63 42.68 23.6 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.528 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -160.15 172.72 16.93 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.615 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 14' ' ' PHE . 95.8 m-85 -103.45 137.09 42.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.001 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 30.2 p -136.7 166.63 23.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.438 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.441 ' CB ' ' HB2' ' A' ' 31' ' ' PHE . 0.4 OUTLIER -138.95 121.58 10.53 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -54.94 122.29 11.41 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.085 2.523 . . . . 0.0 113.414 -177.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 16.3 t -146.32 127.53 7.36 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.267 176.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -85.65 119.28 1.92 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.351 2.034 . . . . 0.0 111.683 174.175 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.8 p -175.63 -43.71 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.1 -30.52 0.17 Allowed Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.342 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.5 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 2.4 t70 -143.2 176.06 9.41 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.94 153.11 25.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.531 ' HZ ' HD23 ' A' ' 52' ' ' LEU . 79.0 m-85 -52.89 124.97 15.51 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -134.31 145.91 49.5 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.09 0.471 . . . . 0.0 111.383 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.3 tt -142.61 135.34 26.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.029 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -91.53 138.8 31.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.785 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.541 ' HA ' ' HG3' ' A' ' 38' ' ' MET . 1.1 mt -68.56 -25.14 64.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.162 -177.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -54.02 -45.48 71.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.542 172.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.66 -44.49 73.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.509 176.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.541 ' HG3' ' HA ' ' A' ' 35' ' ' LEU . 28.3 mtp -60.15 -46.01 91.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.407 ' HZ ' ' HG2' ' A' ' 76' ' ' GLU . 43.0 t80 -69.24 -22.62 63.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.62 -177.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -76.11 -20.72 57.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.165 0.507 . . . . 0.0 110.11 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.84 -3.3 31.97 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.257 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -83.62 117.32 23.09 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 175.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.52 ' HD3' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -126.83 98.52 5.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.072 0.939 . . . . 0.0 111.832 -174.295 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 p -168.54 132.07 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.904 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.25 138.12 38.7 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.0 p -120.23 137.79 52.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.541 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.499 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 10.0 t -104.1 123.88 39.35 Favored Pre-proline 0 N--CA 1.434 -1.24 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 174.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.5 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 35.5 Cg_endo -80.27 157.22 22.82 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.416 2.077 . . . . 0.0 111.451 175.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 23.0 t 88.85 -55.88 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.224 1.01 . . . . 0.0 110.585 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.9 p -89.01 -32.02 17.81 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 47' ' ' CYS . 20.2 m 68.49 74.02 0.28 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.652 176.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.531 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 42.2 tp -132.21 150.28 52.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.0 mtm -135.14 141.12 45.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.076 -175.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.38 148.52 21.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.66 175.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.21 156.66 37.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.837 0.351 . . . . 0.0 110.773 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.407 HG13 ' HB2' ' A' ' 43' ' ' LYS . 7.5 p -132.46 127.99 57.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.151 0.5 . . . . 0.0 111.098 176.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 46.8 t -83.45 105.68 13.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.152 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -113.09 164.65 13.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.572 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.605 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 5.2 t0 -134.12 158.67 43.04 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 173.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.727 ' HB3' HG21 ' A' ' 78' ' ' ILE . 9.0 mptt -64.24 -38.41 90.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.164 0.507 . . . . 0.0 110.17 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -73.53 -36.93 65.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.083 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.73 -38.44 90.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.794 0.33 . . . . 0.0 110.594 176.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 87.6 mt -63.84 -53.46 50.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.558 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.444 ' HA ' ' HG3' ' A' ' 75' ' ' PRO . . . -53.21 -42.92 66.81 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.673 -177.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -59.07 -49.13 79.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.623 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.549 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 70.5 t80 -65.85 -35.96 82.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.28 -177.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.576 ' HD1' ' HB ' ' A' ' 72' ' ' ILE . 27.3 m-85 -53.66 -44.64 69.83 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.614 0.245 . . . . 0.0 110.787 178.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -72.32 -39.92 67.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.699 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -63.75 -36.92 85.48 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.152 -0.477 . . . . 0.0 112.279 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.47 -17.64 33.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.648 0.261 . . . . 0.0 111.417 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.8 37.22 9.56 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.794 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.642 HG22 ' H ' ' A' ' 73' ' ' HIS . 2.0 mt -94.1 -176.04 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.642 ' H ' HG22 ' A' ' 72' ' ' ILE . 66.7 m-70 -79.09 134.99 58.76 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.09 131.84 41.28 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.882 2.388 . . . . 0.0 112.61 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.444 ' HG3' ' HA ' ' A' ' 64' ' ' ALA . 61.3 Cg_endo -73.86 164.09 35.46 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.032 2.488 . . . . 0.0 112.106 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.462 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 10.4 pt-20 -73.51 159.33 84.93 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.128 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 76' ' ' GLU . 14.8 Cg_endo -57.86 143.2 96.19 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.616 2.211 . . . . 0.0 112.916 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.727 HG21 ' HB3' ' A' ' 60' ' ' LYS . 36.3 pt -115.71 174.03 3.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.106 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.03 -11.14 31.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.208 0.528 . . . . 0.0 110.235 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 55.53 -162.53 0.15 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.338 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -113.24 -41.83 3.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.114 0.483 . . . . 0.0 110.18 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.465 -0.779 . . . . 0.0 110.413 177.597 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.459 ' CE ' ' HA ' ' A' ' 1' ' ' MET . 3.2 mmt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.212 0.529 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.3 m -104.5 149.91 25.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.222 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.0 p -86.06 101.15 12.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.16 0.505 . . . . 0.0 109.899 173.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -74.38 -26.77 60.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.369 -171.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -128.98 165.64 20.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.06 0.457 . . . . 0.0 111.635 -174.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.569 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 43.9 tt0 -148.45 116.76 6.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.235 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.489 ' CD1' HG13 ' A' ' 54' ' ' ILE . 4.5 mp -113.43 149.7 15.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -173.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.543 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 43.0 mt-10 -67.8 144.17 55.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.8 0.333 . . . . 0.0 110.25 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.403 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 19.3 tt -57.56 -28.57 31.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.161 177.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -71.69 -35.17 70.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.13 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.474 ' HB3' ' CG2' ' A' ' 7' ' ' ILE . 11.5 t70 -76.84 -40.57 47.37 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 83.7 mmm -49.22 137.18 14.25 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.913 169.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.5 m -79.59 106.87 11.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.403 0.621 . . . . 0.0 110.353 -176.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -75.52 128.2 34.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.558 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 37.4 tp10 -118.03 88.07 30.46 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.822 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 31.7 Cg_endo -63.55 -26.04 69.78 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.71 2.274 . . . . 0.0 111.536 -178.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.12 -29.6 70.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.765 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -110.28 5.21 21.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.528 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.54 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 2.3 mp0 58.86 38.33 24.58 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.948 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -160.4 174.68 13.76 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.051 0.453 . . . . 0.0 111.411 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.403 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 72.0 m-85 -108.35 140.62 41.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.617 177.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.555 ' HB ' ' HD3' ' A' ' 30' ' ' ARG . 40.6 p -136.24 169.22 17.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.467 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.414 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 5.4 t80 -140.99 120.45 8.4 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.05 116.28 2.82 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 123.307 2.672 . . . . 0.0 112.975 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 28.4 t -130.29 138.99 34.29 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.422 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 46.3 Cg_endo -91.7 117.87 0.48 Allowed 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 122.049 1.832 . . . . 0.0 111.734 174.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.4 p 178.83 -43.65 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.753 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.89 -25.33 0.24 Allowed Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.994 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.54 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 2.3 t0 -142.76 175.72 9.61 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.555 ' HD3' ' HB ' ' A' ' 22' ' ' THR . 12.4 ptp180 -114.57 155.54 26.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.587 0.232 . . . . 0.0 111.11 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.636 ' HZ ' HD23 ' A' ' 52' ' ' LEU . 91.0 m-85 -54.57 127.72 29.11 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.16 175.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -124.5 137.9 54.38 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.099 0.476 . . . . 0.0 110.505 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.4 tt -140.66 140.29 33.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.658 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.488 ' O ' ' HG3' ' A' ' 38' ' ' MET . 17.1 m-85 -103.17 136.15 43.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.921 -172.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -56.5 -35.54 68.12 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.103 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.484 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 11.9 t70 -54.34 -51.72 63.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.088 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.97 -29.6 58.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.556 -174.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.488 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 90.4 mtp -65.76 -39.58 91.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.051 176.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -69.71 -23.49 63.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.385 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 36' ' ' ASP . 17.3 mm-40 -73.45 -16.08 61.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.588 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.8 -10.76 38.11 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.883 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -94.04 109.0 20.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.187 0.518 . . . . 0.0 110.331 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.679 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -108.0 102.47 11.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.799 0.809 . . . . 0.0 111.722 -176.11 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 p -164.43 129.3 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.263 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 53' ' ' MET . . . -101.27 143.52 31.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.134 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.09 139.4 47.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.974 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.534 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 17.4 t -107.73 124.02 36.14 Favored Pre-proline 0 N--CA 1.439 -0.982 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.31 175.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.563 ' O ' ' HB3' ' A' ' 49' ' ' SER . 58.5 Cg_endo -74.86 156.84 43.63 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.758 2.306 . . . . 0.0 111.023 173.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.563 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 40.1 t 88.66 -57.46 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.752 0.821 . . . . 0.0 110.906 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.0 p -91.63 -29.14 17.06 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.514 -0.475 . . . . 0.0 109.724 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 47' ' ' CYS . 33.7 t 66.92 70.13 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.517 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.636 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 53.7 tp -125.51 151.32 46.48 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.401 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 32.7 mtm -134.26 138.23 44.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.383 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.489 HG13 ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -142.72 154.43 17.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 177.579 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.569 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 2.4 m-20 -77.09 158.29 30.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.762 0.315 . . . . 0.0 110.403 177.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 86.0 t -132.79 125.3 52.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.847 0.356 . . . . 0.0 111.123 178.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.543 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 89.2 t -77.75 126.42 38.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.084 177.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -142.71 165.11 28.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.713 0.292 . . . . 0.0 111.154 -175.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.564 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 9.6 t70 -132.2 151.83 51.61 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 171.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -63.61 -33.2 75.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.046 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -65.61 -49.51 68.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.12 176.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -60.47 -39.56 88.06 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.086 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 40.9 mt -58.17 -57.15 14.12 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.766 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.5 -40.81 75.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.268 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -66.19 -37.54 85.85 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.434 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -77.81 -33.86 52.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -51.09 -44.84 61.32 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.893 0.377 . . . . 0.0 110.611 172.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -63.03 -45.64 91.34 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.661 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.79 -40.49 88.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.828 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.54 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -78.93 -12.56 60.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.529 -177.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.56 38.3 32.98 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.596 177.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.496 HG23 ' HG2' ' A' ' 19' ' ' GLN . 0.9 OUTLIER -115.66 168.63 7.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 O-C-N 122.892 -0.181 . . . . 0.0 110.709 178.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -57.55 116.34 13.69 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.775 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.506 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 73.3 Cg_endo -76.79 145.64 25.73 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.538 2.158 . . . . 0.0 112.325 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 74' ' ' PRO . 6.9 Cg_exo -73.36 164.71 34.46 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.277 2.651 . . . . 0.0 111.778 176.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -73.73 124.01 89.87 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -47.39 139.97 16.19 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.552 2.835 . . . . 0.0 113.625 -172.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 31.6 pt -120.3 157.44 22.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.658 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -115.89 81.8 1.66 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.963 0.411 . . . . 0.0 110.705 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.4 -3.35 18.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.502 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.74 136.27 33.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.668 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.539 -0.743 . . . . 0.0 110.043 178.987 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.4 mtp . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 121.44 0.638 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.6 p -104.12 173.24 6.39 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.789 176.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.8 p -79.72 126.58 31.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.843 0.354 . . . . 0.0 111.086 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -96.12 -24.62 16.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.72 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.418 ' HB3' ' CG2' ' A' ' 54' ' ' ILE . 47.1 t0 -120.62 167.04 12.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 33.2 tt0 -156.72 110.86 2.72 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.584 ' CD1' HG13 ' A' ' 54' ' ' ILE . 4.2 mp -109.9 147.79 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.003 0.43 . . . . 0.0 111.469 -173.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -65.33 147.01 54.18 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.129 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.676 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 21.0 tt -65.17 -28.46 44.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.371 0.605 . . . . 0.0 110.011 177.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -62.97 -39.13 93.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.618 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.49 ' HB3' ' CG2' ' A' ' 7' ' ' ILE . 19.2 t70 -80.63 -36.03 33.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.515 -175.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 79.9 mmm -54.03 144.81 18.28 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.86 170.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.7 m -91.73 127.34 37.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.688 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.679 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . 47.3 p90 -81.76 138.0 35.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.998 0.427 . . . . 0.0 110.669 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -124.39 84.25 56.67 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.605 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.2 -22.0 54.44 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.03 2.487 . . . . 0.0 112.973 -172.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -68.29 -33.3 74.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.973 0.416 . . . . 0.0 110.586 -178.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -105.61 -5.16 20.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.965 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 64.5 36.3 8.81 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.296 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -145.15 167.98 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.597 -177.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.445 ' HB2' HG23 ' A' ' 33' ' ' ILE . 71.2 m-85 -96.89 146.76 24.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.871 0.367 . . . . 0.0 110.336 177.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 22.3 p -136.82 164.46 28.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.503 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.436 ' HB3' ' CD2' ' A' ' 31' ' ' PHE . 10.1 t80 -147.59 127.02 6.45 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.91 120.42 7.87 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.414 2.742 . . . . 0.0 113.655 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.551 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 11.6 t -136.28 135.98 21.83 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.305 174.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -84.39 118.4 2.23 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 121.901 1.734 . . . . 0.0 111.572 175.19 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 32.0 p 177.14 -46.17 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 164.08 -27.11 0.21 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.326 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.565 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 2.5 t0 -139.63 175.22 9.75 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -113.58 153.17 29.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.496 -177.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.636 ' CD1' ' HB2' ' A' ' 47' ' ' CYS . 97.2 m-85 -50.19 130.66 23.06 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.194 0.309 . . . . 0.0 110.752 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 4.2 pt20 -117.85 134.67 54.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.918 0.389 . . . . 0.0 110.638 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.445 HG23 ' HB2' ' A' ' 21' ' ' PHE . 12.9 tt -147.56 133.87 12.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.288 176.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.422 ' HB2' ' OD2' ' A' ' 37' ' ' ASP . 90.5 m-85 -96.13 147.4 23.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.857 -177.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 35' ' ' LEU . 4.1 mm? -61.0 -33.92 74.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.062 178.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -56.7 -43.38 80.49 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.155 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.422 ' OD2' ' HB2' ' A' ' 34' ' ' TYR . 25.0 m-20 -67.77 -44.39 77.56 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.111 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.414 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 76.1 mtp -61.84 -44.28 97.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.643 -177.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -69.53 -29.23 66.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.68 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -72.94 -18.13 61.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.056 0.455 . . . . 0.0 110.589 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.11 1.41 33.72 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.61 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -108.16 100.61 9.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.153 0.501 . . . . 0.0 109.714 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.549 ' HD3' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -108.63 101.32 10.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.841 0.829 . . . . 0.0 111.03 -171.409 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.8 p -163.43 131.38 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.003 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.1 134.78 42.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.059 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.799 HG22 ' HG2' ' A' ' 53' ' ' MET . 46.7 t -114.74 122.99 69.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.636 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 26.1 t -83.49 124.86 75.14 Favored Pre-proline 0 C--N 1.318 -0.779 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.008 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.565 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 58.8 Cg_endo -73.2 156.64 51.09 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.832 2.355 . . . . 0.0 110.746 173.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.529 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 42.8 t 86.79 -60.38 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.447 0.699 . . . . 0.0 110.876 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 15.7 p -92.56 -24.76 18.62 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.207 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 t 64.48 79.61 0.25 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.535 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.411 HD23 ' N ' ' A' ' 53' ' ' MET . 3.4 tt -131.09 131.01 43.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.799 ' HG2' HG22 ' A' ' 46' ' ' VAL . 27.7 mtm -118.94 136.62 53.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.683 0.277 . . . . 0.0 111.265 -175.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.584 HG13 ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -145.52 155.43 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.66 177.143 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.553 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -76.79 152.24 35.65 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.583 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.7 t -132.7 120.05 40.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.964 0.411 . . . . 0.0 110.291 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.676 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 21.1 t -75.71 149.54 6.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.5 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 55.1 p90 -146.84 164.64 32.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.364 0.126 . . . . 0.0 110.694 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.59 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 14.4 t70 -125.98 156.76 39.32 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.861 0.362 . . . . 0.0 110.625 174.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.889 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 0.8 OUTLIER -60.63 -46.55 89.85 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.08 178.722 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -72.89 -40.67 65.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.726 -177.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -63.77 -39.6 94.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.3 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 66.8 mt -64.21 -52.42 58.91 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.498 176.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.429 ' HA ' ' HG3' ' A' ' 75' ' ' PRO . . . -54.14 -45.12 71.89 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.273 -177.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.48 -44.73 95.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.354 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.679 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 54.6 t80 -66.36 -40.83 90.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.586 -176.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.532 ' HA ' HD12 ' A' ' 72' ' ' ILE . 36.6 m-85 -51.31 -48.43 62.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.923 0.392 . . . . 0.0 110.679 175.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -71.15 -35.68 71.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.833 -177.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -70.14 -45.22 67.26 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.75 -12.68 59.42 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -174.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.8 41.34 8.27 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.424 -0.894 . . . . 0.0 111.387 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.561 HG22 ' H ' ' A' ' 73' ' ' HIS . 2.8 mt -98.2 177.03 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.561 ' H ' HG22 ' A' ' 72' ' ' ILE . 98.5 m-70 -57.36 122.72 56.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 110.324 -0.251 . . . . 0.0 110.324 177.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -52.18 121.76 9.46 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.363 2.708 . . . . 0.0 112.389 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.429 ' HG3' ' HA ' ' A' ' 64' ' ' ALA . 64.0 Cg_endo -74.09 148.1 39.24 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.664 2.242 . . . . 0.0 112.254 -177.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -76.2 148.89 81.58 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.142 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.08 136.0 72.72 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.649 2.233 . . . . 0.0 112.777 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.6 pt -98.3 166.15 2.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.836 -176.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.06 72.99 6.88 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.586 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -159.08 125.03 4.41 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.815 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.55 -48.79 0.9 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.232 173.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.423 177.014 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.942 0.401 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.1 m -94.93 175.29 6.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.013 171.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.2 p -69.71 119.74 14.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.99 0.424 . . . . 0.0 110.752 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -88.14 -14.2 39.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.157 -172.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -142.7 174.76 10.36 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.294 -177.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.554 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 33.5 tt0 -155.67 116.59 3.86 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.466 0.479 . . . . 0.0 109.747 -176.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.434 ' CD1' HG13 ' A' ' 54' ' ' ILE . 1.6 mp -129.33 146.44 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.79 -177.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.552 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 46.4 mt-10 -69.82 145.75 51.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.951 0.405 . . . . 0.0 110.463 174.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.2 tt -55.26 -28.89 22.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.474 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -63.1 -33.61 75.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.721 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -86.16 -31.62 21.71 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.164 -174.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.533 ' HA ' ' HD1' ' A' ' 23' ' ' TYR . 80.2 mtp -65.16 145.33 56.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 110.974 177.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.6 m -72.84 120.32 18.3 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.484 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -79.83 133.98 36.31 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.209 177.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -122.54 89.93 49.61 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.125 0.488 . . . . 0.0 110.061 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.77 -14.89 43.02 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.898 2.398 . . . . 0.0 111.917 -177.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -66.46 -40.3 89.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.488 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.557 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 2.8 t-20 -110.73 0.79 17.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.247 -177.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.738 ' N ' HE21 ' A' ' 19' ' ' GLN . 0.0 OUTLIER 59.83 42.32 16.73 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.834 -179.753 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.557 ' HG2' ' HB3' ' A' ' 18' ' ' ASN . 26.9 ptt? -146.96 174.3 11.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.076 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -114.46 142.27 46.6 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 38.6 p -133.2 145.99 51.09 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.533 ' HD1' ' HA ' ' A' ' 12' ' ' MET . 9.6 t80 -119.61 131.15 24.5 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.55 122.79 12.25 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 123.016 2.477 . . . . 0.0 113.096 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.561 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 22.4 t -139.45 138.76 20.92 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.926 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -91.87 117.99 0.47 Allowed 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.19 1.927 . . . . 0.0 111.859 174.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.464 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 30.7 p -178.54 -52.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.745 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.464 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 172.43 -27.89 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.883 -178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.571 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 2.5 t70 -142.41 176.52 8.94 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.439 ' HE ' ' CB ' ' A' ' 22' ' ' THR . 10.6 ptm180 -114.7 147.51 39.56 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.641 ' CE1' ' HB3' ' A' ' 52' ' ' LEU . 97.7 m-85 -46.97 121.27 3.54 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.517 0.511 . . . . 0.0 110.18 178.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -120.49 131.52 54.77 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.897 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 20' ' ' MET . 14.7 tt -132.54 132.5 60.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.936 176.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.445 ' O ' ' HG3' ' A' ' 38' ' ' MET . 30.5 m-85 -90.27 134.83 34.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.756 -173.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.566 ' HG ' HD13 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -61.46 -30.54 70.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.012 -178.315 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -54.04 -44.82 71.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.943 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . 16.3 m-20 -77.26 -37.67 52.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.768 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.445 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 79.1 mtp -59.88 -42.43 93.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.544 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.437 ' HZ ' ' HG3' ' A' ' 76' ' ' GLU . 47.3 t80 -60.49 -37.73 82.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.7 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.83 -22.22 64.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.768 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.51 7.06 32.66 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.653 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.535 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 8.0 tp10 -93.17 107.01 18.9 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.813 ' HD2' ' HE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -120.48 98.97 6.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.015 0.912 . . . . 0.0 111.68 -174.737 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 p -167.23 130.14 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.261 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.489 ' HB3' HD11 ' A' ' 54' ' ' ILE . . . -100.82 136.04 41.32 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.864 0.364 . . . . 0.0 110.406 -178.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.765 HG22 ' HG2' ' A' ' 53' ' ' MET . 44.7 t -114.07 129.84 69.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.535 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.572 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 13.0 t -99.25 119.46 60.46 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.778 178.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.571 ' HG2' ' CB ' ' A' ' 29' ' ' ASP . 34.4 Cg_endo -69.23 155.93 66.22 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.136 1.89 . . . . 0.0 111.162 175.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.51 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 44.5 t 85.36 -56.19 0.09 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.692 0.797 . . . . 0.0 111.366 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 52' ' ' LEU . 16.3 p -93.65 -18.56 22.03 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.4 t 67.23 43.06 2.13 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.839 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.641 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -94.21 148.55 22.08 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.676 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.765 ' HG2' HG22 ' A' ' 46' ' ' VAL . 48.9 mtm -140.36 135.73 32.45 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.032 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.489 HD11 ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -144.75 152.65 14.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.957 179.43 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 0.4 OUTLIER -76.04 152.95 36.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.879 178.703 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.78 143.37 39.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.552 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 56.5 t -103.07 107.99 23.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.813 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 24.3 p90 -113.57 164.53 13.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.099 -177.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -136.46 158.26 44.86 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.482 ' N ' ' HD2' ' A' ' 60' ' ' LYS . 12.4 mptt -64.02 -33.97 76.96 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.764 176.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -60.13 -54.08 50.19 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.232 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -61.46 -43.9 98.06 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.511 -176.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 35.2 mt -59.86 -49.62 77.0 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.285 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.45 80.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.775 0.321 . . . . 0.0 111.381 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -65.72 -53.73 36.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.452 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -68.91 -33.76 74.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.462 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.518 ' HA ' HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -51.94 -46.23 64.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.916 175.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -67.25 -45.78 75.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.938 0.399 . . . . 0.0 110.983 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -61.51 -49.58 76.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.882 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.84 -20.34 53.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.113 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.97 46.1 10.99 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -177.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.566 HD13 ' HG ' ' A' ' 35' ' ' LEU . 10.7 mt -81.7 165.65 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.53 -0.335 . . . . 0.0 110.303 -173.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.437 ' N ' HG22 ' A' ' 72' ' ' ILE . 27.9 t60 -61.95 133.53 93.93 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.296 178.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -46.69 120.19 3.81 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.611 2.874 . . . . 0.0 113.302 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.402 ' HD3' ' CE1' ' A' ' 67' ' ' TYR . 81.2 Cg_endo -86.68 166.8 8.75 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.954 3.102 . . . . 0.0 112.212 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.437 ' HG3' ' HZ ' ' A' ' 39' ' ' PHE . 39.6 mt-10 -72.52 136.87 80.74 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.21 140.88 24.95 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.213 2.609 . . . . 0.0 113.31 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.2 pt -101.51 151.07 5.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.66 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.97 83.13 4.68 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.125 0.488 . . . . 0.0 110.494 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.34 92.74 7.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.306 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.65 -53.28 2.66 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.656 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.396 179.428 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.6 mtm . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.322 0.582 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 p -118.74 160.02 22.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.365 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.0 p -86.03 130.74 34.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.054 0.454 . . . . 0.0 110.944 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -92.0 -28.18 17.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.439 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -135.81 171.69 14.09 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.067 -171.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 39.7 tt0 -150.58 109.84 3.96 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.02 158.11 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 -175.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.519 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 57.3 mm-40 -61.63 150.59 35.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.138 0.494 . . . . 0.0 111.21 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.691 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 20.6 tt -62.4 -28.7 45.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.227 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -63.2 -29.96 71.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.397 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -79.16 -34.63 43.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.259 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.679 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 90.6 mmm -62.11 118.13 6.93 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 173.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.3 m -71.59 107.86 4.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.406 0.622 . . . . 0.0 110.442 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.597 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 39.0 p90 -74.54 137.6 42.53 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.183 -177.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -114.75 101.93 54.61 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.14 175.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.66 -9.15 23.39 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.072 2.515 . . . . 0.0 112.432 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -93.05 -38.53 11.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.121 0.486 . . . . 0.0 109.877 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.44 HD22 ' HA ' ' A' ' 18' ' ' ASN . 1.3 t-20 -89.39 -5.85 57.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.464 -175.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 73.46 18.2 3.67 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.608 171.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.583 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 27.3 ptt? -161.75 175.71 11.69 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.081 -173.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.679 ' HB3' ' HB3' ' A' ' 12' ' ' MET . 87.3 m-85 -95.76 131.08 42.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.133 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 23.8 p -129.04 137.8 51.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.795 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 36.0 t80 -109.64 122.6 38.81 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.21 121.31 9.18 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.229 2.62 . . . . 0.0 113.193 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.7 t -138.29 141.11 30.61 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.3 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -94.69 118.18 0.25 Allowed 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 122.157 1.905 . . . . 0.0 112.004 173.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.1 p -179.75 -44.95 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.391 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.71 -24.64 0.23 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.143 -177.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.461 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . 4.3 t70 -141.91 177.01 8.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.94 151.04 32.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.933 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.795 ' HB2' ' HB3' ' A' ' 23' ' ' TYR . 75.6 m-85 -54.8 114.67 1.8 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 175.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.41 137.06 52.74 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.992 0.425 . . . . 0.0 110.98 -174.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.583 ' O ' ' HB2' ' A' ' 20' ' ' MET . 14.5 tt -139.64 129.13 29.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.827 173.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.439 ' O ' ' HG3' ' A' ' 38' ' ' MET . 14.1 m-85 -79.59 135.86 36.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.162 -173.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.471 HD12 ' CD2' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -66.88 -36.66 82.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.007 0.432 . . . . 0.0 110.049 -176.751 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 17.3 t70 -61.13 -35.44 77.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.454 176.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -69.54 -42.8 74.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.215 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.616 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 75.5 mtp -65.4 -37.72 87.83 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.5 178.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -69.53 -23.48 63.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.471 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 36' ' ' ASP . 70.4 mm-40 -75.05 -12.51 60.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 176.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.15 -5.42 33.97 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.529 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.616 ' O ' ' HA ' ' A' ' 38' ' ' MET . 0.7 OUTLIER -85.34 146.89 26.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 177.605 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 32.2 pttt -144.89 97.59 3.04 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.586 0.708 . . . . 0.0 111.2 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 p -167.74 126.67 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.036 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 53' ' ' MET . . . -100.54 131.15 46.6 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.966 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.9 p -111.91 139.29 37.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.995 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.436 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 8.6 t -116.34 115.02 40.39 Favored Pre-proline 0 N--CA 1.435 -1.178 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.117 175.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.563 ' O ' ' HB3' ' A' ' 49' ' ' SER . 34.2 Cg_endo -69.0 157.38 62.09 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.601 2.201 . . . . 0.0 111.452 174.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.563 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 35.9 t 88.51 -57.33 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.027 0.931 . . . . 0.0 110.586 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.7 p -90.43 -28.29 18.72 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.003 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.8 t 68.87 54.76 0.46 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.898 177.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 53' ' ' MET . 1.9 tt -114.76 137.2 52.21 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.469 ' N ' HD23 ' A' ' 52' ' ' LEU . 35.6 mtm -132.61 138.23 47.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.021 -178.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -142.49 156.37 18.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 39.9 m-20 -80.21 159.95 25.78 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.59 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 11.2 p -136.32 138.07 47.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.993 0.425 . . . . 0.0 111.052 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.691 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 61.8 t -72.12 141.57 16.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -150.03 155.94 40.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.854 0.359 . . . . 0.0 110.908 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -134.88 155.5 50.57 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -63.73 -34.67 78.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.178 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -73.93 -40.93 62.76 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.035 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -59.4 -46.39 88.84 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.16 0.505 . . . . 0.0 110.269 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 72.9 mt -69.51 -44.55 70.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.412 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.78 -46.69 88.4 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.66 0.267 . . . . 0.0 111.259 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.574 ' O ' ' HG3' ' A' ' 69' ' ' GLU . 23.8 tt0 -64.95 -49.55 69.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.861 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.477 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 80.0 t80 -62.22 -34.81 77.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.151 -178.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.533 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 2.0 t80 -54.18 -44.94 71.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.679 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -76.96 -33.84 57.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.105 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.574 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 48.2 mt-10 -61.17 -49.74 76.01 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.974 0.416 . . . . 0.0 110.859 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.23 -25.95 63.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.158 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.56 33.31 10.33 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.657 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 73' ' ' HIS . 0.6 OUTLIER -72.82 -175.7 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.768 0.318 . . . . 0.0 110.455 177.689 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.567 ' H ' HG22 ' A' ' 72' ' ' ILE . 18.6 m170 -67.32 162.99 50.64 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.071 -173.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.49 115.69 2.09 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.774 2.316 . . . . 0.0 112.771 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.9 158.79 31.1 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.795 2.33 . . . . 0.0 112.604 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -90.57 143.83 29.72 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.641 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -62.23 139.37 77.43 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.374 2.05 . . . . 0.0 112.438 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 40.7 pt -112.65 152.81 14.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.092 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -110.05 95.7 5.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.978 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -129.01 -2.86 5.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.637 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -158.25 -46.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.507 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.18 179.626 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.46 0.069 0 CA-C-O 120.765 0.317 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.6 m -107.18 160.46 15.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.976 0.417 . . . . 0.0 111.184 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.7 p -82.69 127.05 33.04 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.211 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -102.9 -26.64 13.04 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.74 154.06 24.43 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.956 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . 42.3 tt0 -146.3 122.89 11.12 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.613 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 mp -122.61 156.0 27.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.574 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 47.0 mt-10 -73.21 151.93 41.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.266 0.555 . . . . 0.0 111.19 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.442 HD11 ' CZ ' ' A' ' 21' ' ' PHE . 20.4 tt -59.64 -28.59 40.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.59 -178.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -58.8 -38.53 78.78 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.26 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -73.18 -36.56 66.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.98 -174.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 89.5 mmm -58.37 149.92 23.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.188 176.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.4 m -100.9 108.02 19.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.959 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.419 ' HD2' ' HD3' ' A' ' 16' ' ' PRO . 44.6 p90 -74.08 136.03 43.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.011 0.434 . . . . 0.0 111.116 -176.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.426 ' HA ' ' OE1' ' A' ' 15' ' ' GLU . 6.4 tp10 -115.21 86.7 14.64 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.623 176.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.419 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 20.7 Cg_endo -61.31 -28.2 84.2 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.01 2.473 . . . . 0.0 112.455 -174.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -69.53 -20.28 63.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.117 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -111.72 -1.06 15.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.702 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 57.64 43.07 22.95 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.292 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -154.16 165.89 34.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.846 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.49 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 88.0 m-85 -103.87 139.59 38.85 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.609 ' HB ' ' HD3' ' A' ' 30' ' ' ARG . 77.5 p -130.59 169.86 15.04 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 121.141 -0.223 . . . . 0.0 110.929 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -152.77 127.23 4.57 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.36 126.31 21.79 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 123.144 2.563 . . . . 0.0 112.655 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.591 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 9.5 t -135.51 144.3 48.71 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.027 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -86.06 117.92 1.66 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.772 1.648 . . . . 0.0 111.949 173.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.437 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 30.3 p 172.48 -49.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.57 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.437 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 163.19 -24.48 0.19 Allowed Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.398 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.419 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 1.3 t0 -134.61 176.41 8.66 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.351 -0.241 . . . . 0.0 110.351 -177.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.609 ' HD3' ' HB ' ' A' ' 22' ' ' THR . 15.4 ptp180 -109.18 150.77 27.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.942 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.631 ' CD1' ' HB2' ' A' ' 47' ' ' CYS . 97.2 m-85 -55.39 140.46 39.77 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -137.16 134.14 36.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.181 0.515 . . . . 0.0 110.666 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.49 ' CG2' ' HB2' ' A' ' 21' ' ' PHE . 12.4 tt -131.16 130.39 63.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.679 177.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.492 ' O ' ' HG3' ' A' ' 38' ' ' MET . 24.4 m-85 -87.67 147.57 25.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.243 -174.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.481 ' HG ' ' CD1' ' A' ' 72' ' ' ILE . 0.6 OUTLIER -66.7 -35.36 79.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.956 -176.16 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.1 -44.78 79.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.803 178.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.401 ' OD1' ' HB2' ' A' ' 34' ' ' TYR . 3.4 m-20 -64.08 -43.04 96.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.628 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.492 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 55.3 mtp -63.57 -37.59 87.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.488 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -65.32 -35.45 81.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.272 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -70.92 -15.94 62.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.655 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.31 -3.63 59.91 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -81.84 81.64 7.78 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.31 0.576 . . . . 0.0 109.522 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.72 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.64 98.39 11.61 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.358 1.075 . . . . 0.0 110.439 -179.563 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 2.0 p -167.09 129.46 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.802 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 53' ' ' MET . . . -99.46 130.21 45.71 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -107.05 134.36 48.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.147 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.631 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 35.0 t -105.31 123.77 38.57 Favored Pre-proline 0 N--CA 1.433 -1.303 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.093 176.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.626 ' O ' ' HB3' ' A' ' 49' ' ' SER . 33.3 Cg_endo -65.89 156.57 63.6 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.499 2.133 . . . . 0.0 111.044 172.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.626 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 27.4 t 86.21 -61.37 0.05 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.349 0.659 . . . . 0.0 110.963 178.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.4 p -90.99 -23.43 20.4 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.188 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.5 t 68.2 41.57 1.9 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.117 175.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.556 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 54.3 tp -98.79 142.35 30.43 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.112 0.482 . . . . 0.0 109.943 -178.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.476 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 43.5 mtm -132.5 138.01 47.39 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.798 -178.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -141.3 150.38 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 177.305 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 7.3 m-20 -68.85 155.58 39.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.815 0.34 . . . . 0.0 110.181 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 90.7 t -135.29 124.51 41.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.83 176.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.574 ' HB ' ' HA ' ' A' ' 8' ' ' GLU . 41.5 t -75.64 104.84 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -108.67 164.78 12.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.909 -175.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.562 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 13.8 t70 -130.13 146.9 51.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.79 175.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -64.07 -32.56 74.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.975 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -73.57 -40.5 63.86 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.663 0.268 . . . . 0.0 110.606 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.73 -41.27 90.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.872 0.367 . . . . 0.0 110.322 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 67.3 mt -63.85 -48.94 74.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.79 178.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.15 -41.95 93.87 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.879 -177.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -63.06 -53.79 48.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.347 0.594 . . . . 0.0 110.466 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.414 ' CE2' HD11 ' A' ' 72' ' ' ILE . 78.9 t80 -63.81 -36.19 83.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.389 -178.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.466 ' HA ' HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -53.14 -44.71 67.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.119 177.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -69.55 -36.18 76.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.625 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -75.96 -34.34 59.82 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.97 -20.27 24.67 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -177.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.7 57.08 5.12 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.552 HG22 ' H ' ' A' ' 73' ' ' HIS . 6.6 mt -97.81 172.92 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.625 -0.287 . . . . 0.0 110.712 -173.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.552 ' H ' HG22 ' A' ' 72' ' ' ILE . 79.5 t60 -53.0 125.89 41.73 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.476 173.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.47 114.14 2.4 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.784 2.323 . . . . 0.0 112.774 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.03 163.43 3.86 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.314 2.676 . . . . 0.0 111.316 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.77 118.24 67.6 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.99 147.63 55.38 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.887 2.392 . . . . 0.0 113.192 -173.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.0 pt -94.7 -177.63 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.206 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.11 89.14 3.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.885 0.374 . . . . 0.0 110.755 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.46 82.86 8.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.112 0.482 . . . . 0.0 110.143 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.26 -16.03 20.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.918 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.392 -0.813 . . . . 0.0 110.002 -179.412 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 C--O 1.234 0.258 0 CA-C-O 121.52 0.676 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.0 m -131.37 171.26 13.57 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.272 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.3 p -88.77 108.56 19.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.014 0.435 . . . . 0.0 110.32 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -98.33 -0.47 43.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.588 -174.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -134.04 162.95 30.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.53 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 40.1 tt0 -159.86 120.28 3.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.86 -177.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 8' ' ' GLU . 1.8 mp -120.65 161.69 20.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -175.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.402 ' N ' HG22 ' A' ' 7' ' ' ILE . 40.9 mt-10 -74.06 146.81 43.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.371 177.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.0 tt -59.41 -29.69 42.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.422 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -68.84 -28.26 66.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.923 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -79.4 -31.21 42.73 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.99 0.424 . . . . 0.0 110.3 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 82.3 mmm -63.58 128.07 34.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.986 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 22' ' ' THR . 86.2 m -71.83 119.43 15.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.198 0.523 . . . . 0.0 110.899 -177.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.672 ' HB2' ' HE1' ' A' ' 66' ' ' TYR . 36.2 p90 -74.58 138.81 43.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.035 -177.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -129.23 87.71 53.05 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.914 177.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.431 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 18.7 Cg_endo -59.84 -33.02 96.21 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.274 2.649 . . . . 0.0 112.897 -175.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.63 -28.71 70.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.891 -176.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -113.03 4.95 16.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.707 0.289 . . . . 0.0 111.112 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.418 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 2.1 mp0 59.14 32.0 21.73 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.395 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -144.94 159.01 43.6 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.165 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -93.89 141.81 28.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.726 175.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 20.6 p -137.7 141.57 41.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.642 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.456 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 17.6 t80 -125.52 117.82 24.77 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -178.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -48.44 118.53 3.36 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.47 2.78 . . . . 0.0 113.286 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 19.9 t -130.39 135.66 27.76 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.439 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 5.8 Cg_endo -84.74 118.21 2.09 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.869 1.712 . . . . 0.0 111.442 175.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.409 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 29.9 p 174.62 -45.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -177.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.409 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 159.65 -27.1 0.35 Allowed Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.783 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -138.23 176.0 9.08 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.476 ' HG3' ' HB ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -120.06 156.49 30.86 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.155 -177.078 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.64 ' O ' ' HA ' ' A' ' 22' ' ' THR . 97.3 m-85 -56.4 123.03 13.31 Favored 'General case' 0 CA--C 1.518 -0.258 0 O-C-N 123.384 0.428 . . . . 0.0 110.165 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.579 ' HG2' HG22 ' A' ' 22' ' ' THR . 24.2 mt-30 -120.8 137.63 54.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.823 0.344 . . . . 0.0 110.756 -178.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.5 ' HB ' ' HA ' ' A' ' 45' ' ' ALA . 10.1 tt -145.93 125.22 5.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.419 175.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -87.31 149.49 24.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.252 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.625 ' HA ' ' HG3' ' A' ' 38' ' ' MET . 7.7 tp -71.3 -24.65 62.18 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.12 0.485 . . . . 0.0 110.65 -176.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -54.6 -40.15 68.57 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.429 173.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -68.74 -44.56 73.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.202 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.625 ' HG3' ' HA ' ' A' ' 35' ' ' LEU . 15.2 mtp -62.72 -46.48 87.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.602 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.731 ' HZ ' ' HG2' ' A' ' 76' ' ' GLU . 82.3 t80 -65.29 -25.19 67.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.095 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.92 -21.86 65.1 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.226 0.536 . . . . 0.0 110.523 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.75 -2.34 34.03 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.012 -177.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.459 ' HG3' HG12 ' A' ' 44' ' ' VAL . 10.2 tp10 -100.19 130.28 46.3 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 20.3 pttp -122.78 101.25 7.34 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.448 0.642 . . . . 0.0 111.068 -176.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 2.6 p -167.3 129.33 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.258 -177.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.5 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . . . -100.74 141.7 33.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.472 175.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.9 p -122.0 134.37 65.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.906 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.451 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 10.9 t -104.33 128.25 27.42 Favored Pre-proline 0 N--CA 1.438 -1.051 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 174.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.82 156.56 20.85 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.734 2.29 . . . . 0.0 111.553 176.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.0 t 85.95 -55.39 0.07 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.699 0.8 . . . . 0.0 110.681 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 15.9 p -87.32 -32.22 19.77 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 47' ' ' CYS . 16.6 m 68.96 76.26 0.24 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.233 174.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.485 HD23 ' HZ ' ' A' ' 31' ' ' PHE . 57.6 tp -133.56 143.75 48.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.627 175.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.446 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 36.2 mtm -132.42 138.26 47.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.578 -177.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -143.31 152.82 16.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.942 178.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.532 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 2.2 m-20 -70.87 153.3 42.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.648 0.261 . . . . 0.0 110.557 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.526 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 99.9 t -135.46 114.74 16.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.501 176.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.54 117.8 15.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.069 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 43' ' ' LYS . 51.5 p90 -111.7 164.86 12.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.819 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.609 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 15.0 t70 -131.74 159.05 39.56 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.355 177.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.75 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 9.2 mptt -58.74 -44.1 90.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.473 178.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -75.53 -37.27 60.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.987 -176.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -62.1 -39.74 93.49 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.671 177.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 80.7 mt -68.83 -44.23 73.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.468 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.36 -51.27 70.21 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.779 -176.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -70.89 -33.39 70.53 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.362 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.672 ' HE1' ' HB2' ' A' ' 14' ' ' PHE . 56.4 t80 -67.16 -35.71 80.27 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.208 176.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.458 ' HA ' HD12 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -52.52 -46.1 66.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.623 174.269 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -71.51 -43.85 65.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.014 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -72.82 -34.11 66.64 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB1' ' HA ' ' A' ' 19' ' ' GLN . . . -83.05 -17.4 43.38 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.147 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.29 54.52 4.69 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.524 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.591 HG22 ' H ' ' A' ' 73' ' ' HIS . 3.7 mt -104.81 177.94 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.591 ' H ' HG22 ' A' ' 72' ' ' ILE . 13.3 m-70 -92.69 146.53 32.42 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 176.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.481 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 19.2 Cg_endo -57.33 126.23 21.38 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.659 2.906 . . . . 0.0 114.479 -171.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 74' ' ' PRO . 6.0 Cg_exo -78.94 167.45 22.07 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.997 3.132 . . . . 0.0 110.428 169.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.731 ' HG2' ' HZ ' ' A' ' 39' ' ' PHE . 13.8 pt-20 -71.82 143.48 86.92 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.531 ' HG2' ' HB2' ' A' ' 82' ' ' ALA . 77.4 Cg_exo -48.81 137.45 27.37 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.05 2.5 . . . . 0.0 113.773 -170.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 pp -82.59 107.5 14.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.398 -175.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 56.66 11.99 1.01 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.344 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.94 152.36 24.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.796 -178.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.27 133.79 48.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.531 ' HB2' ' HG2' ' A' ' 77' ' ' PRO . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.121 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 121.2 0.524 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 p -97.55 151.3 20.18 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.118 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 53' ' ' MET . 12.3 p -74.09 112.57 10.35 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.944 175.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -95.27 -1.61 51.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.643 -171.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -143.19 171.92 13.43 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 44.3 tt0 -162.19 108.54 1.28 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -177.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.46 ' CD1' HG13 ' A' ' 54' ' ' ILE . 2.2 mp -119.67 151.26 22.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.385 -172.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -63.17 144.62 56.76 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 175.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.3 tt -60.54 -33.28 53.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.206 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.69 -27.82 62.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.209 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.453 ' HB3' HG22 ' A' ' 7' ' ' ILE . 17.8 t70 -73.57 -35.89 65.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.581 -176.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.465 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 81.4 mtp -69.2 153.76 43.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.479 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.1 m -82.12 113.22 19.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.82 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.498 ' HB2' ' CE1' ' A' ' 66' ' ' TYR . 33.4 p90 -77.5 138.73 39.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.946 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -113.5 88.98 14.17 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.47 -29.51 88.82 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.215 2.61 . . . . 0.0 113.901 -169.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.94 -32.52 73.02 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.883 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.473 ' HB2' ' HG2' ' A' ' 20' ' ' MET . 46.6 m-80 -105.02 1.38 28.55 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.466 -173.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 57.28 39.05 28.85 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.032 0.444 . . . . 0.0 110.383 -178.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.473 ' HG2' ' HB2' ' A' ' 18' ' ' ASN . 27.1 ptt? -137.71 170.66 15.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.934 0.397 . . . . 0.0 111.004 -175.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.522 ' HE1' HD23 ' A' ' 35' ' ' LEU . 52.8 m-85 -119.47 144.67 46.86 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.867 176.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 35.6 p -133.03 158.37 42.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.376 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.465 ' CD1' ' HA ' ' A' ' 12' ' ' MET . 4.5 t80 -141.31 129.52 12.21 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -57.7 119.43 6.68 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.985 2.457 . . . . 0.0 113.361 -175.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.465 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 17.3 t -133.21 131.8 21.86 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.304 176.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 25' ' ' CYS . 1.3 Cg_endo -85.31 117.83 1.87 Allowed 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.949 1.766 . . . . 0.0 111.487 173.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 28' ' ' GLY . 28.4 p -179.15 -47.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.648 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.45 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . 168.19 -25.4 0.12 Allowed Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.227 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.54 ' HB3' ' HG2' ' A' ' 48' ' ' PRO . 2.5 t70 -143.29 176.35 9.21 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -117.48 154.33 31.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.326 0.108 . . . . 0.0 110.769 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 22' ' ' THR . 94.3 m-85 -48.4 131.32 16.93 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.528 0.517 . . . . 0.0 111.342 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -127.15 126.87 43.64 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.977 -173.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.462 ' HB ' ' HA ' ' A' ' 45' ' ' ALA . 11.5 tt -148.84 136.4 13.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.321 176.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.448 ' O ' ' HG3' ' A' ' 38' ' ' MET . 91.3 m-85 -98.61 147.06 25.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.954 0.406 . . . . 0.0 111.36 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.522 HD23 ' HE1' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -65.62 -33.91 77.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.297 -178.244 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.79 -42.31 71.63 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.962 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -68.96 -40.53 78.85 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.97 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.448 ' HG3' ' O ' ' A' ' 34' ' ' TYR . 75.2 mtp -63.8 -31.39 72.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.342 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -72.94 -21.19 60.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.624 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -79.1 -6.78 57.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.221 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.08 -18.2 34.03 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.089 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 38' ' ' MET . 33.0 tt0 -94.62 135.09 36.49 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.688 ' HD2' ' HE1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -133.22 101.04 5.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.608 0.718 . . . . 0.0 110.983 -177.365 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 p -165.65 128.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.73 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.462 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . . . -100.07 135.86 40.85 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.004 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p -109.74 134.2 52.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.117 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.544 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 24.6 t -101.17 118.47 60.18 Favored Pre-proline 0 N--CA 1.433 -1.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.896 176.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.571 ' O ' ' HB3' ' A' ' 49' ' ' SER . 24.6 Cg_endo -65.38 156.54 62.79 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.397 2.065 . . . . 0.0 111.034 173.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.571 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 35.6 t 87.13 -56.91 0.04 OUTLIER 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.621 0.768 . . . . 0.0 111.035 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.0 p -92.96 -26.97 17.33 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.132 177.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.7 t 70.27 44.07 0.78 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.927 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 53' ' ' MET . 2.1 tt -101.33 136.22 41.54 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' A' ' 3' ' ' THR . 36.9 mtm -125.07 138.56 54.19 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 -177.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.46 HG13 ' CD1' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -140.45 155.39 23.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.865 178.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.557 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 15.1 m-20 -80.92 159.15 25.04 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.2 t -130.94 126.28 59.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.71 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.7 t -87.49 101.74 11.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.066 0.46 . . . . 0.0 110.642 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.688 ' HE1' ' HD2' ' A' ' 43' ' ' LYS . 47.5 p90 -104.48 164.72 11.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.418 -178.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.506 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 20.3 t70 -128.47 159.5 35.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.944 0.402 . . . . 0.0 110.72 175.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.815 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -59.95 -47.55 85.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.416 177.208 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.13 -36.9 80.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.501 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -69.87 -40.66 75.58 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.618 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 59' ' ' ASP . 42.8 mt -61.57 -44.81 96.34 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.73 177.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.17 -34.4 76.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.932 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -64.84 -54.07 36.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.701 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.498 ' CE1' ' HB2' ' A' ' 14' ' ' PHE . 77.0 t80 -65.0 -34.64 78.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.448 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.64 ' HD1' ' HB ' ' A' ' 72' ' ' ILE . 10.4 t80 -51.46 -47.14 63.21 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.165 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.81 -45.15 62.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.149 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.54 -43.89 88.53 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.12 -25.69 36.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.744 0.307 . . . . 0.0 111.407 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.95 59.06 2.51 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.64 ' HB ' ' HD1' ' A' ' 67' ' ' TYR . 18.4 mt -87.6 162.36 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.503 -0.349 . . . . 0.0 110.137 -176.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.4 ' N ' HG22 ' A' ' 72' ' ' ILE . 21.6 p-80 -61.2 146.25 88.79 Favored Pre-proline 0 C--O 1.232 0.164 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 9.4 Cg_endo -53.19 115.46 2.3 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.993 2.462 . . . . 0.0 111.8 176.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.597 ' HD3' ' CE1' ' A' ' 67' ' ' TYR . 86.1 Cg_endo -92.65 164.54 2.8 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.507 2.804 . . . . 0.0 112.595 -175.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 1.3 mp0 -74.55 138.26 74.25 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 76' ' ' GLU . 52.6 Cg_exo -53.34 144.3 50.12 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.27 2.647 . . . . 0.0 114.188 -172.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.664 HD12 ' HB3' ' A' ' 60' ' ' LYS . 45.3 pt -122.54 152.16 26.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.295 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.94 85.8 3.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.044 0.449 . . . . 0.0 110.341 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.97 -14.23 37.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.008 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -128.55 105.6 8.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.628 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.677 -0.678 . . . . 0.0 110.193 -179.651 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_